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Abstract 
 
 
The influenza virus hemagglutinin (HA) surface protein is a primary antigenic target for 
neutralization of viral infection. HA also mediates membrane fusion between the virus and a cell, 
which is the first critical step during infection. Traditional techniques to study infection 
neutralization by antibodies or the membrane fusion process rely on ensemble measurements, 
confounding the precise mechanism of infection neutralization and obscuring transient 
conformational intermediates. This dissertation describes advances made in a fluorescence 
microscopy-based single-particle fusion assay to overcome the limitations of ensemble 
measurements in these types of studies. Virus particles are labeled to visualize lipid mixing 
between a virus and a target membrane formed upon a glass or polymer support. Optionally, 
the viral lumen can be labeled to visualize the subsequent release of viral contents.  
Recently isolated antibodies recognizing highly conserved epitopes on the HA protein 
that are critical for the protein’s fusogenic capacity are able to neutralize infection from a broad 
range of influenza subtypes. Binding of these antibodies to a virus prior to inducing fusion with a 
target membrane resulted in inhibition of the fusion process, directly confirming one mechanism 
of infection neutralization. Fluorescently labeling the antibodies allowed for functional 
stoichiometric measurements that indicate a virion can be rendered non-fusogenic without the 
need for antibodies to bind and inactivate every HA present on the viral surface. A molecular 
model of fusion inhibition is proposed wherein coordination between neighboring HA is 
disrupted that leads to neutralization of the entire particle.  
Dissertation Advisor: Professor Antoine M. van Oijen Author: Jason John Otterstrom 
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Though polyunsaturated lipids are critical components of biological membranes that 
frequently undergo membrane fusion, their precise effects on the fusion process are poorly 
characterized. A fully automated data extraction program was designed and implemented to 
enhance the reproducibility of selecting fusing and non-fusing virions. Analysis of the resulting 
fusion kinetics revealed that the rate of fusion pore expansion is enhanced by high degrees of 
lipid unsaturation. During fusion at low pH, lower degrees of saturation resulted in the onset of a 
restricted hemifusion state. It is postulated that cholesterol and the HA fusion peptide create a 
molecular fence that confines lipid diffusion between the virus and target membranes.  
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Chapter 1  
Visualization of Membrane Fusion, One Particle at a Time 
 
Abstract 
Protein-mediated fusion between phospholipid bilayers is a fundamental and necessary 
mechanism for many cellular processes. The short-lived nature of the intermediate states visited 
during fusion makes it challenging to capture precise kinetic information using classical, 
ensemble-averaging biophysical techniques. Recently, a number of single-particle fluorescence 
microscopy-based assays have been developed that allow researchers to obtain highly 
quantitative data on the fusion process by observing individual fusion events in real time. These 
assays depend upon changes in acquired fluorescence signal to provide a direct read out for 
transitions between the various fusion intermediates. The resulting data yields meaningful and 
detailed kinetic information on the transitory states en route to productive membrane fusion. In 
this review, we highlight recent in vitro and in vivo studies of membrane fusion at the single-
particle level in the contexts of viral membrane fusion and SNARE-mediated synaptic vesicle 
fusion. These studies afford insight into mechanisms of coordination between fusion-mediating 
proteins as well as coordination of the overall fusion process with other cellular processes. The 
development of single-particle approaches to investigate membrane fusion and their successful 
application to a number of model systems has resulted in a new experimental paradigm and 
opens up considerable opportunities to extend these methods to other biological processes that 
involve membrane fusion. 
 
Material in this chapter was originally published in the journal Biochemistry: 
Otterstrom, J. & van Oijen, A.M. (2013) Visualization of Membrane Fusion, One Particle at a 
Time. Biochemistry 52: 1654-1668. 
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1.1 Introduction 
Membranes comprised of phospholipid bilayers are essential for all cellular life.  They 
encapsulate cytoplasmic components, allow for enrichment of metabolites and restrict the entry 
of foreign pathogens and damaging chemicals. Further, eukaryotes have developed inner 
membranes to form organelles that allow for compartmentalization of metabolic and replicative 
processes.  At times, though, this resolute barrier must be perturbed, broken and subsequently 
reformed – namely, membranes must fuse.  While the final state of fully merged membranes 
from two initially separate bilayers is an energetically favorable one, there are many energetic 
barriers that must be overcome to achieve this final fused state.   
Membrane fusion generally occurs through a series of steps including close bilayer 
apposition, fusion of the proximal leaflets– termed hemifusion – and finally merger of the distal 
leaflets – termed pore formation [1,2].  These metastable intermediates along the fusion 
pathway are depicted in Figure 1-1 and can be experimentally probed, as will be discussed in 
this review. Significant energetic barriers separating these intermediates make the energetic 
landscape a rough terrain to traverse.  Dehydration of a limited area between two closely 
apposed bilayers, formed by a fusion dimple or point-like protrusion, poses the first sizeable 
energy barrier [2,3].  Formation of a hemifusion stalk (Figure 1-1B) is also energetically 
expensive, with an energy barrier to formation that can be on the order of ~20-40 kBT (12-24 
kcal/mol, where 1 kBT ≈ 0.6 kcal/mol) [1,2,4].  The hemifused state can progress in two 
directions: it can develop into a full fusion pore that allows mixing of the contents initially 
separated by the two bilayers (Figure 1-1C); or it can become an extended hemifusion 
diaphragm that is a kinetic dead end and prevents content mixing [6].  In addition, alternative 
pathways could supplant the lipidic hemifusion stalk with a nascent proteinaceous pore that 
subsequently develops into a full lipidic fusion pore [5,7].  Moreover, the initial fusion pore is not 
necessarily a stable structure and work is required to drive it open [5].  If a nascent fusion pore  
3 
 
  
Figure 1-1 – States of protein-mediated membrane fusion that are accessible by fluorescence 
microscopy.  A) Two bilayers (red and black) are in close apposition and separate two luminal 
compartments (blue and grey, respectively). Fusion proteins (brown cylinders) in their extended 
conformation couple the two bilayers and are formed following unfolding of a viral surface fusion 
protein or v-SNARE–to–t-SNARE interaction during docking of a synaptic vesicle.  B) The initial 
refolding of fusion proteins back upon themselves brings sections of the two membranes into 
yet closer apposition and facilitates the onset of hemifusion, which is an intermediate state 
characterized by merger of the proximal leaflets from each of the two bilayers.  In this state, lipid 
molecules are able to exchange between the two proximal leaflets, as indicated by mixing of the 
red and black lipids.  C) Additional fusion protein rearrangements cause full fusion, a state 
characterized by merger of the distal leaflets and the formation of a pore connecting the two 
previously separated compartments to allow content mixing.  In the case of viral fusion, pore 
formation creates a corridor the viral genome can pass through, while in SNARE-mediated 
fusion the fusion pore may be closed before all contents have been released.    
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is prone to collapse, what is the lifetime of a pore and what pore size can be obtained before 
collapse occurs?  If a hemifusion intermediate is formed, what factors determine if it will 
productively develop into a full fusion pore and what is the lifetime of such a hemifused state?  
These aspects of fusion kinetics are of key importance for the proper functioning of a fusogenic 
system and any biological situation driving membrane fusion must evolve to form a stable fusion 
pore of appropriate size. 
Two biological solutions to overcome these energy barriers and traverse the 
intermediate fusion states have been well characterized structurally and functionally: fusion 
proteins on the surface of several enveloped viruses and eukaryotic soluble NSF attachment 
protein receptor (SNARE) proteins.  These transmembrane proteins confer fusogenic capacity 
to the viruses or synaptic vesicles, respectively, that house them.  Recent technological 
advances in fluorescence microscopy have facilitated sensitive and detailed studies of protein-
mediated fusion events at the single-particle level – a single particle in this context being a 
macromolecular object comprised of phospholipids and fusion-mediating proteins, e.g. 
enveloped viruses or vesicles incorporating SNARE proteins, which is appropriately labeled for 
visualization on a fluorescence microscope.  Observing individual fusion events is essential for 
gaining access to the intermediate states visited during membrane fusion and transitions 
between them.  These states are often short-lived and inaccessible to bulk membrane fusion 
studies, where only average kinetic characterization is possible and individual or rare events are 
obfuscated.  Furthermore, the single-particle based experimental designs can (partially) 
overcome technical problems such as vesicle aggregation, bursting or leakiness that are often 
obstacles in bulk phase fusion experiments.  This review aims to highlight a number of recent 
experimental methods used to investigate membrane fusion at the single-particle level.  These 
new approaches are allowing direct visualization of fusion intermediates, and a probing of 
stimuli and conditions governing their behavior. 
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1.2 Fluorescence as a reporter for fusion  
Fluorescence microscopy has proven a revolutionary tool for study of biological systems 
by simultaneously allowing real-time observation, low invasiveness and high specificity.  
Systems to study membrane fusion can be based on individual live cells or on purified, 
individual fusogenic particles (i.e., liposomes or viruses) re-constituted into a controlled fusion 
scenario. Fluorescent probes used in single-particle fusion studies are typically either small-
molecule organic dyes or fluorescent proteins.  Organic dyes are frequently used in membrane 
fusion studies because these can be used to label the lipid-membrane substrates in a 
straightforward manner.  Lipids coupled to bright fluorophores can be mixed with reconstituted 
lipids when used in vitro and can spontaneously insert into biological membranes, such as those 
of intact viruses, and achieve high local concentrations.  Commonly used fluorescent lipophilic 
probes (Table 1) include long-chain dialkylcarbocyanine dyes such as DiD and DiI, and dyes 
having phosphoethanolamine (PE) head groups such as tetramethylrhodamine (TMR-PE or 
TRITCH-PE), octadecyl-rhodamine B (R18), lissamine rhodamine B (Rh-PE), or Texas-red-PE 
(Rh-PE).  These lipophilic dyes provide a direct read-out for lipid mixing between two bilayers, 
either through dequenching or FRET (Förster or Fluorescence Resonance Energy Transfer) 
(Figure 1-2).  It is of critical importance, however, to realize that lipid mixing is not necessarily a 
direct read-out for full fusion.  Full fusion, characterized by a lipidic fusion pore, requires 
separate fluorescent measurement to detect transfer of content after the formation of a pore. 
Various steps in the fusion pathway can be visualized using fluorescence reporters of 
lipid and content mixing; three such visualization strategies are depicted in Figure 1-2.  When 
the lipophilic dyes are incorporated into a bilayer at a sufficiently high concentration, their tight 
molecular packing can cause quenching of fluorescence by relaxation of an excited dye through 
a non-photon emitting process.  When labeled and unlabeled membranes fuse, the lipids rapidly 
re-distribute from the labeled into the unlabeled membrane, decreasing the local concentration 
of the dye molecules in the labeled membrane.  This dilution alleviates the neighbor-neighbor  
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Table 1-1 – Fluorescent Dyes for Visualizing Membrane Fusion 
Fusion Event Type Fluorescent Label Detection  Signal 
a
 
Lipid mixing 
(hemifusion) 
in vitro R18 Dequenching [48] 
Rh110 
b
 Dequenching [38] 
TMR-PE or  
TRITCH-PE 
e
 
Dequenching [57, 58] 
Rh-PE Dequenching [80] 
Dissipation [55] 
DiD Dequenching [11,12] 
DiD + DiI FRET increase [84] 
in vivo DiD Dequenching [61] 
Dissipation [64] 
Content mixing  
or release  
(pore formation) 
in vitro SRB Dissipation [38,48] 
Dequenching [11,12] 
Fluorescein 
c
 Dissipation [48] 
Calcein Dequenching [10] 
DNA hairpin FRET decrease [91,93] 
in vivo Palmitylated  
YFP 
c, d
 
Dissipation and  
Recovery [65] 
Cleaved GFP 
fusion 
c
 
Dissipation [64] 
FM1-43 Dissipation [106] 
FM4-64 Dissipation [20] 
Quantum Dots 
c, d
 Fluorescence increase 
or loss [108] 
a Selected references only; not a complete listing. 
b Not commercially available. 
c
 
pH-sensitive, which might be observed when it is used. 
d
 Not released upon 
partial pore opening. 
e
 Reported to visualize both inner and outer leaflet fusion. 
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quenching and results in a rapid fluorescence increase known as dequenching (Figure 1-2A).  
Detection of this signal is a common indicator for the creation of the hemifusion intermediate 
and has been described as a ‘flash’ [8].  R18, in particular, is a commonly used dye to detect 
lipid mixing because it does not rapidly redistribute between closely apposed membranes in the 
absence of (hemi)fusion and unincorporated dye can easily be removed [9].  The formation of a 
fusion pore can be directly read out through dequenching of a content label contained within 
vesicles or liposomes.  Calcein [10] and Sulforhodamine B [11,12] (Table 1) exhibit a strong 
degree of quenching at high concentration and when the labeled vesicle or liposome contents 
mix with unlabeled buffer a dequenching spike similar to that observed for hemifusion can be 
visualized.  Both dyes are charged compounds and can leak from labeled liposomes, so care 
should be taken to ensure that leakage does not affect experimental outcomes. 
The dyes DiD and DiI can be used as a FRET pair (Table 1), wherein the green-emitting 
DiI is excited by appropriate illumination and its emission is transferred through non-radiative 
resonance to DiD neighbors, which then emit a photon.  This process is highly distance 
dependent and can be observed as an increase in red emission with a concomitant decrease in 
green emission once lipid mixing between two apposed membranes has occurred (Figure 1-
2C).  This technique is commonly used in bulk lipid mixing studies, but has also been applied to 
single-particle fluorescence microscopy studies.   
The advantage of small, organic dyes is their superior photostability and brightness in 
comparison to fluorescent proteins.  These benefits generally come with the difficulty of applying 
them to specifically label a protein or structure of interest in vivo.  Techniques for applying this 
type of labeling are nicely reviewed elsewhere [13-15] as is the applicability fluorescent proteins 
for the labeling of lipid membranes [16-18].  Synaptic and secretory vesicles are exceptions to 
this generality, however, and the exogenous addition of styryl pyridinium dyes can label these 
structures in vivo with good specificity and selectivity.  These types of dyes rapidly insert into the 
outer leaflet of bilayers in a reversible fashion and concomitantly exhibit an increase in fluor- 
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Figure 1-2 – Visualizing membrane fusion through fluorescence signals.  Labeled and surface-
immobilized fusogenic particles are depicted on the left of each panel.  Grayscale images, as 
captured on a CCD camera, and 3D fluorescence profiles above those images show how the 
recorded and peak intensity, respectively, of a particle’s fluorescence signal change through the 
time-course of fusion at a fusion site.  Quantifying the fluorescence intensity present in the CCD 
images provides “intensity vs. time” diagrams.  A) Dequenching upon hemifusion to a large, 
planar bilayer (black) with outward diffusion of lipophilic dyes (red) from the fusion site.  When 
the dequenching signal arises from content mixing of two vesicles, as done by Kyoung et al. 
[11], diffusion away from the site of fusion is not possible.  B) Dissipative fluorescence loss upon 
escape of an aqueous fluorescence signal (purple) from the lumen of a fusogenic particle 
through the fusion pore. A similar fluorescence signal is obtained for lipid mixing when 
dequenching does not occur.  C) FRET-based detection of hemifusion between two immobilized 
and labeled fusogenic vesicles (red and cyan).  Independent excitation of acceptor and donor 
dyes allows for visualization of each of the overlapping vesicles.  Only after fusion is the 
acceptor vesicle visualized via donor dye excitation, producing a high FRET efficiency signal. 
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(Figure 1-2 Continued) 
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escent brightness within a bilayer’s hydrophobic interstice.  Dyes such as FM1-43 and FM4-64 
are commonly used to visualize these types of vesicles, which then appear as punctate 
structures within neuronal or secretory cells.  Fusion events are detected as a loss of signal 
from a fluorescent punctate as the dye molecules departition from the membrane and both 
escape through small fusion pores [19] and become dispersed into the plasma membrane [20].  
Since the entire plasma membrane is labeled in this technique, there are fluorescent 
background and potential phototoxic effects that must be taken into account. 
Fluorescent proteins (FP) make up for their comparatively poor photostability and 
brightness with their in vivo specificity.  A majority of the common fluorescent proteins are 
monomeric and can be genetically encoded as in-frame fusions with a protein of interest at 
either the N- or C-terminal or even within a flexible loop.  Recent reviews [21-24] provide 
detailed overviews of fluorescent proteins, their properties, uses and pitfalls.  One particular 
characteristic of fluorescent proteins that has been exploited in the study of membrane fusion is 
their pH sensitivity (Table 1).  Generally, fluorescent proteins lose fluorescence brightness 
gradually as the pH decreases to acidic conditions, but maintain ~50% of their brightness down 
to ~pH 5.0.  To leverage this effect for the study of secretory and synaptic vesicle dynamics, 
Miesenböch et al. [25] engineered green fluorescent proteins to have increased pH sensitivity.  
Their ‘pHluorin’ mutants displayed a marked change in either the excitation spectrum or 
fluorescent brightness upon neutralization of an acidic synaptic vesicle following fusion with the 
plasma membrane. 
 
1.3 Fluorescence microscopy 
Common fluorescence microscope designs for the study of membrane fusion kinetics 
are the epifluorescent and total internal reflection fluorescent (TIRF) microscopes.  Both are 
wide-field microscopy techniques since they illuminate a large field of view (FOV) continuously.  
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Modern electron-multiplying charge coupled device (EM-CCD) cameras are able to image the 
fluorescence from large FOVs at high frame rates and with single-molecule sensitivity.  
In epifluorescence microscopy, the excitation light propagates through the entire sample, 
causing fluorescence in any of the vast number of molecules it may come across.  This 
illumination strategy gives great penetration depth for imaging, but produces a high background 
that can quickly degrade the signal-to-background ratio in an image.  TIRF microscopy, in 
contrast, selectively illuminates only a very thin region, with a thickness of approximately 100 
nm, immediately above the glass substrate surface.  The exclusion of background fluorescence 
from elsewhere in the sample results in a high signal-to-background ratio for fluorescent 
molecules within the excitation volume at the expense of low penetration depth.  The physical 
explanation for this effect and guidelines for construction of a TIRF microscope are nicely 
described elsewhere [26-28].  TIRF microscopy is particularly useful for the study of membrane 
fusion events because the plasma membrane of many cell types can be brought within the TIR 
illumination volume.  Confocal microscopes can also be used, where the light is focused into a 
diffraction-limited volume or “spot” rather than illuminating a large volume of the sample.  
Images are obtained by raster-scanning the confocal volume throughout a defined FOV and the 
fluorescence information collected with a photomultiplier tube or photo diode.  Fluorescence 
emanating from outside the focal volume of interest is eliminated to provide images with a high 
signal-to-noise ratio and low background.  Even though full images are acquired at a much 
lower time resolution, the signal from one particular spot can be followed with sampling rates 
orders of magnitude higher than with wide-field imaging techniques. 
These microscopy techniques allow for a range of temporal resolutions (Table 2), but the 
spatial resolution is generally dictated by the diffraction limit of ~300 nm.  If sufficient photons 
are collected and the fluorescent particle is a point source with dimensions smaller than the 
diffraction limit, then the particle’s position can be determined to ~1-2 nm accuracy [29], which is 
useful for particle tracking.  Super resolution imaging (i.e. STORM, PALM, etc., reviewed in [30])  
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Table 1-2 – Novel and Notable Single-Particle Experimental Setups for Visualizing Membrane Fusion 
Type Experimental design Microscope Setup 
a
 
Time 
Resolution 
Advantages Limitations 
in vitro SLB-based 
membrane 
fusion 
Docking under  
fusogenic  
conditions 
TIRFM  
[10,47,55] 
1− 100 ms Simultaneous lipid and 
content mixing obser-
vation. 
SLB formation, stability, 
reproducibility. 
Pre-docking 
with fusion 
trigger 
TIRFM  
[38,48] 
100 − 1000 ms Simultaneous lipid and 
content mixing obser-
vation; trigger to fusion 
event time extraction. 
SLB formation, stability, 
reproducibility. 
Tethered 
vesicle− 
vesicle 
fusion 
Pre-docking 
with fusion 
trigger 
TIRFM  
[11,12,84] 
100 − 900 ms Simultaneous lipid and 
content mixing obser-
vation; trigger to fusion 
event time extraction. 
Small number of observa-
tions per experiment 
because of two-body 
binding. 
Confocal  
[92] 
200 − 1000 ms Simultaneous lipid and 
content mixing observa-
tion; potentially larger 
FOV. 
Time resolution depends on 
the size of the FOV. 
in vivo Viral tracking  
within a 
target 
cell 
Temperature- 
or pH-
synchronized  
fusion 
Confocal  
[64,68] 
6 − 8 s Trigger to fusion event time 
extraction 
b
; simultaneous 
lipid and content mixing 
observation; amenable to 
labeling of other cellular 
proteins; three dimen-
sional tracking; potentially 
larger FOV. 
Time resolution depends on 
the size of the FOV; small 
number of observations 
per experiment. 
  Epifluorescence or 
TIRFM  
[69,71,72] 
0.5 − 10 s Simultaneous lipid and 
content mixing observa-
tion; obtain waiting time 
between trigger and fus-
ion events 
b
; amenable to 
labeling of other cellular 
proteins. 
Small number of observa-
tions per experiment. 
Synaptic 
vesicle  
fusion in 
live  
neurons 
Styryl dye 
labeling 
Epifluorescence  
[106,110] 
15 − 36 ms Fluorescent dye can und-
ergo endocytotic recy-
cling; potentially 
amenable to labeling of 
other cellular proteins. 
Whole cell, nonspecific lab-
eling; potential for high 
fluorescence background 
and phototoxicity. 
 Quantum dot  
labeling 
Epifluorescence  
[108] 
33 − 300 ms Direct observation of mult-
iple kiss-and-run fusion 
events; extended obser-
vation with minimal 
photobleaching. 
Broad quantum dot emis-
sion spectra limit labeling 
of other cellular proteins; 
quantum dots exhibit 
higher cellular toxicity 
than dyes or FP; high 
phototoxicity at long 
observation times. 
 pHluorin 
fusion-  
protein 
labeling 
Epifluorescence  
[111] 
9.6 ms Specific labeling of synaptic 
vesicles by SNARE prot-
ein; amenable to labeling 
of other cellular proteins. 
High fluorescence back-
ground; rapid photo-
bleaching. 
a
 Selected references only; not a complete listing. 
b
 Trigger refers either to a synchronizing event or to a change in pH when pH-sensitive 
FP are attached to virions. [68,69] 
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could be used in conjunction with single-particle tracking to precisely localize fusion events 
within a cell, though this has yet to be demonstrated.  
 
1.4 Supported lipid bilayers 
Many in vitro studies of membrane fusion make use of artificial lipid bilayers supported 
by a solid substrate.  Several techniques exist to construct these supported lipid bilayers (SLB) 
and have recently been reviewed for a wide range of applications by Czolkos et al. [31] and 
Richter et al. [32].  For microscopy purposes, they are formed upon the surface of a cleaned, 
hydrophilic glass or quartz substrate and, in many cases, can allow for the incorporation of 
functional transmembrane proteins.  The most common techniques to form SLBs are through 
vesicle rupture and self-spreading [33] and through successive transfer of two phospholipid 
monolayers using a Langmuir-Blodgett approach [34].  In its simplest implementation, the 
former technique requires incubation of a lipid solution with a solid, hydrophilic support, while 
the latter is more involved and involves sequential transfer of the two phospholipid monolayers.  
SLBs can also be formed upon a polymer cushion (such as polyethylene glycol, PEG [35,36]) or 
tethered to the solid substrate (such as with DNA, [35,37]) with the goal of creating a (mostly) 
aqueous volume that entirely separates the bilayer from the substrate’s surface.  High-molecular 
weight dextran has also been used as a cushion suitable for conducting single-particle viral 
fusion experiments [38], expanding on a technique that had been previously reported [39]. The 
practical difficulty in reproducibly creating fluid and continuous SLBs using these methods 
necessitates further work in optimizing surface chemistry. 
 
1.5 Viral membrane fusion 
Influenza hemagglutinin (HA) is the most intensively investigated of all the viral fusion 
proteins.  The structural and functional aspects of HA have been thoroughly discussed in 
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several publications [40-43].  Briefly, HA is a class I trimeric fusion protein, with each monomer 
containing the two disulfide-linked HA1 and HA2 domains.  HA thereby combines the domains 
responsible for receptor binding (HA1) and fusion (HA2) into a single protein machine.  During 
clathrin-mediated endocytosis, the HA2 domain responds to acidification of the endosomal 
lumen by undergoing a conformational unfolding into an extended rod-shaped protein consisting 
of a 3-helix bundle of coiled alpha helices.  The critical pH for this unfolding step is ~pH 5.5 for 
most influenza strains.  Unfolding exposes the hydrophobic N-terminus of HA2, termed the 
fusion peptide, which inserts into the proximal leaflet of the target bilayer.  When the HA2 
refolds back upon itself, the fusion peptide serves as an anchor to bring the target membrane 
into close proximity of the viral envelope.  This action facilitates fusion of the proximal leaflets of 
the two bilayers (Figure 1-1) into a hemifusion structure.  The distal leaflets are merged by 
subsequent re-arrangements of the HA2 transmembrane domain, thereby creating a fusion pore 
for escape of viral contents into cellular cytosol.  The three major classes of viral fusion proteins 
are all trimeric in their fusion-active state and are thought to follow the overarching scheme 
described here for HA [42].  The unfolding event is not necessarily pH-dependent, though, and 
can occur at neutral pH for some virus types.   While these structural rearrangements required 
of HA2 and other fusion proteins to mediate fusion are widely accepted, there is much debate 
regarding the number of activated trimers on the viral surface required to act in concert for the 
fusion process to occur. 
 
1.5.1 Single-particle viral fusion kinetics studied in vitro 
Several decades of fluorescence-microscopy studies of HA-mediated fusion have 
contributed significantly to our understanding of the intermediate states and molecular 
processes that occur en route to viral membrane fusion.  These studies have principally 
implemented two strategies: cell-cell fusion using HA-expressing cells, and single-particle virus-
target or virosome-target fusion.  In the single-particle context of this review, we will focus on the 
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latter of these techniques, though this is not to downplay the many insights into HA-fusion and 
membrane fusion in general provided by studies of cell-cell fusion with fluorescence 
microscopy. 
Target membranes used to study HA-mediated fusion (Figure 1-3A and 3B) at the 
single-particle level are formed by different techniques.  The earliest single-particle studies used 
intact erythrocytes [44,45] or black lipid membranes (BLM) [8,46] as targets for fusion.  A BLM is 
a small circular patch of lipid bilayer painted onto a small hole in a Teflon sheet that serves as 
an aperture to support the bilayer at its edges.  More recent studies were based on the 
formation of glass- or quartz-supported lipid bilayers through incubation with vesicles [38,47,48], 
as described above, or on the immobilization of erythrocytes to a glass surface and rupturing 
them to leave an adhered cellular SLB [49].   
Intact and infectious influenza virions can be readily labeled with high concentrations of 
the self-quenching red-emitting dye R18 [50] without compromising infectivity.  A similar 
octadecyl-rhodamine 110 (Rh110), a green-emitting lipophilic dye, has also been used to 
monitor hemifusion [38], though it is not commercially available.  Viral contents can be 
exogenously labeled with sulforhodamine B (SRB) [38] or with pH-sensitive fluorescein [48] by 
overnight incubation of the virus particles with high concentrations of the dyes.  Loss of these 
content signals during the fusion process (Figure 1-3B) indicates the opening of a fusion pore 
large enough for the dye molecules to pass through (SRB or fluorescein) or the acidification of 
the viral lumen (fluorescein).  HA-mediated fusion events are visualized by first immobilizing the 
intact and labeled virus onto the target membrane, followed by synchronously inducing fusion 
through a rapid pH drop (Figure 1-3B).  Kinetics are extracted as the elapsed time between 
acidification and the dequenching event for hemifusion, or the time passed between pH drop 
and loss of content fluorescence for pore formation or acidification.   
Floyd et al. [38] found that upon decreasing the pH from neutral to a range of pH 4.5-5.3 
the rate of hemifusion rapidly becomes faster with lower target pH.  When the pH is lowered  
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Figure 1-3 – Observing membrane fusion in vitro utilizing fluorescence.  Fusogenic proteins are 
drawn as light brown half-cylinders and docking elements, such as t-SNARE proteins or 
receptor molecules, are drawn as complementary half-cylinders. Lipophilic dye labeling is 
shown in red and content labeling is shown in purple. A) Observation of the transitions from 
particle docking to hemifusion as implemented by Wessels et al. [47] and others [10,55-58].  
Kinetics obtained are: the residency time between docking and the dequenching fusion signal, 
tRes, the 2-dimensional diffusion constant of the lipophilic dye away from the site of fusion, and, 
in some instances, the time between fusion and the onset of outward dye diffusion, tDelay.  B) 
Transitions from triggering fusion to full fusion with a polymer cushion-supported (black mesh 
below lipids) planar bilayer as implemented by Floyd et al. [38].  Kinetics obtained are: time 
between fusion trigger and hemifusion, tH; the time between trigger and full fusion, tF; and the 
time between hemifusion and full fusion, tHL, which is the lifetime of the hemifused state.  C) 
Transitions from triggering fusion to full fusion to an immobilized target vesicle as implemented 
by Kyoung et al. [11].  In contrast to (A) and (B), immobilization is achieved through avidin-biotin 
(brown rectangles and green cones, respectively) interaction rather than through a fusion-
related interaction.  Accessible kinetics are similar to those in (B). 
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(Figure 1-3 Continued) 
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below 4.5, the rate of hemifusion plateaus and is no longer pH dependent.  These results 
confirm a trend initially described by Niles & Cohen [46], but do so with greater sensitivity, 
greater delineation of receptor binding and fusion, and more robust statistics.  In the 
experiments by Floyd et al., the onset of acidification was directly read out as a loss of 
fluorescence signal from a buffer-exposed pH-sensitive fluorescein dye that was bound to the 
target membrane.  The waiting-time distributions between the pH drop and the onset of 
hemifusion showed a clear rise and decay, indicative of multiple biochemical intermediate steps 
[51,52].  Modeling the waiting times with a gamma distribution allowed for an estimation of both 
the velocity of the rate-limiting step in the process and the number of rate-limiting steps that are 
required for hemifusion to occur.  While the rate of fusion in the pH-dependent regime varied 
from 0.03-0.3 s-1, the number of rate-limiting steps remained constant at approximately three.  
This result was interpreted to be that three HA trimer molecules are required to undergo 
conformational unfolding and re-folding to mediate hemifusion.   
A requirement for three HA trimers to undergo a conformational change and coordinate 
their actions for fusion to occur was in agreement with theoretical estimates [53], which were 
based on electrical admittance measurements for fusion of HA-expressing cells with a SLB [54].  
A previous study by Imai et al. [49] followed the hemifusion kinetics in a similar fashion while 
varying the concentration of fusion-active HA present on the surface of reconstituted virosomes.  
With the assumption that assembly of a number, n, of fusogenic HA trimers would be the rate-
limiting step in the kinetics, they fit their data to a function of V = k[HA1,2]
n, where V is the fusion 
rate and ‘k’ is a constant, to obtain n = 0.9±0.4.  They interpreted this to indicate that a single 
HA trimer was necessary and sufficient to mediate fusion, though the waiting-time distributions 
between acidification and hemifusion showed clear rise-and-decay characteristics.  A 
subsequent re-analysis of their waiting time distributions [59] found that their kinetic data was 
identical to that of Floyd et al. [38] and corroborated the need for three HA trimers to undergo 
conformational refolding.  Unfolding of the HA trimer (i.e., the loop-to-helix transition) has been 
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calculated to liberate ~125 kBT (75 kcal/mol) of free energy [60].  If three trimers unfold, only a 
fraction of the total free energy liberated would need to be recaptured to overcome the initial 
energetic barrier to hemifusion [42].   
Wessels et al. [47] observed hemifusion of influenza and Sindbis (an alphavirus with a 
pH-sensitive Class II fusion protein) viruses by first mixing them with acidic solution, then 
exposing them to a target bilayer lacking receptor molecules (Figure 1-3A).  In this experimental 
configuration, the fusion proteins unfold in the absence of a bilayer.  Exposure of their 
hydrophobic fusion peptide/loop causes them to briefly immobilize upon the bilayer just prior to 
fold back and fusion.  The viruses were found to differ in residency time between bilayer 
interaction and fusion.  For influenza, the residency time was constant regardless of conditions.  
For the Sindbis virus, on the other hand, the residency time varied as cholesterol and 
sphingomyelin were added to the phosphatidylcholine/phosphatidylethanolamine target bilayers.  
Separately, the Sindbis residency time also varied with pH, increasing five- to ten-fold as 
conditions were progressively made more acidic.  Hence, viruses can exhibit varied kinetic 
behavior and dependencies starting from a situation in which the fusion proteins have already 
unfolded and only fold-back is necessary.   
Fusion completion by the opening of a full fusion pore, allowing viral content release, 
was also studied by Floyd et al. [38] who employed a dual-labeled virus (rhodamine-110 lipid 
dye in combination with SRB content dye).  The aforementioned hemifusion kinetics were used 
in conjunction with the waiting time between acidification and content signal dissipation to probe 
the lifetime of the hemifused state that exists prior to the opening of a full fusion pore (Figures 
1B, 1C and 3B).  They found that lipid mixing preceded content release and the elapsed time 
between the two events as measured for individual particles provided a direct measure of the 
hemifusion lifetime.  The dwell-time distributions for these lifetimes were well described by a 
single-exponential distribution for the full range of pH 3.5 – 5.3, indicating that only a single rate-
limiting step gave rise to full membrane merger after hemifusion was established. Importantly, 
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the transition from the hemifusion intermediate to pore opening is difficult to access by bulk 
fusion techniques. 
A recent study using viral content labeling by Ivanovic et al. [48] compared the rate of 
SRB signal loss to that of signal loss from the pH-sensitive dye fluorescein.  The latter allowed 
for a measurement of the kinetics for acidification of the viral lumen, mediated by the influenza 
integral membrane proton pump, M2.  Acidification of the viral interior is a critical step for 
release of the viral genome from the structural matrix protein, and internal acidification was 
hypothesized to take place prior to fusion.  Two time points were identified in the single-particle 
acidification study: the time to onset of internal virus acidification following the external pH drop; 
and the time from the onset of internal acidification to loss of half the fluorescent signal, termed 
the dissipation time.  The time to onset and to dissipation were compared for the fluorescein and 
SRB content label and showed that internal viral acidification precedes fusion pore opening, 
occurring on average about 100 seconds earlier at a target pH of pH 4.5.  Using the dissipation 
time of the fluorescence signal, the authors estimated that the M2 channel transferred between 
100 – 400 protons/second into the viral lumen prior to pore opening.  Adding the M2 channel-
blocking molecule Rimantadine caused the fluorescein loss to become kinetically 
indistinguishable from SRB loss, suggesting that with inhibited M2, internal acidification took 
place only after pore formation. Further, the kinetics of SRB loss were indistinguishable from 
those measured in the presence of fully active M2 proton channels. This observation 
established that there was no effect of acidification of the matrix on the kinetics of pore 
formation. 
 
1.5.2 Single-particle viral fusion kinetics in living cells (in vivo) 
Visualization of the fusion between a virus and a cellular target in living cells (in vivo) 
provides insight into how viral fusion proteins mediate fusion during the initiation of infection in 
their intended environment.  Of great interest and importance is the cellular location where and 
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the conditions under which membrane fusion occurs for the infection process to functionally 
begin.  These initial steps are well characterized for some viruses, such as influenza, while they 
are contested for others, such as HIV-1.  It is advantageous that in these studies the virus is 
necessarily added exogenously and so can be labeled and manipulated independent of the 
target cellular system.  The bright lipophilic dye DiD is often used to label the envelope of a 
number of viruses types, such as influenza, HIV, murine leukemia virus (MLV), and avian 
sarcoma leucosis virus (ASLV).  In some cases, it incorporates to a degree sufficient for 
dequenching upon membrane fusion [61-63], or can report fusion through disappearance of the 
fluorescent signal upon near infinite dilution into large cellular membranes [64-66,66]. 
Measuring fusion kinetics requires a synchronization time point from which the time until 
lipid mixing (hemifusion) can be measured (Figure 1-4A).  A sudden temperature jump starting 
in a range of 4ºC to 18ºC and rising rapidly to 37ºC has served as synchronization in numerous 
experiments [61,64,67,68].  Acidification of the extracellular buffer can force pH-dependent viral 
fusion at the plasma membrane [65]. Alternatively, incubation with ammonium chloride can be 
used to neutralize all cellular compartments followed by its removal to allow endosomal 
acidification, thus synchronizing the fusion of internalized virions [69].  Acidification of individual 
endosomes harboring and transporting viruses can be directly measured by incorporating 
transmembrane domain-associated GFP proteins to the viral envelope [68,69].  Detection of a 
pH-drop and subsequent fusion allows for direct kinetic measurements to be made en route to 
infection, akin to in vitro measurements for extraction of pH dependencies.   
Tracking the location of a labeled virus particles has provided valuable information 
regarding entry, subsequent trafficking and egress of new virus particles.  These results have 
been reviewed by Brandenburg & Zhuang [70], along with a discussion of additional labeling 
techniques and pitfalls.  The relevance of trafficking behavior to viral membrane fusion was first 
described by Lakadamyali et al. [61] who followed the movement of intact influenza virus 
following endosomal internalization.  The authors describe a three-stage transport process in 
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which the virus is first bound to the cell periphery with a low degree of mobility, and then 
suddenly undergoes a unidirectional, rapid movement toward the cell nucleus (Figure 1-4A).  
This transport behavior is most often tightly coupled with clathrin-coated pit formation [62].  
Finally, the virus experiences intermittent back-and-forth movement finally terminating in 
membrane fusion with the endosome in the perinuclear region of the cell.   
Trafficking of intact dengue virus [63] and ASLV-Env pseudoviruses [66,68] also gave 
rise to such a three-stage transport behavior, indicating it may be a general pathway followed by 
viruses during endocytosis.   Pseudoviruses are particles having surface proteins from one virus 
type and a core from a second virus type, for instance HIV-1 Env fusion proteins with a MLV 
core of matrix proteins with associated genome [67].  Concomitant labeling of the early and late 
endosomal markers Rab5 and Rab7, respectively, provides information regarding the particular 
stage of endosomal maturation during which membrane fusion is most likely to occur [69,71].  
Single-particle tracking has also shown that the surface receptor to which a virus first binds a 
target cell can directly affect subcellular transport, the rate of fusion and the compartment where 
the viral core is released [66,68,69]. 
To assess infection with single-particle fluorescence assays, it is necessary to 
separately and simultaneously measure the release of viral contents.  Such observations allow 
for detection of intermediates along the fusion pathway, such as hemifusion and small, nascent 
fusion pores.  Melikyan and colleagues have developed several strategies for detecting content 
release by incorporating pH-sensitive fluorescent proteins into the lumen of a number of 
pseudoviruses.  One such pseudovirus was constructed to have a palmitylated YFP coating the 
luminal leaflet of the viral membrane [65].  Small, transient fusion pores were observed to allow 
mixing between viral contents and the cytosol, but without release of the lipid-bound protein 
from within the virus.  Half of these small and non-expanding fusion pores had surprisingly long 
lifetimes, lasting for tens of seconds and some as long as several minutes.  The size of the 
fusion pore can also be dependent upon the receptor used by the virus and the compartment in  
23 
 
  
Figure 1-4 – In vivo visualization of membrane fusion during viral infection and synaptic firing.  
A) Lipid mixing and content release during viral infection as utilized by Miyauchi et al. [64] and 
described in the text.  Lipophilic dye to monitor membrane mixing is indicated in red, content 
labeling in purple and the velocity of viral movement in light blue.  Dual-labeled viruses first bind 
to the target cell at the start of path 2.  Once fusion is synchronized the virus may undergo 
hemifusion with the plasma membrane via paths 1 or 3, or with the endosome via paths 2 or 3 
that releases viral contents into the target cell.  B)  Subquantal and full quantal content release 
during synaptic vesicle fusion based upon the experimental design of Aravanis et al. [106,107].  
Fluorescence from FM1-43 is shown in red and stimulatory pulses are indicated as vertical 
hashes in the intensity diagrams.  Path 1 depicts kiss-and-run fusion with multiple events and 
path 2 depicts full fusion event without prior kiss-and-run.  Synaptic vesicle transport was not 
directly followed by particle tracking; rather it was inferred from the fusion kinetics.  Quantum 
dots report kiss-and-run fusion events through a small fluorescence increase [108] rather than 
signal loss. 
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which fusion occurs [66,68].  These observations indicated that pore expansion could be a 
significant energetic barrier to infection following hemifusion.    
Another method used with several pseudoviruses involves use of the MLV Gag protein 
fused to a GFP in such a way that when the Gag is cleaved during viral maturation, it becomes 
a freely diffusing fluorescent viral-content marker [64,66-69,72].  A recent study using this type 
of pseudovirus [64] provided strong support that the pH-independent HIV-1 Env proteins 
mediate an endosomal route for viral entry and fusion, similar to pH-dependent viral surface 
proteins like HA.  Miyauchi et al. [64] followed the fusion pathway through the disappearance of 
either the DiD envelope dye, which indicated hemifusion with the cellular plasma membrane, or 
the GFP content marker, which indicated content release (Figure 1-4A); fusion with an 
endosome resulted in a persistent DiD signal and loss of the content signal.  Using a number of 
HIV-1 pseudoviruses and one fully infectious strain, they observed many viruses fusing with the 
plasma membrane, but not losing their contents (Figure 1-4A.1), while others had a persistent 
lipid signal and a rapid content loss (Figure 1-4A.2).  Importantly, the viruses exhibiting plasma-
membrane hemifusion often showed limited movement, while those losing their contents 
showed transport towards the cell nucleus before content loss and a continued movement of the 
lipid dye afterward, observations consistent with endosomal trafficking and perinuclear viral-
genome release.  A very few number of viruses showed loss of both signals (Figure 1-4A.3), 
with a considerable delay separating content release from lipid mixing.  The delay time between 
lipid mixing and content release was consistent with the time measured as being necessary for 
endocytosis (10-15 minutes).  These observations were supported with experiments providing a 
cellular read out to indicate successful viral-core transfer.  Moreover, a long-lived intermediate 
state following HIV-1 Env mediated lipid mixing and preceding content loss had been reported 
previously [67], consistent with the observations of Miyauchi et al.   
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As further evidence of HIV-1 endosomal uptake and fusion, Miayuchi et al. [64] and a 
follow-up study by de la Vega et al. [72] showed that inhibition of the dynamin GTPase (the 
protein responsible for scission of clathrin-coated pits from the plasma membrane during 
endocytosis) abolished viral content release, but did not inhibit lipid mixing with the plasma 
membrane.  Together, these studies indicated that the HIV-1 Env fusion protein can mediate the 
transition into a long-lived hemifusion state with the plasma membrane before the virus is 
internalized, but that a functional fusion pore is not created at the plasma membrane, rather 
within the endosome.     
Taken together, these studies demonstrate that the intermediates in viral fusion as 
derived from biophysical, biochemical and structural data are experimentally resolvable at a 
single-particle level.  The kinetic insight obtained with these studies has contributed significantly 
to our understanding of the molecular mechanisms by which fusion proteins catalyze fusion. 
Moreover, additional processes, such as acidification of the viral lumen, can occur in parallel 
with traversing of the intermediate physical states leading to membrane fusion.  Results also 
indicate that there is a coordination between viral surface proteins that must occur for 
membrane fusion to occur and that the kinetics for coordination vary with pH regimes.  Within a 
cellular context, endosomal trafficking and maturation appear to provide  receptor-dependent 
pathways for productive viral fusion.  Such deep understanding of the molecular nature of fusion 
intermediates may prove crucial to relate in vivo and in vitro observations as well as to develop 
novel antiviral therapeutics that neutralize specific intermediates along the fusion pathway . 
 
1.6 SNARE-mediated membrane fusion 
Recently, fluorescence microscopy has also been applied extensively to the study of 
fusion of membranes driven by the SNARE machinery in eukaryotes.  SNARE proteins are 
responsible for the fusion of synaptic vesicles with the neuronal plasma membrane, supporting 
rapid action potential-triggered exocytosis of neurotransmitters into the synaptic cleft.  Function 
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of these proteins has been the subject of thorough and recent reviews by Brunger and 
colleagues [73,74], only a brief outline of how they mediate fusion is given here. 
The SNARE proteins are divided into two groups: ‘target’ t-SNARE proteins anchored to 
the luminal side of the plasma membrane and ‘vesicle’ v-SNARE proteins anchored to the 
synaptic vesicles, which contain neurotransmitters.  The principal t-SNARE proteins are 
syntaxin-1 (Syx) and SNAP25, while synptobrevin-2 (Syb, also known as VAMP, Vesicle 
Associated Membrane Protein) is the principal v-SNARE.  Together, these three proteins are 
considered the functional core responsible for mediating membrane fusion.  Synaptotagmin-1 
(Syt) and complexin are two important protein factors that interact with the SNARE proteins and 
have been incorporated into single-particle SNARE fusion studies; the factors Munc13 and 
Munc18, though critical for vesicle priming [75], have not yet been included in such studies.  Syt 
is the calcium (Ca2+) sensor required for fast synchronous release of neurotransmitters and 
complexin is a modulator regulating SNARE-driven exocytosis.  For fusion to occur, SNARE 
proteins first associate with each other to form a tetra-alpha-helical complex comprised of two 
SNAP25 proteins, one Syx and one Syb that, together, link the v- and t-membranes in close 
proximity.  In response to a rapid influx of Ca2+ ions into a neuron following the arrival of an 
action potential, the SNARE proteins re-fold upon each other in a fashion enhanced by the 
concerted action of additional protein factors.  These interactions bring the apposed membranes 
into close proximity and facilitate their fusion, releasing neurotransmitters into the synaptic 
junction for action potential propagation. 
Neurotransmitter release has been demonstrated to occur in as little as 0.2 milliseconds 
following an action potential [76].  Additionally, neurons can be required to transmit high-
frequency signals rapidly and continuously.  There are two principal modes by which a vesicle 
can fuse during exocytosis.  One is complete fusion, where the vesicle fully collapses to become 
continuous with the plasma membrane and simultaneously releases its entire contents [77].  
These vesicles are replenished by de novo synthesis coupled with endocytotic recycling.  
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Alternatively there is “kiss-and-run” fusion where the exocytotic vesicle does not undergo 
complete fusion, but rather releases a portion of its contents  followed by fusion pore closure 
[78].  The kinetics and intermediates involved in both modes of fusion are amenable to 
fluorescence microscopy and their study paints a picture of the bilayer rearrangements and 
vesicle cycling that occur during action potential propagation. 
 
1.6.1 Single-particle SNARE fusion kinetics studied in vitro 
In vitro studies attempting to reconstitute the SNARE fusion process have traditionally 
been performed using bulk lipid-mixing assays.  Recent investigations are moving these studies 
onto the microscope to observe the vesicles fusing individually.  Single-vesicle fusion studies 
have the advantage over ensemble-averaging experiments in their ability to directly differentiate 
full fusion and content mixing from hemifusion and lipid mixing.  This differentiation avoids the 
misinterpretation of implying content mixing by only monitoring lipid mixing, a potential pitfall 
discussed elsewhere [12,79].  As well, these studies can clearly distinguish docking of a v-
SNARE vesicle to a t-SNARE membrane from the subsequent fusion event.  Docking is 
observed as the rapid increase of fluorescence from the background at a localized spot as the 
vesicle becomes immobilized upon the target surface.  Lipophilic dyes used in vitro for labeling 
the vesicle bilayer are often PE-modified lipids such as, TMR-PE/TRITCH-PE [57,58], R18 [10], 
and Rh-PE [55,56,80-83].  These dyes can indicate lipid mixing through fluorescence 
dequenching (Figure 1-2A).  Alternatively, DiD and DiI can be used to follow lipid mixing 
measured as an increase in FRET [84-87] (Figure 1-2C) or as a dequenching signal [11,12].  
Here, we discuss in detail two experimental geometries developed to observe the fusion 
reaction as mediated by SNARE’s – one using a planar SLB target and the other using tethered 
target vesicles. 
A planar SLB formed upon an hydrophilic quartz, glass, or polymer substrate allows 
observation of SNARE-dependent fusion between the SLB and individual fusogenic vesicles 
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(Figures 3A and 3B).  The t-SNARE proteins are typically contained in the target planar SLB, 
while the v-SNARE protein is present in small unilaminar vesicles (SUV) that bind and 
subsequently fuse to the SLB.  Dequenching signal from lipid dye in the v-SNARE vesicles is a 
common read out for lipid mixing since dye dilution into the SLB can easily be visualized.  The 
contents of these vesicles have been filled with fluorescent dyes such as calcein [10,88], which 
reports on the opening of a fusion pore through dequenching followed by fluorescence signal 
loss.  The continuity of the SLB can be monitored within the experimental setup by labeling the 
SLB using NBD-PE [80,81,83] and performing FRAP measurements immediately prior to fusion 
experiments.  Fusion kinetics are measured as the elapsed time between docking and 
dequenching and require rapid image acquisition, with frame acquisition times as low as 1-5 
milliseconds [10,55] (Figure 1-3A). 
A consensus remains to be established for the results produced from planar SLB-based 
experiments.  Fusion was observed in some experimental setups in the absence of the in vivo 
obligate protein SNAP25 [10,58,88] and in the absence of Ca2+ [55,58,88].  Bowen et al. [88] 
demonstrated that the fusion they observed was the result of laser-induced heating, though this 
may not be the case for the other works cited.  Their data also indicated that SNAP25 was 
required to form stable interaction between Syx and Syb prior to fusion.  There are, however, a 
number of key observations were shared between SLB-based studies.  Hemifusion to the SLB 
was measured to occur 5-20 milliseconds after docking to the bilayer [10,55,56].  Release of a 
content dye to indicate full fusion was measured to occur ~100 ms after lipid mixing, but this 
observation was convoluted with vesicle rupture that released content dye into the space above 
a SLB rather than below it [10].  Using polarized laser illumination in a TIRF microscope, 
Kiessling et al. [56] observed the topology changes of the vesicle bilayer as it fused with the 
planar target.  They found that the vesicle becomes flattened along the substrate only 8 ms after 
fusion begins.  While fast, these kinetics are still much slower than the 0.2 ms response 
observed in living cells [76].  Phospholipid head groups and their ratios appear to have an effect 
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both on docking and fusion efficiency, but there are still differences reported between different 
experimental designs and setups (discussed in [82]).  Finally, SLB-based single-particle studies 
have estimated that 5-10 SNARE complexes are needed to induce fusion [55,83], though 
estimates of as high as 15 complexes exist in the literature [89].  A bulk fusion study measuring 
only lipid mixing without content mixing found, in contrast, that a single SNARE complex could 
give rise to lipid mixing [90]. 
In the tethered-vesicle experimental approach, first developed by Yoon et al. [84] (Figure 
1-3C) separate populations of v- and t-SNARE containing vesicles are observed while fusing 
together.  Either the v-SNARE [84-86,91] or t-SNARE [11,12] vesicles are immobilized upon a 
substrate with no preference in terms of effect [87].  Glass or quartz substrates are coated with 
a PEG/biotinylated-PEG layer to reduce non-specific interactions, wherein the sparse amounts 
of biotin-PEG enable vesicle immobilization  through neutravidin-mediated binding with 
biotinylated lipids in the vesicles.  Lipid mixing is observed via TIRF microscopy as a FRET 
signal between DiI and DiD (Figure 1-2C), though scanning confocal microscopy has also been 
used [92].  Fusion pore opening can be followed through dequenching of SRB [11] without 
outward dissipation.  A novel strategy to follow the expansion of a fusion pore utilizes a DNA 
hairpin encapsulated in the v-SNARE vesicles [91,93,94].  The hairpin is labeled at both ends 
such that when it folds upon itself, the two FRET-pair dyes are in close proximity and give a high 
FRET signal.  Upon pore expansion a complementary DNA strand present in the t-SNARE 
vesicles binds to and opens the hairpin, alleviating the donor dye quenching on a time scale 
much faster than the pore expansion kinetics [91] and indicating that the vesicles are joined by a 
fusion pore at least 2 nm in diameter [93].  This labeling strategy allows for separation of lipid 
mixing, nascent pore opening and subsequent pore expansion.  
The tethered-vesicle experimental geometry has recapitulated some of the requirements 
and observations seen in in vivo neuronal SNARE fusion.  Specifically, the Ca2+ induction 
[11,12,85,93]and SNAP25 [12,85,87] dependency of fusion has been reproduced by several 
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groups.  As well, the hemifusion intermediate has been interpreted from the FRET efficiency 
data of lipid mixing [84,85,93].  Lipid mixing after docking of one vesicle to another showed 
heterogeneity with two kinetic populations.  When coupled with the SNARE-related factors 
complexin and Syt,  the time constant for lipid mixing of the fast population was typically in the 
range of 100-950 ms [11,12,85,86,92].  These times are likely upper bounds on the fast 
population set by the experimental equipment used, since the video acquisition rate was lower 
than that achieved in the planar SLB experiments [11,12].  The slower kinetic component was 
on the order of 3-10 seconds and occurred upon Ca2+ triggering of the SNARE proteins in the 
absence of the complexin and Syt factors [11,85].  In agreement with these kinetic 
measurements, docking was found to be the rate-limiting step in the SNARE fusion process 
[87,92].  Docking kinetics between complementary SNARE vesicles were found to be enhanced 
10- to 100-fold by the SNARE-related factors complexin and Syt [11,85,92].   
Of particular note, Kyoung et al. [11] enhanced the tethered-vesicle design to include a 
SRB content label for the v-SNARE vesicles, which allows for direct read out of content mixing, 
as well as a Cascade Blue fluorescent signal to indicate the arrival of the fusion-inducing Ca2+ 
solution (Figure 1-3C).  Within the tethered-vesicle design, they successfully reproduced fast 
content release kinetics on the millisecond time-scale that was both Ca2+ induced and 
dependent on the presence of both complexin and Syt.  Extraction of waiting times between 
Ca2+ arrival and hemifusion or content release allowed for a kinetic analysis of the fusion 
process.  They found that in the presence of the Syt and complexin factors, a “rapid burst” 
constituting simultaneous lipid and content mixing was prevalent.  This phenomenon was 
characterized by a waiting-time distribution for both fluorescent signals that was well described 
by a double exponential, indicative of two populations with each displaying different kinetics.  
The rapidly fusing portion constituted a majority of the vesicle population and displayed a fusion 
time constant of 250 milliseconds, approximately equal to the frame rate used to capture the 
fusion movies.  Because of this experimental limitation, intermediates between lipid mixing and 
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content release were not observable.  The slower portion of the population displayed a time 
constant of ~1.5 seconds.  Without Syt and complexin, however, the SNARE proteins alone 
could not efficiently generate these “rapid bursts” or the two kinetic populations.  Instead, the 
waiting-time distributions were described by a single exponential with a rate constant of ~3 
seconds.  A subsequent study by Diao et al. [12] used a similar experimental design with a more 
physiological 250 mM Ca2+ and a shorter frame exposure time of 100 milliseconds, but still did 
not resolve an intermediate state between lipid and content mixing.  Addition of the complexin 
protein enhanced the rapid bursting behavior and the emergence of two kinetic populations of 
fusing vesicles.  In the presence of SNARE and Syt proteins only, however, a larger number of 
long-lived hemifusion intermediates were observed that did not evolve into full fusion endpoints.   
Enhancement of productive fusion pathways by accessory proteins is supported by 
recent tethered-vesicle experiments done by Lai et al. [93].  Therein the authors report that the 
Syt protein interacts with SNARE proteins to significantly enhance vesicle docking, hemifusion 
and the opening of a nascent pore large enough for SRB molecules to pass through.  Moreover, 
using the aforementioned FRET-labeled DNA hairpin, they to found that pore expansion is 13-
fold slower than nascent fusion pore opening and that expansion is very inefficient in the 
absence of Syt or Ca2+.  Incorporating complexin into the fusion scheme caused the rate of 
nascent pore opening to increase 21% and the rate of pore expansion to double.  Thus 
productive fusion pore opening and expansion are modulated, at least, by the accessory 
proteins Syt and complexin, which can enhance full fusion both in terms of rate and efficiency. 
 
1.6.2 Single exocytotic vesicle fusion in live hippocampal neuronal cells 
Fluorescence microscopy-based kinetic measurements have also proven insightful for 
the in vivo study of exocytosis.  Methods to fluorescently label exocytotic vesicles in living cells 
are well reviewed elsewhere by Ge et al. [95] and by Keighron et al. [96].  These methods have 
been implemented in monitoring processes closely related to exocytosis, such as endocytosis 
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[97,98], the role of other key cellular components on exocytosis [99], and non-synaptic 
exocytosis [100-103].  For continuity with the previous section, the following discussion will 
focus on synaptic exocytosis in hippocampal neurons and primarily on the kinetic discernment 
between kiss-and-run fusion and complete fusion wherein the synaptic vesicle fully collapses. 
Synaptic vesicles are commonly labeled with organic styryl dyes, such as FM1-43, that 
have proven powerful tools for studying exocytosis in living cells [95,96].  For instance, FM1-43 
was used to determine that 1/3 – 1/4 of the vesicles at the synapse are located in close 
proximity to the plasma membrane and belong to a readily releasable pool of vesicles, while the 
remaining vesicles belong to a recruitable reserve pool more distal from the synapse [104,105].  
As mentioned previously, these dyes exhibit enhanced fluorescence in hydrophobic 
environments, but also reversibly departition from membranes into the aqueous vesicular 
lumen.  This behavior allows the dissipation of the dye signal to report on the formation of a 
fusion pore rather than lipid mixing.  Aravanis et al. [106,107] used FM1-43 in hippocampal 
nerve cells, where exocytotic vesicles are clustered into synaptic boutons of approximately 30 
vesicles.  Using a minimum labeling protocol, they observed individual synaptic vesicles using 
epifluorescence microscopy.  Consistent with other reports of this system [97,109], each vesicle 
contained a “quantal” amount of dye such that the fluorescent signals from individual vesicles 
was comparable.  Fusion of individual vesicles to the plasma membrane was observed as a loss 
of fluorescent signal from the vesicle in response to a physiologically relevant 10-Hz train of 
stimulating electrical pulses (Figure 1-4B).   
Aravanis et al. [106,107] found that upon stimulation, 85% of the fusing vesicles lost a 
sub-quantal portion of their fluorescence signal in a single fusion event (Figure 1-4B.1), while a 
minority of 15% lost their entire fluorescence signal in a single event (Figure 1-4B.2).  Analysis 
of dwell times between initial stimulation and 20% fluorescence loss indicated that the majority 
of observed  fusion events arose from vesicles in the readily releasable pool of vesicles.  
Further, the times over which fluorescence dropped from 20% to 80% indicated that the vesicles 
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did not experience complete collapse during fusion.  By unambiguously following the behavior of 
individual particles, they observed single vesicles undergoing multiple kiss-and-run fusion 
events (Figure 1-4B.1).  The latency periods (i.e., number of stimuli) for the first and second 
fusion events were ~5 and ~7 stimulating electrical pulses, respectively.  Thus it appeared that a 
vesicle could undergo repeated fusion events following a rapid retrieval or “re-priming” event, 
which retained large amounts of vesicular contents and caused the latency of a second fusion 
event to be slightly longer than for the first. 
Slow, sub-quantal fluorescence loss was confirmed by Richards et al. [19] using a 
similar experimental design, but with elevated potassium concentration as a stimulus.  Their 
calculations estimated that the kiss-and-run fusion pore had a diameter of ~1 nm.  While 
transient, these non-complete fusion events still give rise to lipid-mixing between the vesicle and 
the plasma membrane [20]. Sub-quantal content loss is stimulation dependent, however, and 
either disappears or is unresolvable at high-frequency stimulation of 100 Hz, where only full 
quantal release was observed [110].  
Zhang et al. [108] incorporated bright quantum dots (Qdot) to label hippocampal synaptic 
vesicles and directly detected both kiss-and-run and complete fusion.  In contrast to loss of 
FM1-43 fluorescence signal, the Qdot emission intensity increased ~15% upon opening of a 
kiss-and-run fusion pore, due to neutralization of the acidic intravesicular pH upon pore opening.  
This persistent fluorescence signal allowed Zhang et al. to resolve multiple kiss-and-run fusion 
events in single vesicles with improved signal-to-noise and extended observation times.  Kiss-
and-run events were easily distinguished from complete fusion events, which were observed as 
a full loss of fluorescent signal and subsequent diffusion of the Qdot away from a fusion site.  
They found that, initially, kiss-and-run fusion was the predominant type of fusion and arose from 
the readily releasable pool of vesicles, but that complete fusion became dominant after 
extended stimulation.  Kinetically, kiss-and-run fusion events had shorter latencies than 
complete fusion at stimulation frequencies of 0.1 and 10 Hz, though vesicles exhibiting kiss-and-
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run fusion would eventually undergo complete fusion.  For the vesicles exhibiting kiss-and-run 
fusion, those undergoing the largest number of kiss-and-run events prior to complete fusion 
displayed the shortest latency period between subsequent events.   Together, the observations 
of Zhang et al. indicate that the readily releasable pool of vesicles favor kiss-and-run fusion that 
have shorter latency periods.  Once these vesicles are depleted and replenished by vesicles 
from a reserve pool, the likelihood of a kiss-and-run event diminishes and the full fusion events 
displaying a longer latency become predominant. 
A recent study measured a lower bound on the number of SNARE complexes required 
for exocytotic fusion in vivo.  Sinha et al. [111] fused the specialized pH-sensitive fluorescent 
protein pHluorin [25] to the luminal portion of the v-SNARE Syb2 protein.  These pHl-Syb2 
proteins readily incorporated into hippocampal neuron synaptic vesicles.  Initially, fluorescence 
of the pHluorin was quenched within the acidic synaptic vesicle, but stimulation-induced fusion 
caused a quantal fluorescence increase upon neutralization of the acidic lumen.  Plotting the 
distributions of fluorescence increases showed several equally spaced peaks and 
photobleaching analysis indicated that each peak corresponded to a single pHl-Syb2 protein 
within the synaptic vesicles.  Measurements made with neuronal cells containing only pHl-
labeled Syb2 proteins resulted in a multi-peaked distribution lacking a peak at a quantum of 
one, whereas neurons having both labeled and unlabeled Syb2 gave a distribution with a 
distinct one-quantum peak.  Sinha et al. thus concluded that a minimal fusion SNARE complex 
required two Syb2 proteins.  Because each assembled SNARE complex is estimated to have 
~35 kBT (21 kcal/mol) [112] of energy available, the coordinated effect of two Syb2 proteins 
would be more than sufficient to surmount the initial energy barrier separating the initial barriers 
to fusion (see Introduction).   
Taken together, these studies of SNARE-mediated fusion have identified at least two 
regimes of fusion kinetics that are found in vivo and two regimes in vitro.  The in vivo situation 
appears to be linked to a shift from vesicles initially present at the membrane to the recruitment 
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of vesicles from the cellular interior, transitioning from shorter latency periods to longer ones.  
The in vitro regimes are likely tied to the dependencies of the SNARE process on accessory 
proteins.  These results hint towards regulatory processes that control these fusion machines to 
appropriately enhance their fusogenicity or to restrict their catalytic potential, i.e. full vesicular 
membrane merger, and allow only partial content release. 
 
1.7 Outlook 
The experimental approaches described here provide a solid foundation for moving 
forward on a number of fronts.  With respect to further investigations into general aspects of 
membrane fusion, lipid dependencies for the various fusion systems can be probed in a 
straightforward manner.  Target bilayers studied in in vitro systems can be readily manipulated 
to incorporate a range of lipid types and these lipids can be exogenously added and 
incorporated into in vivo systems.  Lipids such as lysophosphatidylcholine are considered to 
inhibit HA-mediated cell-cell fusion through a change in membrane curvature [113].  
Demonstration of this effect in single-particle fusion assays of both HA-fusion and SNARE 
fusion would establish the role of curvature as a general property affecting protein-mediated 
fusion as catalyzed by the fully intact systems.  Cholesterol is another molecular player whose 
role in fusion has not been fully clarified, being required for some viruses to fuse and irrelevant 
for others.  Single-particle assays could potentially distinguish if an effect of cholesterol arises 
from requirements regarding lipid arrangements or if the effect arises at the level of interactions 
between the fusion protein and proximal lipid components.  With respect to experimental 
advances, differentiation of distal leaflet mixing from proximal leaflet mixing at the single-particle 
level would provide another level of understanding regarding expansion of a lipidic fusion pore. 
Concerning fusion-specific scenarios, mutational studies in conjunction with single-
particle fusion detection can firmly establish the role of environmental sensitivities and of critical 
amino-acid residues in governing the fusion behavior .  Relatedly, live-cell single-particle fusion 
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studies can aid in delineating the role that additional cellular factors play in modulating fusion 
mechanisms.  SNARE-related fusion relies on intracellular transport and signaling pathways to 
shift appropriately between the readily releasable pool and reserve pool of fusion vesicles.  Viral 
fusion, too, can require dynamic cellular components, for instance the molecular trigger causing 
pH-independent HIV-1 Env mediated content release within an endosome that is not present at 
the cellular surface. 
Technical advances can also play a role, most predominantly in the area of automated 
data selection.  All single-particle studies require, first, experimental optimization to obtain high 
signal-to-noise ratios in the recorded fusion movies.  Once this initial step is achieved, an 
equally difficult challenge is presented in the extraction and analysis of the fluorescence time 
trajectories.  These challenges can require extensive computer programing, frequently 
supplemented by manual selection of fusion events, an analysis strategy that can take days to 
weeks once a successful experimental run is obtained [81,94].  While development of 
automated analysis algorithms are time consuming, the result can decrease analysis time up to 
100-fold [114].  Some steps toward this automatization have been taken with live-cell studies of 
exocytosis and are reviewed briefly by Burchfield et al. [115].  Similarities in the fluorescence 
signal obtained for both in vitro and in vivo studies of viral and SNARE fusion (Figure 1-2; and 
compare Figure 1-3 with Figure 1-4) could allow for unification of analysis strategies among the 
diverse areas of study and contributing research groups.  Progress on this front, in particular, 
has the potential to drive the field forward by facilitating many more experimental permutations 
to be performed within a single study, provided by less time-consuming and more consistent 
data analysis. 
 
37 
 
1.8 References  
1. Chernomordik LV, Kozlov MM. (2003) Protein-lipid interplay in fusion and fission of biological 
membranes. Annu Rev Biochem 72: 175-207. 
2. Markvoort AJ, Marrink SJ. (2011) Lipid acrobatics in the membrane fusion arena. Curr Top 
Membr 68: 259-294. 
3. Efrat A, Chernomordik LV, Kozlov MM. (2007) Point-like protrusion as a prestalk intermediate 
in membrane fusion pathway. Biophys J 92: L61-L63. 
4. Kuzmin PI, Zimmerberg J, Chizmadzhev YA, Cohen FS. (2001) A quantitative model for 
membrane fusion based on low-energy intermediates. Proc Natl Acad Sci U S A 98: 7235-
40. 
5. Jackson MB. (2011) Inferring structures of kinetic intermediates in ca(2+)-triggered 
exocytosis. Curr Top Membr 68: 185-208. 
6. Melikyan GB, White JM, Cohen FS. (1995) GPI-anchored influenza hemagglutinin induces 
hemifusion to both red blood cell and planar bilayer membranes. J Cell Biol 131: 679-691. 
7. Chernomordik LV, Kozlov MM. (2005) Membrane hemifusion: Crossing a chasm in two leaps. 
Cell 123: 375-382. 
8. Niles WD, Cohen FS. (1991) Fusion of influenza virions with a planar lipid membrane 
detected by video fluorescence microscopy. J Gen Physiol 97: 1101-1119. 
9. Blumenthal R, Gallo SA, Viard M, Raviv Y, Puri A. (2002) Fluorescent lipid probes in the 
study of viral membrane fusion. Chem Phys Lipids 116: 39-55. 
10. Wang T, Smith EA, Chapman ER, Weisshaar JC. (2009) Lipid mixing and content release in 
single-vesicle, SNARE-driven fusion assay with 1-5 ms resolution. Biophys J 96: 4122-
4131. 
11. Kyoung M, Srivastava A, Zhang Y, Diao J, Vrljic M, et al. (2011) In vitro system capable of 
differentiating fast Ca2+-triggered content mixing from lipid exchange for mechanistic 
studies of neurotransmitter release. Proc Natl Acad Sci U S A 108: E304-E313. 
12. Diao J, Grob P, Cipriano DJ, Kyoung M, Zhang Y, et al. (2012) Synaptic proteins promote 
calcium-triggered fast transition from point contact to full fusion. elife 1: e00109. 
13. Wombacher R, Cornish VW. (2011) Chemical tags: Applications in live cell fluorescence 
imaging. J Biophotonics 4: 391-402. 
14. Dieterich DC. (2010) Chemical reporters for the illumination of protein and cell dynamics. 
Curr Opin Neurobiol 20: 623-630. 
38 
 
15. Reymond L, Lukinavicius G, Umezawa K, Maurel D, Brun MA, et al. (2011) Visualizing 
biochemical activities in living cells through chemistry. Chimia (Aarau) 65: 868-871. 
16. Cairo CW, Key JA, Sadek CM. (2010) Fluorescent small-molecule probes of biochemistry at 
the plasma membrane. Curr Opin Chem Biol 14: 57-63. 
17. Yano Y, Matsuzaki K. (2009) Tag-probe labeling methods for live-cell imaging of membrane 
proteins. Biochim Biophys Acta 1788: 2124-2131. 
18. Bissig C, Johnson S, Gruenberg J. (2012) Studying lipids involved in the endosomal 
pathway. Methods Cell Biol 108: 19-46. 
19. Richards DA, Bai J, Chapman ER. (2005) Two modes of exocytosis at hippocampal 
synapses revealed by rate of FM1-43 efflux from individual vesicles. J Cell Biol 168: 929-
939. 
20. Taraska JW, Almers W. (2004) Bilayers merge even when exocytosis is transient. Proc Natl 
Acad Sci U S A 101: 8780-8785. 
21. Chudakov DM, Matz MV, Lukyanov S, Lukyanov KA. (2010) Fluorescent proteins and their 
applications in imaging living cells and tissues. Physiol Rev 90: 1103-1163. 
22. Day RN, Davidson MW. (2009) The fluorescent protein palette: Tools for cellular imaging. 
Chem Soc Rev 38: 2887-2921. 
23. Wiedenmann J, Oswald F, Nienhaus GU. (2009) Fluorescent proteins for live cell imaging: 
Opportunities, limitations, and challenges. IUBMB Life 61: 1029-1042. 
24. Shaner NC, Steinbach PA, Tsien RY. (2005) A guide to choosing fluorescent proteins. Nat 
Methods 2: 905-909. 
25. Miesenböck G, De Angelis DA, Rothman JE. (1998) Visualizing secretion and synaptic 
transmission with pH-sensitive green fluorescent proteins. Nature 394: 192-195. 
26. Fish KN. (2009) Total internal reflection fluorescence (TIRF) microscopy. Curr Protoc Cytom 
Chapter 12: Unit12.18. 
27. Mattheyses AL, Simon SM, Rappoport JZ. (2010) Imaging with total internal reflection 
fluorescence microscopy for the cell biologist. J Cell Sci 123: 3621-3628. 
28. Millis BA. (2012) Evanescent-wave field imaging: An introduction to total internal reflection 
fluorescence microscopy. Methods Mol Biol 823: 295-309. 
29. Yildiz A, Forkey JN, McKinney SA, Ha T, Goldman YE, et al. (2003) Myosin V walks hand-
over-hand: Single fluorophore imaging with 1.5-nm localization. Science 300: 2061-2065. 
30. Manley S, Gunzenhauser J, Olivier N. (2011) A starter kit for point-localization super-
resolution imaging. Curr Opin Chem Biol 15: 813-821. 
39 
 
31. Czolkos I, Jesorka A, Orwar O. (2011) Molecular phospholipid films on solid supports. Soft 
Matter 7: 4562-4576. 
32. Richter RP, Berat R, Brisson AR. (2006) Formation of solid-supported lipid bilayers: An 
integrated view. Langmuir 22: 3497-3505. 
33. Nollert P, Kiefer H, Jahnig F. (1995) Lipid vesicle adsorption versus formation of planar 
bilayers on solid surfaces. Biophys J 69: 1447-1455. 
34. Brian AA, McConnell HM. (1984) Allogeneic stimulation of cytotoxic T cells by supported 
planar membranes. Proc Natl Acad Sci U S A 81: 6159-6163. 
35. Wagner ML, Tamm LK. (2000) Tethered polymer-supported planar lipid bilayers for 
reconstitution of integral membrane proteins: Silane-polyethyleneglycol-lipid as a cushion 
and covalent linker. Biophys J 79: 1400-1414. 
36. Roder F, Waichman S, Paterok D, Schubert R, Richter C, et al. (2011) Reconstitution of 
membrane proteins into polymer-supported membranes for probing diffusion and 
interactions by single molecule techniques. Anal Chem 83: 6792-6799. 
37. Rawle RJ, van Lengerich B, Chung M, Bendix PM, Boxer SG. (2011) Vesicle fusion 
observed by content transfer across a tethered lipid bilayer. Biophys J 101: L37-L39. 
38. Floyd DL, Ragains JR, Skehel JJ, Harrison SC, van Oijen AM. (2008) Single-particle kinetics 
of influenza virus membrane fusion. Proc Natl Acad Sci U S A 105: 15382-15387. 
39. Elender G, Kuhner M, Sackmann E. (1996) Functionalisation of Si/SiO2 and glass surfaces 
with ultrathin dextran films and deposition of lipid bilayers. Biosens Bioelectron 11: 565-
577. 
40. Skehel JJ, Cross K, Steinhauer D, Wiley DC. (2001) Influenza fusion peptides. Biochem Soc 
Trans 29: 623-626. 
41. Harrison SC. (2005) Mechanism of membrane fusion by viral envelope proteins. Adv Virus 
Res 64: 231-261. 
42. Harrison SC. (2008) Viral membrane fusion. Nat Struct Mol Biol 15: 690-8. 
43. White JM, Delos SE, Brecher M, Schornberg K. (2008) Structures and mechanisms of viral 
membrane fusion proteins: Multiple variations on a common theme. Crit Rev Biochem Mol 
Biol 43: 189-219. 
44. Georgiou GN, Morrison IE, Cherry RJ. (1989) Digital fluorescence imaging of fusion of 
influenza virus with erythrocytes. FEBS Lett 250: 487-492. 
45. Lowy RJ, Sarkar DP, Chen Y, Blumenthal R. (1990) Observation of single influenza virus-
cell fusion and measurement by fluorescence video microscopy. Proc Natl Acad Sci U S A 
87: 1850-1854. 
40 
 
46. Niles WD, Cohen FS. (1991) The role of N-acetylneuraminic (sialic) acid in the pH 
dependence of influenza virion fusion with planar phospholipid membranes. J Gen Physiol 
97: 1121-1140. 
47. Wessels L, Elting MW, Scimeca D, Weninger K. (2007) Rapid membrane fusion of individual 
virus particles with supported lipid bilayers. Biophys J 93: 526-538. 
48. Ivanovic T, Rozendaal R, Floyd DL, Popovic M, van Oijen AM, et al. (2012) Kinetics of 
proton transport into influenza virions by the viral M2 channel. PLoS One 7: e31566. 
49. Imai M, Mizuno T, Kawasaki K. (2006) Membrane fusion by single influenza hemagglutinin 
trimers. kinetic evidence from image analysis of hemagglutinin-reconstituted vesicles. J Biol 
Chem 281: 12729-12735. 
50. Hoekstra D, de Boer T, Klappe K, Wilschut J. (1984) Fluorescence method for measuring 
the kinetics of fusion between biological membranes. Biochemistry 23: 5675-5681. 
51. Loparo JJ, van Oijen AM. (2009) Single-molecule enzymology. In: Hinterdorfer P, van Oijen 
A, editors. Handbook of Single-Molecule Biophysics. New York, NY: Springer New York. 
pp. 165-182. 
52. Floyd DL, Harrison SC, van Oijen AM. (2010) Analysis of kinetic intermediates in single-
particle dwell-time distributions. Biophys J 99: 360-366. 
53. Bentz J. (2000) Minimal aggregate size and minimal fusion unit for the first fusion pore of 
influenza hemagglutinin-mediated membrane fusion. Biophys J 78: 227-245. 
54. Melikyan GB, Niles WD, Cohen FS. (1995) The fusion kinetics of influenza hemagglutinin 
expressing cells to planar bilayer membranes is affected by HA density and host cell 
surface. J Gen Physiol 106: 783-802. 
55. Domanska MK, Kiessling V, Stein A, Fasshauer D, Tamm LK. (2009) Single vesicle 
millisecond fusion kinetics reveals number of SNARE complexes optimal for fast SNARE-
mediated membrane fusion. J Biol Chem 284: 32158-32166. 
56. Kiessling V, Domanska MK, Tamm LK. (2010) Single SNARE-mediated vesicle fusion 
observed in vitro by polarized TIRFM. Biophys J 99: 4047-4055. 
57. Liu T, Wang T, Chapman ER, Weisshaar JC. (2008) Productive hemifusion intermediates in 
fast vesicle fusion driven by neuronal SNAREs. Biophys J 94: 1303-1314. 
58. Liu T, Tucker WC, Bhalla A, Chapman ER, Weisshaar JC. (2005) SNARE-driven, 25-
millisecond vesicle fusion in vitro. Biophys J 89: 2458-2472. 
59. Dobay MP, Dobay A, Bantang J, Mendoza E. (2011) How many trimers? modeling influenza 
virus fusion yields a minimum aggregate size of six trimers, three of which are fusogenic. 
Mol Biosyst 7: 2741-2749. 
41 
 
60. Huang Q, Sivaramakrishna RP, Ludwig K, Korte T, Bottcher C, et al. (2003) Early steps of 
the conformational change of influenza virus hemagglutinin to a fusion active state: Stability 
and energetics of the hemagglutinin. Biochim Biophys Acta 1614: 3-13. 
61. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X. (2003) Visualizing infection of individual 
influenza viruses. Proc Natl Acad Sci U S A 100: 9280-9285. 
62. Rust MJ, Lakadamyali M, Zhang F, Zhuang X. (2004) Assembly of endocytic machinery 
around individual influenza viruses during viral entry. Nat Struct Mol Biol 11: 567-573. 
63. van der Schaar HM, Rust MJ, Waarts BL, van der Ende-Metselaar H, Kuhn RJ, et al. (2007) 
Characterization of the early events in dengue virus cell entry by biochemical assays and 
single-virus tracking. J Virol 81: 12019-12028. 
64. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB. (2009) HIV enters cells via 
endocytosis and dynamin-dependent fusion with endosomes. Cell 137: 433-444. 
65. Melikyan GB, Barnard RJO, Abrahamyan LG, Mothes W, Young JAT. (2005) Imaging 
individual retroviral fusion events: From hemifusion to pore formation and growth. Proc Natl 
Acad Sci U S A 102: 8728-8733. 
66. Jha NK, Latinovic O, Martin E, Novitskiy G, Marin M, et al. (2011) Imaging single retrovirus 
entry through alternative receptor isoforms and intermediates of virus-endosome fusion. 
PLoS Pathog 7: e1001260. 
67. Markosyan RM, Cohen FS, Melikyan GB. (2005) Time-resolved imaging of HIV-1 env-
mediated lipid and content mixing between a single virion and cell membrane. Mol Biol Cell 
16: 5502-5513. 
68. Padilla-Parra S, Matos PM, Kondo N, Marin M, Santos NC, et al. (2012) Quantitative 
imaging of endosome acidification and single retrovirus fusion with distinct pools of early 
endosomes. Proc Natl Acad Sci U S A 109: 17627-17632. 
69. Padilla-Parra S, Marin M, Kondo N, Melikyan GB. (2012) Synchronized retrovirus fusion in 
cells expressing alternative receptor isoforms releases the viral core into distinct sub-
cellular compartments. PLoS Pathog 8: e1002694. 
70. Brandenburg B, Zhuang X. (2007) Virus trafficking - learning from single-virus tracking. Nat 
Rev Microbiol 5: 197-208. 
71. van der Schaar HM, Rust MJ, Chen C, van der Ende-Metselaar H, Wilschut J, et al. (2008) 
Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. 
PLoS Pathog 4: e1000244. 
72. de la Vega M, Marin M, Kondo N, Miyauchi K, Kim Y, et al. (2011) Inhibition of HIV-1 
endocytosis allows lipid mixing at the plasma membrane, but not complete fusion. 
Retrovirology 8: 99. 
42 
 
73. Brunger AT, Weninger K, Bowen M, Chu S. (2009) Single-molecule studies of the neuronal 
SNARE fusion machinery. Annu Rev Biochem 78: 903-928. 
74. Brunger AT. (2005) Structure and function of SNARE and SNARE-interacting proteins. Q 
Rev Biophys 38: 1-47. 
75. Ma C, Li W, Xu Y, Rizo J. (2011) Munc13 mediates the transition from the closed syntaxin-
Munc18 complex to the SNARE complex. Nat Struct Mol Biol 18: 542-549. 
76. Llinas R, Steinberg IZ, Walton K. (1981) Relationship between presynaptic calcium current 
and postsynaptic potential in squid giant synapse. Biophys J 33: 323-351. 
77. Heuser J. (1989) The role of coated vesicles in recycling of synaptic vesicle membrane. Cell 
Biol Int Rep 13: 1063-1076. 
78. Ceccarelli B, Hurlbut WP, Mauro A. (1973) Turnover of transmitter and synaptic vesicles at 
the frog neuromuscular junction. J Cell Biol 57: 499-524. 
79. Kyoung M, Zhang Y, Diao J, Chu S, Brunger AT. (2012) Studying calcium-triggered vesicle 
fusion in a single vesicle-vesicle content and lipid-mixing system. Nat Protoc 8: 1-16. 
80. Fix M, Melia TJ, Jaiswal JK, Rappoport JZ, You D, et al. (2004) Imaging single membrane 
fusion events mediated by SNARE proteins. Proc Natl Acad Sci U S A 101: 7311-7316. 
81. Karatekin E, Rothman JE. (2012) Fusion of single proteoliposomes with planar, cushioned 
bilayers in microfluidic flow cells. Nat Protoc 7: 903-920. 
82. Domanska MK, Kiessling V, Tamm LK. (2010) Docking and fast fusion of synaptobrevin 
vesicles depends on the lipid compositions of the vesicle and the acceptor SNARE 
complex-containing target membrane. Biophys J 99: 2936-2946. 
83. Karatekin E, Di Giovanni J, Iborra C, Coleman J, O'Shaughnessy B, et al. (2010) A fast, 
single-vesicle fusion assay mimics physiological SNARE requirements. Proc Natl Acad Sci 
U S A 107: 3517-3521. 
84. Yoon TY, Okumus B, Zhang F, Shin YK, Ha T. (2006) Multiple intermediates in SNARE-
induced membrane fusion. Proc Natl Acad Sci U S A 103: 19731-19736. 
85. Yoon TY, Lu X, Diao J, Lee SM, Ha T, et al. (2008) Complexin and Ca2+ stimulate SNARE-
mediated membrane fusion. Nat Struct Mol Biol 15: 707-713. 
86. Lee HK, Yang Y, Su Z, Hyeon C, Lee TS, et al. (2010) Dynamic Ca2+-dependent 
stimulation of vesicle fusion by membrane-anchored synaptotagmin 1. Science 328: 760-
763. 
87. Smith EA, Weisshaar JC. (2011) Docking, not fusion, as the rate-limiting step in a SNARE-
driven vesicle fusion assay. Biophys J 100: 2141-2150. 
43 
 
88. Bowen ME, Weninger K, Brunger AT, Chu S. (2004) Single molecule observation of 
liposome-bilayer fusion thermally induced by soluble N-ethyl maleimide sensitive-factor 
attachment protein receptors (SNAREs). Biophys J 87: 3569-3584. 
89. Montecucco C, Schiavo G, Pantano S. (2005) SNARE complexes and neuroexocytosis: 
How many, how close? Trends Biochem Sci 30: 367-372. 
90. van den Bogaart G, Holt MG, Bunt G, Riedel D, Wouters FS, et al. (2010) One SNARE 
complex is sufficient for membrane fusion. Nat Struct Mol Biol 17: 358-364. 
91. Diao J, Su Z, Ishitsuka Y, Lu B, Lee KS, et al. (2010) A single-vesicle content mixing assay 
for SNARE-mediated membrane fusion. Nat Commun 1: 54. 
92. Christensen SM, Mortensen MW, Stamou DG. (2011) Single vesicle assaying of SNARE-
synaptotagmin-driven fusion reveals fast and slow modes of both docking and fusion and 
intrasample heterogeneity. Biophys J 100: 957-967. 
93. Lai Y, Diao J, Liu Y, Ishitsuka Y, Su Z, et al. (2013) Fusion pore formation and expansion 
induced by Ca2+ and synaptotagmin 1. Proc Natl Acad Sci U S A 110: 1333-1338. 
94. Diao J, Ishitsuka Y, Lee H, Joo C, Su Z, et al. (2012) A single vesicle-vesicle fusion assay 
for in vitro studies of SNAREs and accessory proteins. Nat Protoc 7: 921-934. 
95. Ge S, Koseoglu S, Haynes CL. (2010) Bioanalytical tools for single-cell study of exocytosis. 
Anal Bioanal Chem 397: 3281-3304. 
96. Keighron JD, Ewing AG, Cans AS. (2012) Analytical tools to monitor exocytosis: A focus on 
new fluorescent probes and methods. Analyst 137: 1755-1763. 
97. Gandhi SP, Stevens CF. (2003) Three modes of synaptic vesicular recycling revealed by 
single-vesicle imaging. Nature 423: 607-613. 
98. Balaji J, Ryan TA. (2007) Single-vesicle imaging reveals that synaptic vesicle exocytosis 
and endocytosis are coupled by a single stochastic mode. Proc Natl Acad Sci U S A 104: 
20576-20581. 
99. Aoki R, Kitaguchi T, Oya M, Yanagihara Y, Sato M, et al. (2010) Duration of fusion pore 
opening and the amount of hormone released are regulated by myosin II during kiss-and-
run exocytosis. Biochem J 429: 497-504. 
100. Bai L, Wang Y, Fan J, Chen Y, Ji W, et al. (2007) Dissecting multiple steps of GLUT4 
trafficking and identifying the sites of insulin action. Cell Metab 5: 47-57. 
101. Jiang L, Fan J, Bai L, Wang Y, Chen Y, et al. (2008) Direct quantification of fusion rate 
reveals a distal role for AS160 in insulin-stimulated fusion of GLUT4 storage vesicles. J Biol 
Chem 283: 8508-8516. 
102. Jaiswal JK, Rivera VM, Simon SM. (2009) Exocytosis of post-golgi vesicles is regulated by 
components of the endocytic machinery. Cell 137: 1308-1319. 
44 
 
103. Allersma MW, Wang L, Axelrod D, Holz RW. (2004) Visualization of regulated exocytosis 
with a granule-membrane probe using total internal reflection microscopy. Mol Biol Cell 15: 
4658-4668. 
104. Murthy VN, Stevens CF. (1999) Reversal of synaptic vesicle docking at central synapses. 
Nat Neurosci 2: 503-507. 
105. Pyle JL, Kavalali ET, Piedras-Renteria ES, Tsien RW. (2000) Rapid reuse of readily 
releasable pool vesicles at hippocampal synapses. Neuron 28: 221-231. 
106. Aravanis AM, Pyle JL, Harata NC, Tsien RW. (2003) Imaging single synaptic vesicles 
undergoing repeated fusion events: Kissing, running, and kissing again. 
Neuropharmacology 45: 797-813. 
107. Aravanis AM, Pyle JL, Tsien RW. (2003) Single synaptic vesicles fusing transiently and 
successively without loss of identity. Nature 423: 643-647. 
108. Zhang Q, Li Y, Tsien RW. (2009) The dynamic control of kiss-and-run and vesicular reuse 
probed with single nanoparticles. Science 323: 1448-1453. 
109. Murthy VN, Stevens CF. (1998) Synaptic vesicles retain their identity through the endocytic 
cycle. Nature 392: 497-501. 
110. Chen X, Barg S, Almers W. (2008) Release of the styryl dyes from single synaptic vesicles 
in hippocampal neurons. J Neurosci 28: 1894-1903. 
111. Sinha R, Ahmed S, Jahn R, Klingauf J. (2011) Two synaptobrevin molecules are sufficient 
for vesicle fusion in central nervous system synapses. Proc Natl Acad Sci U S A 108: 
14318-14323. 
112. Li F, Pincet F, Perez E, Eng WS, Melia TJ, et al. (2007) Energetics and dynamics of 
SNAREpin folding across lipid bilayers. Nat Struct Mol Biol 14: 890-896. 
113. Chernomordik LV, Leikina E, Frolov V, Bronk P, Zimmerberg J. (1997) An early stage of 
membrane fusion mediated by the low pH conformation of influenza hemagglutinin 
depends upon membrane lipids. J Cell Biol 136: 81-93. 
114. Mittal A, Leikina E, Chernomordik LV, Bentz J. (2003) Kinetically differentiating influenza 
hemagglutinin fusion and hemifusion machines. Biophys J 85: 1713-1724. 
115. Burchfield JG, Lopez JA, Mele K, Vallotton P, Hughes WE. (2010) Exocytotic vesicle 
behaviour assessed by total internal reflection fluorescence microscopy. Traffic 11: 429-
439. 
 
 
45 
 
 
Page intentionally left blank. 
46 
 
Chapter 2 
 
Boerries Brandenburg 1, Wouter Koudstaal 1, Jaap Goudsmit 1, Vincent Klaren 1, Chan Tang 1, 
Miriam V. Bujny 1, Hans J. W. M. Korse 1, Ted Kwaks 1, Jason J. Otterstrom 2,3, Jarek Juraszek 1, 
Antoine M. van Oijen 2, Ronald Vogels 1 and Robert H. E. Friesen 1 
 
1) Crucell Vaccine Institute, Janssen Center of Excellence for Immunoprophylaxis, Leiden, The 
Netherlands 
2) Centre for Synthetic Biology, Zernike Institute for Advanced Materials, Groningen, The 
Netherlands 
3) Harvard Biophysics Program, Harvard Medical School, Boston, MA, USA 
 
 
 
The experimental design was conceived by Dr. Boerries Brandenburg and Dr. Antoine van 
Oijen. I designed and constructed the fluorescence microscope used in the single-particle 
experiments and adapted the fusion assay [24,25] to incorporate the H1N1 and H3N2 strains 
together with high concentrations of fusion inhibiting antibody. Together with Chan Tang, we 
established conditions for fluorescent labeling of the virions that did not abrogate viral infectivity. 
I performed all single-particle experiments, wrote analysis scripts to extract and analyze 
resulting fusion efficiencies and performed statistical analysis on the data obtained. I wrote the 
initial version of section 2.2.2 describing and interpreting the single-particle data that was used 
by Dr. Boerries Brandenburg to write the manuscript. I wrote the methods section A1.1 in 
Appendix 1, and I used my data to make panels B, C, D and E of Figure 2-2 and also 
supplemental movies M1-5 and M1-6. 
47 
 
Chapter 2 
Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization 
 
Abstract 
 Human monoclonal antibodies have been identified which neutralize broad spectra of 
influenza A or B viruses. Here, we dissect the mechanisms by which such antibodies interfere 
with infectivity. We distinguish four mechanisms that link the conserved hemagglutinin (HA) 
epitopes of broadly neutralizing antibodies to critical processes in the viral life cycle. HA-stem 
binding antibodies can act intracellularly by blocking fusion between the viral and endosomal 
membranes and extracellularly by preventing the proteolytic activation of HA. HA-head binding 
antibodies prevent viral attachment and release. These insights into newly identified ways by 
which the human immune system can interfere with influenza virus infection may aid the 
development of novel universal vaccines and antivirals. 
 
 
 
 
 
 
 
 
 
Material in this chapter has been accepted for publication in the journal PLoS One: 
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M., Kwaks, T., Otterstrom, J., Juraszek, J., van Oijen, A.M., Vogels, R. and Friesen, R. H. E. 
(2013) Mechanisms of hemagglutinin targeted influenza virus neutralization. PLoS One.; 
Accepted. 
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2.1 Introduction 
Influenza viruses continue to be a major cause of morbidity and mortality due to 
shortcomings of currently available vaccines and antivirals. Despite the well-established role of 
neutralizing antibodies in the defense against influenza virus infection [1,2] there is a lack of 
evidence on how such antibodies interfere with infection. Further understanding of their 
mechanisms of action, correlated to the structures involved, may guide the design of better 
vaccines and antivirals. 
Neutralizing antibodies mainly target the hemagglutinin (HA) protein, the major envelope 
glycoprotein of influenza viruses. The HA protein is synthesized as a single precursor protein 
(HA0) and requires cleavage by host serine proteases into two disulfide-linked subunits, HA1 
and HA2, for the virus to be infectious [3,4]. The HA1 “head” subunit mediates attachment of the 
virus to target cells through interactions with sialic acid receptors. After endocytosis of the virus, 
acidification of the endosomes triggers large conformational changes in the HA2 “stem” subunit 
leading to fusion of the viral and endosomal membranes and release of the viral genome into 
the cytoplasm, allowing the infection to progress.  
The vast majority of neutralizing antibodies in infected or vaccinated individuals 
interferes with attachment of the virus to cellular receptors by binding to exposed, highly 
variable loops that surround the receptor binding site. Antibodies binding to these regions are 
typically strain-specific and immunity following natural exposure or vaccination is mostly 
restricted to closely related strains. However, in the last five years, several human antibodies 
with remarkably broad neutralizing activity against influenza virus have been generated and 
characterized. Most of these broadly neutralizing antibodies (bnAbs), such as CR6261, F10, 
CR8020, FI6, and CR9114, were shown to bind to epitopes in the HA stem which are highly 
conserved among various influenza virus subtypes and have heterosubtypic neutralizing activity 
[5–10]. Others, like CH65, 5J8, CR8033, and C05, bind (close) to the receptor binding site on 
the HA head and show broad neutralizing activity within one subtype, or neutralize selected 
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isolates from several subtypes [10–13]. Many of these bnAbs have been shown to have 
therapeutic efficacy in animal models [5,7–10,12,14,15] and several are being developed as 
monoclonal antibody therapies. The broad activity of both groups of bnAbs is a result of the high 
level of conservation of their respective epitopes, which in turn appears to be caused by 
structural constraints imposed on the HA protein by the necessity to retain its key functions; 
receptor binding and fusion. To understand the structural basis of the broad activity, much effort 
has been focused on the molecular characterization of the bnAbs and their epitopes with the 
ultimate goal of developing a universal vaccine against influenza virus [1,16–18]. Stem binding 
antibodies as well as head binding antibodies have multiple ways by which they can interfere 
with the viral life cycle [19–21]. Detailed knowledge on the mechanisms of action of bnAbs, as is 
presented here, is critical for understanding how the human immune system interferes with 
processes that are pivotal for influenza virus infection and spread. 
 
2.2 Results 
2.2.1 Stem-binding bnAbs are internalized by live cells in complex with viral particles, reach late 
endosomes, and prevent infection 
Stem-binding neutralizing antibodies have been postulated to inhibit the fusion process 
based on their interaction with the HA2 subunit and lack of activity in hemagglutination-inhibition 
(HAI) assays, which specifically detect antibodies that interfere with attachment of the virus to 
sialic acid receptors. Indirect evidence supporting this notion comes from biochemical studies 
showing that such antibodies can block the conformational changes of recombinant HA required 
for membrane fusion [6,8,10], or prevent the formation of syncytia in HA-expressing cells [7,22]. 
Such a mechanism of action implies that these antibodies are internalized together with the 
virus and reach late endosomes, but this has so far not been shown. By using fluorescence 
single particle tracking methods we investigated the fate of viral particles and bound antibodies 
during infection of live cells (Figure 2-1A) [23]. Movies of cells incubated with fluorescently 
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labeled CR8020 mixed with H3N2 virus, and CR6261 mixed with H1N1 virus (CR8020 and 
CR6261 specifically bind Group 2 and Group 1 influenza A viruses, respectively. Table A1-1), 
reveal that stem-binding antibodies are indeed internalized in complex with the virus and 
transported along the microtubule cytoskeleton (Figure 2-1B,C; Movies M1-1, M1-2). The joint 
and directed movement of internalized viruses and bound antibodies is evident from their high 
degree of co-localization over consecutive frames. This behavior was exclusively observed for 
viruses and bound stem-binding antibodies since head-binding antibodies prevent viral 
internalization to begin with and no evidence for the internalization of unbound antibody could 
be found (Figure A1-1A,B; Movies M1-3, M1-4). Furthermore, pulse-labeling with a dye sensitive 
for low-pH vesicles, combined with single particle tracking in cells, demonstrated that virus-
antibody complexes reach acidic late endosomes (Figure 2-1D,E). Prolonged tracking of cells 
that had internalized virus-antibody complexes allowed us to determine their individual fate. 
Following a pre-incubation with H3N2 virus, stem-binding bnAb CR8020 was observed co-
localizing with viral particles inside cells at early time points (Figure 2-1F, Table A1-2). Cells 
were imaged every 30 minutes for 15 hours after which they were fixed and probed for the 
expression of influenza nucleoprotein (NP), which was used as an indicator for infection. In cells 
that had internalized CR8020 in complex with the virus, no NP expression was detected (Figure 
2-1G), indicating that the bound bnAb successfully prevented infection. In contrast, a 
comparable number of particles led to full infection in the control experiment in which H3N2 
virus had been pre-incubated with a non-binding control antibody (Figure 2-1H,I). Similar results 
were obtained for the inhibition of infection by H1N1 virus following pre-incubation with CR6261 
(Figure A1-2). 
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Figure 2-1 – Stem-binding bnAbs are internalized into live cells in complex with viral particles, 
reach late endosomes, and prevent infection. A) Experimental layout. Fluorescently labeled 
viruses and antibodies were pre-incubated and subsequently added to live cells and tracked. 
Whether or not cells were eventually infected was determined by staining for influenza NP after 
tracking individual cells for 15 hours. B and C) Stills of movies (Movies M1-1 and M1-2) showing 
the joint and directed motion of R18-labeled A/Aichi/2/1968-X31 (H3N2) (red) and AF647-
labeled CR8020 (green) (B), and R18-labeled A/Puerto Rico/8/1934 (H1N1) virus (red) and 
AF647-labeled CR6261 (green) (C), along TubulinTracker-stained microtubules (white) of live 
MDCK cells (nucleus, blue) approximately 30 minutes after addition of the pre-incubated virus-
antibody mixtures. Dashed lines outline the trajectories of the virus-antibody complexes (red 
triangles) as seen in movies M1-1 and M1-2. D) A/Aichi/2/1968-X31 (H3N2) virus was pre-
incubated with AF647-labeled CR8020 (green) before addition to live MDCK cells labeled with 
LysoTracker (magenta) and imaged when virus-antibody complexes reached the perinuclear 
region. Arrows indicate co-localization of virus-antibody complexes with low-pH vesicles (white). 
E) As in (D), except that here A/Puerto Rico/8/1934 (H1N1) virus and AF647-labeled CR6261 
were used. F) R18-labeled A/Aichi/2/1968-X31 (H3N2) virus (red) was incubated with AF647-
labeled CR8020 (green) before addition to live MDCK cells expressing a GFP-cell tracer (grey 
cell outline). Virus-antibody complexes (co-localization shown in yellow, compare also split 
channels in the inset) were detected in live cells 30 minutes after inoculation. G) To determine 
whether internalized virus-antibody complexes prevent infection, the fate of individual cells was 
assessed by tracking them over night (imaged in 30 min intervals). 15 hours post-incubation 
(hpi) the same cells (including their progeny) were fixed and stained for expression of influenza 
nuclear protein (NP, blue). H) Incubation of R18-labeled A/Aichi/2/1968-X31 (H3N2) virus (red) 
with non-binding AF647-labeled CR6261 did not result in internalization of antibody. Only viral 
particles were detected in live cells 30 minutes after addition of the virus-antibody mixture and 
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(Figure 2-1 Continued) infection was  not prevented, as demonstrated by the expression of NP 
(blue) in these same cells 15 hours later I). Examples of progeny cells are indicated with 
numbers. Scale bars B-E equal 10 µm, F-I equal 25 µm. 
 
2.2.2 Stem-binding bnAbs prevent membrane fusion 
The finding that stem-binding bnAbs reach late endosomes in complex with the virus is 
congruent with the assumption that such antibodies can prevent infection by blocking fusion of 
the viral and endosomal membranes. To directly observe the interference of viral fusion by 
bnAbs, a single particle fusion assay was applied (Figure 2-2A). Hereto, the envelope 
membrane of virus particles were fluorescently labeled at a density of lipophilic dye molecules 
that led to fluorescence self-quenching [24,25]. Labeled viruses were subsequently incubated 
with various concentrations of stem-binding bnAbs (optionally fluorescently labeled). Virus-
antibody complexes were then bound to receptor proteins embedded in a target membrane and 
imaged. Upon lowering of the pH, HA molecules of individual viral particles incubated with a 
non-binding control antibody or low concentrations of bnAbs undergo conformational change 
and mediate membrane fusion. This event is observed as a rapid temporary increase in 
fluorescence signal (Figure 2-2B,C, yellow triangles; Movie M1-5). Increasing bnAb 
concentrations dramatically decrease the number of fusing virus particles (Figure 2-2D-G, Movie 
M1-6), demonstrating the direct inhibition of membrane fusion by stem-binding bnAbs.  
 
2.2.3 Preventing proteolytic cleavage of HA is an additional mechanism of neutralization for 
some stem-binding bnAbs 
The inhibition of the fusion between the virus and the endosome is a mechanism shared 
by all neutralizing stem binding bnAbs described to date. Inhibiting the cleavage of HA0 into 
HA1 and HA2 fragments removes the fusogenic potential of HA and is a second mechanism 
adding to the potency of some of the stem binding Abs. Stem-binding bnAbs CR8020 and FI6 
recognize epitopes which partially overlap with the fusion peptide and bind close to the cleavage  
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Figure 2-2 – Stem-binding bnAbs prevent membrane fusion in an in vitro single particle fusion 
assay. A) Assay setup in microfluidic chamber mounted on an inverted fluorescent microscope. 
(B and D) Stills of movies of individual R18-labeled A/Aichi/2/1968-X31 (H3N2) or (C and E) 
A/Puerto Rico/8/1934 (H1N1, Movie M1-5 and M1-6) virus particles (magenta) incubated with 
AF488-labeled bnAbs (green) and bound to sialic acid decorated proteins embedded in a 
supported lipid bilayer where they co-localize (white, merge). Upon lowering the pH from 7.4 to 
5.0 (t=0 seconds), viruses incubated with only 15 nM CR8020 or CR6261 undergo HA-mediated 
fusion with the target membrane, visualized as a rapid increase in signal due to fluorescence 
dequenching followed by diffusion of R18 molecules away from the fusion site (B and C, yellow 
triangles), whereas no fusion events occur when viruses are incubated with 1500 nM bnAbs (D 
and E). Scale bars equal 3 μm; illumination conditions and image contrast settings are identical 
in B-E. (F and G) The percentage of H3N2 and H1N1 particles undergoing fusion after the pH 
drop decreases with increasing concentrations of CR8020 and CR6261, respectively (black 
symbols). In contrast, high concentrations of bnAbs used as non-binding control antibody have 
no effect on the percentage of fusion (open symbols). 
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site of HA [8,9]. Both have been reported to not only inhibit the conformational change of HA, 
but to also prevent trypsin from cleaving the extracellular domain of purified HA in vitro [8,9]. To 
test the contribution of inhibiting HA cleavage on the potency of CR8020, we generated a batch 
of H3N2 virus of which the HA proteins were uncleaved by harvesting the virus after a single 
round of infection in the absence of trypsin. As expected, such ‘uncleaved’ virus was only 
infectious on MDCK cells after treatment with trypsin (Figure 2-3A). Next, we compared the 
potency of CR8020 against this virus treated with trypsin either before, or after addition of the 
antibody (Figure 2-3B). When CR8020 was added before cleavage, a nine-fold increase in 
potency was found compared to when antibody was added to previously cleaved virus (Figure 
2-3C,D). This difference shows that the in vitro neutralizing potency of CR8020 is based on 
prevention of both fusion and cleavage. However, although porcine trypsin is widely used to 
render influenza viruses infectious in cell culture, in human lungs cleavage is thought to be 
mediated by membrane-bound proteases such as TMPRSS-2, and -4 and Human Airway 
Trypsin [26] and potentially also by secreted proteases like tryptase Clara, miniplasmin, and 
ectopic anionic trypsin [3]. Human lung derived Calu-3 cells form polarized epithelia and 
express TMPRSS-2 and -4 [27]. These cells allow the propagation of influenza virus in the 
absence of trypsin, indicating that cellular serine proteases are capable of mediating cleavage 
of progeny virus (Figure A1-3A). Interestingly, uncleaved virus is not infectious when added to 
Calu-3 cells, suggesting that cell-associated proteases are unable to cleave the HA of 
‘incoming’ virus particles (Figure A1-3B). In order to compare the cleavage status of the HA on 
viral particles produced in the presence and absence of CR8020, we infected Calu-3 cells with 
H3N2 virus and added the antibody two hours later. In this way we prevented interference of the 
antibody with the initial infection, but allowed it to bind immediately to newly expressed HA 
molecules on the cell surface. Virus particles were harvested from the supernatant 20 hours 
post infection and analyzed by Western blot. Whereas in the presence of a non-binding control 
antibody (CR6261) a portion of the HA molecules on viral particles were cleaved, as indicated  
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Figure 2-3 – Blocking HA cleavage by CR8020 has an additive effect on virus neutralization in 
vitro. A) Expression of influenza NP (green) in MDCK cells (nuclei labeled with DAPI in blue) 16 
hours after inoculation with A/Wisconsin/67/2005 (H3N2) virus of which the HA was uncleaved 
(top) or cleaved by prior incubation with trypsin (bottom). B) Experimental layout to study the 
additive effect of cleavage inhibition on the potency of CR8020 in vitro. C) A/Wisconsin/67/2005 
(H3N2) virus was either first incubated with trypsin and then with a serial dilution of neutralizing 
antibody (i.e. CR8020 after trypsin), or the virus was first incubated with serial dilutions of 
antibody and then treated with trypsin (i.e. CR8020 before trypsin). After 18 hours of infection, 
cells (nuclei stained with DAPI, blue) were stained for infection (NP expression, green). D) 
Graph shows numerical analysis of results; normalized percentage of infection versus antibody 
concentration was used to compare the IC50 values for each condition. Change in IC50 is 9.2-fold 
(95 % C.I. 6.8-12.3). E) Calu-3 cells (polarized human lung epithelia) were infected with cleaved 
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(Figure 2-3 Continued) A/Wisconsin/67/2005 (H3N2). Virus was washed away after 2 hours, 
and cells were incubated with test and control antibody for 18 hours in the absence of trypsin. 
Newly produced viral particles released into the culture supernatant were harvested and the HA 
cleavage status was analyzed by Western blot (using rabbit polyclonal anti-HA serum). The 
presence of the HA2 band is indicative for cleavage (the HA1 band is not efficiently stained by 
the polyclonal serum). 
 
by the presence of the HA2 band, CR8020 efficiently blocked HA cleavage at a concentration as 
low as 0.4 µg/mL (Figure 2-3E). Interestingly, not all HA molecules incorporated in viral particles 
need to be cleaved to allow spread of infection in Calu-3 cells, as apparent from the observation 
that virus spreading in these cells in the absence of trypsin (Figure A1-3A) contains both 
cleaved and uncleaved HA (Figure 2-3E). Nevertheless, in the presence of sufficient amounts of 
CR8020, newly budded viral particles contain only uncleaved HA molecules, rendering them 
non-infectious. This shows, in a physiological situation, that CR8020 inhibits cleavage and 
spread of influenza virus and that a single type of antibody can act intra-cellularly (fusion 
inhibition) as well as extra-cellularly (cleavage inhibition). 
 
2.2.4 HA head-binding antibodies not only block attachment, but also viral egress 
Head-binding neutralizing antibodies are well-documented to prevent viral attachment to 
the receptor. However, we have recently described two bnAbs, CR8033 and CR8071, which 
bind to the globular head of influenza B HA and are able to inhibit viral egress [10]. Whereas 
CR8033 also interferes with attachment of the virus to its cellular receptor, egress inhibition 
appears to be the only neutralization mechanism of CR8071. Since both head- and stem-
binding antibodies can bind to HA on the surface of infected cells (Figure A1-1C), we 
hypothesized that egress inhibition is a more common mechanism of action for antibodies 
directed against HA of influenza A and B. To test this, cells were infected and three hours later, 
various stem- and head-binding antibodies were added (Table A1-1). Delaying the addition of 
antibodies ensured unhindered initial infection and allowed assessment of the effect on egress 
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only. Twenty hours after infection, the amounts of newly produced viral particles present in the 
supernatants and cell lysates were analyzed. Since the presence of the neutralizing antibodies 
would interfere with assays assessing virus titers (e.g. TCID50), we used Western blot analysis 
to determine the amount of virus. As observed with influenza B specific antibodies CR8033 and 
CR8071, the presence of head-binding antibodies against influenza A viruses of the H1N1 
(CR9020, CH65 and 2D1) and H3N2 (CR8057) subtypes led to a significant reduction in the 
amount of viral particles released into the supernatant (shown by the absence of HA), while the 
production and accumulation of HA in the cell was not affected (Figure 2-4A,B and Figure A1-
5A). In contrast, the presence of HA stem-binders (CR6261 and CR8020) had no effect on the 
amount of viral particles released into the supernatant. Thus, egress inhibition appears to be a 
common mechanism of antibodies directed against the head region of HA of both influenza A 
and B viruses. Since head-binding antibodies are dominant in the response to infection or 
vaccination, we were interested to see whether polyclonal serum (besides the well-documented 
inhibition of receptor interaction) could also inhibit viral egress. Indeed, addition of HA-specific 
polyclonal mouse serum to infected cells caused a concentration dependent reduction of viral 
particles in the supernatant, without affecting the accumulation of HA in the cell (Figure 2-4C).  
Confirmation that head-binding antibodies inhibit egress comes from Scanning EM 
(SEM) images showing that whereas separate budding particles are present at the surface of 
infected cells in the presence of stem-binding antibody CR6261, large aggregates of particles 
are visible in the presence of each of the head-binding antibodies (Figure 2-4E and Figure A1-4, 
A1-5C). Transmission EM (TEM) images further reveal that the aggregated virions resemble 
fully formed free virus particles, with an electron dense core due to the vRNPs and spike 
proteins on the surface (Figure 2-4F,G and Figure A1-4, A1-5D,E). Moreover, completely 
formed viral particles surrounded by an endosomal membrane were detected in the cytoplasm 
near the surface, suggesting that un-budded particles can be re-internalized (red triangles in  
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Figure 2-4 – HA head binding antibodies inhibit influenza virus egress. (A) Calu-3 cells were 
infected with A/Puerto Rico/8/1934 (H1N1) and 3 hours later stem-binding antibody CR6261 or 
head-binding antibody CH65 was added. Twenty hours later, the amounts of HA present in the 
cell supernatant (S) and lysate (L) were analyzed by Western blot (HA0 band shown). (B) As in 
(A) except that cells were infected with A/Wisconsin/67/2005 (H3N2) virus and stem- and head-
binding antibodies CR8020 and CR8057, respectively, were used. (C) Naïve mice were 
immunized and boosted twice with DNA encoding the HA of influenza A/Brisbane/59/2007 
(H1N1) virus. Serum was collected and added to MDCK cells 3 hours after infection with the 
same virus. The amount of newly produced particles in culture supernatants and cell lysates 
were analyzed 20 hours later by Western blot (HA0 band shown). As positive and negative 
controls 1 µg/mL of CR9020 and CR8057 were included, respectively. (D) Fab fragments of 
head-binding antibodies CH65 and CR8057 were added 3 hours after infection of MDCK cells 
with A/Puerto Rico/8/1934 (H1N1) and A/Wisconsin/67/2005 (H3N2) virus, respectively, and 20 
hours later the amounts of HA present in the supernatant were analyzed as above. (E) SEM 
images of the surface of MDCK cells infected with influenza A/New Caledonia/20/1999 (H1N1), 
A/Wisconsin/67/2005 (H3N2), or influenza B/Florida/04/2006 virus and subsequently incubated 
(from 3 hours post infection) with CR6261 (50 µg/mL, 333 nM), CH65 (10 μg/mL, 67 nM), 
CR8057 (0.5 µg/mL, 3 nM) or CR8033 (2.5 μg/mL, 17 nM) respectively. Representative images 
of three independent experiments are shown. Scale bar 1 μm. (F and G) As in (E) except TEM 
images of ultrathin sectioned MDCK cell (re-internalized particles indicated with red triangles). 
Scale bar in (F) 500 nm and in (G) 100 nm. 
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(Figure 2-4 Continued)  
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Figure 2-4G and Figure A1-5E). In all these aspects, the phenotype is similar to what is seen 
with the antiviral drug zanamivir, which inhibits egress by blocking the enzymatic activity of the 
neuraminidase (NA) protein (Figure A1-5C-E). 
We hypothesized that HA head-binding antibodies inhibit egress by cross-linking of 
newly formed virions to each other and to HA on the cell membrane. In line with this hypothesis, 
the presence of the monovalent Fab fragments of CR8057, CR8033 and CR8071 had no effect 
on the amount of HA in the supernatant of cells infected with H3N2 and influenza B virus, 
respectively (Figure 2-4D and Figure A1-5B). Interestingly however, the Fab fragment of CH65 
did result in a reduction of HA in the supernatant of cells infected with H1N1 virus, similar to the 
IgG molecule. Considering the phenotypic resemblance with zanamivir, one may speculate that 
CH65 prevents NA from performing its function through steric hindrance, rather than through 
cross-linking newly formed virions. However, it is also possible that all these antibodies inhibit 
egress in the same way (be it through hindrance of NA or otherwise), but that differences in 
affinity, or the orientation in which they bind to HA determines whether the Fab alone or the 
larger IgG molecule is required. Either way, our results show that many, if not all, head-binding 
neutralizing antibodies, next to preventing attachment to the receptor, also inhibit egress.  
 
2.3 Discussion 
The in vivo activity of antiviral antibodies is thought to be a combination of direct 
mechanisms of action (e.g. neutralization) and indirect mechanisms of action, generally 
mediated by immune cells (e.g. NK cells) or complement factors interacting with the Fc-tail of 
the bound antibodies and inducing cell toxicity [28,29]. In this study, we focused on the direct 
mechanisms of action of bnAbs as a consequence of their binding to different epitopes on HA. 
By using live cell imaging and infectious viruses we distinguish four physiologically relevant 
mechanisms by which anti-HA antibodies can interfere with the pivotal functions of HA and 
neutralize the virus: inhibition of receptor binding, inhibition of membrane fusion, inhibition of 
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HA0 cleavage and inhibition of egress. These mechanisms, being so diverse and tailored to 
different stages in the life-cycle of the influenza virus (Figure 2-5A), are not readily captured in a 
single assay format. Consequently, when assessing the potency of a particular antibody, 
antiviral, or a (universal) vaccine, it will be necessary to use various assays. Indeed, the use of 
HAI and standard microneutralization assays is one of the reasons why the existence of bnAbs 
has long gone undetected [30]. Likewise, some of the head-binding antibodies described 
previously may in addition to preventing attachment also inhibition egress [11,13,31–33]. 
Because the epitopes of the bnAbs studied here (and several others) are known, we can link 
their mechanisms of action to specific regions on the HA molecule (Figure 2-5B). Although this 
link is not absolute in the sense that only antibodies binding to these regions exert these 
mechanisms [34], the bnAbs show us highly conserved sites where interference with crucial 
processes involving HA is possible (Figure 2-5A,B). This information may be exploited to design 
broad-spectrum anti-influenza virus molecules since the broad reactivity of these antibodies 
means that antivirals mimicking their mechanisms of action will be broadly active, provided that 
they bind to the same highly conserved regions on HA.  
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Figure 2-5 – Mechanisms of action of bnAbs map to conserved regions on HA and 
thereby reveal conserved vulnerabilities of influenza virus. (A) Influenza virus life cycle 
highlighting the four distinct mechanism of actions of HA head-binding (green) and 
stem-binding (blue) bnAb. (Panel B, left) X-ray structure of an uncleaved H3 trimer 
(A/Hong Kong/1/68 PDB 1HA0) in a space filling representation. For clarity, only one 
monomer of the trimer is colored (HA1 green, HA2, yellow). The head region, 
comprising lectin and vestigial esterase domains, and the stem region, containing the 
fusion machinery, are indicated with dotted black lines. The receptor binding site is 
plotted in blue and the cleavage site in pink. The regions around these sites (solid 
orange lines) are the footprints of sialic acid and trypsin, respectively. To roughly 
estimate the trypsin footprint, a trypsin structure (PDB 1YF4) was docked on the HA 
cleavage site such that the cleaved HA arginine overlapped with the bound arginine 
from 1YF4. HA amino-acids within 5A from trypsin were then taken as an approximation 
of the footprint. (Panel B, right) Footprints, indicated by solid cyan lines, of the bnAbs 
studied here superimposed on HA: CH65 and CR6261 footprints are plotted on HA from 
A/South Carolina/1/1918 (PDB ID 3GBN), and the CR8020 footprint on A/Hong 
Kong/1/1968 HA (PDB ID 3SDY). For the flu B antibodies, the B/Brisbane/60/2008 
structure (PDB ID 4FQM) is used. Each of the HA structures has been colored with 
amino-acid conservation index, corresponding to their respective virus groups: H1 – 
group1, H3 – group 2 and B – entire influenza B. Conservation was calculated based on 
the NCBI flu database set as of December 2011, assuming a number of conservative 
substitutions [8]. Red color corresponds to more than 99 % conservation, white to less 
than 60 % conservation. Additional human antibodies of which the epitopes and/or 
mechanism(s) of action are known are indicated on the far right. 
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(Figure 2-5 Continued) 
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2.4 Materials and Methods 
2.4.1 Cell Culture  
Suspension PER.C6® (sPER.C6®) cells [35,36] were cultured in Adenovirus Expression 
Medium (AEM, Invitrogen) supplemented with 4 mM L-glutamine and passaged twice weekly. 
Cells were cultured at 37°C, 10 % CO2 in a shaking incubator. The canine kidney cell line MDCK 
(ATCC, CCL-34) was cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented 
with 10 % fetal bovine serum and 2 mM L-Glutamine and passaged twice weekly. The lung 
adenocarcinoma cell line Calu-3 (ATCC, HTB-55) was cultured in the same medium 
supplemented with Non Essential Amino Acids and passaged once a week. Cells were cultured 
at 37°C, 10 % CO2. All culture reagents were purchased from Invitrogen (Carlsbad). 
 
2.4.2 Viruses  
Purified wild type influenza viruses A/Puerto Rico/8/1934 (H1N1) and A/Aichi/1968-X31 
(6:2 reassortant of A/Puerto Rico/8/1934 with the HA and NA segments of A/Aichi/1968 (H3N2)) 
propagated in eggs were purchased from Charles River Laboratories and used for live cell 
imaging. Stock samples were certified to contain 2 mg of protein per mL and stored at -80 ºC. 
A/New Caledonia/20/1999 (H1N1), A/NYMC/X-181 (6:2 reassortant of A/Puerto Rico/8/1934 
with the HA and NA segments of A/California/07/2009 (H1N1)), A/Puerto Rico/8/1934 (H1N1), 
A/New Caledonia/20/1999 (H1N1), A/Brisbane/59/2007 (H1N1), A/Wisconsin/67/2005 (H3N2), 
A/Aichi/2/1968-X31 (H3N2), A/NYMC/X-161B (A/Puerto Rico/8/1934 with the HA and NA 
segments of A/Wisconsin/67/2005 (H3N2)), and B/Florida/04/2006 were grown by infecting 
sPER.C6® cells with virus at MOI 1x10-4 in infection medium (AEM and VP-FSM (2:1), 
supplemented with 2.6 mM L-glutamine and 3 µg/mL trypsin (all reagents from Invitrogen)). 
After 72 h of incubation, virus containing cell culture supernatant was harvested by 
centrifugation at 4000 g for 10 min. Virus aliquots were stored at -80 ºC. For colocalisation and 
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entry studies in live cells, A/New Caledonia/20/1999 and A/NYMC/X-161B were purified by 
ultracentrifugation at 27,000 rpm for 2 h at 4 ºC through a 25 % sucrose cushion. The virus 
pellet was resuspended in NTE buffer (150 mM NaCl, 10 mM Tris, 1mM EDTA), pH 7.4 
overnight at 4 ºC before aliquotting and storage at -80 ºC.  
Uncleaved viruses were produced by infecting sPER.C6® cells with cleaved virus at MOI 
2 for 2 h in infection medium without trypsin. Cells were subsequently washed extensively with 
10 % FBS in PBS and incubated in infection medium in the absence of trypsin. Virus 
supernatant was harvested by centrifugation at 4000 g for 10 min. All incubations were done at 
35 ºC, 10 % CO2, on a shaking platform. Uncleaved status of HA was confirmed by Western 
blotting after probing with H1-HA or H3-HA specific polyclonal serum and infection assays to 
confirm the absence of infection without prior treatment with 5 µg/mL trypsin for 30 min at 37 ºC. 
All viruses were specifically titrated to reach > 90 % infection in each of the experimental 
conditions. Controls confirmed the successful infection in every experiment. 
 
2.4.3 Antibodies (IgG expression, Fabs and polyclonal sera) 
Fully human IgG1 antibodies CR6261, CR8020, CR8033, CR8057, CR9020, CR11054, 
and CR11055 were constructed and expressed as described previously (Ekiert et al., 2011). 
Fab fragments were obtained by IdeS digestion of antibodies, followed by purification via protein 
G (GE Healthcare), cation exchange (MonoS, GE Healthcare), and gel filtration (Superdex200, 
GE Healthcare). All antibodies and Fab fragments were more than 97 % pure and monomeric. 
Influenza A nucleoprotein (NP) specific monoclonal mouse antibody was obtained from 
Abbiotec (clone 5D8) and for influenza B NP from Santa Cruz (sc-52027). Goat F(ab’)2 anti-
mouse- or anti-human Alexa Fluor conjugated secondary antibodies (Invitrogen) were used for 
fluorescent imaging at 2 µg/mL. HA specific rabbit polyclonal serum for Immunoblot analysis 
was obtained from Protein Sciences. Secondary HRP-coupled anti-rabbit F(ab’)2-fragment were 
purchased from Jackson Immuno Research Laboratories (111-036-047). Polyclonal sheep sera 
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directed against B/Florida/4/2006 (07/356, sheep 478 and 479) were obtained from the NIBSC 
and derived from sheep immunized with the respective purified HA. HA-specific polyclonal 
serum was derived from mice immunized intramuscularly three times at a 3-week interval with 
50 µg plasmid DNA encoding full-length A/Brisbane/59/07 HA, codon-optimized for mammalian 
expression, mixed with 50 µg plasmid DNA encoding murine Granulocyte Macrophage-Colony 
Stimulating Factor (GM-CSF). 
In all experiments antibodies were either used at a range of concentrations or at 
sufficiently high concentration to neutralize the virus under the given experimental settings. This 
was confirmed by neutralization controls in every experiment. Imaging also confirmed that the 
used antibody concentrations were sufficient to binding nearly 100 % of viral particles including 
infectious and potentially non-infectious particles (Figure 2-1, Figure A1-1, Table A1-2). 
 
2.4.4 Virus labeling 
Purified and concentrated viruses were diluted in HNE buffer (5 mM Hepes, 140 mM 
NaCl, 0.2 mM EDTA, pH 7.4) for labeling. The lipophilic fluorescent dye, Octadecyl Rhodamine 
B chloride (R18, Molecular Probes) dissolved in DMSO or DMSO alone as a mock labeled 
control was added to the samples to a final dye concentration of 1-2µM and 0.4-0.5 % DMSO. 
The samples were mixed for 2-3h at room temperature, protected from light. Unincorporated 
dye was removed by passing the virus-dye solution through a PD-10 desalting column (GE 
Healthcare). Fractions containing labeled virus were pooled and labeling verified by 
fluorescence microscopy.  
To confirm that labeling did not affect the infectivity of viruses, labeled- and mock-
labeled virus samples were compared in imaged based infection assays (Figure A1-6). Only 
batches of labeled virus showing less than 2 fold differences in titer were used. 
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2.4.5 Antibody labeling 
For imaging studies, HA-specific monoclonal antibodies were fluorescently labeled 
according to manufacturer’s guidance with the amine reactive dyes (Molecular Probes) Alexa 
Fluor 488 (AF488) or Alexa Fluor 647 (AF647). Briefly, dye dissolved in DMSO was added to 
antibodies diluted in sodium bicarbonate buffer to a basic pH. For each antibody different dye 
concentrations where tested to avoid over-labeling. Contents were mixed and incubated for ~2h 
protected from light. Free dye was removed from the sample by desalting and buffer exchange 
using PD-10 sephadex G-25 columns (GE Healthcare). Antibodies were labeled with 3-8 dyes 
per IgG molecule.  
The biological activity of all labeled antibodies was confirmed and compared to 
unlabeled antibodies in viral neutralization assays before they were used in imaging 
experiments. Only batches of labeled antibodies showing less than 2 fold differences in titer 
where used. 
 
2.4.6 Virus Neutralization Assay (VNA) 
MDCK cells were seeded on the day of experiment at 40,000 cells/well into 96-well flat 
bottom plates. Antibodies were serially diluted, mixed with an equal volume of viral inoculum 
and incubated for 2 h at 37 ºC in  medium (DMEM supplemented with 2 mM L-glutamine and 3 
µg/mL trypsin-EDTA). The mixture (~100 TCID50/well) was then added to confluent MDCK 
monolayers in quadruplicate. Cells were cultured for 72h before supernatant was added to an 
equal volume of 1 % Turkey red blood cells and incubated for 1h at room temperature in a 96-
well V-bottom plate. The absence of hemagglutination was defined as protection. Titers were 
determined using the Spearman-Kärber formula. 
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2.4.7 Hemagglutination inhibition (HI) Assay 
Virus was diluted to 8 HA units/50µL and 25µL was combined in quadruplicate wells with 
an equal volume of antibody serially diluted in PBS. Plates were incubated for 1h at 37 ºC in 96-
well V-bottom plates. 50 µL of 1 % Turkey red blood cells was then added to each well and 
incubated for 1h at room temperature. Button formation was scored as evidence of 
hemagglutination inhibition. Titers were determined using the Spearman-Kärber formula. 
  
2.4.8 Imaging 
All experiments were performed using black flat bottom 96-well imaging plates (BD 
Falcon) which were sealed with oxygen permeable film (Sigma Aldrich) before imaging. Images 
were taken after laser-based auto-focusing using a Pathway 855 high content imager (Becton 
Dickinson) equipped with different objectives (Olympus: 4X 0.16 NA, 20X 0.75 NA, and 40X 
0.90 NA). Movies were taken with the 40X objective at4 frames/s while alternating between two 
channels over the duration of 3-5 min. For the overnight tracking of cells images were 
automatically taken at pre-defined positions over the duration of ~15 h at ~30 min intervals. 
Confirming infection (NP expression) after fixation and staining of the cells was carried out at 
the same pre-defined positions with the 40X objective, and also throughout the well with a 20X 
objective to determine the percentage of infected cells. Images of individual channels where 
overlaid and movies were compiled using ImageJ software [37]. Due to limited recording speed 
and alternating channels the registration of fast moving particles is not perfectly synchronized 
leading sometimes to the artificial separation of virus and antibody signal in adjacent movie 
frames. To determine the percentage of infected cells, image channels (e.g. cell nucleus and 
cytoplasm) were analyzed and segmented using Attovision software (Becton Dickinson) 
followed by the IC50 value calculation by SPSS software (IBM) and graphs plotted using 
GraphPad Prism software. 
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2.4.9 Imaged based infection assay 
Cells were infected with an MOI of 3 for at least 15 h and then rinsed twice with PBS 
followed by fixation with 80 % ice cold acetone for 10 min. After removing the acetone and 
drying the wells the plates were washed 3 times with 300 µL per well wash buffer (PBS, 0.05 % 
Tween-20) then incubated for 1 h with mouse anti-influenza NP antibody (1 µg/mL) in antibody 
dilution buffer (1 % BSA, 0.1 % Tween-20 in PBS) at room temperature. After washing three 
times with 300 µL wash buffer the wells were incubated with 2 µg/mL goat-anti mouse AF488 
labeled secondary antibody and 1 µg/mL 4',6-diamidino-2-phenylindole (DAPI) for 1 h. After 
three wash steps buffer was replaced with 100 µL PBS containing 0.25 mM Sodium Azide, 
plates sealed, and imaged. 
 
2.4.10 HA-specific staining of particles and infected cells 
All staining steps described below were performed for 1h at room temperature in the 
dark. Viral particles: R18-labelled A/New Caledonia/20/99 (H1N1), A/Puerto Rico/8/34 (H1N1), 
A/NYMC/X-161B (H3N2) or A/Aichi/68-X31 (H3N2) virus was diluted in CO2-independent 
medium (Invitrogen) supplemented with 2 mM L-glutamine and spotted onto glass bottom 96-
well imaging plates for 30 min at 37 ºC before washing with PBS and staining with anti-HA 
specific antibodies at 5 µg/mL in 1% BSA/PBS, followed by detection with 2 µg/mL goat anti-
human-Alexa Fluor 647 secondary antibody. Wells were washed four times with medium before 
replacing with CO2-independent (phenol red free) medium (Invitrogen) supplemented with 2 mM 
L-glutamine for imaging.  
Infected cells: MDCK cells were infected overnight with virus serially diluted in DMEM 
supplemented with 2 mM L-glutamine before fixing with either 3% paraformaldehyde (PFA) in 
PBS or ice cold 80% acetone for 10 min. Staining was carried out as mentioned for viral 
particles under both permeabilizing (acetone) and non-permeabilizing (PFA) conditions. Under 
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permeabilizing conditions, cells were also stained for influenza NP to confirm the presence of 
viral infection. Nuclei were counterstained with 0.1 µg/mL DAPI. 
 
2.4.11 Virus entry inhibition 
An immunofluorescence entry assay was designed to assess the ability of HA head-
binding antibodies to prevent viral internalization into cells. R18-labelled H1N1 or H3N2 (MOI 3) 
was pre-incubated with Alexa-Fluor 647 labeled HA-specific antibodies to a final concentration 
of 30 µg/mL (200 nM) for 1h at 37 ºC before being added to MDCK cells seeded in 96-well 
black-sided imaging plates (Becton Dickinson). MDCK cells stably expressing a GFP cell 
marker (OriGene, Rockville, USA) were incubated with virus for 15 min at 37 ºC followed by 
treatment of the cells with 0.05 U/well neuraminidase (Sigma) for 5 min at 37 ºC to remove non-
internalized viruses. Cells were washed twice with PBS before imaging live in CO2-independent 
medium supplemented with 2 mM L-glutamine.  
 
2.4.12 Virus internalization 
An immunofluorescence internalization assay was designed to assess the ability of HA 
stem-binding antibodies to be internalized into cells in complex with infectious virus particles. A 
pre-determined amount of R18-labelled H1N1 or H3N2 virus giving rise to 90-100 % infection 
under the following experimental conditions was pre-incubated with Alexa-Fluor 647 labeled HA-
specific bnAbs to a final concentration of 30 µg/mL (200 nM) for 1h at 37 ºC. MDCK cells were 
treated for 5min at 37 ºC with the cell permeant nuclear counterstain Hoechst 33342 (10 µg/mL, 
Invitrogen), followed by treatment with 3µM tubulin tracker green reagent (Molecular Probes) for 
30 min at 37 ºC to stain the microtubules. Cells were then incubated for 15 min at 37 ºC with the 
prepared virus-antibody mixture, followed by treatment with 0.05U/well neuraminidase (Sigma 
Aldrich) for 5 min at 37 ºC. All reagents were diluted in CO2-independent medium supplemented 
with 2 mM L-glutamine. Cells were washed four times in medium before imaging live in CO2-
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independent medium supplemented with 2 mM L-glutamine and the glucose oxidase/catalase 
oxygen scavenging system (GODCAT, 1 % glucose, 0.5 mg/mL glucose oxidase, 40 µg/mL 
catalase; all reagents from Sigma) to prevent photobleaching [38]. To avoid a decrease in cell 
viability and viral replication the exposure with light and oxygen scavenging system was limited 
to two hours and the medium then replaced. Movies were captured at manually selected 
positions with a 40X 0.90 NA objective. 
 
2.4.13 Virus colocalization 
Mock-labelled H1N1 or H3N2 virus was pre-incubated with Alexa-Fluor 647 labeled anti-
HA bnAbs to a final concentration of 30 µg/mL (200 nM) for 1h at 37 ºC. Immediately prior to 
infection, MDCK cells were treated for 5 min at 37 ºC with the cell permeant nuclear dye 
Hoechst 33342 (Invitrogen) at 10 µg/mL. Cells were then infected with the virus-mAb mixture 
(MOI 3) mixed 1:1 with 100 nM Lysotracker Red reagent (Molecular Probes) for 15 min at 37 ºC, 
followed by treatment with 0.05 U/well neuraminidase (Sigma Aldrich) for 5 min at 37 ºC. All 
reagents were diluted in CO2-independent medium supplemented with 2 mM L-glutamine. Cells 
were washed four times with medium before imaging live in CO2-independent medium 
supplemented with 2 mM L-glutamine and the glucose oxidase/catalase oxygen scavenging 
system.  
 
2.4.14 Colocalization analysis 
To determine percentage colocalization between R18-labelled virus and AF647-labelled 
antibodies, images were analyzed using ImageJ software with the particle analysis plugin – 3D 
Object Counter [39]. 
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2.4.15 Overnight cell tracking 
A pre-determined amount of R18-labelled H1N1 or H3N2 virus giving rise to 90-100 % 
infection under the following experimental conditions, was pre-incubated with Alexa-Fluor 647 
labeled anti-HA bnAbs to a final concentration of 30 µg/mL (200 nM) for 1h at 37 ºC. MDCK 
cells stably expressing a GFP cell marker, were seeded into 96-well black-sided imaging plates 
and subsequently infected with the virus-mAb mixture for 15min at 37 ºC, followed by treatment 
with 0.05 U/well neuraminidase for 5 min at 37 ºC. All reagents were diluted in CO2-independent 
medium supplemented with 2 mM L-glutamine. Cells were washed extensively before imaging 
live for 15 h in CO2-independent medium supplemented with 2 mM L-glutamine and 1 % FBS. 
The following day, cells were fixed with ice cold 80 % acetone for 10min and stained for 
influenza A NP expression as previously described to confirm infection inhibition in the presence 
of neutralizing antibody. 
 
2.4.16 Single particle fusion assays  
Fusion experiments were executed as described in the supporting information. Briefly, 
R18-labeled viruses were pre-incubated with either AF488 labeled or unlabeled bnAb. A 
proteoliposome solution was added to the microfluidic flow cell to form a glass-supported planar 
lipid bilayer. Virus-bnAb mixture was added to the flow cell and viruses were immobilized onto 
the planar lipid bilayer (Figure A1-2). Fluorescein-labeled streptavidin was then added followed 
by washing. Viral fusion was initiated by rapid injection of a pH5 buffer and recorded using an 
inverted TIRF microscope setup. Fusion events were detected as a sharp temporary increase in 
the fluorescence. Fusion percentage was calculated as the number of fusion events divided by 
the total number of virions observed in a field of view.  
 
73 
 
2.4.17 HA-cleavage inhibition  
To study the additive effect of HA-cleavage inhibition, uncleaved A/Wisconsin/67/05 
(H3N2, MOI 3) was either first incubated with trypsin (Gibco) at 1.5 µg/mL, followed by 
incubation with antibodies serially diluted from 0 - 10 µg/mL (0 - 67 nM), or, first incubated with 
antibodies serially diluted from 0 - 10 µg/mL, followed by incubation with trypsin at 1.5 µg/mL. 
FBS was added to a final concentration of 10 % after trypsin treatment to inhibit trypsin activity 
and all incubation steps were carried out for 45 min at 37 ºC. Virus-antibody mixtures were then 
added to confluent MDCK monolayers and allowed to incubate overnight. HA cleavage status 
was verified by Western blot analysis with a portion of the treated samples (data not shown). 
Cells were fixed with ice cold 80 % acetone for 10 min and stained for influenza A NP 
expression as described above. Calu3 cells were infected with cleaved A/Wisconsin/67/05 
(H3N2) or A/New Caledonia/20/99 (H1N1) with an MOI 3 in DMEM supplemented with 2 mM L-
Glutamine. Three hours post infection cells were washed twice with PBS and incubated 
overnight with a concentration range (0-100 µg/mL) of test or control antibody in 50 µL medium 
and incubated overnight. The following day, the medium of three replicate wells was pooled and 
spun down for 10 min at 200 x g to remove cell debris. One well from each triplicate was used to 
obtain cell lysate by resuspending the cell layer in 150 µL lysis buffer (50 mM Tris-HCl, 150 mM 
NaCl, 5 mM EDTA, 1 % Triton X-100, pH 7.5). As a positive control for HA cleavage, 
supernatant from cells infected with virus in the absence of antibody was used and treated with 
5 µg/mL trypsin for 30 min at 37 ºC for complete HA cleavage. Samples were then subject to 
Western blot analysis. To confirm viral infection, plates were also fixed and stained with ice cold 
80 % acetone for 10 min and stained for Influenza A NP expression.  
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2.4.18 Statistical analyses 
Single-particle fusion, and cleavage inhibition data were analyzed using a 4-parameter 
logistic model in which for variance stabilization the ‘transform both sides’ approach was used 
as described previously [40]. For transformation, a logit transformation was selected:  
 
 
 
where F represents the proportion fusing virions over total virions, D and A represent 
respectively the upper and lower asymptote, B represents a slope factor, X represents the 
antibody concentration (nM) and C represents the inflection point (estimated on a log10 scale). 
For stabilization of the model fusion data obtained without antibody present was placed at an 
infinite low antibody concentration. Conditions with no events were set to 1 fusion event.  
To be able to determine the effect of trypsin on the potency of CR8020, the model was 
modified to include an indicator variable in the estimation of the inflection point that takes the 
value 0 for data before trypsin and a 1 for data after trypsin (C + ID*∆c). The difference, in 
location, between the dose-response curves is then indicated by c and represents a difference 
in potency of the mAb under these conditions. Statistical analysis was performed using IBM 
SPSS statistics (version 20).  
 
2.4.19 SDS-PAGE and Immunoblotting  
Relative amounts and cleavage status of hemagglutinin in the samples were determined 
by Western blotting. First 2 µL reducing agent (Invitrogen) and 5 µL 4x loading buffer (Ivitrogen) 
was added to 13 µL sample followed by 10 min incubation at 90 ºC. Proteins in each sample 
were resolved by 4-12% Bis-Tris SDS-PAGE (NUPAGE, Invitrogen) followed by trans-blotting 
onto a PVDF membrane (0.45 μm, P-Immobilon, Millipore, Massachusetts) in transfer buffer 
(NUPAGE, Invitrogen) containing 5 % methanol at 30 V for 60 min. The membrane was blocked 
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by incubation in blocking solution containing 4 % non-fat dry milk (Bio-Rad) in TBST (20 mM 
Tris-HCl, 150 mM NaCl, 0.2 % Tween 20) overnight at 4 ºC. The blocked membrane was 
incubated with rabbit anti-HA1 or -HA3 polyclonal serum, 60 ng/mL for 1 h at room temperature 
and washed 3 times with TBST. Subsequently, the membrane was incubated with goat anti-
rabbit peroxidase conjugated F(ab’)2 fragment (1:3,000 v/v) for 1 h at room temperature. After 
three washes with TBST, the membranes were incubated for 5 min with ECL-Plus substrate 
solution (GE Healthcare). Stained proteins were visualized using Amersham Hyperfilms (GE 
Healthcare).  
 
2.4.20 Egress inhibition assay  
Four hours prior to the experiment, 40,000 MDCK cells per well were seeded in 
DMEM/glutamine into flat bottom 96 well imaging plates (BD Falcon). The amount of virus 
needed to achieve 90-100 % infection was titrated in a separate experiment. The required 
amount of virus was added to the cells washed twice with PBS and incubated at 37 °C, 5 % 
CO2. After three hours, the supernatants were removed and cells were washed twice with PBS 
to remove non-internalized virus particles. Cells were replenished with 50 µL infection medium 
containing serial diluted antibodies. After incubation for 16 – 18 h at 37 °C, 5 % CO2, the 
supernatants were harvested, spun down to remove debris (200 x g for 10 min). The remaining 
cells were lysed (Tris HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 1 % (v/v) Triton-X). Lysate and 
supernatant samples were treated with loading buffer and reducing agent, incubated for 10 min 
at 90 °C, and analyzed by SDS-PAGE and Western blot to determine the amount of virions 
produced and released into the supernatant. As a control for infection, replicate identically-
treated wells were fixed with 80 % acetone and the number of infected cells was assessed 
using the imaged based infection assay (data not shown).  
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2.4.21 Scanning electron microscopy of influenza virus infected cells  
MDCK cells seeded on coverslips (sterile 15 mm thermanox plastic, Thermo Scientific, 
#174969) were infected with a pre-determined amount of virus (separate experiment) to yield 
90 – 100 % infected cells 18 h post infection. Three hours after the initial infection, the 
supernatants were removed; cells were washed thrice with PBS, before media containing the 
indicated concentration of antibodies were added. After an additional 15 h, the cell culture 
medium was removed and cells were fixed in phosphate buffered 2.5 % glutaraldehyde buffer 
pH 7.4 for 1 – 2 h and stored at 4 °C until further analysis. The coverslips were rinsed in PBS 
followed by distilled water and then dehydrated in 70 %, 95 %, anhydrous ethanol and finally in 
acetone and subjected to critical point drying in acetone and liquid CO2. Finally, the cells were 
mounted on alumina stubs and coated with a thin layer of carbon and examined in a Zeiss Ultra 
55 SEM field emission microscope using an accelerating voltage of 3 keV and InLens detection 
at Vironova, Sweden.  
 
2.4.22 Transmission electron microscopy of influenza virus infected cells  
MDCK cells seeded on coverslips were infected with a pre-determined amount of virus 
(separate experiment) to yield 90 – 100 % infected cells 18 h post infection. Three hours after 
the initial infection, the supernatants were removed; cells were washed thrice with PBS, before 
media containing the indicated concentration of antibodies were added. After an additional 15 h, 
the cell culture medium was removed and cells were fixed in phosphate buffered 2.5 % 
glutaraldehyde buffer for 1 – 2 h and stored at 4 °C until further analysis. The samples were 
subsequently scraped and pelleted using a table top centrifuge, before being washed twice in 
0.1 M phosphate buffer and chemically post-fixed with 2 % osmium tetroxid (OsO4) in 0.1 M 
phosphate buffer for 2 h at 4 °C followed by stepwise dehydration with ethanol, followed by LX 
112-embedding by stepwise infiltration and polymerization at 60 °C. Microtome sections of 
~ 60 nm were prepared and applied to one-slot formvar nickel grids. The sections were finally 
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post-stained with uranyl acetate and Reynold’s lead citrate before being imaged with a FEI 
Tecnai 10 electron microscope run at 100 kV accelerating voltage using a 2k x 2k Veleta CCD 
camera (Olympus Soft Imaging Systems) at Vironova, Sweden. 
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Chapter 3 
Single-Particle Studies Quantitatively Relate Influenza Membrane-Fusion Kinetics 
with Stoichiometry of Neutralizing Antibodies 
 
Abstract 
Neutralization of influenza virus infectivity as a direct action of antibody binding is of key 
importance in the design of next-generation vaccines and prophylaxes.  The two novel 
antibodies CR6261 and CR8020 have recently been shown to inhibit influenza A hemagglutinin 
(HA)-mediated membrane fusion through epitope binding and efficiently neutralize infection [1].  
Here, we directly correlate the number of antibodies or Fab fragments bound to a virion with that 
virus particle’s capacity for membrane fusion using single-particle fluorescence microscopy. 
Individual virus particles bound by labeled antibodies or their Fab fragments are visualized 
during their fusion to a planar supported bilayer.  The fluorescence intensity arising from the 
virus-bound antibodies or Fab is directly proportional to the number present on the viral surface 
and so provides access to the stoichiometry required for fusion inhibition.  We find fusion 
inhibition by both antibody and Fab with stoichiometries that leave large numbers of unbound 
HA epitopes on the viral surface.  Simultaneous kinetic measurements of the fusion process 
reveal that those few particles capable of fusion at high antibody/Fab coverage display 
significantly slower hemifusion kinetics. Overall, our results support a membrane fusion 
mechanism requiring the stochastic, coordinated action of multiple HA trimers and a model of 
fusion inhibition by stem-binding antibodies through disruption of inter-HA coordination.  
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3.1 Introduction 
Antibodies neutralizing the infection from a broad spectrum of influenza viruses are 
seeding new hopes for more effective – and perhaps universal – vaccines to thwart annual 
influenza A epidemics [2-5].  Influenza is an enveloped virus decorated with large numbers of 
the fusion protein hemagglutinin (HA) embedded in its viral membrane (Figure 3-1A).  HA is a 
protein of keen interest because it is a critical antigenic target of the immune system and 
antibodies targeting it can exhibit direct neutralizing activity [1,6-9][9].  Furthermore, HA 
represents a model system for the study of protein-mediated membrane fusion [10].  Decades of 
investigation have elucidated the main principles of HA-mediated membrane fusion, but a 
number of open questions still remain [10] and the ways HA-antibody interactions can disrupt 
the fusion process are still in need of thorough characterization [11,12].  
The HA protein is a homotrimeric transmembrane protein with each protomer consisting 
of two separate, disulfide-linked domains [13,14].  The HA1-containing “head” domain distal 
from the viral envelope contains a binding site for sialic acid moieties that allow a virus to bind to 
a target cell.  The HA2-containing “stem” is comprised mostly of the envelope-proximal 
ectodomain and the transmembrane domain.  During infection, influenza viruses are initially 
taken into a cell by clathrin-mediated endocytosis.  In response to the low pH of late 
endosomes, the stem undergoes drastic conformational changes that serve to mediate fusion 
between the viral envelope and the endosomal membrane to release the viral genome into a 
cell and initiate infection.  Influenza A HA is classified into 17 subtypes that are collected into 
two phylogenetically distinct groups [15,16] – Group 1 and Group 2 – and hence exhibits 
substantial antigenic drift.  Head-binding antibodies typically recognize variable loop regions 
surrounding the receptor site and thus show strain-specific neutralization [5,9,17], though some 
can neutralize a limited set of viral strains [18-20].  In contrast, stem-binding antibodies 
recognize an epitope region that is highly conserved between influenza strains [21] and possess 
a broad neutralization capacity that can span an entire phylogenetic group [6,7,18,22-24] or 
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even across the two groups [8,18,25].  Antibodies against such conserved regions are of 
interest for their use as anti-flu therapeutics and for rational design of vaccines, HA-binding 
proteins and small molecules [2-5,26]. 
Two well characterized broadly neutralizing, stem-binding antibodies are the Group 1 
HA-specific CR6261 and the Group 2 HA-specific CR8020 [6,7,22].  They are effective in 
neutralizing influenza infection from a broad range of strains both prophylactically and 
therapeutically in animal models [7,27].  We recently demonstrated that binding of HA by these 
antibodies directly resulted in inhibition of HA-mediated viral membrane fusion [1].  Due to 
epitope similarity, fusion inhibition is likely to be an effect shared by the other known broadly 
neutralizing, stem-binding antibodies C179, F10, FI6v3, 39.29, 81.39 and CR9114 [8,18,23-25].  
The ability of antibodies to block fusion confirms the accessibility of their membrane-proximal 
epitope on intact viruses despite the dense packing of surface proteins (Figure 3-1A), and was 
also recently shown by cryo-electron tomography [28].  An open question regarding stem-
binding antibodies is the binding stoichiometry required for virus neutralization.    
Neutralization stoichiometry is at least partly dependent on the binding affinity, Kd, for the 
antibody to its epitope [5,29]. Though of key importance to determining an antibody’s 
neutralization efficacy, Kd on the a viral surface in its structurally and physiologically relevant 
context is often not known. [5,30]. Moreover, virus pleiomorphy and high surface protein density 
can occlude many epitopes, blocking antibody accessibility and reducing avidity for the epitope. 
A previous stoichiometry measurement on influenza using quantification through radioisotope 
labeling of neutralizing antibodies found that infectivity could be reduced by 50% with as few as 
~50 antibody molecules, but reductions to 0.05% infectivity required more than 1200 antibodies 
[31].  These results are in line with multi-hit and coating models describing stoichiometry, which 
predict large numbers of epitopes must be bound for a virus to be neutralized, rather than 
single-hit models involving a critical site vulnerable to neutralization [11,12,32].  The antibodies 
used in these studies, however, were poorly characterized in terms of epitope mapping and their  
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Figure 3-1 – Experimental design and readouts. A) Transmision electron micrographs at 
45,000x of two influenza A viruses, H1N1 on top and H3N2 on the bottom. B) Schematic 
depiction of experimental design. Alexa 488-labeled IgG (or Fab) are bound to R18-labeled 
influenza A viruses (magenta-edged sphere). Viruses are then immobilized on a glass-
supported planar bilayer through interaction with glycophorin A; pH-sensitive fluorescein (pKa 
6.4) is also bound to the bilayer surface. Fluorescence is excited and detected via objective 
TIRF microscopy. Zoom-in: acidification of the virus particles causes membrane fusion to occur 
that results in escape of the R18 dye from the viral membrane into the target bilayer through a 
hemifusion intermediate and produces a dequenching signal. C) Left: false-color still frames 
from a fusion movie at time points before (upper) and 20 seconds after (lower) the pH drop; 
scalebar = 10 m. For each frame, the left half-image visualizes IgG/Fab (green spots, 50 nM 
incubation) and fluorescein (diffuse background), while the right half-image simultaneously 
visualizes the R18-labeled viruses (magenta) and their low pH-induced dequenching (white 
triangles). Right: image montage of the virus highlighted by the yellow square. Subsequent 
frames from the fusion movie show a virus covered with a sub-inactivating number of IgG 
molecules (green) fusing to the bilayer, seen as a flash of R18 intensity (magenta) followed by 
its diffusion outward (scalebar = 1 m). D) Fluorescence time trajectory for the highlighted virus 
in (C) where time t = 0 is set after the average green fluorescence intensity sharply decreases 
upon arrival of the fusion-inducing pH 5.0 buffer.  The virus-bound IgG/Fab fluorescence used 
for stoichiometry measurements is indicated by the dark-green box, located 1 second after the 
pH drop and enclosing 3 seconds worth of fluorescence information.  Hemifusion is observed for 
this virus particle by the abrupt increase in R18 fluorescence. The time to hemifusion, themi, 
occurs for this virus at t ≈ 30 seconds. 
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precise mechanism of action.  Furthermore, the traditional viral plaque assays that were used 
are prone to complicating factors, such as dependencies on cell type and cell confluency [11], 
and the potential to miss single-round infection [33].  Additionally, neutralization arose from a 
convolution of cell-binding inhibition, inhibition of membrane fusion, aggregation of virus 
particles and the abrogation of post-entry events that cannot be directly delineated from one 
another [9,12]. 
We previously adapted our single-particle viral fusion assay [34] to incorporate high 
concentrations of CR6261 and CR8020 to demonstrate that these antibodies act directly to 
inhibit HA-mediated membrane fusion [1].  The experimental design of the single-particle fusion 
assay described in [1] is extended to quantify the number of CR6261 or CR8020 antibodies 
(IgG) or their Fab-fragments (Fab) that must bind to a virus for membrane fusion to be inhibited.  
We find that under conditions of maximal hemifusion inhibition, virus particles rendered non-
fusogenic likely contain many HA trimers that are unbound and could be triggered by low pH. 
Furthermore, binding of the neutralizing IgG/Fab molecules causes a delay in the kinetics of 
membrane fusion.  The high temporal resolution and single-particle nature of our methodology 
are crucial in gaining access to this information and provide insight into the mechanism of HA-
mediated fusion that is difficult to obtain via conventional approaches [35]. 
 
3.2 Results 
3.2.1 Fluorescently labeled IgG and Fab inhibit hemifusion.   
Low pH-induced HA-mediated hemifusion of a virion to a planar target bilayer is 
visualized as a rapid fluorescence burst at the site of a virus particle, as depicted in Figure 3-1 
and previously described [34,36].  Prior to immobilization on the bilayer surface, R18 labeled 
viruses (A/Puerto Rico/8/34 H1N1 or A/Aichi/68-X31 H3N2) were incubated with the broadly 
neutralizing, stem-binding antibodies CR6261 or CR8020 (collectively: IgG), or their Fab 
fragments (crF6261 or crF8020, respectively), at varying concentrations. Viral infectivity 
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following R18 labeling was previously confirmed (Appendix 1), so that the viruses used here are 
infectious particles. Incubation conditions ensured that IgG/Fab binding equilibrium had been 
achieved prior to immobilization and dissociation over the course of the experiment was found 
to be negligible (Figure A2-1, Appendix 2).  Immobilization of the virus on the glass-supported 
bilayer was not hampered by IgG/Fab binding (Figure A2-2).  We have previously reported a 
sigmoidal, dose-dependent reduction in the hemifusion efficiency of H1N1 or H3N2 viral strains 
upon binding of these IgG that was influenza-group specific [1]. Here, the use of antibodies 
covalently labeled with pH-insensitive Alexa Fluor 488 dye molecules (CR6261af488 and 
CR8020af488, 5 dyes/IgG; Figure A2-3 and Table A2-1) also showed a dose-dependent 
reduction in the hemifusion efficiency (Figure 3-2A).  A similar sigmoidal dose-dependent 
decrease in hemifusion efficiency resulted from viral incubation with Alexa 488-labeled Fab 
fragments of these two antibodies (crF6261af488 and crF8020af488, 2.4 dye/Fab; Figure A2-3 
and Table A2-1).  Since hemifusion efficiency is reduced by Fab as well as IgG, we conclude 
that inhibition of influenza HA-mediated fusion does not require bivalent binding, but arises 
solely from epitope recognition. 
Separately, we found that viral content release was inhibited to a similar extent as 
hemifusion, indicating that hemifusion is a functional readout for full fusion (Figure A2-4).  Under 
conditions where few IgG were bound to the virus and full fusion occurred, antibody-labeled 
hemagglutinin proteins could be seen to diffuse into the target bilayer after successful content 
release (Movie M2-1), demonstrating successful merger of the viral membrane with the target 
supported bilayer. 
 
3.2.2 Maximal hemifusion inhibition by IgG binding occurs below full epitope occupancy   
The stoichiometry of IgG/Fab binding is determined as a quotient of two intensity 
measurements. The dividend is the integrated fluorescence intensity arising from virus-bound 
IgG/Fab immediately after the pH drop (Figure 3-1C), which is proportional to the number of  
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Figure 3-2 – Hemifusion inhibition and 
antibody stoichiometry.  In each panel IgG 
inhibition and binding data are in the left 
column graphs (solid fit lines), Fab data are 
in the right column (dashed fit lines); the 
upper rows are the H1N1 strain (blue) and 
lower rows are H3N2 (black).  Each data 
point represents a single experimental run, 
best-fit lines are in blue or black and their 
95% confidence bands are in light blue or 
grey. A) Hemifusion efficiency decreases as 
the concentration of neutralizing IgG or Fab 
is increased. B) The number of neutralizing 
IgG or Fab bound to virions increases as 
the concentration used for incubation with 
virus increases. C) Plot of hemifusion data 
(A) versus the number of IgG or Fab bound 
to the viral surface (B) allows for estimation 
of the number of IgG/Fab required for a 
given reduction in hemifusion efficiency.  Fit 
lines used are: logistic function (A), 
hyperbolic function (B) and a combination of 
these two (C) (Table A2-2 and Appendix 2).  
Fit lines in (C) are truncated at high 
coverage that correspond to the plateau 
values obtained in (A) and (B) at high IgG or 
Fab concentrations.    
 
88 
 
Table 3-1 – Summary of stoichiometric and kinetic results*  
Virus 
Neutralizing 
Molecule 
Number of IgG/Fab 
bound at maximal 
hemifusion 
inhibition 
Number of IgG/Fab 
bound at half-
maximal hemifusion 
inhibition  
Fractional 
occupancy at 
half-maximal 
inhibition ** 
Fold-increase of 
hemifusion time: 
upper plateau 
relative to lower  
H1N1 
CR6261 IgG 155  (107–202) 31   (8–69) 0.20  (0.04–0.48) 2.2  (1.6–3.0) 
crF6261 Fab 248  (158–338) 74   (39–119) 0.30  (0.12–0.55) 2.7  (1.6–4.5) 
H3N2 
CR8020 IgG 130  (112–149) 83   (62–107) 0.64  (0.46–0.84) 2.1  (1.5–2.9) 
crF8020 Fab 493  (394–592) 261 (192–340) 0.53  (0.36–0.73) 2.6  (2.2–3.0) 
* values in parenthesis report 95% confidence intervals. 
** calculated as the quotient of the number of IgG/Fab bound at half-maximal hemifusion inhibition and the number  
  bound at maximal hemifusion inhibition. 
 
IgG/Fab present. The divisor is the integrated intensity from individual IgG/Fab, which is 
obtained separately by visualizing the molecules under identical illumination conditions in the 
absence of virus and target bilayer (Figure A2-5).  Dividing these two intensity measurements 
provides the number of molecules bound to an individual virion. IgG/Fab labeling efficiency was 
>99% for IgG and ~90% for Fab (Figure A2-3 and Table A2-1).  Numbers of bound IgG/Fab 
were corrected for the presence of a small amount of unlabeled molecules using these 
percentages. The total internal reflection fluorescence (TIRF) conditions utilized were in a range 
where the fluorescence emanating from the virus-bound IgG/Fab was independent of TIR angle 
(Figure A2-5), while still allowing for suppression of background fluorescence and high signal-to-
noise. 
Figure 3-2B shows a sigmoidal increase in the mean number of IgG or Fab molecules 
bound to all viruses (i.e. fusing and non-fusing) upon increasing IgG/Fab concentrations.  The 
upper plateau from a fit to the data provides an estimate for the average number of IgG/Fab 
molecules that are needed to maximally inhibit HA-mediated hemifusion. These and other 
stoichiometric values are summarized in Table 3-1 with all calculated fit parameters reported in 
Table A2-2. For both virus strains, we find that more Fab molecules are required to achieve 
maximal hemifusion inhibition compared with IgG. The H3N2 strain has ~3.8-fold more Fab than 
IgG under conditions of maximal hemifusion inhibition, while the H1N1 strain has ~1.6-fold more 
Fab than IgG.   
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We estimated the number of HA trimers on each virus for comparison to the number of 
IgG/Fab bound at maximal hemifusion neutralization. Electron microscopy of the H1N1 and 
H3N2 viral strains indicated that they are morphologically similar (Figure 3-1A) and each have 
an average envelope diameter of 125 nm (Figure A2-6). Using results from recent cryoelectron 
tomography reconstruction of virus particles similar to those used here [28,37], we estimate 
there are ~375 HA trimers on each virus. This value agrees with previous estimates that were in 
the range of 300-500 trimers per 120 nm diameter virus particle [38-40].  With data from Table 
3-1 we estimate a binding stoichiometry of 0.41 CR6261 IgG per HA and 0.35 CR8020 IgG per 
HA at maximal hemifusion inhibition. For the Fab, we estimate a binding stoichiometry of 0.69 
crF6261 Fab per HA and 1.31 crF8020 per HA. These observations are consistent with 
predictions that the physical size and bivalent binding of IgG molecules would lower their 
stoichiometries relative to the smaller and monovalent Fab fragments [28]. 
Steric interactions between surface proteins and IgG/Fab molecules as they pack 
together on a viral surface were investigated in silico using a simulation designed to study 
protein packing and prevent protein overlap. To this end, thousands of random, two-
dimensional, protein dense viral surfaces were generated through a Monte Carlo procedure 
(Figure A2-7) utilizing the crystallographic dimensions of the envelope proteins (HA, NA, M2) at 
appropriate relative concentrations. Increasing numbers of IgG/Fab were bound to HA in accord 
with their co-crystal structure [7,22]. The number of IgG/Fab bound to HA when overlap 
minimization could no longer be achieved was taken as the maximum number of molecules 
sterically allowed on the viral surface.  
Simulations indicated that 270-300 IgG molecules could sterically fit on a viral surface. 
Though the viral surface was represented in 2D, these values were in excellent agreement with 
3D cryoEM tomography predictions that 75% of the 375 HA were available for binding [28]. The 
simulations revealed that bivalent IgG binding prevailed until ~175 molecules were present on 
the viral surface, at which point monovalent binding became dominant. These simulation results 
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suggest that the experimentally determined 155 CR6261 or 130 CR8020 IgG bound at maximal 
hemifusion neutralization (Table 3-1) would bind bivalently to abrogate the fusogenicity of 
approximately 310 or 260 HA trimers, respectively. As such, we conclude that not all sterically 
available epitopes need to be bound for influenza viruses to be inhibited from undergoing 
membrane fusion.  As such, it is likely that fusion-competent HA trimers remain on the surface 
of virions whose fusogenicity is inhibited through IgG binding.  Lastly, simulation results 
indicated that approximately 500 Fab molecules sterically fit on the surface of an influenza 
particle.  This value agrees with the experimentally measured number of crF8020 Fab bound, 
however only about half as many crF6261 bind at maximal hemifusion inhibition. This difference 
is discussed in the following section. 
 
3.2.3 Low occupancies can significantly reduce the extent of hemifusion.   
Combining measurements of hemifusion efficiency with the calculated number of virus-
bound IgG or Fab molecules allows us to directly correlate the inhibition of HA-mediated 
hemifusion on a per bound-molecule basis.  Data and fits displayed in Figures 3-2A and 3-2B 
are combined and shown in Figure 3-2C showing this correlation (data fitting in Appendix 2).  
Directly relating coverage with hemifusion efficiencies allows for estimation of the number of 
IgG/Fab molecules needed to reduce the likelihood of a virus undergoing hemifusion by half 
(half-maximal hemifusion inhibition, Table 3-1). Similar to the requirements for maximal 
hemifusion inhibition, more Fab than IgG are needed for half-maximal fusion inhibition.   
We define the fractional occupancy to determine the fraction of available binding sites on 
the viral surface that IgG or Fab molecules must occupy for the likelihood of hemifusion to be 
reduced by half. It is the quotient of the number of IgG/Fab bound at half-maximal hemifusion 
inhibition and the number bound at maximal hemifusion inhibition (Table 3-1). We find that the 
fractional occupancies are similar between 6261 IgG and Fab, and also between 8020 IgG and 
Fab. There is a difference in the hemifusion response to increasing fractional occupancy 
91 
 
between the two viral strains, however, with the H1N1 strain showing a higher susceptibility to 
hemifusion inhibition at lower fractional occupancies compared to the H3N2 strain.  
Discrepancies in response to IgG/Fab binding could arise from differences in avidity 
and/or accessibility of the IgG/Fab for their epitopes on the two viral strains, or from inter-strain 
variation in surface protein density or composition [40,41]. An additional rationale for the 
differing responses could relate to a notable difference in the behavior of the 6261 and 8020 
epitopes upon exposure of HA to low pH [7,42]. The 6261 epitope primarily comprises the ‘A’ -
helix (HA2 residues 38-55) that participates in the loop-to-helix transition undergone by HA and 
remains contiguous throughout the unfolding and refolding process. In contrast, the 8020 
epitope is split during low pH conformational changes with the ‘G’ -helix (HA2 residues 145-
153) remaining membrane proximal and the -sheet near the fusion peptide (HA2 residues 32-
36) being extended distally from the viral membrane to allow insertion of the fusion peptide into 
a target. Such a difference in epitope behavior may allow the H3 HA to more readily escape 
from the conformationally inactivated state imposed by 8020 binding, consistent with its more 
robust hemifusion response to both the IgG and the Fab (Figure 3-2C). An H3 hemagglutinin 
trimer being better able to “slip its handcuffs” may also relate to the similarity in the number of 
IgG molecules required for maximal hemifusion inhibition of the two strains, while there is a 
nearly 2-fold discrepancy between the Fab (Table 3-1). If double binding was needed to ensure 
H3 does not escape the inactivated state, then it follows that more monovalent 8020 Fab than 
6261 Fab would be needed, while a comparable number of bivalent 8020 and 6261 IgG could 
engage in double HA binding. 
 
3.2.4 IgG/Fab binding delays the time to hemifusion   
The time to hemifusion is measured as the time between disappearance of the 
fluorescein signal (pH drop) and the onset of lipophilic dye escape from the site of viral fusion  
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Figure 3-3 – Hemifusion is delayed at higher 
IgG/Fab concentrations. Data are displayed as in 
Figure 3-2, and are fit with a hyperbolic function 
having a constant offset (Table A2-2). Fold-
increases in hemifusion times between zero and 
the highest IgG/Fab concentrations are listed in 
Table 3-1. 
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(Figure 3-1C).  Concomitant with a decreasing efficiency of hemifusion and increasing numbers 
of bound IgG/Fab, we find that the time required for the remaining fusion-competent particles to 
undergo hemifusion becomes longer as the concentration of IgG/Fab increases (Figure 3-3).   
The hemifusion times increase from their base-line values at zero IgG/Fab to plateau 
values at high IgG/Fab concentrations in a sigmoidal fashion. The baseline hemifusion time in 
the absence of IgG/Fab was 46 seconds for the H1N1 strain and 30 seconds for the H3N2 
strain.  At the highest IgG concentrations both viral strains show an upper plateau for 
hemifusion times that is an approximately 2-fold increase over their baseline values (Table 3-1).  
When bound by the corresponding Fab, both virus strains exhibit slightly larger increases, 
showing more than a 2.5-fold increase over their baselines. Differences between the delays 
caused by IgG and Fab may result from differences in their physical size and/or their HA binding 
valencies. A bivalently binding IgG abrogates the fusogenicity of trimers that are neighbors and 
may interfere with fusion processes that occur over long time scales, but that are left intact by 
the monovalent Fab.  The observation of an upper plateau for all cases is consistent with 
inactivation of HA membrane fusion capacity upon prolonged exposure to acidic conditions [43]. 
It suggests that viral HA have a temporal window-of-opportunity following acidification to induce 
fusion before they become inactivated. 
 
3.3 Discussion 
We describe a new method for quantitatively determining the numbers of broadly 
neutralizing, stem-binding antibodies or their Fab fragments bound to individual influenza virus 
particles.  The experimental design allows for direct correlation between the stoichiometry of 
antibody binding and its functional impact on viral fusogenicity and kinetics. Our stoichiometry 
results indicate that maximal inhibition of membrane fusion by IgG does not require all sterically 
available epitopes to be bound, which may leave pH sensitive HA trimers on the surface of a 
non-fusogenic virion. Fab molecules are also capable of inhibiting HA-mediated membrane 
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fusion, albeit with higher stoichiometry, demonstrating that bivalent IgG binding is not a requisite 
for inhibition of membrane fusion. Concomitant with decreasing hemifusion efficiency at higher 
IgG/Fab coverage, we observe a 2- to 2.5-fold kinetic delay in the hemifusion process. These 
observations are consistent with a molecular model for fusion inhibition whereby blockage of 
HA’s low-pH conformational triggering by IgG/Fab binding prevents the accumulation of 
triggered HA into a sufficient density for membrane fusion to occur and is depicted in Figure 3-4.  
The presence of sterically available HA epitopes on the surface of a fusion-inhibited 
virus is consistent and in support of a mechanism of HA-mediated membrane fusion requiring a 
coordinated action between multiple HA’s for membrane fusion to be productive [34,36,44,45]. 
That the fusogenicity of a single HA could be abrogated by removal of coordination partners 
without IgG or Fab having to directly bind that particular HA implies the existence of a network 
of inter-HA connectivities on the viral surface (Figure 3-4). In this context, network connections 
at neutral pH would be established by the relative geometry and distance between neighboring 
HA. Network connections become stochastically activated upon acidification when neighboring 
HA undergo their conformational extension and latch on to a target membrane. If a sufficient 
number of HA trimers are physically close enough in space and are refolding within a close 
enough window of time, then they are able to coordinate their work and mediate the onset of 
lipid hemifusion. If HA is exposed to low pH for extended periods of time, however, it inactivates 
by non-productively refolding and also disrupts the HA coordination network. Thus, timing of the 
entire fusion process represents the interplay between 1) low pH-induced, stochastic firing of 
individual HA trimers; 2) stochastic coordination between HA post-firing to mediate productive 
membrane fusion; and 3) low pH-induced inactivation of the activated HA (Figure 3-4). 
Predictions from a recent study by Ivanvovic et al. [36] simulating the stochastic inter-HA 
coordination mechanism are consistent with our findings that hemifusion kinetics are delayed by 
binding of either IgG or Fab molecules. They found that increasing proportions of non-fusogenic  
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Figure 3-4 – Cartoon illustrating inter-HA network disruption by IgG binding that leads to fusion 
inhibition.  A) Fusogenic HA at neutral pH in the pre-fusion conformation (light blue spikes) 
initially have network connectivities (blue dashed lines) dictated by their spatial geometry 
relative to one another.  B) Binding of IgG (black ‘Y’) inactivates the HA (light grey spikes) by 
preventing their low pH-induced conformational changes and disrupts the network between 
neighboring HA.  C and D) Exposure to low pH conditions triggers HA to unfold into fusion-
competent conformations (red spikes) and activates the inter-HA network (thick blue lines) 
between neighboring, triggered HA. E and F) Continued low pH exposure causes HA 
inactivation by non-productive re-folding (dark grey spikes), also removing inter-HA connections 
(grey lines).  Network disruption begins prior to low pH activation in the presence of IgG/Fab 
binding (B, D and F), but in their absence it begins only in late stages after network activation 
(E). Productive fusion would arise at locations with a sufficiently high density of activated inter-
HA connectivities. Both IgG/Fab binding and low pH inactivation can inhibit membrane fusion 
even in the presence of fusogenic HA. 
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HA on the simulated viral surface caused slower kinetics due to disruption of inter-HA 
coordination. Binding of 6261 or 8020 IgG/Fab on the surface of our infectious virus particles 
increases the proportion of inactive HA on the surface of our infectious viruses [1], slowing 
hemifusion kinetics. Thus, 6261 and 8020 IgG/Fab inhibit membrane fusion through disruption 
of the coordination network between neighboring HA trimers. 
It is of interest that the delay in hemifusion time imparted by Fab is longer than that for 
IgG. The aforementioned simulation [36] indicated that increasingly larger fractions of non-
fusogenic proteins gave rise to progressively slower kinetics. The larger delay in hemifusion 
time observed with Fab suggests that more HA may be rendered non-fusogenic when viral 
fusion is inhibited by Fab as compared to IgG. A need for fewer HA to be inactivated by IgG to 
achieve maximal hemifusion inhibition compared to Fab implies that, indeed, HA’s nearest 
neighbors are critical for maintenance of the trimer’s capacity to mediate fusion. 
Our single-particle studies detect a subtle difference between the susceptibility of the 
H1N1 and H3N2 viruses to hemifusion inhibition upon IgG/Fab binding that is not borne out in 
the physiological context of infection. Both IgG molecules are similarly capable of 
prophylactically preventing and therapeutically treating lethal influenza infection in mice [6,7]. As 
well, since the influenza virus has a high multiplicity of infection (MOI) [1], data in Figure 3-2C 
and Table 3-1 indicate that low fractional occupancies could be sufficient to decrease the 
fusogenic virus population below the MOI needed for a sustained infection. Moreover, the stem-
binding antibodies are up to nine-fold more potent in neutralizing viral infection by preventing 
proteolytic cleavage that activates HA compared to neutralization through fusion inhibition alone 
[1]. Lastly, the observed delay in fusion time would lead to extended exposure of a virus to the 
harsh environment of late endosomes, conditions which could lead to viral degradation prior to 
successful membrane perforation. As such, the high epitope coverage we measure is likely not 
necessary to stop infection in viral neutralization assays. Rather, using high IgG/Fab epitope 
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coverage here has provided novel insight into the mechanism of inter-HA coordination 
mediating membrane fusion and the mechanism for fusion inhibition by stem-binding antibodies. 
Steric interference on the viral surface may also contribute to fusion inhibition upon 
antibody binding, but comparison of Fab versus IgG stoichiometry does not necessarily shed 
clear light on the subject. The ~67% reduction in protein mass through use of a Fab also comes 
at the expense of one paratope, whose effect in neutralizing nearest neighbors could be 
important. As well, the ~50 kDa Fab are still quite large and comparable to the size of a single 
HA1/HA2 monomer.  The use of peptides [3] or small molecules [26] capable of inhibiting HA’s 
low pH conformational changes would be valuable for delineating HA-inactivation versus steric 
effects and could be studied using the experimental design described here. 
 
3.4 Materials and Methods 
Microfluidic flow cells were used for all experiments and were constructed using cleaned 
microscope cover slips (25 x 25-mm, No. 1, VWR, USA) affixed to a quartz top using double-
sided tape (Grace Bio-Labs), as previously described [34] or non-permanently adsorbed to a 
single-use multi-channel PDMS (polydimethylsiloxane; Dow Corning, Slygard 184) chip, which 
was formed by standard PDMS cast molding techniques [46,47].   
Proteoliposomes containing the sialoglycoprotein glycophorin A (GYPA; full-length with a 
GST tag, Abnova, Taipei City, Taiwan) were formed as previously described [1] by mixing lipids 
solubilized in detergent with the GYPA.  Removal of detergent with Bio-Beads (SM-2 absorbent, 
Bio-Rad Laboratories, Inc.) formed multilaminar proteoliposomes, which were incubated in the 
glass-bottomed microfluidic channels for 45 minutes to form contiguous, planar bilayers through 
spontaneous rupture.  The bilayers enabled virus immobilization and prevented non-specific 
adhesion of labeled IgG/Fab molecules. 
Influenza A virus strains R/8/34 (H1N1) and Aichi/68/X:31 (H3N2) propagated in SPF 
eggs were purchased from Charles River (North Franklin, Connecticut, USA; 2 mg/ml total viral 
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protein) and used without further purification.  Labeling was performed for three hours by 
diluting virus stocks 1:3 into Hepes buffer, then adding octadecyl rhodamine B lipophilic dye 
(R18, Invitrogen Inc.) dissolved in dimethyl sulfoxide (DMSO) to a final concentration of 1 M 
dye and <0.5% v/v DMSO.  Unincorporated dye was removed using PD-10 desalting columns 
(GE Healthcare). Fractions of 200 l were collected and the three with the highest particle count 
were pooled into a single volume and used for fusion experiments. 
Alexa 488 labeling of IgG and Fab was done according to manufacturer specifications 
(Invitrogen) to obtain high degrees of protein labeling. 
Fusion experiments were conducted as previously described [1] by incubating labeled 
viruses with labeled IgG/Fab for 45-60 minutes, then immobilizing them on a bilayer formed 
within a microfluidic cell, followed by fluorescein-labeled streptavidin (Invitrogen).  Immobilized 
viruses were observed using a 60x, TIRF objective on an Olympus IX-71 inverted microscope 
equipped with 488 nm and 561 nm lasers (Sapphire models, Coherent Inc.) aligned in objective-
based TIR mode.  Green and red emissions were simultaneously visualized on either half of an 
EMCCD camera (Hamamatsu Photonics K.K.) using either a home-built or commercial dual-
view (Photometrics, Tucson, AZ, USA) system.  HA-mediated fusion was initiated by adding 
pH 5.0 citric acid buffer and fusion events recorded continuously with 200 ms exposure 
time.  Fluorescence intensity arising from individual IgG/Fab molecules adsorbed to clean 
glass and in pH 5.0 buffer was done under identical illumination conditions.   
Data analysis was performed using custom MATLAB (Mathworks Inc.) scripts, 
similar to those previously described [1,34].   Briefly, viruses were identified in the red R18, 
then paired with locations separately identified in the green Alexa 488 channel.  Recorded 
fusion movies were corrected for laser illumination profile and fluorescence background 
before fluorescence extraction.  The fusion-inducing pH drop was identified to set time t=0 
(Figure 3-1).  Lipid mixing trajectories were analyzed manually to select those particles 
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showing dequenching behavior upon escape of the self-quenched R18 dye into the target 
bilayer.  Experiments showing fewer than 25 virions in a field of view were rejected.  For 
stoichiometry calculations, green-channel trajectories were averaged for 15 frames (three 
seconds) beginning one second after the pH drop (Figure 3-1D).  The number of virus-
bound IgG/Fab molecules was quantified as a ratio of their integrated intensity when bound 
to the integrated intensity of IgG/Fab individually (Appendix 2, Figure A2-5).  The time to 
hemifusion is calculated as the elapsed time from pH drop to the onset of hemifusion 
dequenching. 
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Chapter 4  
Fusion Tracker: Principles and Development of Computational Tools for the 
Automated Analysis of Influenza Virus Membrane Fusion Events 
 
Abstract 
Observation of membrane fusion events mediated by the hemagglutinin surface protein 
of influenza viruses has provided a wealth of information regarding the functioning of these 
fusion proteins. The experimental design is conceptually straightforward: label the viral 
membrane and lumen with fluorophores that escape the confines of the particle only upon 
successful membrane fusion to a target bilayer.  Release of the membrane dye upon fusion of 
the viral outer leaflet to the target bilayer indicates hemifusion and loss of the lumen dye 
indicates full fusion and expulsion of the viral contents.  In practice, the fluorescence signals 
recorded from observation of fusion events (trajectories) can be complicated, confounding and 
difficult to interpret. Significant effort is required to discriminate true fusion events from noise 
and non-events.  Currently, separation of the fluorescence trajectories into true fusion events 
and non-events is performed manually and depends upon visual inspection of the data, 
potentially leading to bias and errors. An automated analysis algorithm has been developed 
based upon maximum likelihood estimators and least squares fitting to address such bias and 
errors. It has the added benefit of also reducing the time involved in extraction of membrane 
fusion kinetic data.  Programmatic implementation of the algorithm is robust and results in the 
ability to extract kinetics of the hemifusion process comparable to those published previously, 
which were extracted by manual trajectory selection.   
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4.1 Introduction 
Single-molecule experiments probing biochemical kinetics provide a window into the 
fine, physical details underpinning the function of proteins.  Though successfully designing and 
carrying out experiments detecting single molecules is difficult, it is only half of the story.  Once 
fluorescence recordings of a biochemical event are obtained, the fluorescence signals must be 
extracted and interpreted in the context of the process being observed.  While experimental 
design allows prediction for the type of fluorescence changes that should occur following a 
biochemical reaction, many complicating factors can make event detection of real events 
complicated, tedious and time consuming.  Herein lies the elephant in the room: the raw data 
from single-molecule biophysical experiments are complex and heterogeneous, and necessitate 
both biological and technical knowledge for their interpretation to be correct.  As a result of this 
complexity, data analysis can represent a significant barrier to obtaining results once a 
successful experiment is completed.   
Visualizing the process of membrane fusion mediated by the influenza virus surface 
spike protein hemagglutinin upon exposure to an acidic environment relies upon recording two 
fluorescence signals.  One is a lipid signal arising from fluorescent lipid dyes incorporated into 
the phospholipid envelope of an influenza virus.  The second is a fluorescence signal from an 
aqueous dye staining the lumen of the viral particle.  Both signals are stably incorporated into 
the virus particles until hemagglutinin successfully fuses the viral membrane to a target 
membrane [1-3].  Kinetics of the fusion process are measured as the elapsed time between 
virus particle acidification and release of either the lipid or content dye from the virus, as well as 
the time between the lipid and content release signals.  Lipid dye release indicates the onset of 
hemifusion, or lipid mixing, between the virus and a target, while content dye release indicates 
the onset of pore formation and the creation of a corridor through which the viral contents can 
escape from the lumen.  The time between these two events is the lifetime of the transient 
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hemifusion intermediate (hemifusion lifetime), wherein only the proximal leaflets of the virus and 
target are fused, while the distal leaflets remain separate (Figure 4-1). 
The state of the art to extract these waiting times is to manually analyze the 
fluorescence intensity from each individual virus over time – its fluorescence trajectory -  and 
separate out those trajectories depicting true fusion events from those that do not.  The 
selection process is guided by visual inspection [1-4] of the trajectories and involves creating 
hundreds of plots of the form depicted in Figure 4-1C.  A researcher then decides whether any 
of the given trajectories appear to show characteristics of membrane fusion based upon their 
personal experience.  The characteristics a trajectory must possess have not been defined 
quantitatively, though they can be described qualitatively.  True hemifusion signals typically 
include a large and rapid intensity increase corresponding to dequenching of the lipid dye, 
termed the hemifusion time, followed by a relatively gradual signal dissipation as the lipid dye 
diffuses from the viral envelope into the planar, target bilayer (Figure 4-1).  Pore formation 
signals include only a large signal dissipation indicating the contents of the viral lumen have 
been released, defining the pore formation time, and which ideally follows a hemifusion event.   
Extraction of waiting times from fluorescence signals selected in this fashion have 
provided valuable insight into the mechanism of hemagglutinin-mediated fusion [1-3,5,6].  These 
studies, though, focused primarily on the time of lipid dequenching and content dissipation and 
not on the kinetics involved with lipid signal dissipation.   Modeling the waiting time distribution 
for hemifusion dequenching by a gamma distribution allows for extraction of two valuable pieces 
of kinetic information: the speed of the rate limiting step in the multi-step fusion process, and the 
number of rate limiting steps that are required for fusion to have occurred [1].  The gamma 
distribution is: 
 
 
(4-1) 
where k is the speed of the rate limiting step and N is the number of steps in the reaction.
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Figure 4-1 – Experimental setup and fluorescence read out that Fusion Tracker software is 
designed to analyze. A) Cartoon of a dual-labeled virus particle having a lipid dye (blue) and a 
content dye (purple), along with an idealized fluorescence trajectory, adapted from [7] and 
Chapter 1. The virus is immobilized upon a planar bilayer supported by dextran as in [1] and 
provides a constant level of fluorescence emission. Following a stimulus that acts as a fusion 
trigger, the hemagglutinin proteins on the viral surface (brown) mediate fusion of the proximal 
leaflets of the viral and target bilayers. Initial merger and lipid mixing causes a lipid dequenching 
signal (LQ), observed as a sharp fluorescence increase. Shortly after dequenching, the lipid dye 
diffuses away from the site of fusion, causing a lipid dissipation signal (LP). Once the distal 
leaflets of the virus and target bilayers have merged, the contents of the virus are lost, causing a 
content dissipation signal (CP). Time points corresponding to these three events in the idealized 
trajectory are indicated with labeled arrows. B) Sections of an image from a two-color 
membrane fusion recording, 50 x 25 m in size, are shown in false color. Channels are aligned 
as described in the text with the content signal in the top part (purple) of the image and lipid 
signal in the bottom (blue). Merger of the two emission channels allows for co-localization of the 
dual-labeled virus signals (merged image, bottom). Small 2 x 2 m regions highlighted by the 
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(Figure 4-1 Continued) yellow squares show that some virus particles have only a content 
signal (i) and others have only a lipid signal (ii), but many have both fluorescent labels (iii, 
white). C) Sample fluorescence trajectories that are typically analyzed visually. It is 
straightforward to distinguish an exemplary trajectory (i) for a virus particle undergoing LQ, LP 
(blue) and CP (purple) from a trajectory that clearly does not show any fusion activity (ii). 
Determining the fusion behavior for the virus trajectory shown in (iii) using consistent and 
quantitative criteria is not straightforward, as it shows characteristics of both lipid dissipation and 
content dissipation. D) Portions of the fusion trajectory in (C.i) are adequately captured by the 
model functions described in the text (gray, transparent fit lines). i) Equation 4-2 models the 
sharp signal increase upon lipid dequenching. ii and iii) Equation 4-3 models the dissipative 
fluorescence losses in the lipid (ii) and content (iii) signals. Fit lines in (i) and (ii) are extended 
beyond the fluorescence signal to facilitate visualization of the fitting model as described in 
Equations 4-2 and 4-3.  
 
Previous studies have demonstrated that N is fairly constant over a range of pH values 
used to induce fusion and typically varies from a value of 2–4 [1,3].  The N parameter is 
interpreted to represents the number of hemagglutinin proteins required for hemifusion to occur.  
Mathematically, N governs the shape of the distribution and under- or over-sampling portions of 
a distribution will give rise to large discrepancies in the determined N value.  Sampling errors 
can occur due to unexpected intensity fluctuations typical in single-molecule trajectories and 
because of viral movement prior to membrane fusion.  This movement is both Brownian and 
directed, the latter arising from a drag force upon the particle caused by flow of fusion-inducing 
low-pH buffer into the experimental chamber [3].   Drag-induced rolling of the virus on the 
surface of a bilayer comes to a halt as the hemagglutinin proteins extend into the bilayer, fixing 
a virus into position for fusion.  Since previous studies extracted fluorescence intensity using a 
fixed region of interest in the fusion recordings [1], rather than particle tracking, arrival of a virus 
particle could mimic the fluorescence signal of a virus undergoing solely dequenching.  Hence, 
the extracted fusion kinetics and the interpretations they imply are strongly dependent upon the 
reproducibility with which an investigator will consistently select or reject the same type of 
fluorescence signals.   
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Other single-molecule approaches have attempted to overcome the human element in 
data selection and waiting time extraction by designing and utilizing statistical models for 
determining significant changes in fluorescence trajectories.  These mathematical tools have 
been applied in an automated analysis format to study fluorophore photobleaching [8], quantum 
dot blinking [9], microtubule assembly via optical trapping [10] and helicase unwinding of DNA 
via FRET [11].  Single-molecule trajectories from these studies are largely step-like in character, 
showing discrete intensity heights that characterize distinct molecular states.  Statistically 
significant deviations from those heights can be detected by change-point analysis [12], an 
approach that looks for a higher likelihood of transitioning between two molecular states rather 
than remaining in one at every time point within a trajectory.  With this tool, it is possible to 
identify the number of molecular states visited by an individual molecule.  In automatically 
analyzing these stepping trajectories, the investigators do not set a priori presumptions about 
the number or locations of the states, the only requirement is that they be statistically resolvable 
within the noise of the experimental system.   
In contrast, trajectories of membrane fusion represent a continuum of fluorescence 
intensity levels as the hundreds of fluorophores initially trapped within the virus particle are 
rapidly redistributed to the target and/or surroundings.  However, the underlying principle of a 
state change remains, however. As a consequence, determining when a virus transitions from a 
non-fused into a fused state should be amenable to analysis by similar logic and statistical tools.  
This chapter represents the first attempt at adapting the change-point analysis tool [12] to 
automatically separate trajectories depicting true fusion events from those that do not without 
human intervention.  The assumptions of the statistical model are reversed from their use in 
identification of discrete stepping levels, in that viruses are assumed to have their lipid or 
content signal in only one of two states: either fused or non-fused.  With this presumption, 
mathematical models approximating the shape of fluorescence trajectories during successful 
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fusion events can be fit to the data and allow for identification of fusion events from noise 
(Figures 4-1 and 4-6).   
Dequenching signals are modeled as sigmoidal functions having the form:  
 
 
(4-2) 
where p is a vector containing these parameters: p1, the plateau intensity value before 
dequenching; p2, the plateau value after dequenching; p3, the inflection point of the intensity 
increase; and p4, the duration of the dequenching event.  Dissipation signals are modeled with 
the Gaussian function describing two-dimensional diffusion, so as to capture information 
regarding lipid dye diffusion upon hemifusion:  
 
 
(4-3) 
where r is the radius around a virus particle in m that is used for fluorescence intensity 
integration, and p is a parameter vector representing: p1, the intensity value before dissipation; 
p2, size of the signal loss upon dissipation (i.e. initial intensity minus final intensity); p3, the frame 
indicating the onset of signal dissipation; and p4, the two-dimensional diffusion constant in 
m2/second.  H(t- p3) is the Heaviside function and is invoked to remove the contribution of the 
exponential at times less than p3.  Fits of Equations 4-2 and 4-3 as determined by the algorithm 
described are depicted in Figures 4-1 and 4-6.   
 As shown here, these models sufficiently describe fluorescence trajectories of 
membrane fusion and allow automated separation of fusing events from non-fusion.  In addition, 
the designed analysis algorithm outlined in Figure 4-2 also performs particle tracking to reduce 
the confounding influence of viral motion.  Tracking also allows for extraction of the kinetics of 
hemagglutinin unfolding as a result of acidification [3]  in an automated fashion.  Further, by 
fitting the trajectories to mathematical models, we are able to access the rich kinetic details 
present in the trajectories that has not yet been investigated.  Kinetic information such as the 
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diffusion constant for dye release, the elapsed time until hemifusion dissipation, elapsed time 
between hemifusion dequenching and dissipation and the duration of a dequenching event can 
now be readily extracted and subject to analysis (see Chapter 5).  The intent of the program 
design is that workers in the field of single-particle membrane fusion can utilize the software or 
its theoretical foundations to increase data throughput while also standardizing data analysis 
when extracting membrane fusion kinetics.  Here, the theory underlying the selection algorithm 
and its application to the case of analyzing membrane fusion is described in detail.  This chapter 
together with Appendix 3 will allow future investigators to utilize, adapt and expand the back-end 
analysis program that has been developed. 
 
4.2 Algorithm design 
The analysis platform is conceptually laid out in Figure 4-2, which shows the main steps 
involved in automated analysis of a fluorescence recording of the membrane fusion events 
arising from immobilized virus particles.  It is designed to accept one split-field, dual emission 
channel recording (one fluorescent reading for the lipid signal and the second for the content 
signal, Figure 4-1) and perform two sequential types of analysis.  The first type is image 
analysis where labeled virus particles are detected, they are tracked as the fluid flow causes 
them to roll upon the bilayer surface, and their fluorescence over time is extracted (termed 
fluorescence trajectory).  This step also involves a number of calculations to correct the 
fluorescence levels in each recorded frame.  The second type is decision analysis to determine 
which of the trajectories represents a true fusion event and which do not.  The theoretical basis 
of the statistics used for making trajectory selection decisions is discussed first, followed by an 
overview of image analysis and details of the decision algorithm that uses the statistical tests to 
select particle trajectories. 
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Figure 4-2 – Schematic outline of data flow and trajectory selection implemented in the 
designed analysis program.  A) Image Analysis serves to correct the images for the illumination 
profile and fluorescence background.  Extracted fluorescence trajectories from identified and 
tracked particles are subjected to decision analysis algorithms that separate trajectories of 
virions undergoing membrane fusion from those that do not.  Results are compiled in a fashion 
that user-defined trajectory analysis parameters can be iteratively altered to trim data without 
having to repeat the slow MLE-based trajectory analysis.  Principal steps in the boxes are color 
coded to indicate the processing speed of each sub-step.  Blue is rapid requiring less than one 
minute, yellow is intermediate requiring 2-5 minutes and red can require upwards of one hour.  
The red step has been parallelized to reduce computational time, but can still be time 
consuming depending on available computational power.  B) Outline of the sequential steps 
comprising the Boolean decision function spanning the two portions of the Decision Analysis 
algorithm.  This function chooses which individual particle trajectories are accepted for inclusion 
in reported kinetics or are rejected.   
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4.2.1 Statistical tests  
Statistical tests can be used for automated decision making by allowing for rejection of a 
null hypothesis with a certain degree of confidence or significance, .  This value represents the 
theoretical frequency of incorrectly or falsely rejecting the null hypothesis of a test.  As depicted 
in Figure 4-2, a series of statistical tests has been concatenated to define a Boolean decision 
function designed to determine which of the extracted fluorescence trajectories represent fusion 
events falling within the definitions of the function. 
Two tests are used in defining the decision function comprising the analysis algorithm.  
One is the Student’s t-test, which is used to test if the mean of a single distribution is zero or if 
the mean value of two distributions is equal (i.e. the mean of their difference is zero).  It is a 
valid test when estimating the mean of a sample to determine if it derives from a Normal 
distribution.  While single fluorophores exhibit Poisson-based shot noise, fluorescently labeled 
virus particles have hundreds of individual fluorophores.  As such, they collectively give rise to a 
noise profile that is the convolution of hundreds of Poisson distributions and is approximately a 
normal distribution, in agreement with the Central Limit Theorem.  The “normalcy” of the 
integrated signal noise is shown in Figure 4-3 and supports the assumption of normally 
distributed noise in the trajectories of integrated fluorescence.   
The t-test is used to in a number of instances, with null hypothesis rejection leading 
either to acceptance or rejection of a particle or trajectory under inspection.  Specifically, it is 
used to check that the intensity noise of the trajectories is sufficiently Normal and null 
hypothesis rejection leads to particle rejection.  Subsequently, it is used to ensure that changes 
in intensity around a point of interest are statistically relevant with null hypothesis rejection 
leading to acceptance of an intensity change.   
The second statistical test is a maximum likelihood estimator test (MLE).  This test 
estimates the optimal parameters when fitting a mathematical model to data and determines if 
the fit is statistically relevant as compared to a fit by a null model.  Briefly, a domain of the  
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Figure 4-3 – The integrated fluorescence signal of the virus particles is normally distributed.  A) 
Fluorescence trajectory of hemifusion for a single influenza virion showing a dequenching 
intensity increase rapidly followed by signal dissipation caused by outward movement of the 
lipid dye.  This trajectory is subsequently analyzed in Figures 4-5 and 4-6.  The time between t = 
0 and the first possible event point (Figure 4-5) is highlighted with a red box.  Intensity within 
this region is plotted in (B) and corresponds to the intensity used to test for normalcy of the 
signal noise (Figure 4-2B).  B) Distribution of the integrated fluorescence intensity values from 
the box in (A).  It is well-fitted by a Normal distribution having  = 638 AU,  = 94.1 AU.  Fitting 
results in an adjusted R2 of 0.909 and the distribution passes a Student’s t-test with a p-value of 
0.929 and passes an Anderson-Darling test for normalcy with p = 0.644. 
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fluorescence trajectory containing a point of interest is fit by two functions: 1) a model describing 
a change in the intensity; and 2) a null model that describes the absence of a change.  The 
fitting domain selected from the trajectory is varied to obtain a number of fits for comparison to 
each other.  The domain where the change model is both statistically significant and maximally 
better than the null model is taken to be the location of an event.  If these conditions are not 
met, it is determined that no intensity change has occurred. 
The change-point algorithm recently described by Yang [12] described the use of MLE to 
identify points of sudden changes in intensity in acquired fluorescence trajectories.  In his 
description, extreme values of a ratiometric likelihood estimator occur at frames where there is a 
sudden change in fluorescence intensity.  The likelihood ratio is defined as:  
 
 
(4-4) 
where LN is the function describing the likelihood of obtaining the observed intensities in N 
frames given a particular fit function.  The MLE test involves calculating the likelihood value that 
a change occurs at a particular point within a trajectory, dividing it by the null likelihood that 
there is not a change at that point, and comparing their ratio to an analytical threshold set 
through a user-defined  value.  If the likelihood ratio is above the threshold, then it may be 
considered a real event, otherwise it is considered not to have a change in signal intensity.    
In the analysis algorithm described here, there being a change in fluorescence intensity 
corresponds to a dequenching or dissipation event, described by the mathematical models in 
Equations 4-2 and 4-3.  There being no change in fluorescence intensity is taken to correspond 
to gradual intensity changes described by a simple line of the form y = B*t+A.  This null model 
was selected because those particles that clearly do not show fusion upon visual inspection 
often show no obvious change in intensity throughout their trajectory and visually appear to 
change linearly in time.  Photobleaching usually does not cause a significant non-linear effect in 
the extracted trajectories due to the low laser power used in observing viral fusion events ( 
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typically ~1 W/cm2).  As such, bleaching in the trajectories often appears more linear than 
exponential, in accord with the Taylor series of the exponential function. 
The likelihood function, LN, is defined in terms of the joint density function, g, describing 
the probability of obtaining the observed values Z = {z1, z2, z3, …, zN} in each of N frames given 
input parameters, , appropriate for the density function.  Since each frame in a recording is 
obtained independently, the likelihood, LN, can be described as:  
 
 
(4-5) 
where  represents the parameters describing the probability density function g.  The Z values 
used in the algorithm are the residual values , obtained as the difference 
between the recorded fluorescence intensity values in each frame, yf, and the fit to one of the 
models.  The model can be from Equations 4-2 or 4-3, or the null model (straight line), and p is 
the vector of parameters at time t=f used in models from Equations 4-2 or 4-3, or B and A for 
the model of the null fit. 
Model fits from Equations 4-2 or 4-3 may be relevant for only a short interval within a 
particular trajectory, notably when a dequenching event is rapidly followed by a dissipation 
event as in Figure 4-1.  To this end, model fitting is performed from an initial frame n to a final 
frame m within the trajectory so as to detect short-lived and subsequent events, where the total 
length of the trajectory is N and 1 ≤ n < m ≤ N.  Computationally, it is much faster to compute 
the logarithm of the likelihood ratio, which converts the quotient into a difference and the 
products in to summations.  Incorporating these changes, Equation 4-4 becomes:  
 
 
(4-6) 
Using the assumption that the signal noise of the highly-labeled virus particles is 
Normally distributed, i.e. , and 
117 
 
presuming that a perfect fit results in an average residual value of zero, i.e. z = 0, the two 
summations each acquire the form:  
 
 
(4-7) 
Here, S = m-n+1 and is the total number of frames used for fitting,  is the signal noise 
determined for the fluorescence trajectory and p is the vector of fit parameters determined by 
least squares fitting.  Calculation of the log likelihood ratio, then, is the difference between the 
sum of the squares of the residuals to the model fit (Equation 4-2 or 4-3) and the sum of the 
squares of the residuals to the null, linear fit.  
  The domain giving rise to optimal model fitting is determined by varying either n or m 
over a range [a, b] to obtain a set of log-likelihood ratio values.  If n is varied, then values for a 
and b are restricted to 1 ≤ a < b < m, and likewise if m is varied, then n < a < b ≤ N.  The 
maximum of the set of log-likelihood ratio values is used to define the test statistic 
 
 
(4-8) 
where the notation a ≤ n, m ≤ b is to indicate that for either n or m being varied, the one being 
varied must lie between [a,b], while the other is fixed and not confined to this restriction.  This 
test statistic is then compared to the analytical threshold CS,1- that depends on the number of 
frames, S, used to determine QS and the user-defined significance level, .  As described by 
Yang, CS,1- is obtained by numerically solving for it in the expression (Equation 8 in [12]):    
 
 
(4-9) 
where for simplification the dependence on the number of frames, S, is simplified using: T = 
ln[(1-h2)/h2] and h = ln[S]3/2/S.  This expression for CS,1- is only valid if the noise profile of the 
underlying data is Normally distributed, hence analyzed particles analyzed must be ensured to 
have Normally distributed signal noise.  The MLE-based Boolean test then returns the result of 
the test:    
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(4-10) 
Additionally, the fit parameters in the vector p must satisfy the condition of a signal increase for 
dequenching (p2 > p1, Equation 4-2) or a signal decrease for dissipation (p2 > 0, Equation 4-3).  
In addition to being used for determination of optimal fitting parameters for dequenching and 
dissipation fusion events, this MLE test is used for determination of the rolling stop frame of the 
particles moving in buffer flow. 
 
4.2.2 Image analysis  
Image analysis begins by detecting a number of image correction factors, localizing virus 
particles, tracking their movement and finally extracting their fluorescence over the duration of 
recording.  The recorded images are corrected for electronic offset, Gaussian illumination profile 
of the excitation beam and fluorescence background across a field of view.  These corrections 
result in images that are flat with respect to the illumination beam and that have the peak of their 
pixel intensity distribution centered at zero.   
Virus particles are initially localized by averaging a user-defined number of frames after 
the viruses have stopped rolling (see Appendix 3).  The positions they assume at this point in a 
recording are obtained the using a merger of the two emission channels and are typically the 
same as the location where they undergo fusion.  Registration of the two channels is performed 
by calculating the cross correlation between the two channels [13] to obtain a rigid [row, column] 
offset translation for moving from any position in one channel to the corresponding position in 
the other channel.  Channel merger prior to particle identification allows for localization of all 
viruses, even if they contain only one of the two fluorescence signals, i.e. if a virus is only lipid-
labeled or only content-labeled (Figure 4-1). 
Intensity peaks corresponding to virions are detected in the merged image using a 
discoidal filter [14].  This filter draws two concentric circles around each pixel in an image –  rin 
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and rout where rin < rout, and the outer circle’s pixels do not include those of the inner circle – and 
filtered image is the difference between the average pixel intensities within these two radii.  
Virus particles are localized as clusters of bright fluorescence peaks that lie above a threshold 
value in the filtered image and have a minimal size (user-defined) or larger. The threshold is set 
as +m* where  and  are the average and standard deviation of the pixel values in the 
discoidally filtered image, respectively, and m is a user-defined multiplication factor (Appendix 
3).  The locations of these peaks are transferred to the merged image of the two channels, 
where each intensity peak is fit with a 2D Gaussian function [15].  Fitting is performed to obtain 
the size of the fluorescence spot, quantified as the width, w, of the Gaussian fit.  Large particles 
are excluded from analysis, with ‘large’ defined as lying above a +m*  threshold, with  and  
being the average and standard deviation of the particles widths and m being user defined 
(Appendix 3). 
Once these initial virus locations are identified, virus movement throughout the course of 
the recorded movie is tracked.  Tracking information is used to correct for microscope drift and 
to determine the frame when rolling viruses come to a stop [3].  Tracking of the virus particles is 
greatly facilitated by the high degree of labeling of the virus particles.  Because they each have 
hundreds of fluorophores, the particles do not exhibit blinking and are thus present in every 
recorded frame up until they undergo fusion. 
Identification of the rolling stop-frame utilizes a MLE test for two distance trajectories: the 
distance of a virus in each frame relative to its initial position and the distance relative to its final 
position.  Both of these data appear sigmoidal in time with the former showing an increase as 
the virus gets farther away from its initial location, and the latter showing a decrease as the virus 
gets closer to its final location (Figure 4-4).  Only those particles having a maximal displacement 
within their distance curve larger than a user-defined number of pixels are considered for stop-
frame determination.  To find the stop frame, both distance curves are fit with the sigmoid of  
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Figure 4-4 – Tracking of virus particles allows for calculation of the frame where the virus stops 
rolling.  A) Tracking trajectory of a virus particle.  The grey-scale image shows the path of a 
virion with the grey-scale value set relative to the time the virus spent at each location. The 
overlaid trajectory found through particle tracking begins when the particle starts moving in 
frame 50 (green) and ends at frame 170 after the particle has stopped rolling (red).  B) Distance 
trajectories used to identify the rolling stop frame.  The distance from the virus’ initial position (i) 
and from its final position (ii) are shown in blue; position trajectories are smoothed for fitting, but 
is not plotted for clarity.  Movement trajectories are well fit by sigmoidal functions (red dashed 
lines).  The lower bound of the upper plateau in (i) and the upper bound of the lower plateau in 
(ii) are black dashed lines.  The first passage frame of the trajectory beyond these thresholds is 
taken as the rolling stop frame.  Here, it was found to be frame 109 in (i) and 127 in (ii), so the 
reported value is 118. 
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Equation 4-2, which allows for estimation of the upper and lower plateau values of the 
respective sigmoids.  Comparison of the sigmoidal fit to that of a fit to a straight line (i.e. 
constant position) allows for calculation of a QS test statistic for comparison to a CS,1-  threshold 
from Equations 4-8 and 4-9, respectively. If the test of Equation 4-10 is passed, then fit 
parameters are tested to ensure they correspond to sigmoidal increases/decreases. Two frames 
are identified: the first frame when the distance curve passes the lower bound of the upper 
plateau when analyzing distance from the initial position (Figure 4-4B.i); and the first frame 
below the upper bound of the lower plateau when analyzing distance from the final position 
(Figure 4-4B.ii).  When these two frames are not equal, their mean value is recorded.  Particles 
found moving in both channels have the average of all four stop-frames reported.  
Virus particle locations in every frame of the recording allows for extraction of each 
particle’s fluorescence intensity throughout the movie without interference from particle 
movements.  All pixels within a distance that is a multiple of the previously calculated width, w, 
are utilized for signal integration and trajectory compilation (Appendix 3).  For instance, if the 
user defined a value of m = 2, then all pixels within a distance of 2w from the center of the 
Gaussian fitting are used for signal integration.  This distance corresponds to r in Equation 4-3.  
Integration of the pixel intensities for each viral particle provides a unique dual fluorescence 
time-trajectory that captures the full fusion behavior of each individual virus particle.  These 
trajectories are then subjected to a Boolean decision function (Figure 4-2B) that selects which 
trajectories indicate successful membrane fusion and which do not. 
 
4.2.3 Decision analysis  
Decision analysis begins, as outlined in Figure 4-2B, by rejecting dimmer particles 
because they often give rise to poorly interpretable trajectories.  Dim particles are identified 
according to their signal-to-noise, calculated at the beginning of a trajectory.  Those particles 
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whose ratio is below a user-defined threshold are rejected (Appendix 3).  The noise profile of 
the trajectory itself is tested for how closely it corresponds to a Normal distribution by subjecting 
it to a Student’s t-test.  Those particles determined to have a non-Normal noise profile are 
rejected.  This test is necessary, since the likelihood ratio calculated in Equation 4-6 and the 
analytical threshold used for QS comparison are dependent upon the assumption of Normally 
distributed noise [12].   
Trajectories having a satisfactorily Normal noise profile are smoothed using a Fourier 
filter [16] and the smoothed trajectory analyzed using two sliding-window based filters.  These 
filters identify time points corresponding to large signal increases or large signal decreases, as 
depicted in Figure 4-5.ii-v.  The use of sliding window filters to initially select a few key points of 
interest reduces the required computational overhead by focusing the least squares fits to 
domains that are most likely to have an event detected.  The alternative would be to scan the 
entire trajectory, which can be more than 1500 frames in length, from beginning to end and 
determine if a dequenching or dissipation event was fit significantly at some point within the 
trajectory.  
One filter is a Savitzky-Golay (SG) filter (built-in MATLAB function) acting upon the first 
derivative of the smoothed trajectory.  It is a digital filter that fits a line through all points within a 
window that slides through the length of the trajectory.  The other filter is a sliding window 
difference filter that calculates the difference between the average signal in a window 
immediately prior to and immediately after each point in the trajectory, akin to the smoothed 
trajectory’s first derivative.  A threshold is defined for the output of each filter (Figure 4-5) as  ± 
m*, where  and  are the average value and standard deviation of the filtered first derivative, 
respectively, and m is a user-defined multiplication factor.  Regions of the filtered first 
derivatives lying above the upper threshold designate possible intensity increases and regions 
below the lower threshold are possible intensity decreases.  The peak value above or below the  
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Figure 4-5 – Filtering by two sliding window-based filters allows identification of initial points of 
interest that may be fusion events. i) The trajectory of Figure 4-3 is analyzed by the Savitzky-
Golay (SG) derivative filter (ii and iii), and by a sliding window difference filter (iv and v) to 
identify time points that may correspond to fusion events. Raw data is shown as light blue and 
smoothed data used for intensity change identification is the overlaid heavy blue line.  Identified 
points of interest that are sent for MLE-based fitting are indicated as purple circles for intensity 
increases or as black squares for intensity decreases.  The confidence intervals ascribed to 
each potential event point are set by the collective domains of the first derivative above or below 
the thresholds in ii-v and are indicated by the filled purple or grey box underlying each circle or 
square, respectively.  For instance, the decrease near t = 20 is identified repeatedly in (ii-v), with 
a large domain in (v) lying beyond the threshold, hence it has a large confidence range. 
ii through v) The smoothed first derivative data of the trajectory in (i) is shown as a blue line; 
thresholds determined as ±2* of this first derivative are shown as dashed red lines.  The first 
derivative is set to zero for t < 0.   ii and iv) A window size of 17 frames is used and identifies 
two increases of interest (purple cross) near t ~ 15 and 60 seconds and two decreases (black 
‘x’) both near t ~ 20 seconds. The increase near t=0 is found only in the SG filter and is rejected. 
iii and v) A window size of 51 frames is used and identifies two decreases near t ~ 0 and 20 
seconds.  The decrease near t=0 is rejected because the intensity change at its location is 
determined non-significant by the Boolean decision function of Figure 4-2B, hence a square is 
not placed at its location in (i).    
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threshold is taken as the possible event point and a pseudo-confidence interval around each 
point is defined as the first and last frame where the filtered derivative surpasses the threshold. 
While these filters have the advantage of being computationally fast, they will almost 
invariably return a possible event point, though the event point returned may appear spurious 
and uninteresting upon visual inspection.  Often, a number of these undesirable possible event 
points are identified by one of the two filters, but they are less often identified by both filters. 
Increases/decreases detected by both filter types are thus selected as initial points for possible 
events (Figure 4-5).  Such discrimination constitutes the first level of event point selection.  
These initial “guesses” are screened to confirm that the signal intensities before and after the 
event frames are statistically significant using a t-test.   
Different filter window sizes are useful for detecting different signals – small windows for 
short events and large windows for long events.  Dequenching events are rapid and short-lived 
(Figure 4-5.ii,iv), while signal dissipation events arising from diffusion are longer-lived events 
(Figure 4-5.iii,v).  To detect both signals in a single trajectory, the window used for filtering the 
first derivative to detect events is increased from an user-defined initial value until the window 
size is large enough that no events are detected above or below the thresholds.  Points whose 
pseudo-confidence regions overlap are grouped together to define initial guesses for plausible 
event points.   
Finally, these initial guess points are used as initialization parameters for least squares 
fitting of the raw fluorescence trajectories to the model functions of Equations 4-2 and 4-3 for 
identification of dequenching or dissipation, respectively.  The behavior of these empirical, 
mathematical models mirrors that observed in the fluorescence trajectories obtained from fusing 
virions (Figures 4-1 and 4-6).  Extracted fit parameters provide estimates for the kinetics 
associated with an individual fusion event and are determined with upper and lower confidence 
bounds (see Appendix 3).  When dissipation occurs during hemifusion detection, it corresponds 
to the outward diffusion of the lipid dye into the target bilayer away from the site of hemifusion.  
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The dissipation Equation 4-3 has been used previously to extract the two dimensional diffusion 
constant of the lipid dye [5] following a dequenching event.  In the case of pore formation, 
dissipation of the signal from the contents of the virus could be ascribed to the diffusion of the 
dye in the area between the coverslip and the bilayer created by the dextran cushion.  In the 
analysis described here (and in Chapter 5), it is treated only as a rate of signal loss and is not 
directly interpreted with a physical meaning. 
For each initial guess point, a domain surrounding it is defined and taken as a section of 
the whole trajectory to be used for fitting, as described in the Statistical Tests section.  Edges of 
the domains defined by n and m are varied between a and b in such a way that, ideally, the 
trajectory information is well approximated by the null model at one extreme and gradually fit 
with increasing likelihood by the model function of interest.  For dequenching, the starting frame, 
n, is fixed as either the left-most edge of the trajectory or the upper bound for the immediately 
preceding guess point, and the end frame, m, is varied from the lower bound of the guess point 
being probed up to either the next guess point or the end of the trajectory.  For dissipation, n is 
varied from either the left edge of the trajectory or the upper bound of the immediately preceding 
guess point up to the upper bound of the guess point being probed, and m is fixed as either the 
lower bound of the subsequent guess point or the end of the trajectory.  In this fashion, the 
MLE-based statistical test determines 1) the statistically optimal fitting domain and 2) the 
corresponding best fit parameters that extract valuable kinetic information.  If the MLE test is not 
passed, then the fit at the guess point is rejected. 
The existence of an analytical threshold in the MLE test is useful because it is 
conceptually easy to understand and define.  In practice, however, the values for CS,1- obtained 
are often quite small compared to many values of QS that are calculated.  It often occurs that the 
four-parameter models of Equations 4-2 or 4-3 produce QS values indicating a statistically better 
fit to the data that is not corroborated by visual inspection of the resulting fit line.  This 
discrepancy arises because the four parameter fit lines are better able to accommodate  
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Figure 4-6 – Dequenching and dissipation signals are automatically fit and detected using 
maximum likelihood estimators. A) Trajectory from Figure 4-3 is analyzed using the three points 
of interest identified in Figure 4-5 to perform the MLE test within the domains indicated by the 
purple, black and red boxes. Equation 4-2 is used for the points in (i) and (iii); Equation 4-3 is 
used for (ii). Intensity increase in (i) and decrease in (ii) are found to be dequenching and 
dissipation events shown as thick purple and black lines, respectively. The increase in (iii) is 
rejected and not fit.  B) Values for the QS estimator as one edge of the fitting domain is varied to 
find maximal values above the analytical threshold, shown as dashed red lines.  In (i) and (iii) 
the starting time point for fitting is fixed and the end time point of the fitting box is varied to find 
where QS becomes maximal.  In (ii) the end time point is fixed and the starting time point is 
varied.  C) R2 values for the fits performed within the indicated domains and corresponding to 
QS values in (B).  Maximal values of QS and R
2 correspond for (i) and (ii), but not for (iii), hence 
(i) and (ii) are accepted and (iii) is rejected.  
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intensity fluctuations than is the two parameter linear null model.  To reduce the occurrence of 
this type of error, a model fit passing the MLE test of Equation 4-10 is compared to its R2 value, 
both of which depend upon the fitting residuals, zf.  Situations where the fit should be accepted 
show a maximal QS value that corresponds to a nearly maximal R
2 value (Figure 4-6.i,ii).  At 
those points that should be rejected however, the QS value rises above the CS,1- threshold, but 
the overall R2 value of the fit is not yet maximal and the QS value falls back below the CS,1- 
value shortly after this fluctuant point (Figure 4-6.iii).   
To help ensure fits to fluctuant points are rejected, the MLE test is performed twice.  The 
first round of MLE testing determines at what starting/ending frame the QS value is maximal 
and, also, where the R2 value is maximal.  In the second round, the average of these two 
starting/ending positions is used to set the appropriate edge of the fitting domain and the MLE 
test performed again.  If the frame giving maximal QS and R
2 values are in close proximity, then 
it is likely that the second round QS value will also be larger than the threshold.  If they are far 
apart, however, it is likely that the large QS value occurred due to a fluctuant point and the 
second round QS value will be below the threshold and the fit to the guess point rejected. 
Fit parameters determined by the sequential MLE tests are checked to ensure that a 
dequenching fit corresponds to an intensity increase, and that dissipation fits correspond to an 
intensity decrease.  In this fashion, fluorescence trajectories are determined to have a 
dequenching or dissipative signal without any manual intervention.  Parallel processing is 
utilized to perform MLE-based fitting of multiple trajectories simultaneously on separate CPU 
cores, which greatly reduces the overall required computational time.    It was found that with a 
single processing core, approximately 400 single-channel trajectories of 1500 frames required 
approximately one hour of processing time. 
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4.2.4 Extracted fusion kinetics  
Kinetic information extracted from the fluorescence trajectories selected to represent 
membrane fusion events is in the form of waiting times.  These times are the elapsed time 
between the detected pH drop and the onset of signal dequenching or the onset of signal 
dissipation. The time points extracted are depicted schematically in Figure 4-1.  Once the slow 
MLE-based fitting procedure has been completed, selection of trajectories to acquire fusion 
kinetics is computationally fast and can be iterated to filter out trajectories based on user-
defined parameters.  Statistically significant dequenching and dissipation fits can be selected 
based on signal-to-noise thresholds of the resulting fit parameters or by setting absolute limits 
for the permitted values of the p4 fit parameters (see Appendix 3).  In both Equations 4-2 and 4-
3, the p4 parameter determines the duration of a particular event and certain limits may be 
desirable.  Fast or slow events could indicate strange behavior, such as detachment of a virion 
from the bilayer in the case of dissipation or influx of fluorescence from neighboring virions in 
the case of dequenching, respectively.  The p4 parameter is useful also for extraction of physical 
properties relevant to the fusion process.  For dequenching, this parameter describes the width 
of the dequenching event.  For dissipation, this parameter describes the diffusion constant of 
the fluorescent signal, a quantity of potential use when observing movement of lipid signal 
dissipation.  
For dequenching fits, the elapsed time between the pH drop and dequenching is 
determined to be the first time point when the MLE-determined fit is greater than the upper 
bound for the p1 parameter.  This time constitutes the moment when the intensity increase is 
above the base line.  In previous studies [1,2] and in Chapters 2 and 3 the hemifusion time was 
taken as the point where the first derivative of the trajectory was maximal as determined using 
only a SG filter.  The current time point determination reproduces the previously observed 
kinetics because this first passage time is, necessarily, near the region where the trajectory will 
have its largest first derivative.    The p3 parameter could also have been used, but in this case 
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the fluorescence signal is already increasing and the parameter does not truly capture the first 
moment when the signal can be confidently determined to be increasing. 
For dissipation fits, the elapsed time between the pH drop and the onset of dissipation is 
taken to be the p3 parameter resulting from the fits.  This is the moment in the trajectory when 
the Heaviside function allows the diffusion equation to match with the observed fluorescence 
loss.  This definition for the onset of signal dissipation more reliably captures the initiation point 
than does the previous determination of dissipation time, which was the minimum value of the 
trajectory’s first derivative again determined by a SG filter.  Empirically, this moment occurred 
closer to the mid-point of a dissipative signal.  It is expected that extraction of the onset time for 
dequenching or dissipation in the manner described here will be systematically smaller than 
time points identified only by a SG filter, though the absolute difference will be small relative to 
the speed of relevant fusion kinetics.  
The fitting-based algorithm now provides access to additional kinetic information not 
previously considered in viral membrane fusion studies.  These kinetic data include: the lipid 
signal dissipation time, elapsed time between lipid dequenching and lipid dissipation (Figure 4-
1), elapsed time between lipid dissipation and content dissipation and the duration of the lipid 
dequenching event.     
 
4.3 Results validation 
Accumulation of waiting times from the selected fusion trajectories into distributions 
provides insight into the biochemical mechanism underlying membrane fusion.  There is no 
absolute “gold standard,” however, for reliably comparing acquired distributions.  Rather, 
comparison of the results acquired by this automated algorithm must be compared to those 
resulting from manual trajectory selection.  To validate the kinetics obtained from trajectories 
selected using the algorithm described here, the waiting time distribution of hemifusion 
dequenching obtained by the algorithm from a single fusion recording is compared to 
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distributions acquired from two independent, manual trajectory selections of the same recording.  
Only the hemifusion dequenching time is compared between the different analysis methods 
because too few hemifusion lifetime and pore formation events are observed in a single fusion 
recording to allow comparison of these event distributions.  The fusion recording used for 
validation is of X31 influenza A fusing to a bilayer comprised of DOPC*, POPC** and 
Cholesterol in a 2:2:1 ratio at a pH of 5.0 and is one included by Floyd et al. in their publication 
originally describing the single-particle membrane fusion assay [1].   The results from automated 
analysis are compared to a third manual selection found to be over-correcting for particle motion 
and under-sampling the earliest time bins, which serves as a negative control. 
Figure 4-7 presents the results of the comparison of the hemifusion waiting time 
distributions obtained through automated analysis to those obtained manually.  The first manual 
selection indicated as ‘Manual #1’ was performed by Daniel Floyd and the selected data were 
later aggregated with additional experimental data to obtain his final published results [1].  I 
performed the second manual selection (Manual #2) by visually inspecting both the extracted 
fluorescence trajectory and each virus particle at its location in the recorded fusion movie.  This 
particle-by-particle selection using both pieces of information required approximately 2.5-3 
hours to screen approximately 300 particles and allows comparison of the time involved in such 
scrutinous trajectory selection.  I also performed the trajectory selection giving rise to the 
‘erroneous’ waiting time distribution prior to the more careful trajectory selection giving rise to 
‘Manual #2.’   Selection giving the erroneous distribution involved only visual inspection of the 
extracted fluorescence trajectories. The difference in particle selection was found to arise from 
over-estimation of particle motion in the early portion of the fluorescence trajectory, which led to 
excessive trajectory rejection and under-sampling of early fusion events.  Each distribution in 
Figure 4-7 includes time points from approximately 100 particles, which is twice the estimated  
*   1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC);   
** 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) 
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Figure 4-7 – Kinetic data compiled from automated analysis reproduces results obtained from 
accepted, manual data selection.  A) Hemifusion waiting time distributions are shown with 
corresponding fits by the gamma distribution.  Accepted manual selections #1 and #2 are shown 
in light blue and grey with fits in blue and black, respectively.  Automated analysis is shown in 
yellow with a yellow fit line.  The erroneous manual selection is shown in red with a dark red fit 
line.  Reports of a t-test comparing the distribution means is reported in Table 4-1.  B) Gamma 
distribution fitting parameters k and N for the fits shown in (A) are shown with error bars 
representing 95% confidence bounds for the fits.  Values for k and N published in [1] are shown 
for reference as vertical dashed lines. 
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number of data points needed to distinguish an N value of 2 from a value of 4, under the 
assumption of equal trajectory selection [17]. 
Automated particle selection accounts for particle motion by incorporation of a particle 
tracking algorithm and, thus, early time bins should be unaffected by virus rolling.  Full analysis 
of the two-color fusion recording, including fluorescence trajectory extraction followed by 
selection by the Boolean decision function, required approximately 25 minutes on a computer 
containing two CPU’s.  For the analysis considered here, the fits of hemifusion dequenching 
were required to give fit parameters having a signal-to-noise of at least one with no additional 
data filtering to restrict values for the dequenching time (p4, Equation 4-2).  The signal-to-noise 
requirement was varied from values of one to five with no effect on the results obtained. 
The hemifusion waiting time distribution extracted by the automated algorithm matches 
nicely to the distributions measured for both Manual #1 and Manual #2, as can be observed in 
Figure 4-7A.i,ii,iii.  The erroneous distribution stands apart from the other three distributions, a 
visual observation captured both in comparisons of the distribution means by a t-test (Table 4-1) 
and in the extracted k and N values.  
 
Table 4-1 – Statistical comparison of kinetic distributions using the Student’s t-test  
Comparison t-test p-value 
Manual #1 vs. Manual #2 0.799 
Manual #1 vs. Automated 0.693 
Manual #2 vs. Automated 0.866 
Manual #1 vs. Erroneous 0.170 
Manual #2 vs. Erroneous 0.087 
Automated vs. Erroneous 0.129 
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Fit parameters obtained by modeling the three distributions in Figure 4-7A.i,ii,iii with a 
gamma distribution (Figure 4-7B) are in good accord with each other, lying within each other’s 
95% confidence intervals.  They are also in good correspondence with the published values of k 
= 0.071 and N = 2.3 [1].  The erroneous distribution of Figure 4-7A.iv gives rise to k and N 
values that do not agree with i, ii and iii or with the published values.  The trend of greater 
similarity between Manual #1 and Manual #2 with the automated distribution is observed in the 
larger t-test p-values indicating greater degrees of similarity than for any of them with the 
erroneous distribution.  While the p-values obtained for comparison with the erroneous 
distribution do not fall below the commonly accepted p = 0.05 level to establish a statistically 
significant difference, they are substantially smaller than the values obtained in comparing 
distributions in Figure 4-7A.i,ii,iii.  Based on the agreement between the kinetics extracted by 
the automated algorithm and those obtained by manual analyses, the automated selection of 
fusion trajectories is thus considered to be comparable to that performed manually. 
 
4.4 Future development 
Algorithm design and testing to this point indicate it is robust and can be operated in 
batch processing to sequentially analyze multiple fusion recordings without the need for user 
intervention. Testing the algorithm to provide the data included in this chapter, along with the 
analysis described in Chapter 5, required the automated analysis of 74 separate fusion 
experiments consisting of 24,391 individual virus particles.  Not only is the time required for data 
analysis reduced by nearly 6-fold and made more reproducible through use of this program, 
additional kinetic time points and parameters can now be studied.  Detection of the time when a 
lipid signal undergoes dissipation following dequenching allows for two additional intermediate 
times to be probed: the time between lipid dequenching and dissipation (as observed in Figures 
4-1 and 4-6) and the time between lipid dissipation and content signal dissipation.  Both of these 
values are related to the hemifusion lifetime and the point where lipid merger has begun, but 
134 
 
viral contents have not yet been released.  As well, the two-dimensional diffusion constant of the 
lipid dye escaping from the viral envelope may provide information regarding the nature of the 
hemifusion stalk formed upon initial membrane merger.  To make this programmatic algorithm 
more amenable to use in the field of membrane fusion, however, additional development will be 
required.   
One fundamental development is expansion of the recording conditions that can be 
accepted by the program, principally for particle detection.  At present, only two channel movies 
having dually labeled virus particles can be accepted as an input.  The emission channels must 
be separated into the top-half and bottom half of each frame, with the pore formation occurring 
in the red (longer wavelength) channel on top and the hemifusion occurring in the green (shorter 
wavelength) channel on bottom.  Single color and other split-field orientations such as green-top 
and red-bottom, or left-right orientations with the green or red on either side of each image, 
should be incorporated to allow input flexibility.  As described in Appendix 3, all of the scripts 
requiring a particular image layout have options defined for the various orientations described, 
but have yet to be tested.  Additionally, accommodation of full image recordings, rather than 
split-field, should be included, since detection setup allows for the largest possible field of view. 
For particle detection, the currently implemented program uses a merger of the two 
channels to locate particles.  An alternative two-color identification strategy that needs to be 
accommodated is localization of viruses in only one channel, i.e. red channel, that are then 
transferred to the green channel.  This method as used in Chapter 3 allowed measurement of 
the fluorescence arising from fluorescently labeled antibodies bound to the immobilized virus 
particles even if the fluorescence signal from the antibodies was too faint to be readily detected.  
As well, single-color fusion experiments to follow solely hemifusion or pore formation need to be 
accommodated. 
To facilitate the definition of the analysis conditions and parameters to be used, a 
graphical/guided user interface (GUI) is in need of development.  The GUI should allow users to 
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define the image and trajectory analysis parameters described in Appendix 3 in an intuitive and 
understandable fashion.  One suggested method would be to ask a user to define parameters 
sequentially, first by loading a fusion recording and acquiring a sample image that can be used 
for determination of filtering parameters for particle detection.  Once particles are detected and 
tracked, particles known to the user to be ideal fusion trajectories should be chosen through a 
point-and-select method.  The fluorescence trajectory of these nicely fusing virions can be 
plotted and the trajectory selection parameters defined to ensure that the few tested trajectories 
visualized are accepted by the Boolean decision function. 
Additional validation metrics should also be evaluated.  While it was shown here that the 
kinetics extracted by the automated algorithm are comparable to those resulting from manual 
selection, the error of trajectory selection has not been evaluated or compared to manual 
selection.  As such, the true positive/negative and false positive/negative selection percentages 
remain to be determined for the algorithm.  These ratios should also be determined for analysis 
of movies of varying quality, where the focus and brightness of the recordings is varied.    
Though the limitations of this analysis method have yet to be fully evaluated, the proof-
of-principle validation for the power of the maximum likelihood estimator-based selection criteria 
in choosing fusion trajectories has been achieved.  Further advancement of the algorithm 
described here is sincerely hoped for and given the imparted advantages of increased data 
throughput and of improved reproducibility of the analyzed data, it is certainly warranted.   
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Chapter 5 
Polyunsaturated Lipids Enhance Influenza Hemagglutinin Membrane Fusion 
Kinetics and Efficiency as Revealed by Single Virus-Particle Observation 
 
Abstract 
Biological membranes where membrane fusion is rapid and frequent possess 
substantially different lipid compositions compared to more static plasma membranes, likely 
reflecting the dynamic nature of the membrane fusion process. They contain larger amounts of 
polyunsaturated fatty acids (PUFA) that are characterized by high degrees of acyl chain 
flexibility and water permeation in contrast to monounsaturated fatty acids (MUFA). Here, a 
planar phosphatidylcholine bilayer comprised of either MUFA or PUFA lipids is formed on a 
dextran support and serves as a target for fusion by influenza viruses via hemagglutinin (HA)-
mediated fusion. Individual virus particles are observed using a dual-color fluorescence 
microscopy-based fusion assay that simultaneously records lipid- and content-mixing events [1]. 
Automated and quantitative analysis reveals that fusion to MUFA bilayers frequently produces a 
long-lived state of restricted hemifusion where viral and bilayer lipids are fused, but do not freely 
intermix. HA is capable of forming a fusion pore through the restricted hemifusion intermediate 
wherein viral content is released after lipids initially begin to mix, but prior to free intermixing of 
the viral and bilayer lipids. When fusing to PUFA bilayers, viruses are less prone to enter a 
restricted hemifusion state, and release their contents more rapidly and more efficiently. It is 
postulated that the confined lipid diffusion present during the restricted hemifusion state results 
from the formation of a molecular fence created by the influenza fusion peptide and cholesterol 
present at the site where fusion takes place. 
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5.1 Introduction 
Infection of a cell by the influenza virus begins when the virus binds to the surface of its 
target, enters the cell via clathrin-mediated endocytosis, then perforates the endosomal 
membrane to release its viral genome into the cytosol and begin cellular hijacking.  Both of 
these initial steps in the infection process are mediated by the viral surface protein 
hemagglutinin (HA) [2]. The HA fusion protein represents a model system for understanding 
viral membrane fusion, where energetic barriers separating the final fusion product [3,4] must be 
crossed without the use of ATP or other external energy source. As a result, viral HA are highly 
dependent upon both the sequence and structure of the protein itself [5] and the properties of 
the membrane to which it will mediate fusion [6]. 
HA is a homotrimeric transmembrane protein embedded at high copy number into the 
phospholipid membrane of the influenza virus. Each HA monomer is initially produced in a 
fusion inactive form, HA0, that upon proteolytic cleavage forms two disulfide-linked domains, 
HA1 and HA2, that constitute the pre-fusion form of the protein [7]. The HA1 domain is located 
distal from the viral membrane and contains a sialic acid receptor binding pocket that serves to 
bind a virus to the surface of target cells [2][8]. The viral membrane-proximal HA2 domain 
represents the primary fusion machinery of HA, containing the highly conserved N-terminal 
fusion peptide and the viral membrane embedded C-terminal transmembrane region (Figure 5-
1A) [9]. HA2 is capped by the HA1 domain and locked into a metastable conformation at neutral 
pH. Upon exposure to acidic conditions below pH 5.5 in the late endosome of a cell, the HA2 
undergoes a massive conformational change, unfurling the hydrophobic fusion peptide from its 
initial position in a pocket near the viral membrane and inserting it into the target membrane 
[10,11]. This extended intermediate of HA acts to couple the viral and target bilayers and has 
been detected only indirectly [5]. Subsequent re- folding of the extended conformation back 
upon itself is thought to bring the two membranes into close apposition through formation of a 
nipple-like structure that facilitates the onset of lipid mixing between the proximal leaflets (Figure   
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Figure 5-1 – Experimental design for visualizing membrane hemifusion and full fusion of 
influenza virus particles to target bilayers of varying composition. A) A proposed mechanism for 
HA-mediated membrane fusion, focusing only on the HA2 domain (panel adapted from ref. 
[10]). Left to right: the HA2 domain is folded at neutral pH to sequester the fusion peptide 
(yellow) into a hydrophobic pocket; upon acidification the HA2 domain unfolds into the extended 
intermediate to embed the exposed fusion peptide into the target membrane; the extended 
structure collapses to bring the apposed membranes into close proximity, presumably through 
formation of a dimple structure [3]; lipid mixing begins with a lipidic hemifusion stalk that unites 
the proximal leaflets of the two membranes and allows dequenching to occur (D); a fusion pore 
is opened through action of the HA transmembrane domain to allow escape of viral contents. B) 
As described in [1] influenza virus particles are dually labeled with a green lipophilic dye in their 
envelope (blue-green) and a red aqueous dye marking the viral lumen (magenta). Virions are 
immobilized on a dextran-supported planar phospholipid bilayer through specific interaction of 
HA with sialic acid moieties presented by gangliosides. Bilayers are comprised of one of four PC 
141 
 
(Figure 5-1 Continued) lipid types (shown below the experimental diagram) in a 4:1 molar ratio 
with cholesterol. The pH-sensitive fluorescein dye (bright green) is attached to the bilayer 
surface and serves as an internal pH meter. C) Dual colored viruses are observed 
simultaneously in two emission channels that are super-imposed here. Fluorescence from the 
viral envelope and lumen are false-colored green and magenta, respectively. Many viruses 
contain only one signal, but some (white) contain both fluorescence signals and report on both 
lipid mixing and pore formation. D) Onset times for fusion events relative to loss of fluorescein 
signal (t=0, acidification time) are extracted from fluorescence trajectories after fitting. The lipid 
dequenching time (black), TLQ, is determined by fitting a portion of the lipid trajectory (blue-
green) with Equation 5-2. Lipid dissipation time (red), TLP, and the rate of outward lipid diffusion 
into the bilayer, D2D, are determined by fitting the same trajectory with Equation 5-3. Content 
dissipation time (blue), TCP, and the rate of content signal loss, Vcontent, are determined by fitting 
the content trajectory (magenta) with Equation 5-3. Fits are determined in an automated fashion 
using maximum likelihood estimators (Chapter 4 and reference [12]). The trajectory for this 
particular virion depicts the restricted hemifusion state, indicated by a delay between lipid 
dequenching and dissipation.  Pore formation occurrs through a restricted hemifusion 
intermediate and prior to free intermixing of the viral and target bilayers. The fusion of this 
particle is seen in Supplementary Movie M4-1. 
 
5-1A) [2,3,10,11]. The state of initial lipid mixing is defined as hemifusion and is described in 
terms of a highly curved stalk. Following lipid mixing, the palmitoylated C-terminal 
transmembrane domain acts to facilitate the opening of a fusion pore connecting the viral lumen 
with the cytosol for release of the viral genome [13,14].  
Lipid head groups and their contribution to spontaneous membrane curvature have been 
demonstrated to play an important role in facilitating or inhibiting the fusion process. Formation 
of a hemifusion stalk is inhibited by lipids having positive curvature, such as 
lysophosphatidylcholine (LPC), while negative curvature oleic acid or lipids having 
phosphatidylethanolamine (PE) head groups facilitate its formation [6,15,16]. Fusion pores have 
the opposite curvature and their formation is also lipid dependent, being facilitated by positive 
curvature and inhibited by negative curvature [15,17]. In comparison to the zero-curvature 
phosphatidylcholine (PC) lipids, PE and plasmalogen lipid species have been demonstrated to 
be generally more fusogenic [16,18]. 
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The fatty acid (FA) composition of phospholipids comprising lipid bilayers has received 
less attention in terms of their contribution to the fusion mechanism. Biological membranes 
undergoing critical membrane fusion events, such as those of synaptic vesicles [19], the gray 
matter of the cerebral cortex [20], and sperm plasma membranes [21], contain large amounts of 
the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid (22:6) and its metabolic 
precursor linolenic acid (18:3) . The presence of PUFA is important for proper health of the 
tissues they form and PUFA deficiencies correlate with presence of disease, such as 
Alzheimer’s [22] and infertility [23]. As well, the PE and plasmalogen lipids in these tissues are 
common reservoirs of PUFA [20,24].  
The influenza virus lipidome is primarily composed of 16 to 18-carbon length saturated 
and monounsaturated lipids present principally in PC and glycosphingolipids [25,26]. A minor 
amount of the influenza membrane does consist of PUFA, though, being 14% of all PC and 39% 
of PE [26]. The composition of the influenza virus is quite important for proper virus stability and 
infectivity [27], and directed lipid oxidation through the use of small molecules has been 
demonstrated to neutralize influenza viruses [28]. Since PUFA lipids are particularly sensitive to 
oxidation, they may be critical targets of such targeted oxidation. 
Incorporation of unsaturated lipids into in vitro systems for the study membrane fusion 
serves to increase the rate of fusion [18,29-31] compared to bilayers of monounsaturated FA 
(MUFA). Lipid membranes consisting of phospholipids having PUFA show greater acyl chain 
fluctuations [32], and larger degrees of lipid fluidity and water permeation [33-35] than those of 
MUFA. It has been postulated that the enhanced acyl chain dynamics may allow for filling of 
voids created during fusion since PUFA more readily form the inverted hexagonal lipid phase 
that is similar to hemifusion stalk [36].   
The dual color viral fusion assay originally described in [1] is adapted here to study the 
effect of MUFA and PUFA acyl chains on the kinetics of HA-mediated membrane fusion. Briefly, 
X31 influenza viruses were labeled with a green lipophilic dye staining their membrane and a 
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red water soluble sulforhodamine B (SRB) dye staining their lumen. The green lipid dye 
incorporates into the virus particle at concentrations sufficient to enable self-quenching and a 
marked decrease of the fluorescence intensity when incorporated into the viruses. As depicted 
in Figure 5-1B, labeled viruses were immobilized upon dextran-supported bilayers [1] were 
comprised of 20% cholesterol and 80% symmetric diacyl PC lipids having one of the four 
following fatty acid chains: 1,2-dioleoyl-PC (diC18:1), 1,2-dilinolenoyl-PC (diC18:3), 1,2-
dierucoyl-PC (diC22:1), 1,2-didocosahexaenoyl-PC (diC22:6). Disappearance of the fluorescein 
signal upon acidification of the virus (pH drop) indicates the synchronization of the fusion 
process for all viruses and sets time t = 0 seconds. Shortly thereafter, the virus particles fuse 
with the target bilayers and the fluorescence emitted during the fusion process is recorded in 
two spectrally separated channels (Figure 5-1C). 
Lipid mixing of the viral lipids with the target is observed to occur with two distinct 
signals: lipid dequenching and lipid dissipation (Figure 5-1D).  Dequenching of the green 
lipophilic dye corresponds to the onset of a hemifusion stalk. The signal arises from initial mixing 
between viral and bilayer lipids that alleviates neighbor-neighbor dye molecule quenching and 
thereby increase emitted fluorescence. Following dequenching, dissipation of the lipid signal is 
observed as the lipid dye continues to escape from the viral envelope and freely diffuses 
outward from the site of fusion. Content release is observed as a loss of fluorescence signal in 
the red fluorescence channel and occurs as the small SRB molecules rapidly escape the viral 
lumen through a pore formed in the viral envelope.  
A key development since this viral fusion assay was first described by Floyd et al. [1] is 
the automated analysis script described in Chapter 4. In addition to making data selection more 
rapid and objective, it also provides additional kinetic information that has not yet been 
investigated. Specifically, the time between pH drop and lipid dissipation, which has only been 
qualitatively noted in previous studies [1,5,37], is now readily accessible for kinetic study. The 
rate of signal dissipation for the lipid and content signals similarly provide information about the 
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mobility of the dyes being observed. These rates of signal loss are also reported by the 
automated analysis script and can now be studied with large numbers of identified events.  
This chapter details the kinetics found for various steps in the fusion process and their 
dependencies on the degree of unsaturation present in the target bilayer. Overall, the 
polyunsaturated lipids substantially affect the fusion process after the lipid dequenching event. 
As such, the additional information about dissipation onset and rate that can now be accessed 
is crucial to detect the impact that acyl chain polyunsaturation has on the fusion process.   
 
5.2 Results 
5.2.1 Lipid dequenching and initial mixing 
Movement of the fluorescent dye from the viral membrane into the proximal leaflet in the 
target bilayer relieves concentration-dependent dye quenching and gives rise to a sharp 
fluorescence increase (dequenching) in the fluorescence trajectory of a virion. The moment 
taken as the onset of lipid dequenching, TLQ, is indicated in Figure 5-1D and its extraction from 
the fluorescence trajectory of the lipid dye is described in the methods section.  As observed in 
Figure 5-2A, lowering the pH used to stimulate HA-mediated hemifusion causes more than a 
10-fold decrease in the time for the onset of the initial stage of lipid mixing, in agreement with 
previous fusion studies [1]. In varying the lipid composition of the target bilayer, it is observed 
that the median time to fusion is slowest for the diC22:1PC lipid, while the other three lipid 
compositions show faster kinetics.  Inspection of the waiting time distributions themselves 
shows a subtle effect, however, with the diC18:1 and diC18:3 distributions being nearly identical 
(Figure 5-2B) and the diC22:1 and diC22:6 showing comparatively broader distributions (Figure 
5-2C). 
All of the hemifusion waiting-time distributions show a notable rise and decay, though, 
which is characteristic of a multi-step biochemical process.  This behavior is expected and 
consistent with other investigations of HA-mediated hemifusion [1,5,38-40] and is interpreted to  
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Figure 5-2 – The kinetics of initial lipid mixing between the virus and its target are subtly faster 
for fusion to bilayers comprised of shorter acyl chains. A) The time between pH drop and lipid 
dequenching, indicating the time for onset of initial lipid mixing between the virus and target 
bilayer. Target bilayers are comprised of 18:1 (blue open circles), 18:3 (orange filled upward 
triangles), 22:1 (red open squares) or 22:6 (cyan filled downward triangles) diacyl PC 
phospholipids. Data points are median values ± interquartile range for distributions of all 
dequenching times. B and C) Distribution of waiting times for lipid signal dequenching during 
fusion to bilayers having acyl chains of 18 (B) or 22 (C) carbons in length at pH 4.5. Colors as in 
(A) and fit lines are to a gamma distribution. D and E) Fit parameters from analysis of waiting 
time distributions by a gamma function (Equation 5-1) showing the rate of the rate-limiting step, 
k, in (D) and the number of rate-limiting steps, N, in (E). Colors as in (A); data points are values 
found for fits to distributions of all observed dequenching events for the relevant condition ± 
90% confidence intervals. Connecting lines are guides for the eye. 
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be the coordinated participation of multiple HA trimers in driving the hemifusion process. Use of 
the gamma distribution to extract detailed kinetic information about the multi-step biochemical 
reaction of HA-mediated hemifusion has been previously described [1,41]. The gamma 
distribution is: 
 
 
(5-1) 
where k is the rate of the rate-limiting step in the multi-step process and N is the number of rate-
limiting steps that occur.  Gamma distribution fit lines to the hemifusion waiting-time distributions 
for the four lipids at pH 4.5 are also shown in Figure 5-2 and highlight the differences between 
the distributions.   
Comparing the k value extracted for fusion to the four lipid types as the fusion-inducing 
pH is lowered from 5.3 to 3.5 recovers two previously observed [1] kinetic regimes (Figure 5-
2D).  At higher pH values, the rate-limiting step shows a pH dependency, becoming nearly 10-
fold faster as the pH is lowered from pH 5.3 to pH 5.0.  Below pH 5.0, however, the rate k 
changes comparatively little, staying within the same order of magnitude.  It is therefore 
interpreted that the pH-induced conformational unfolding of the hemagglutinin protein dominate 
the kinetic process between pH 5.3 and 5.0, whereas below pH 5.0 re-folding of HA to induce 
membrane merger becomes the rate limiting step.  Re-folding is necessarily influenced by the 
properties of the target membrane given the substantial geometrical changes it must undergo 
[42,43].   
Kinetic differences observed upon variation of the target bilayer composition are 
consistent with this interpretation and show a lipid-dependent separation of k values between 
pH 5.0 and pH 3.5 (Figure 5-2D). In line with Figure 5-2B, target bilayers of diC18:1 and diC18:3 
lipids show similar k values that are, generally, faster than the k values for diC22:1 and diC22:6 
in the lipid-dominated low-pH kinetic regime.  This observation suggests that there is a subtle 
kinetic advantage for the shorter lipids during the onset of initial lipid mixing. The difference in 
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rates may be partially related to a hydrophobic mismatching between the 16-18-carbon length 
viral membrane and the thicker target bilayers of 22-carbon length acyl chains [25,26,44]. 
Bilayers having 18-carbon length acyl chains, on the contrary, would have a thickness 
comparable to that of the virus and would also have more favorable interactions with the 
hemagglutinin transmembrane region. At pH 3.5, when HA is running at maximum velocity, the 
increased amount of acyl chain disorder presented by the diC22:6 PUFA may overcome the 
hydrophobic mismatch effect and drive the system yet faster.   
The number of HA’s participating in the fusion process, N, extracted from gamma 
distribution analysis confirms that multiple HA’s consistently participate in the fusion process.  
The N value is significantly larger than one at all pH values and is largely contained between 
values of 2 and 5, consistent with previous reports for the number of HA required to drive 
hemifusion [1,5,38].  Overall, the distributions of waiting times between pH drop and initiation of 
lipid mixing suggest a subtle enhancement of lipid mixing kinetics when a virus fuses to a target 
bilayer comprised of acyl chains similar in length to those of the viral envelope. 
 
5.2.2 Lipid dissipation and full lipid intermixing 
Dissipation of the lipid signal occurs once the lipophilic dye molecules initially contained 
in the viral membrane are able to freely intermix with the lipids of the proximal leaflet of the 
target bilayer after the initial mixing giving a dequenching signal.  In this state, the lipophilic dyes 
diffuse radially outward from the site of fusion into the target bilayer. The moment taken as the 
onset of lipid dissipation, TLP, is indicated in Figure 5-1D and its extraction from the fluorescence 
trajectory of the lipid dye is described in the methods section.   
In decreasing from a fusion pH of 5.3 to 3.5, the time for free lipid intermixing decreases 
by nearly 10-fold for all target lipid compositions tested (Figure 5-3A).  This fold-decrease is in 
rough agreement with the decrease in time until initial lipid mixing indicated by dequenching 
(Figure 5-2A).  In stark contrast, though, is the significant lipid dependency evident in Figure 5-
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3A.  In the case of lipid dissipation, the degree of acyl unsaturation plays an important role in 
governing the kinetics of the onset of free lipid intermixing, rather than its length.  At fusion pH’s 
4.5 and 3.5 target bilayers comprised of PUFA undergo free lipid intermixing at a time 4-5 fold 
faster than MUFA bilayers.   
Between the MUFA bilayers, the diC18:1 undergoes free lipid intermixing slightly faster 
than the diC22:1.  This trend is consistent with a better hydrophobic mismatch between the viral 
membrane and the shorter 18-carbon acyl chain as was observed in Figure 5-2D.  Alternatively, 
the diC22:1 may exhibit a comparatively higher degree of acyl chain order compared to the 
diC18:1, given that it has a longer stretch of saturated hydrocarbon linkages between its PC 
head group and its cis unsaturated at carbon 13.  As well, it’s gel-to-liquid transition temperature 
of +13ºC [Avanti Lipids published value] is substantially higher than the -17ºC transition 
temperature of diC18:1, consistent with the diC22:1 having a greater propensity for acyl chain 
order [45]. For the PUFA bilayers, the more highly unsaturated and disordered diC22:6 shows 
faster intermixing between the viral and target bilayers than the diC18:3.  The slightly shorter 
time to free lipid intermixing may be related to the extended region of saturated hydrocarbon 
linkages directly below the PC head group of diC18:3 that is absent in diC22:6 (Figure 5-1B).  In 
accord with this, the transition temperature of diC18:3 is slightly higher at -60ºC compared to -
68ºC for diC22:6.  These results indicate that the kinetics governing the onset of full lipid 
intermixing is highly dependent on the degree of acyl unsaturation and, likely, disorder. 
The rate of lipid signal dissipation is the two-dimensional diffusion constant for the 
lipophilic dye as is escapes from the viral membrane into the target bilayer through the lipidic 
hemifusion stalk. Figure 5-2B demonstrates that the rate of dye diffusion into target bilayers of 
different composition has a marked dependency on the composition of the target bilayer.  The 
2D diffusion constant of the lipid dye is largest for the highly disordered diC22:6, followed by the 
diC18:3, then diC18:1 and diC22:1.  This ordering corresponds to the kinetics for the onset of 
lipid dissipation observed in Figure 5-3A where diC22:6 is the fastest and diC22:1 is the   
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Figure 5-3 – Polyunsaturated acyl chains cause substantially faster onset of free lipid 
intermixing and lead to faster content release. Colors as in Figure 5-2. A and D) Elapsed time 
between pH drop and the onset of lipid signal dissipation (A) or the onset of content signal 
dissipation (D) is plotted versus the pH used to induce membrane fusion. The former in (A) 
represents the onset of full lipid intermixing between the viral envelope and target bilayer, and 
the latter in (D) represents the opening of a fusion pore large enough for escape of the small 
molecule dye out of the lumen of the virus. B and E) Fit parameter for the rate of dissipative loss 
of the lipid signal (B) or of the content signal (E) as depicted in Figure 5-1. Lipid signal 
dissipation provides measurement for the diffusion constant of the lipid dye as it leaves the site 
of initial fusion and spreads into the target bilayer. The rate of content signal loss represents a  
qualitative read-out for the rate of fusion pore expansion. C and F) Efficiency of lipid (C) or 
content (F) signal dissipation calculated as the number of particles per experiment showing a 
detectable dissipation signal divided by the total number of virus particles identified.  Data points 
in A, B, D and E are medians ± interquartile range for distributions of all events measured, data 
in C and F are mean values from all experiments performed ± standard deviation. 
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 slowest. The correlation between larger 2D diffusion constants measured for the different lipids 
and a shorter time to onset of free lipid intermixing is statistically significant for pH values 5.0, 
4.5 and 3.5 (Appendix 4, Figure A4-1). This correlation exists only when comparing different 
experimental conditions, however, and no correlation was found between the time an individual 
virus undergoes free lipid intermixing and the 2D diffusion constant measured for its signal 
dissipation. Because the diffusion constant depends on lipid packing, head group area and acyl 
chain ordering [33], the data in Figure 5-3A and B confirm that the onset of free lipid intermixing 
occurs faster for those lipids showing a lower degree of lipid packing and acyl chain ordering. 
The efficiency of full lipid intermixing is calculated as the number of virus particles 
producing a lipid dissipation signal divided by the total number of virus particles observed in an 
experiment. It is observed in Figure 5-3C viruses fusing to bilayers of PUFA show a significantly 
higher efficiency in undergoing free lipid intermixing as compared to bilayers of MUFA.  The 
highest efficiency is largely correlated with the larger diffusion constants and faster kinetics to 
the onset of lipid dissipation.  Hence, viruses fusing to bilayers of polyunsaturated lipids undergo 
free lipid intermixing at a higher rate and with higher efficiency than during fusion to bilayers of 
monounsaturated lipids. The enhancement in kinetics and efficiency imparted by the PUFA is 
correlated to the higher degree of acyl chain disorder and mobility of lipids within the bilayer. 
 
5.2.3 Content dissipation and fusion pore opening 
Dissipation of the content signal indicates the opening of a fusion pore large enough for 
the small SRB dyes to pass through and escape the viral lumen and mixing of the distal leaflets 
of the viral and target bilayers. The moment taken as the onset of content dissipation, TCP, is 
indicated in Figure 5-1D and its extraction from the fluorescence trajectory of the content dye is 
described in the methods section. The elapsed time between the pH drop and the onset of 
content release shows a pH dependency, occurring faster at lower pH in accord with the faster 
onset of initial lipid mixing and dequenching (Figure 5-3D). The kinetics for the onset of content 
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release show that the viral content is released slightly earlier during fusion to a bilayer of 
diC22:6 lipids, but the lipid dependency is not as pronounced as observed for lipid signal 
dissipation. Interpreting pore-formation waiting time distributions with the gamma distribution 
(Equation 5-1) is extremely challenging [1,41] and was not undertaken.  Overall, the kinetics for 
the onset of pore formation are not heavily dependent upon the acyl chain composition of the 
target bilayer. 
The rate of content signal dissipation provides a qualitative measure for how rapidly the 
fusion pore is opening, since a larger pore will allow more SRB dye molecules to escape per 
unit time. As can be seen in Figure 5-3E, the rate of content release is found to have a notable 
pH and lipid dependency. It is unlikely that the rate of content release is reporting on the 
opening of multiple fusion pores, given that their formation is energetically costly (15-20 kBT) 
and considered to be a rare nucleation event [46].   
At pH 5.3, the rate of content release is equivalent for all the lipids tested, with the lipid 
dependency being observed for pH 5.0 and below. Hemagglutinin transmembrane domains 
have been demonstrated to be essential for the productive formation of a fusion pore [13].  As 
such, the pH-dependent conformational rearrangements undertaken by HA in mediating 
membrane fusion are likely to be important contributors to the observed pH dependency. Faster 
content release at lower pH may be attributed to a higher degree of synchronization among the 
HA trimers in undergoing conformational changes since these changes will be driven to occur 
more rapidly.   
For pH 5.0 and below, the fastest content release is observed for fusion of viruses to the 
diC22:6 PUFA, followed by the diC18:3 PUFA.  Content release is comparable between the 
diC18:1 and diC22:1 MUFA and substantially slower than for either PUFA for fusion below pH 
5.0. Unfortunately, It is not possible to directly calculate the diameter of the fusion pore allowing 
release of the content dye because the precise number of fluorophores present in the viral 
lumen is unknown.  Content labeling, as described in methods, involves passive diffusion of the 
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SRB dye into the virus, and hence it also escapes passively giving lower degrees of labeling in 
viruses over time.  Further, the contents of the virus particles are tightly packed with the RNA-
nucleoprotein genome and M1 capsid, leaving unknown space for the SRB dyes to sterically fit. 
Qualitatively, however, the rate of content signal loss can be used to compare the relative sizes 
of the fusion pores that form, with the larger pores giving rise to faster loss of the content signal 
[47]. Hence, it is concluded that expansion of the fusion pore is most rapid when viruses are 
fusing to target bilayers comprised of PUFA lipids.   
The efficiency of fusion pore opening is slightly pH dependent, being more efficient at 
lower pH values.  This, again, may be attributed to greater synchronization between HA trimers 
at lower pH. Notably, there is no clear trend in terms of lipid dependency, neither with respect to 
acyl chain length or degree of unsaturation.  This observation suggests that the opening of a 
fusion pore itself is not dependent upon the lipid type, but is instead driven by the HA 
transmembrane domain. Once a pore is opened, though, the PUFA lipids facilitate its expansion 
to allow rapid release of the viral lumen contents. 
 
5.2.4 Comparing the fusion time points 
Comparison of the three fusion time points – lipid dequenching, lipid dissipation and 
content dissipation – to each other allows for reconstruction of the order of events en route to 
productive membrane fusion. It is observed in Figure 5-4A that for pH values of 5.3 and 5.0 both 
the MUFA and PUFA bilayers show similar trends wherein first lipid dequenching occurs, 
followed by lipid dissipation and, finally, content dissipation.  At pH 4.5 and below, however, 
there is a notable difference between the two lipid classes.  
The PUFA bilayers continue to show a close correspondence between lipid dequenching 
and lipid dissipation, both of which occur more rapidly at lower pH. In contrast, the MUFA 
bilayers demonstrate a flattening out of the time to lipid dissipation that results in a considerable 
delay between lipid dequenching and lipid dissipation. On a molecular level, it represents a 
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delay between initial lipid mixing and free lipid intermixing, indicating there is a confinement of 
the lipid diffusion between the viral and target bilayers.  A confinement of outward lipid diffusion 
following initial lipid contact has been described previously as restricted hemifusion [48]. The 
duration of the restricted hemifusion is long enough that the content dissipation, in fact, occurs 
before free lipid intermixing for MUFA bilayers at pH 3.5. An example of this order of events is 
depicted in the fluorescence trajectory of Figure 5-1D wherein a lipid dequenching signal is 
clearly observed, but the lipids do not diffuse away from the virus until several seconds after the 
dequenching event.  
The restricted hemifusion state appears to have a dependency on lipid type and on the 
pH used to incite fusion, since it is longer-lived for viruses fusing to target bilayers comprised of 
MUFA lipids at pH 4.5 and below.  This combination of dependencies suggests that it is both the 
interaction of HA with the target bilayer together with the bilayer’s intrinsic properties that cause 
and maintain the state of confined lipid diffusion. The pH dependency in particular may indicate 
that the number of HA N-terminal fusion peptides inserted into the bilayer could play a role. For 
fusion to PUFA bilayers this confined state is very short lived at all pH values, noted by the 
close agreement of the lipid dequenching and lipid dissipation populations. This observation 
indicates that large amounts of polyunsaturated lipids disrupt the molecular configurations 
necessary to maintain a state of confined lipid diffusion around the site where lipid mixing is 
initiated. 
It is consistently observed that the formation of a fusion pore follows the dequenching 
signal for all experimental conditions probed.  Hence, a lipidic hemifusion intermediate between 
the proximal leaflets of the viral and target bilayers precedes the opening of a fusion pore, in 
agreement with previous observations [1,48]. The surprising observation that the formation of a 
fusion pore can occur before the free intermixing of lipids in the proximal leaflets indicates that 
the HA trimers are able to form a fusion pore through a restricted hemifusion intermediate. Such  
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Figure 5-4 – HA can induce pore formation prior to full lipid intermixing when mediating fusion 
to monounsaturated lipids at low pH. Data for elapsed time to lipid dequenching is shown in 
black, to lipid dissipation in red and to content dissipation in blue. A) Elapsed time between pH 
drop and the three membrane fusion events extracted from the fluorescence trajectories. Data 
points are medians ± interquartile range for distributions of all event times measured. The 
number of events detected for each fusion condition is described in Table A4-1 of Appendix 4. 
The lipid used in the target bilayer is indicated in the respective plot with bilayers of 
monounsaturated lipids in the top row and polyunsaturated lipids in the bottom row. B) 
Distribution of the three event times for fusion to the bilayers comprised of acyl chains 22-
carbons in length.  The top row is at the pH of 5.3 and the bottom row at pH 3.5. The left column 
corresponds to diC22:1PC and the right column to diC22:6PC. Each plot is the probability 
distribution of all events detected for a particular combination of pH and lipid. Insets into the 
plots are the cumulative density distributions corresponding to the probability distributions and 
highlight the delay in lipid dissipation after content dissipation during fusion at pH 3.5 to the 
bilayer of monounsaturated diC22:1PC. 
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behavior is consistent with the data of Figure 5-3F wherein the opening of a fusion pore 
depends on the action of HA and not on the acyl chain composition of the target. 
Inspection of the waiting time distributions for the three fusion time points under differing 
experimental conditions in Figure 5-4B confirms that the restricted hemifusion state is long lived 
for MUFA bilayers at low pH.  For fusion at pH 5.3, both the diC22:1 MUFA and diC22:6 PUFA 
lipids show similarly broad waiting time distributions for lipid dequenching, lipid dissipation and 
content dissipation.  At pH 3.5 both diC22:1 and diC22:6 lipids have distributions for the content 
release time that remain closely associated with the lipid dequenching distributions, though with 
a slight delay.  The two signals also have similar widths for both lipid types, as observed at the 
higher pH.  The waiting time distribution for lipid dissipation does not show such consistency 
between the lipid types or the high and low pH values.  For diC22:6 the lipid dissipation remains 
closely associated with the lipid dequenching signal and shows a similar width in the 
distribution.  In contrast, the diC22:1 lipid dissipation distribution is exceptionally broad relative 
to the width of the lipid dequenching distribution.  It is so broad that a considerable population is 
still present at times greater than 30 seconds post pH drop, a time when most content 
dissipation has already occurred.  The delay in time to lipid dissipation is equally stark in the 
inset cumulative distribution of Figure 5-4B for diC22:1 at pH 3.5.  In contrast, the inset diC22:6 
cumulative distributions at pH 3.5 are quite similar.      
Analysis of the entire population of observed fusion events indicates the influenza HA 
trimers are capable of forming a fusion pore through a restricted hemifusion state since content 
signal dissipation can precede lipid signal dissipation. Moreover, it appears that termination of a 
restricted hemifusion state to allow lipid signal dissipation is highly dependent upon the acyl 
chain composition of the target bilayer and the pH used to stimulate fusion. The lipid 
dequenching signal to indicate initial mixing of the proximal leaflets and the content dissipation 
signal to indicate opening of a fusion pore both show only a subtle or no lipid dependency, 
respectively (Figure 5-2 and Figure 5-3). For these observations to be true, however, they must 
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be consistent on the level of single particles showing at least two of the three fusion time points 
(dual-event particles).  As such, measurement of elapsed time between lipid dequenching and 
lipid dissipation, and between lipid dissipation and content dissipation in dual-event particles 
should show a lipid dependency.  There should be no lipid dependency in the elapsed time 
between lipid dequenching and content dissipation.  
 
5.2.5 Dual-event particles confirm population level observations 
Most of the virus particles observed show only one of the three fusion events (Figure 5-
1) with sufficient signal-to-noise to permit detection.  A considerable minority of particles, 
though, shows at least two of the three fusion events being compared in Figure 5-4; the number 
of virus particles showing two events is included in Table A4-1.  These fusion events are 
valuable because they allow for direct observation of the transient intermediate that exists 
between two of the fusion events.  Such intermediates are accessible only through observation 
of viral membrane fusion at the single-particle level and hence support the justification for 
pursuing this type of experimental design. The kinetics of dual event particles correspond very 
well with the kinetics of the population as a whole (Figure A4-2), indicating that particles 
showing two fusion events are not a kinetic population separate from single-event particles. 
The confinement lifetime for a dual-event particle can be defined as the elapsed time 
between the lipid dequenching signal and the lipid dissipation signal: TConfine = TLP – TLQ. It 
represents the time when the proximal leaflets have hemifused enough to give rise to a 
dequenching signal, but outward lipid diffusion has not yet occurred. In accord with population 
data, the confinement lifetime shows a pronounced lipid dependency for pH 4.5 and below 
(Figure 5-5A). The confinement lifetime is shorter for viruses fusing to bilayers comprised of 
PUFA lipids.  The distribution of confinement lifetimes is well represented by a  single 
exponential distribution (Figure 5-5B), indicating that a single rate-limiting step separates the 
state of initial lipid mixing that gives dequenching from the final state of free lipid intermixing. 
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Extraction of the decay constant for the confinement lifetime by fitting with an exponential 
distribution (Figure 5-5C) reinforces the observation that the state of confined lipid diffusion is 
rapidly disrupted when the target bilayer has large amounts of PUFA lipids.  The decay constant 
also clearly shows a pH dependency for the release of confined lipid diffusion, suggestive of a 
role by HA in the restricted hemifusion state. 
The hemifusion lifetime was previously defined [1] as the elapsed time between lipid 
dequenching and content dissipation: THL = TCP – TLQ. Though the nomenclature of a hemifusion 
lifetime would suggest the end of a hemifused state, the data in Figure 5-4 indicate that a 
restricted hemifusion state does not necessarily end with the content dissipation signal. 
Nonetheless, this terminology will be utilized here for consistency with the previous study. The 
hemifusion lifetime thus represents the time when the proximal leaflets have hemifused, but a 
fusion pore large enough for escape of small molecule dyes has not yet formed. In accord with 
the population data, the hemifusion lifetime does not show a lipid dependency (Figure 5-5D).  
Instead, only a pH dependency is observed.  Such a pronounced pH dependency was not 
observed previously [1] and may be the result of alterations made to the geometry of the 
microfluidic channel used and the increase in flow rate during influx of the low pH buffer (see 
methods).  Nevertheless, the distribution of hemifusion lifetimes shows a single exponential 
character, as was observed previously [1] (Figure 5-5E).  Extracting the hemifusion lifetime 
decay constants reinforces both the presence of a pH dependency and absence of a lipid 
dependency in the transition from initial lipid mixing to initial pore formation. 
The final intermediate state that can be extracted from dual-event particles is the inter-
dissipation time: Tdsp = TCP – TLP. When this value is less than zero, it represents the time that a 
fusion pore was open to allow content release while lipid diffusion was confined. When Tdsp is 
greater than zero, it represents the time that the proximal leaflets of the virus and target bilayer 
are fully intermixed while the distal leaflets are unmerged and the viral contents are contained.  
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Figure 5-5 – Particles showing two events confirm that the confinement lifetime is longer during 
fusion at low pH to bilayers of monounsaturated lipids, while the hemifusion lifetime has no lipid 
dependency. Data points in A and D are median values ± interquartile range, and in C and F 
they are fit values ± 95% confidence intervals.  Color scheme as in figure 5-2. A) Confinement 
lifetime is defined as the elapsed time between lipid dequenching and lipid dissipation for 
particles showing both signals. A pH and lipid dependency in the confinement lifetime can be 
observed. B) The distributions for confinement lifetimes providing the data in (A) are well fit by a 
single exponential distribution. The confinement lifetimes for diC18:1PC and diC18:3PC at pH 
4.5 are shown with their corresponding fit lines. C) Rate of confinement decay from exponential 
fits to the confinement lifetime distributions. D) Hemifusion lifetime is defined as the elapsed 
time between lipid dequenching and content signal dissipation for particles showing both 
signals. A pH dependency can be observed, but no lipid dependency. E) Distributions of 
hemifusion lifetimes are well described by single exponential distributions, as described 
previously [1]. Hemifusion lifetimes for diC18:1PC and diC18:3PC at pH 4.5 are shown with their 
corresponding fit lines. F) Rate of hemifusion decay from exponential fits to hemifusion lifetime 
distributions.  
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The inter-dissipation time distributions did not show trends overtly indicative of any 
particular waiting time distribution. As such, the cumulative distributions of the inter-dissipation 
times were compared in Figure 5-6A. For each pH value used to induce fusion a larger portion 
of the cumulative distributions for the monounsaturated lipids are below zero as compared to 
the polyunsaturated lipids.  A more overt comparison is performed in Figure 5-6B where the 
percentile of inter-dissipation times falling below zero is directly compared between MUFA and 
PUFA bilayers over the range of pH values. At all pH values for the 18-carbon length lipids and 
at pH 4.5 and below for the 22-carbon length acyl chains, the MUFA lipids showed a higher 
percentile of instances when content release occurred prior to free intermixing of the viral and 
target lipids, i.e. TCP < TLP, than the PUFA lipids.  These observations are in accord with the 
kinetics extracted on the population level that the influenza HA is capable of forming a fusion 
pore through a restricted hemifusion intermediate, which occurs more commonly during fusion 
to bilayers having large amounts of monounsaturated lipids.  
 
5.3 Discussion and future direction 
It is widely accepted that membrane fusion mediated by HA initiates with lipid mixing in 
the formation of a hemifusion stalk that is subsequently opened into a fusion pore in a manner 
depending on both lipids and the HA transmembrane domain [1,5,6,13,42,48-50]. The results 
presented here agree with this order of events and provide insight into the effect of 
polyunsaturated lipids on the kinetics of the membrane fusion and the mechanism of the fusion 
process itself.  We find two principal kinetic effects arising from the presence of PUFA in target 
bilayers.  The first is to enhance the rate and efficiency of free lipid intermixing between the 
virus and target (Figure 5-3). The second is to substantially increase the rate of content loss 
during pore formation, which is surprisingly not accompanied by an increase in pore formation   
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Figure 5-6 – Particles showing two events confirm content release is more likely to occur prior 
to full lipid intermixing during fusion to bilayers of monounsaturated lipids at low pH. Color 
scheme as in Figure 5-2. A) Cumulative distributions of inter-dissipation times for the 18-carbon 
(top row) and 22-carbon (bottom row) length acyl chains at varying pH values (columns). B) 
Percentile corresponding to an inter-dissipation time of zero in (A), which is the percentile of 
dual-event particles where content dissipation occurred prior to lipid dissipation (TCP < TLP). 
Fusion to monounsaturated lipids shows higher percentiles of content dissipation prior to lipid 
dissipation than polyunsaturated lipids. 
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efficiency. Previous studies of viral fusion at the single-particle level did not focus on the rate of 
content release or the kinetics for the onset of lipid dissipation.  The observations made here 
were enabled through the use of the automated data selection algorithm described in Chapter 4 
that extracts a large amount of kinetic data from the information-rich fluorescence trajectories. 
Mechanistically, it is observed that lipid mixing can lead to a state of restricted 
hemifusion evidenced by a delay between the lipid dequenching and dissipation signals (Figure 
5-4). While such a state has been reported in previous studies of cell-cell fusion mediated by HA 
[31,48,50], we demonstrate that persistence of a restricted hemifusion state is modulated by the 
composition of the target bilayer to which a virus is fusing. The restricted hemifusion is longer 
lived during fusion to bilayers having monounsaturated acyl chains while it more rapidly 
transitions to a state of free lipid intermixing when the target is comprised of polyunsaturated 
acyl chains (Figure 5-5). Further, we find that HA is capable of opening fusion pores large 
enough for small molecule dyes to pass through while engaged in a restricted hemifusion state 
(Figure 5-4 and Figure 5-6). 
 Previous investigations of the restricted hemifusion state suggested that it involved 
confined lipid diffusion and demonstrated that it required the presence of large numbers of 
activated HA trimers [48]. Specifically, cleaving the unfolded HA allowed lipids to freely diffuse 
away from the fusion site. It was postulated that a ring of HA trimers in the viral membrane form 
to drive membrane fusion and act as a molecular fence surrounding the initial hemifusion stalk 
that restricts lipid movement. 
 Data presented here are consistent with a dependency on activated HA to form a 
restricted hemifusion state [48] as observed in the pH dependency for the onset of delayed lipid 
dissipation during fusion to MUFA bilayers (Figure 5-4). At high pH, when fewer HA are likely to 
stochastically unfold per unit time, a state of restricted hemifusion is not observed.  The 
restricted hemifusion state is entered only at the lower pH values, when many fusion peptides 
could be expected to insert into the target bilayer in a short period of time.   
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Our observation that the restricted hemifusion state is disrupted by the presence of 
PUFA in the target bilayer suggests that the molecular fence confining lipid diffusion is present 
in the target bilayer, however, and not in the viral membrane. Data in Figure 5-3 indicate that 
higher lipid mobility correlates with faster onset of free lipid intermixing and an end to a 
restricted hemifusion state. As such, molecular species that decrease lipid mobility may be 
sufficient to give rise to confined lipid diffusion observed during restricted hemifusion. It is 
postulated that the molecular fence confining lipid diffusion is formed by two components and 
lies within the footprint of the virus immobilized on a target bilayer. One component is HA fusion 
peptide that becomes inserted into the target bilayer in large numbers following acidification of 
the virus.  The second is cholesterol that escapes from the viral membrane and enters the target 
bilayer upon the initial lipid mixing causing dequenching. Both of these hydrophobic molecular 
species have been measured to increase acyl chain order and reduce the free volume present 
in bilayers containing monounsaturated lipids [44,45,51,52]. Such ordering of the acyl chains 
results in lower lipid mobility [33] and could give rise to a state of confined lipid diffusion 
depicted in Figure 5-7.  
Viral structures revealed by cryoelectron tomography indicate that there are enough 
fusion peptides present in the footprint of a virus to influence lipid mobility. The spherical viruses 
were described to have a radius of 75 nm from their center to the tip of their spike proteins and 
contain around 375 HA trimers [53]. If the viral footprint consists of a hemisphere where all 
available fusion peptides are inserted and the area per lipid is taken to be 70 Å2 (approx. value 
for both diC18:1 [54] and diC22:1 [45]), then the resulting peptide:lipid ratio in the viral footprint 
would be approximately 1:100. Significant free volume reduction and acyl chain ordering in 
membranes of diC18:1 have been measured at the 1:100 ratio [51]. Interaction between the 
influenza fusion peptide and PUFA containing membranes has yet been investigated, but 
simulations of protein transmembrane domain at high concentrations in PUFA bilayers have 
indicated a substantial reduction in lipid mobility within the bilayer due to molecular crowding  
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Figure 5-7 – Model for the creation of an HA fusion peptide-cholesterol molecular fence 
restricting lipid diffusion away from a site of fusion. i) Pre-fusion immobilization of a virus to a 
target bilayer when lipophilic dyes are in a quenched state. ii) Upon acidification, a virus initially 
enters a state of confined lipid mixing and gives rise to a dequenching signal. This state is 
initially entered when fusing to a bilayer comprised of either monounsaturated fatty acids 
(MUFA, top path) or polyunsaturated fatty acids (PUFA, bottom path). Zooming in on the lipids 
(grey-black) near the perimeter of the hemifusion stalk highlights the composition-dependent 
orientation of cholesterol (CH, brown) in the bilayer. For MUFA bilayers, CH is oriented normal 
to the plane of the bilayer and interacts with acyl chains to increase acyl chain ordering and 
reduce lipid mobility [44]. For PUFA bilayers, CH is oriented parallel to the plane of the bilayer 
[58,59] where it may interact with acyl chains to a lesser extent, allowing higher lipid mobility 
[33]. In both cases, the HA fusion peptide (yellow) can act to increase acyl chain ordering and 
as a large steric hindrance to diffusion. Evolution of the fusion process from (ii) then depends on 
lipid type. The commonly observed sequence of fusion events at pH 3.5 is depicted in (iii) and 
(iv). For MUFA bilayers (iii-m), the restricted hemifusion state persists when a nascent fusion 
pore opens to release the SRB content dye. Outward lipid diffusion (iv-m) occurs at a later time 
following sufficient expansion of the fusion pore. For PUFA bilayers (iii-p), the system quickly 
escapes from the restricted hemifusion state to allow outward lipid diffusion. Nascent fusion 
pores expand rapidly (iv-p) to quickly release the SRB dye contained in the viral lumen. Note: 
All dimensions in the two zoom-in sections are scaled relative to an estimated 70 Å2 per 
phosphatidylcholine (PC) lipid molecule and HA trimers are excluded for clarity. 
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and steric effects [55,56]. To estimate the relative area occupied by the fusion peptides, we take 
the fusion peptide to be a rectangular block in the 2D area of the bilayer having a projected 
length of 26 Å and width of approximately 8 Å (PDB: 2JRD [57], viewing perpendicular to the 
plane of the target bilayer). The fusion peptides then have an area equivalent to approximately 3 
lipid molecules and would occupy approximately 3% of the bilayer area, which may introduce 
steric effects and reduce lipid mobility. Such ordering and steric effects of the fusion peptide 
could contribute to the dependency of the restricted hemifusion intermediate on the amount of 
activated HA present.  
The viral envelope of egg-derived X31 viruses, as used here, have been found to consist 
of ~50 mol% cholesterol [27]. The target bilayer was designed to have 20 mol% cholesterol.  If 
these two mix in equal proportions lipid dequenching occurs, then the approximate cholesterol 
concentration in the area of the viral footprint would be near 35 mol% cholesterol. Acyl chain 
order and lipid-cholesterol lateral area was found to increase for both diC18:1 and diC22:1 lipids 
at this concentration [44]. Further, membranes containing MUFA have been shown to have a 
larger reduction in lateral diffusion upon addition of cholesterol compared to membranes 
containing PUFA [33]. Specifically, evidence suggests that the acyl chains of the 
monounsaturated lipid molecules are compressed by cholesterol’s rigid sterol rings [60] as it 
orients parallel to the plane of the acyl chains [61]. Cholesterol has a pronouncedly different 
interaction with diacyl PUFA phospholipids, however, becoming sequestered to the middle of a 
bilayer perpendicular to the plane of the acyl chains [58,59]. Hence, when a virus is fusing to the 
PUFA bilayers the cholesterol is removed from an area where it can interact with lipids or the 
fusion peptide and cannot contribute to the formation of a molecular fence constricting lipid 
diffusion, as depicted in Figure 5-7. The sequestration of cholesterol by PUFA lipids could 
explain why the restricted hemifusion was observed less frequently when viruses fused to 
bilayers of diC18:3 and diC22:6. 
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Release from the restricted hemifusion state to allow free lipid intermixing could occur 
through two paths.  In one path, the local lipid composition in the footprint of the virus does not 
permit formation of a molecular fence to confine lipid diffusion. This situation could be expected 
to arise more frequently during fusion to bilayers of PUFA due to cholesterol sequestration. In 
the second path, expansion of the fusion pore alleviates the restricted hemifusion state.  
Presumably, the concentration of both the fusion peptide and cholesterol would have to be at a 
critical concentration or higher for a molecular fence to be created and maintained. As the fusion 
pore expands, the area surrounding a hemifusion stalk also expands thereby decreasing the 
local fusion peptide and cholesterol concentration. When expansion reduces the local 
concentrations below a critical value, the fence breaks and lipid molecules exhibit free 
intermixing, giving rise to the lipid dissipation signal (Figure 5-7). Data here suggest that fusion 
pores expand more rapidly for the bilayers of PUFA (Figure 5-3E) and lipid dissipation would 
thereby occur faster. Hence, both scenarios are consistent with the data presented that bilayers 
of polyunsaturated lipids give rise to earlier onset of free lipid intermixing. 
Testing this model would consist of performing two additional experimental variations.  
To assess the contribution of the influenza fusion peptide to the onset of a restricted hemifusion 
state, the number of fusion peptides inserting into a target could be reduced by use of small 
molecules [62] or peptides [63] that block HA low pH conformational changes. These peptides 
bind to influenza HA and prevent their low pH conformational changes. Their small size has the 
advantage over neutralizing antibodies in avoiding additional steric effects that could inhibit 
fusion. Assessing the contribution of cholesterol would involve reducing the cholesterol content 
in the target bilayer to zero. A priori, it is unclear if this reduction would be sufficient to observe a 
statistically significant change in the kinetics of the restricted hemifusion state, since cholesterol 
can still be contributed by the virus. Removing some cholesterol from the virions may be 
possible, though it has been previously found that cholesterol depletion markedly affects fusion 
by the influenza virus [64]. Incorporating either of these experimental variations while fusing 
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virions to bilayers of diC18:1 or diC22:1 at pH 3.5 would be expected to reduce the delay 
between lipid dequenching and dissipation signals (Figure 5-4A). Such a change should be 
accompanied by an increase in the rate of confinement decay (Figure 5-5C) as the restricted 
hemifusion state should last for shorter amounts of time and reduce the percentile of dual 
events having TCP < TLP (Figure 5-6B). 
Opening a fusion pore through a hemifusion diaphragm is energetically costly [46] and 
simulations have found that it can be triggered by the movement of water molecules across an 
unstable bilayer [65]. It is thus surprising that we do not find an enhanced efficiency of pore 
opening during fusion to the PUFA bilayers, though it is known that polyunsaturated lipids have 
higher degrees of water penetration [35]. In contrast, addition of positive curvature LPC lipid to 
the inner leaflet of red blood cells did increase the efficiency of pore opening and content 
release [48]. It may suggest that PUFA are important in a biological context for helping drive 
open a nascent fusion pore to avoid premature closing or flickering, while the lipid head group 
separately affects the likelihood that a fusion event will occur.  Such speculation is in line with 
the presented data of faster content release (Figure 5-3E). Additionally, it may help explain why 
large amounts of polyunsaturated lipids are present in synaptic vesicles and sperm membranes 
[21,34] and why they are typically incorporated into the highly fusogenic plasmalogen or PE type 
lipids [20].  
In summary, the fusion of influenza viruses to target bilayers of varying acyl chain 
composition was studied at the single-particle level using fluorescence microscopy. 
Fluorescence trajectories of the fusion events were analyzed  using an automated fitting-based 
algorithm to identify the various time points along the fusion pathway and the rate of signal 
change. Extracted kinetics indicate that fusion to monounsaturated lipids leads to a long-lived 
restricted hemifusion state wherein lipid diffusion is confined. Influenza HA is capable of forming 
a fusion pore through a restricted hemifusion intermediate. Lastly, fusion to polyunsaturated 
lipids leads to more rapid escape from a restricted hemifusion state and results in faster release 
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of viral contents. Future work will investigate a proposed model for the combined effect of 
influenza fusion peptides and cholesterol in creating a restricted hemifusion state. 
 
5.4 Materials and methods 
5.4.1 Materials 
X31 influenza virus particles propagated in the allantoic cavity of fertilized chicken eggs 
were purified in the lab of Prof. J. Skehel and kindly sent at a concentration of 10 mg/ml total 
viral protein for use in the fusion assay. Virus particles were dual-labeled in two subsequent 
steps. Red sulforhodamine B dye (Sigma-Aldrich) dissolved in deionized water at 20 mM was 
mixed with 5 l of purified virus to a final dye concentration of 13 mM and incubated either over 
night at room temperature or for 48 hours at 4ºC. Free dye was removed by passing the virus-
dye solution through a PD-10 sephadex column (GE Healthcare). Fractions of 200 l were 
collected and those containing the highest virus concentrations were visible by eye and 
appeared red. The two most intensely red fractions were pooled together and mixed with green, 
lipophilic octadecyl rhodamine 110 (Rh110) to a final dye concentration 0.06 mg/ml (i.e. 3 l of 
dye solution per 100 l of content-labeled virus). The Rh110 dye was synthesized in-house [1] 
and dissolved in DMF at 2 mg/ml. Content-labeled virus was mixed with Rh110 for 2-3 hours, 
then the dual labeled viruses were separated by passage through another PD-10 column. The 
three brightest fractions were pooled together and used in the same day. 
Phospholipids used for the formation of planar bilayers were purchased from Avanti 
Polar Lipids (Alabama, USA) and used without further purification or treatment: ovine wool 
cholesterol, 1,2-dioleoyl-sn-glycero-3-phosphocholine (diC18:1), 1,2-dilinolenoyl-sn-glycero-3-
phosphocholine (diC18:3), 1,2-dierucoyl-sn-glycero-3-phosphocholine (diC22:1) and 1,2-
didocosahexaenoyl-sn-glycero-3-phosphocholine (diC22:6). Lipid formulations included 19.7 
mol% cholesterol, 79.3 mol% PC lipid, 1 mol% bovine brain disialoganglioside GD1a (Sigma), 
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and 0.0022 mol% N-((6-(biotinoyl)amino)hexanoyl)-1,2-dihexadecanoyl-snglycero- 3-
phosphoethanolamine (biotin-X DHPE, Life Technologies).  
 
5.4.2 Liposome preparation 
To prepare liposomes, lipids dissolved in chloroform were mixed at appropriate ratios 
and the chloroform subsequently removed. For the monounsaturated diC18:1 and diC22:1, 
removal was performed drying under an argon flow, followed by vacuum desiccation for two 
hours. Lipid mixtures containing the polyunsaturated diC18:3 and diC22:6 were found to 
undergo extensive oxidation during vacuum desiccation. Instead, chloroform was removed by a 
constant flow of argon for 1-1.5 hours. Once dried, the lipid mixtures were suspended in HNE 
buffer (5 mM hepes, 140 mM NaCl, 0.1 mM EDTA, pH 7.4), subjected to repeated 
freeze/thawing cycles and extruded using polycarbonate membrane filters having a 100 nm 
pore diameter (Avanti Polar Lipids). Liposomes were prepared fresh the day of use at 2.5 mM 
total lipid.  
 
5.4.3 Dextran functionalized cover slips 
Dextran functionalized microscope cover slips were prepared similar to previous 
description [1]. Briefly, glass cover slips (25 x 25 mm, No. 1.5, VWR Scientific) were cleaned by 
subsequent 15 minute sonication treatments of detergent, acetone, ethanol, and 1M KOH. 
Cover slips were rinsed and dried at 110ºC for one hour, then cleaned in an oxygen plasma 
cleaner. Cleaned cover slips were functionalized with (3-glycidooxypropyl) trimethoxysilane 
(Gelest Inc, Morrisville, PA, USA) dissolved into isopropanol at 0.2% by volume. Functionalized 
cover slips were cured for 1 hour at 80ºC, then covered with dextran (dextran 500; 
Pharmacosmos A/S; mean MW 5 x 105 Da) dissolved in deionized water at 0.3 g/ml and allowed 
to react for two days. 
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5.4.4 Microfluidic channels 
Microfluidic channels for the fusion experiments were formed by PDMS 
(polydimethylsiloxane, Dow Corning, Sylgard 184) using common cast molding techniques 
[66,67]. First, a silicon wafer having a relief pattern corresponding to five non-intersecting 
channels was prepared using standard photolithographic techniques and SU-8 negative 
photoresist. PDMS was mixed at a 9:1 ratio of elastomer to curing agent, degassed to remove 
bubbles, poured on top of the silicon master and allowed to cure either at 60ºC for four hours or 
under desiccation at room temperature for 48 hours. Solid blocks of PDMS containing the relief 
pattern were easily removed from the silicon wafer and cut to fit the glass cover slips. Each chip 
housed five microfluidic channels having inner dimensions 0.5(w) x 0.2 (h) x 10(l) mm and 
separated by 0.5 mm. PDMS chips were used to form the experimental flow channel by 
adsorbing them to a dextran-functionalized cover slip. Leakage between channels was 
prevented by applying pressure to the PDMS chip using a specially designed flow cell holder 
and microscope stage adaptor. Inlet and outlet polyethylene tubing (PE20 and PE60, 
respectively; Intramedic) was coupled to each microfluidic channel to allow rapid buffer 
exchange using a negative pressure syringe pump (Harvard Apparatus Model 11 syringe 
pump). 
 
5.4.5 Microscope design 
Fluorescence microscopy was performed using an inverted fluorescence microscope 
(Nikon TE-2000U) equipped with a high numerical aperture (NA = 1.45) 60x oil-emersion 
objective. Dual-labeled viruses were illuminated by 488 nm and 561 nm lines from an 
argon/krypton gas laser (Coherent Innova 70C) that were focused onto the back focal-plane of 
the microscope objective and aligned into objective-based total internal reflection (TIR) mode. 
Green and red emitted fluorescence was filtered using a 500-to-540 nm and 600-to-640 nm dual 
band-pass emission filter (Chroma Technology). The colors were spectrally separated using a 
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dichroic mirror and each emission channel was focused onto separate regions of a 512 x 512 
pixel electron multiplying CCD camera (Andor Technology DV 887-BI, 16 m pixel size). 
 
5.4.6 Fusion assay  
Fusion experiments were performed at room temperature, which fluctuated between 21-
23ºC. Microfluidic channels comprised of a dextran-functionalized cover slip adsorbed to a 
PDMS chip were mounted to the microscope stage. The flow channel was initially hydrated by 
flowing in HNE buffer, then the liposome solution was added and allowed to incubate with the 
dextran surface for a minimum of 20 minutes.  Dual-labeled virus particles were diluted between 
20 and 50-fold in HNE, then added to the flow chamber, which also flushed out excess lipids. 
Virus particles were allowed to bind to the surface until the coverage density was such that 
approximately 200-400 particles were visible in a field of view. Streptavidin-fluorescein 
conjugates at a concentration of 4 g/ml in HNE was added to the flow chamber to wash out 
unbound virus particles. Finally, video recording was begun and the low pH buffer (10 mM citric 
acid, 140 nM NaCl, 0.2 mM EDTA) was added to the flow chamber to induce HA-mediated 
fusion. Lipids and virus solutions were flowed into the flow channel at a flow rate of 100 l/min 
and the low pH buffer at 500 l/min.  Frame exposure time was 50 ms for fusion at pH 3.5, 100 
ms for fusion at pH 4.5 and 5.0 and 200 ms for fusion at pH 5.3.  Laser power was adjusted to 
ensure a similar photon count rate per frame (i.e. intensity was double for pH 3.5 compared to 
pH 4.5, and was half for pH 5.3 compared to pH 4.5). 
In comparison to the original implementation of this viral fusion assay [1], a number of 
modifications were incorporated. The microfluidic channels were constructed by PDMS chips 
rather than being created by hand through the use of quartz tops and double-sided tape. 
Repeated use of PDMS chips ensured that the flow channels of all experiments had identical 
geometries. Incorporation of multiple channels also allowed for more robust and high-throughput 
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data acquisition. A syringe pump with a definable flow rate was used for buffer exchange rather 
than a peristaltic pump that had an unknown flow rate, but that was estimated to have been 
approximately 100 l/min. Addition of the low-pH buffer was therefore approximately 5-fold 
faster for the experiments performed here than in the original experimental setup, though the 
flow profile was still parabolic given the dimensions of the flow channel [68].  
 
5.4.7 Data extraction and analysis 
Disappearance of the fluorescein signal upon acidification of the virus is defined as the 
pH drop and sets time t = 0 seconds. To identify the frame where the pH drop occurs, the 
sigmoidally-decreasing fluorescein signal was analyzed as previously described [1]. Briefly, the 
slope at the inflection point is determined and the frame when it crosses base-line fluorescence 
once all fluorescein signal has dissipated is set as the pH drop frame. 
The fluorescence trajectories of individual virus particles were extracted and analyzed 
using the MATLAB-based Fusion Tracker automated analysis software package described in 
Chapter 4. In brief, virus particles in the fluorescence recordings were identified through 
discoidal filtering [69] and then fit with two-dimensional Gaussian functions to determine their 
width. A circle of twice the Gaussian width centered at particle’s location was used for 
integration of the particle’s fluorescence intensity. Fluorescence intensity extracted from each 
frame of a recording was corrected for the laser illumination profile, background fluorescence 
and channel cross-talk. The acquired fluorescence trajectories (emitted fluorescence intensity 
over time) were fed into the Boolean decision function described in Chapter 4. This function 
identifies trajectories having potential events based on a particle’s inherent signal-to-noise, its 
noise profile characteristics and on the existence of large, rapidly occurring intensity changes. 
Portions of the trajectory identified to contain large intensity changes were fit with one of two 
functions that serve 1) to determine the timing and rate of an event and 2) to separate transient 
signal fluctuations from true fusion events.  
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Large intensity increases in trajectories of the green, lipid channel were fit using a 
sigmoidal function defined as the dequenching equation:  
 
 
(5-2) 
where p is a vector containing the parameters: p1, the plateau intensity value before 
dequenching; p2, the plateau value after dequenching; p3, the inflection point of the intensity 
increase; and p4, the duration of the dequenching event. The moment for the onset of lipid 
dequenching, TLQ, is determined to be the first frame when the value of the dequenching fit rises 
above the upper 95% confidence bound of the p1 parameter.  
Large intensity decreases in both the lipid and content signal trajectories were fit using 
the dissipation equation: 
 
 
(5-3) 
where r is the radius around a virus particle in m that is used for fluorescence intensity 
integration, and p is a parameter vector representing: p1, the intensity value before dissipation; 
p2, size of the signal loss upon dissipation (i.e. initial intensity minus final intensity); p3, the frame 
indicating the onset of signal dissipation (i.e. p3 = TLP or TCP for the lipid or content signal, 
respectively); and p4, the rate of signal loss. For lipid signal dissipation, p4 is the two-
dimensional diffusion constant in m2/second [70], while for content signal dissipation it is 
simply the rate of intensity loss and is not interpreted to correspond to a physical constant. H(t- 
p3) is the Heaviside function and is invoked to remove the contribution of the exponential at 
times less than p3..  
The fitting of portions of trajectories with Equations 5-2 or 5-3 was performed by an 
automated analysis script that determines the most statistically relevant region for fitting using a 
maximum likelihood estimator [12]. This estimator takes the quotient of probabilities for 
obtaining the residuals found by fitting the trajectory with Equations 5-2 or 5-3 and the 
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probability for the residuals found by fitting the same trajectory with a straight line. An analytical 
threshold is set by defining an acceptable false-positive rate and if the ratio is larger than this 
threshold, then the fit is accepted, otherwise the fit is rejected. Statistically relevant fits were 
used to determine the signal-to-noise of the detected event and fits falling below a defined 
threshold value were rejected. The threshold for lipid dequenching fits was varied between 1.0-
2.5, while the threshold for either lipid or content dissipation was set at 2.0. Lipid signal 
trajectories were permitted to have a single dequenching event that occurred prior to a single 
dissipation event. If more than one dequenching event was detected, then both dequenching fits 
were thrown out. Similarly for dissipation events. If a lipid dissipation event was detected prior to 
the lipid dequenching event, the particle was rejected.  Content signal trajectories were allowed 
to have a single dissipation event only.  
Fusion time points extracted from accepted fits of the trajectories were aggregated 
together for kinetic analyses presented in Figure 5-2 through 5-6. All fitting was performed in 
MATLAB using least squares fitting and the error reported for determined fit values corresponds 
to the 95% confidence interval for the relevant parameter. 
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Chapter 6 
Conclusions and Outlook 
 
6.1 Conclusions 
Protein-mediated membrane fusion is a critical biological process for breaching the 
phospholipid bilayers that compartmentalize cells, cellular substructures and virus particles. As 
discussed in Chapter 1, single-particle studies visualizing membrane fusion are providing 
detailed insights into the mechanism, kinetics and timing of the fusion process, thereby 
complementing previous ensemble and structural studies. These latter types of studies 
investigating fusion by the influenza hemagglutinin (HA) protein, in particular, have resulted in a 
number of mechanistic models for the molecular events that occur during membrane fusion [1-
3]. Though insightful, these early studies only accessed average measurements over a 
population of virus particles or fusion as mediated by HA expressed on cell surfaces rather than 
incorporated into infectious particles. The single-particle fusion assay originally developed by 
Floyd et al. allowed for real-time visualization of the membrane fusion process as mediated by 
HA [4]. Their results revealed the kinetic nature of previously invisible intermediate states and 
established a conceptual framework for interpreting single-particle fusion kinetics [5]. 
Subsequent use of this assay advanced knowledge of viral lumen acidification via the M2 
channel during fusion [6] and of the kinetic underpinnings of HA’s low-pH conformational 
changes that engage a virus particle with a target membrane [7]. The work described in this 
dissertation demonstrates the utility of the single-particle fusion assay as a platform for the 
study of viral fusion inhibitors (Chapters 2 and 3) and provides insight into the lipid dependency 
of the fusion process after HA conformational unfolding (Chapter 5). Lastly, prototype software 
has been developed to rapidly and reproducibly analyze recordings of viral membrane fusion, 
extracting fusion kinetics in a fully automated fashion (Chapter 4). 
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Neutralization of influenza infection through antibody binding can occur through 
numerous pathways such as inhibition of target cell binding, fusion inhibition or prevention of 
progeny virus release. Because these effects are not necessarily mutually exclusive, discerning 
a mechanism of action directly related to antibody binding is challenging in ensemble fusion 
assays or with viral infection assays [8,9]. Incorporation of the broadly neutralizing, stem-binding 
antibodies CR6261 and CR8020 into the fusion assay, as described in Chapter 2, served to 
directly demonstrate that binding of these antibodies to their epitope inhibits HA-mediated 
membrane fusion. This direct visualization confirmed that the IgG molecules are able to 
recognize and bind their epitope on infectious virus particles and produce a functional effect. It 
also validates ensemble biochemical experiments of solubilized HA (i.e. not on a virus) 
indicating that antibody binding prevents HA’s low-pH conformational change [10,11].   
Adapting the fusion assay and associated analysis in Chapter 3 for the use of 
fluorescently labeled antibodies at high concentrations enabled simultaneous measurement of 
binding stoichiometry and its functional effect on membrane fusion. Both stoichiometric and 
kinetic results indicate that not all HA trimers on a virus need to be bound by antibody or Fab for 
fusion to be inhibited. This observation is in accord with models for HA-mediated membrane 
fusion requiring the concerted action of multiple HA trimers [4,12,13]. Furthermore, it suggests 
the molecular mechanism for fusion inhibition occurs via disruption of pH-triggered HA 
aggregation into a requisite geometry and of sufficient number for membrane fusion to ensue. 
This mechanism of fusion inhibition is likely to be shared by other broadly neutralizing, stem-
binding antibodies because of overlap and similarities in their epitopes on the HA protein 
[10,11,14-16].  Overall, Chapters 2 and 3 serve as proof-of-concept studies demonstrating that 
the study of fusion inhibitors using the single-particle fusion assay provides both direct 
conformation of fusion inhibition and detailed information on the inhibition mechanism. 
Lipidomics studies indicate the lipid composition of biological membranes frequently 
undergoing fusion events have substantially larger amounts of unsaturated lipids compared to 
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those of more other membranes [17,18]. Simply identifying their presence or studying the 
biophysical characteristics of the lipids through NMR or SAXS [19,20], however, does not 
provide insight into their function in the fusion process. The role of acyl-chain unsaturation was 
addressed in Chapter 5 where the target bilayers formed upon a dextran cushion were 
comprised of lipids having either polyunsaturated fatty acids (poly-UFA) or the more common 
monounsaturated fatty acids (mono-UFA). Kinetic analysis revealed that the rate of content 
release and the onset of full lipid intermixing between viral and target bilayers are heavily 
affected by the presence of poly-UFA. Viruses fusing to poly-UFA bilayers show faster content 
loss than for mono-UFA bilayers, which suggests that poly-UFA lipids may facilitate the rapid 
expansion of a fusion pore. When fusing to mono-UFA bilayers at low pH, where lipid effects are 
most prevalent, viruses more readily entered a state of restricted hemifusion wherein lipids were 
not allowed to freely diffuse between the viral and target bilayers. Escape from this state was 
significantly more rapid during fusion to poly-UFA bilayers. Interestingly, HA is capable of 
forming a fusion pore despite the restricted lipid movement and with kinetics that are insensitive 
to target bilayer composition. The restricted hemifusion state is postulated to arise from acyl 
chain ordering due to the presence of HA fusion peptide and cholesterol in the area immediately 
surrounding a fusion site. These observations suggests that the mechanism of pore formation 
mediated by the HA transmembrane domain may be largely insensitive to acyl chain ordering 
and lipid phase at the hemifusion diaphragm.  
Extracting large amounts of kinetic data from fluorescence recordings of viral membrane 
fusion is an arduous task. To facilitate reproducible data extraction and analysis, a MATLAB-
based software package was designed and implemented to automatically identify fusion events 
from the viruses’ fluorescence trajectories. As described in Chapter 4, automated analysis of 
trajectories using statistical analysis, Boolean tests and maximum likelihood predictors [21] can 
identify fusion events to extract kinetics that are comparable to scrutinous manual selection. 
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Achieving the implementation of such a program addresses the need for a more unified 
approach to data analysis in the field of single-particle membrane fusion identified in Chapter 1. 
 
6.2 Outlook and future directions 
Steric contributions to the inhibition of membrane fusion by stem-binding antibodies 
remain to be fully resolved. The use of Fab fragments for comparison to the three-fold larger 
IgG molecules in Chapter 3 indicated that more Fab molecules are required for a similar degree 
of fusion inhibition. Using Fab to compare with IgG, however, alters both the size of the 
inhibitory molecule along with its binding valency. Given the influenza group-specific similarities 
in the fractional occupancies between IgG and Fab, relative to the stoichiometry of maximal 
fusion inhibition, HA binding and hence binding valency is certainly a major contributor to the 
inhibitory effect. Nonetheless, Fab fragments are still fairly large and could act to sterically 
occlude the close apposition of target and viral membranes in a fashion similar to full IgG. 
Measuring the binding stoichiometry of small HA-binding peptides shown biochemically to block 
HA’s low-pH conformational change [22] would provide good insight into the effect of steric 
occlusion. Their size of ~12 kDa should allow them to be fluorescently labeled without affecting 
their binding avidity. If HA binding is the principle determinant for the functional observation of 
hemifusion inhibition, then similar numbers of peptides as Fab fragments would be required for 
comparable reductions in fusion efficiency. If steric factors play a significant role, however, the 
numbers of peptides should be substantially higher than the number of Fab needed, since by 
molecular weight they are approximately one quarter a Fab and less than one-tenth of an IgG. 
 A separate measurement to probe the steric occlusion required to inhibit membrane 
fusion would be to incubate the virus with acylated-PEG molecules. These amphiphilic 
molecules have been used to form planar bilayers tethered to a PEG surface (see Appendix 2 
and [23]). The hydrophobic acyl group should incorporate into the viral envelope, similar to R18, 
and allow the PEG polymer to occupy space between HA trimers without affecting their pH 
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sensitivity. Fluorescently labeled PEG would allow for stoichiometric measurements that could 
be directly coupled to the volume they occupy on the viral surface. 
Fusion-inhibiting small peptides [22] or small molecules [24] could also be utilized to 
probe the model for the restricted hemifusion state presented in Chapter 5. There, this state is 
proposed to arise, in part, due to the large amount of HA fusion peptide near a fusion site. 
These fusion inhibitors would reduce the number of HA fusion peptides that become inserted 
into the target bilayer with minimal steric effects. If the local fusion peptide concentration is 
critical to the onset of the restricted hemifusion state during fusion to mono-UFA bilayers at low 
pH, then increasing concentrations of fusion inhibiting molecules should affect kinetics related to 
lipid dissipation. A reduction in the confinement lifetime of Figure 5-5 and in the inter-dissipation 
time measured in Figure 5-6 would be anticipated. Such reductions would bring the trends in the 
fusion kinetics for mono-UFA bilayers more in line with those of poly-UFA bilayers. Cholesterol 
is also postulated to play a role in the restricted hemifusion state and it can easily be removed 
from the target bilayer. Problematically, cholesterol is likely to be added locally to the fusion site 
upon hemifusion of the viral and target membranes such that little kinetic change may result. 
While cholesterol could potentially be removed from the influenza viruses using cyclodextrin, 
this has been shown to substantially reduce the virus’s fusogenicity [25]. 
Extension of the single-particle fusion assay to visualize the fusion of virus particles to 
surface-immobilized vesicles would provide a number of opportunities to study new aspects of 
pore formation. Preliminary results obtained by a master’s student in the van Oijen group, 
Kumar Sourav Das, indicate that such fusion geometry is possible for the use with influenza. 
Further, it has been demonstrated in the study of SNARE-mediated fusion [26,27]. Liposomes 
have two advantages over a planar bilayer. Firstly, both leaflets of a properly immobilized 
liposome are fluid and free from interactions with any surfaces. Secondly, and importantly, they 
can encapsulate buffers and probes that may be able to investigate the rate of fusion pore 
expansion.  
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One approach would be to visualize the escape of the viral genome using a labeled RNA 
or DNA hairpin whose fluorescence changes upon binding to the viral RNA. The kinetics of 
fusion pore opening presented in Chapter 5 report the release of a small sulforhodamine dye. 
This molecule can fit through a pore substantially smaller than the eight massive 
ribonucleoprotein complexes (RNP) comprising the viral genome, but which are the essential 
elements for establishment of viral infection. To detect release of the RNP two components 
could be loaded into a liposome. One is an RNA or DNA hairpin labeled on either end with 
either a FRET (fluorescence resonance energy transfer) pair, as in [27], or a dye with a 
quenching agent [28]. The second is a small molecule, membrane impermeable protein 
denaturant that would first enter the viral lumen through a nascent pore and denature the RNP. 
Denaturation of the RNP should release the RNA from association with proteins so that it may 
interact with the hairpin to form an RNA hybrid, causing a rapid FRET decrease or dequenching 
fluorescence increase. Alternatively, high salt concentrations within a liposome could allow for 
dissociation of the proteins that are electrostatically bound to the viral RNA, though this may 
interfere with hybridization. Combined with fluorescence dequenching upon lipid mixing, readout 
of RNP release would provide insight into the kinetics and efficiency of the pore expansion 
process. 
In his Ph.D. dissertation, Dr. Dan Floyd [29] described preliminary results on 
development of a FRET-based experimental system to visualize the initial membrane 
fluctuations prior to the onset of hemifusion. His design utilized zero-mode waveguides to create 
a localized evanescent field for fluorescence excitation whose width was less than the diameter 
of a virus particle. Such dimensions would, in theory, allow for reasonable signal-to-noise FRET 
measurements between the viral and target bilayers labeled with appropriate lipophilic dyes. An 
alternative excitation strategy would be the use of stimulated emission depletion microscopy 
(STED) [30]. With this type of microscope design, a sub-diffraction sized spot of illumination 
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could be created to generate FRET between the two bilayers and record the onset of 
hemifusion with higher time resolution than what can be achieved using CCD cameras. 
By and large, however, the biggest area for expansion of the utility of the single-particle 
viral fusion assay is its application to new virus types. Preliminary work on chikungunya virus 
being performed in the van Oijen lab is looking promising. The self-contained nature of the 
disposable PDMS microfluidic channels makes this assay potentially safe and amenable for 
fusion studies on more lethal viruses, such as HIV or even Ebola. As well, it is plausible that 
immobilized liposomes filled with quenched calcein dye could be used to investigate the 
membrane penetration mechanism of non-enveloped viruses. Finally, further development of 
the analysis software described in Chapter 4 would make data analysis less technically 
demanding and, hopefully, enhance assay accessibility to the virology field in general.  
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Appendix 1  – Supplementary information for Chapter 1 
 
This appendix contains the following supplementary information: 
A1.1 Supporting materials and methods for the single particle fusion assay 
A1.2 Supplementary figures 
A1.3 Supplementary tables 
A1.4 Supplementary movies descriptions 
A1.5 Supplementary references 
 
A1.1 Supporting materials and methods for the single particle fusion assay 
A1.1.1 Microfluidic flow cell construction  
Microfluidic flow cells were constructed for fusion experiments using cleaned glass 
microscope cover slips (25 x 25-mm, No. 1, VWR) and either a PDMS (polydimethylsiloxane; 
Dow Corning, Slygard 184) chip or a quartz top affixed with double sided tape (Grace Bio-Labs) 
as described previously [1,2]. A PDMS chip was used with unlabeled antibodies, while the 
quartz was used for AF488-labeled antibody experiments. PDMS chips formed by standard 
PDMS cast molding techniques [3] housed five parallel channels of dimensions 0.5(w) x 0.2 (h) 
x 10(l) mm and were non-permanently adsorbed to the clean glass cover slips. Holes were 
punched into the chip to allow insertion the PE20 inlet and PE60 outlet tubing (BD Intramedic; 
I.D = 0.38 mm and 0.76 mm, respectively). The PDMS chip with glass bottom was clamped in a 
home-built PDMS-chip housing and affixed to the microscope stage with a custom adaptor.  
 
A1.1.2 Proteoliposome Preparation 
Chloroform solutions of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) (Avanti Polar 
Lipids), cholesterol (Avanti Polar Lipids) and N-((6-(biotinoyl)amino)hexanoyl)-1,2-
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dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt (Biotin-X DHPE, 
Invitrogen) were mixed in a molar ratio of 0.8:0.2:2.5x10-5. The lipid mixture was dried under an 
argon stream, then for two hours under vacuum. Lipids were resuspended in HNE buffer to 5 
mg/mL, freeze/thawed five times with liquid nitrogen, then extruded (mini-extruder, Avanti) using 
0.2 µm pore size filters at ~40 °C. Triton X-100 (VWR) was added to a final concentration of 0.5 
% (w/v) and incubated in the liposome suspension at 37 °C for 15 min then on ice for 15 min. 
Sialoglycoprotein glycophorin A (GYPA) – full-length recombinant protein with a GST tag 
(Abnova) – was added to solubilized lipids at a lipid:protein molar-ratio of approximately 
1:40,000 and allowed to mix at 4 °C for 30 min. Triton-X detergent was removed by two 
successive two hour incubations with Bio-Beads (SM-2 absorbent, Bio-Rad Laboratories, Inc.) 
at 4 °C using 200 mg Bio-Beads per 300 µL of solution. Glycophorin A membrane protein was 
used in lieu of membrane-bound gangliosides, such as GD1a, because we found that the H1N1 
virus strain did not become immobilized upon planar bilayers containing sialic acid presented in 
this fashion.  
 
A1.1.3 Microscope Setup 
Single-particle fusion assays were conducted on an inverted dual color fluorescent 
microscope (Olympus IX-71) equipped with a 60x NA 1.49 oil immersion objective (Olympus 
APON60OTIRF), and both 488 nm blue and 561 nm yellow continuous-wave solid state lasers 
(Sapphire models, Coherent Inc.) aligned in objective-based Hi-Lo total internal reflection (TIR) 
mode [4]. Emitted fluorescence light was filtered using a custom-ordered microscope filter cube 
(Chroma Ltd.) allowing passage of wavelengths: 495 to 550 and 570 to 710. The green 
fluorescein/AF488 and red R18 emitted fluorescence signals were spectrally separated in a 
home-build dual view setup utilizing a long-pass dichroic mirror (Thorlabs DMLP567), passed 
through band-pass filters (Chroma ET525-50m and ET605-70m, respectively) and focused onto 
either half of an EMCCD camera (Hamamatsu Photonics K.K., Image-EM model C9100-13).  
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A1.1.4 Fusion Experiment 
R18-labeled viruses were diluted 10-fold into a solution of either 100 % Alexa Fluor-488 
labeled or 100 % unlabeled antibodies, bringing the antibodies to the desired final 
concentration, and then incubated at room temperature for 30 min prior to flow cell addition. The 
proteoliposome solution was added to the microfluidic flow cell mounted to the microscope 
stage using negative pressure from a syringe pump (New Era Pump Systems Inc., NE-1000) 
connected via a six-valve manifold (Qosina, Edgewood, NY, USA) and allowed to incubate for 
30 min at room temperature, spontaneously forming a glass-supported planar lipid bilayer 
Figure 2-2A). The fusion experiments were executed as reported previously [1, 2] in a fashion 
similar to wherein virus in the antibody solution was added to the flow cell and viruses were 
observed to immobilize upon the fluid, continuous, planar bilayer. Fluorescein-labeled 
streptavidin (Invitrogen) was subsequently added at a concentration of 6 µg/mL with unlabeled 
antibodies or at 0.2 µg/mL with labeled. This was followed by a 2 minute wash at 100 µL/min 
with clean HNE buffer to remove unbound viruses, unbound antibodies and unbound 
streptavidin-fluorescein. Viral fusion was initiated by rapid injection of a citric acid buffer (10 mM 
citric acid, 140 mM NaCl, 0.2 mM EDTA, pH 5.0) at 200 µL/min and recorded using Metavue 
imaging software (Life Science Imaging Ltd.) at an acquisition rate of 5 Hz and maximal EM 
gain until all fusion events had ceased. Images in figure 2 and supplementary movies S5 and 
S6 were created using ImageJ.  
 
A1.1.5 Data Analysis 
Recorded fusion movies were processed and analyzed in a fashion similar to that 
previously described [1, 2]. Individual viral particles were identified and their fluorescent 
trajectories extracted using home-written MATLAB code. Arrival of the acidic buffer led to 
disappearance of the fluorescein signal and synchronization of viral fusion. The onset of fusion 
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between the virus and target bilayer was visualized by sudden increases in the R18 signal, 
caused by fluorescence dequenching, followed by outward diffusion of the R18 molecules into 
the target bilayer away from the fusion site. Red-channel fluorescent trajectories (fluorescence 
at a spot over time) of the viruses were extracted from recorded movies and plotted for manual 
selection. Trajectories showing clear dequenching spikes followed by dissipative signal loss 
were directly classified as fusing virions. Trajectories showing characteristics of dequenching 
and/or dissipative signal loss, but with poorer signal strength, were subjected to further manual 
inspection. In this case, a virus particle in question is observed in the recorded fusion movie. 
Viruses showing a rapid outward movement of lipid molecules away from the virus identifiable 
by eye were also classified as fusing virions. The percent hemifusion in each experiment was 
calculated as the number of particles in a field of view determined to undergo fusion divided by 
the total number of particles initially detected in the same field of view. Experiments of fusion at 
each antibody concentration were conducted at least three times and experiments having fewer 
than 25 particles detected in a field of view were not included in the final analysis. Additionally, 
experiments showing 25 fusing particles or fewer were subjected to two rounds of particle 
selection to reduce the likelihood of false-event selection.  
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A1.2 Supplementary figures 
 
 
Figure A1-1 – Stem-binding bnAbs co-localize with influenza particles in vitro and in live cells, 
bind on the surface of infected cells. (A) Influenza A/Puerto Rico/8/1934 (H1N1) and 
A/Aichi/2/1968-X31 (H3N2) viruses were labeled with the lipophilic dye octadecyl rhodamine B 
(R18, red), spotted onto glass, and incubated with fluorescently labeled antibodies CR6261 or 
CR8020. Head-binding control antibodies, CR9020 (binding to head region of a narrow 
spectrum of H1 HAs) and CR8057 (binding to the head region of a narrow spectrum of H3 HAs) 
were used in combination with R18-labeled A/New Caledonia/22/1999 (H1N1) and 
A/Wisconsin/67/2005 (H3N2), respectively. Antibodies CR6261 and CR8020 served as non-
binding controls on H3N2 and H1N1 viruses, respectively. Virus-antibody complexes were 
bound to the glass bottom of 96 well plates and imaged. R18-labeled virus and AF647-labeled 
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(Figure A1-1 Continued) antibody are shown in separate channels in grayscale and in the 
merged image in red and green, respectively. Antibodies co-localize with the virus to which they 
bind in vitro. (B) Live MDCK cells expressing a GFP cell marker (grey) were incubated for ~20 
min (at 37ºC) with viral particles (red) pre-incubated with antibodies and imaged as in (A). To 
allow detection of internalized particles only, non-internalized particles were removed by 
neuraminidase treatment. Whereas head-binding antibodies prevent internalization, stem-
binding bnAbs co-localize with internalized viral particles (yellow). (C) MDCK cells were 
infected, fixed 15 hours later, and subsequently stained with anti-HA antibodies as in (A) and 
anti-influenza A nucleoprotein (NP) antibody to confirm infection (magenta, only detectable 
under permeabilizing conditions). Infected cells were also incubated with fluorescently labeled 
bnAb (green) to demonstrate their ability to bind surface-expressed HA and budding viral 
particles.
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Figure A1-2 – CR6261 is internalized into live cells in complex with H1N1 viral particles and 
prevents infection.  (A) Separate channels (in grey scale) of a three color image showing live 
MDCK cells expressing a GFP-cell tracer incubated with R18-labeled A/Puerto Rico/8/1934 
(H1N1) virus in complex with AF647-labeled CR6261. Internalized virus-antibody complexes 
(red triangles) were detected in live cells 30 min after inoculation. Individual cells were tracked 
over 15 hours before being fixed and stained for influenza nuclear protein (NP) to detect 
infection. (B) Control experiment showing that incubation of R18-labeled A/Puerto Rico/8/1934 
(H1N1) virus with non-binding AF647-labeled CR8020 did not result in internalization of 
antibody. Only viral particles are detectable inside live cells 30 min after inoculation and 15 
hours later these cells were infected as evident from the expression of NP. 
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Figure A1-3 – Calu-3 cells support the propagation of influenza virus in the absence of trypsin, 
but cannot be infected by uncleaved virus. (A) Calu-3 cells were infected with 10 TCID50 cleaved 
A/Wisconsin/67/2005 (H3N2) influenza virus in the absence of trypsin. 24 hours after infection 
cells (nuclei blue) were fixed and stained for influenza NP (green) as indication for infection. (B) 
100 TCID50 of uncleaved A/Wisconsin/67/2005 and A/Brisbane/59/2007 (harvested from MDCK 
cells in the absence of trypsin) were added to Calu-3 cells with or without trypsin. Uncleaved 
virus is not infectious but can be rendered infectious when treated with trypsin. Images (A and 
B) show an entire well.  
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Figure A1-4 – Influenza virus egress. Scanning electron microscopy (SEM) and transmission 
electron microscopy (TEM) images of the surface of (A) non-infected or (B) influenza 
(B/Florida/04/2006) virus infected MDCK cells. High numbers of spherical viral particles are 
budding off the surface and are clearly distinguishable form microvilli or smooth cell protrusions 
by size, electron density, and their double membrane. Scale bar in SEM is 1 μm and in TEM 
200 nm. 
 198 
 
 
  
Figure A1-5 – HA head binding antibodies inhibit influenza virus egress. (A) Calu-3 cells were 
infected with A/Puerto Rico/8/1934 (H1N1) and 3 hours later head-binding antibody CR9020 or 
2D1 was added. Twenty hours later, the amounts of HA present in the cell supernatant (S) and 
lysate (L) were analyzed by Western blot (HA0 band shown). (B) As in (A) except MDCK cells 
were infected with B/Florida/04/2006 and the Fab fragments of CR8071 and CR8033 were used 
in the egress assay. (C) SEM images of the surface of MDCK cells infected with influenza 
A/California/07/2009 (H1N1), A/New Caledonia/20/1999 (H1N1), A/Wisconsin/67/2005 (H3N2), 
or influenza B/Florida/04/2006 virus and subsequently incubated (from 3 hours post infection) 
with 2D1 (5 µg/mL), CR9020 (15 μg/mL), and Zanamivir (0.5µM) respectively. Representative 
images of three independent experiments are shown. Scale bar (C) 1μm. (D-E) As in (B) except 
TEM images of ultrathin sectioned MDCK cell (re-internalized particles indicated with red 
triangles). Scale bar in (D) 500 nm and in (E) 100 nm. 
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Figure A1-6 – R18 labeled influenza virus remain infectious. MDCK cells were infected with 
R18- or MOCK-labeled A/Puerto Rico/8/1934 (H1N1) or A/Aichi/2/1968-X31 (H3N2) and the 
number of infected cells (nucleus stained with DAPI, blue) for each virus was determined by 
staining for influenza NP expression (green). 
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A1.3 Supplementary tables 
Table A1-1 – Characteristics of bnAbs, control antibodies, and Fabs used in this study.  
IgG1s/ Fabs 
HA 
Epitope 
VNA titer [µg/mL] HAI titer [µg/mL] 
Breadth
[h]
 Ref. 
H1N1 H3N2 B H1N1 H3N2 B 
CR6261 Stem 3.58 [a] - - - - - broad A-G1 [5] 
CR8020 Stem - 2.2 [b] - - - - broad A-G2 [6] 
CR8033 Head - - 0.02[c] - - 0.22[c] 
broad B 
[7] 
CR8033 Fab Head - - 2.63[c] - - 4.42[c] 
CR8071 Head - - 2.04[c] - - - 
broad B 
CR8071 Fab Head - - - - - - 
CH65
[g] Head 0.44 [d] - - 0.88 [d] - - 
broad H1 [8] 
CH65 Fab Head 4.20 [d] - - 17.7[d] - - 
2D1
[g] Head 0.08 [e] - - 0.22 [e] - - narrow H1 [9] 
CR9020 Head <0.01 [d]
 
- - 0.22 [d] - - narrow H1 [i] 
CR8057 Head - <0.01 [f] - - 0.03 [f] - 
narrow H3 [6] 
CR8057 Fab Head - <0.02 [f] - - 0.03 [f] - 
 
[a]  A/Puerto Rico/8/34 
[b]  A/Aichi/2/68-X31  
[c]  B/Florida/04/06 
[d]  A/New Caledonia/20/99 
[e]  NYMC X-181 (6:2 reassortant of PR8 with the HA and NA segments of A/California/07/09)  
[f]  A/Wisconsin/67/2005 
[g] The variable heavy and light chains of CH65 and 2D1 were cloned into Crucell’s human IgG 
backbone. The resulting IgGs (CR11055 and CR11054, respectively) have identical specificity as the 
published antibodies. 
[h] A = Influenza A virus, G1 = influenza A virus group 1 (comprises the H1, H2, H5, H6, H8, H9, H11, 
H12, H13, H16 and H17 subtypes), G2 = influenza A virus group 2 (comprises the H3, H4, H7, H10, H14 
and H15 subtypes) B = influenza B virus 
[i]    Chapter 2 and Appendix 1 data 
–    No activity 
 
Table A1-2 – Co-localization of virus-antibody complexes in infected MDCK cells 
Virus Strain bnAb # cells counted 
# particles 
counted 
% colocalization virus 
+ bnAb 
Stdev 
H1N1 A/PR/8/34 
CR6261 175 605 93.5 1.9 
CR8020 142 582 0.2 0.5 
H3N2 A/Aichi/68-X31 
CR8020 159 1257 92.0 5.6 
CR6261 153 1158 0.14 0.3 
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A1.4 Supplementary movies descriptions 
 
Movie M1-1 – Stem-binding bnAb CR8020 is internalized into live cells in complex 
with H3N2 virus particles. R18-labeled A/Aichi/2/68-X31 (H3N2) virus particles pre-incubated 
with AF647-labeled CR8020 are internalized into live MDCK cells (nucleus, blue). Movie (~27 
min past incubation, mpi) shows the directed motion of virus particles (red) together with mAbs 
(green) along TubulinTracker-stained microtubules (white).  
 
Movie M1-2 – Stem-binding bnAb CR6261 is internalized into live cells in complex 
with H1N1 virus particles. R18-labeled A/Puerto Rico/8/34 (H1N1) virus particles pre-
incubated with AF647-labeled CR6261 are internalized into live MDCK cells (nucleus, blue). 
Movie (~40 mpi) shows the directed motion of virus particles (red) together with mAbs (green) 
along TubulinTracker-stained microtubules (white). 
 
Movie M1-3 – Stem-binding bnAb CR8020 is not internalized after incubation with 
H1N1 virus particles. After incubation of R18-labeled A/Puerto Rico/8/34 (H1N1) virus particles 
(red) with AF647-labeled non-binding control antibody CR8020, only virus particles are 
internalized ~33 mpi into live MDCK cells (nucleus, blue). 
 
Movie M1-4 – Stem-binding bnAb CR6261 is not internalized after incubation with 
H3N2 virus particles. After incubation of R18-labeled A/Aichi/2/68-X31 (H3N2) virus particles 
(red) with AF647-labeled non-binding control antibody CR6261, only virus particles are 
internalized ~41 mpi into live MDCK cells (nucleus, blue). 
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Movie M1-5 – H1N1 virus incubated with only 15nM CR6261-AF488 can undergo 
fusion. Representative portions of dual-color fluorescence viral fusion recordings obtained with 
200 ms exposure times; scale bar equals 2 µm. R18-labeled A/Puerto Rico/8/34 (H1N1) virus 
(false colored magenta, center column) incubated for 30 min with 15 nM  AF488-labeled 
CR6261 (green, right column). Co-localization between the virus and bound bnAb (white) is 
shown in the left column (merge). Time t = 0 indicates drop of pH from 7.4 to 5.0. Fusion events 
are observed as the rapid increase in fluorescence signal (dequenching) at the site of a virus, 
followed by quick, outward diffusion of the lipophilic R18 dye away from the fusion site. Both 
movies (M1-5 and M1-6) were recorded under identical illumination conditions. Contrast settings 
of the 15 nM bnAb incubation has been enhanced 25% relative to the 1500 nM incubation 
(Movie S6). All images were scaled 4-fold larger using bicubic interpolation. For assay details 
see experimental procedures. 
 
Movie M1-6 – H1N1 virus incubated with 1500nM CR6261-AF488 is fusion 
incompetent. As in (M1-5) except, R18-A/Puerto Rico/8/34 (H1N1, magenta) was incubated 
with 1500nM AF488-labeled CR6261 (green).  The higher bnAb concentration inhibited HA-
mediated fusion and no dequenching or R18 diffusion is observed. Both movies (M1-5 and M1-
6) were recorded under identical illumination conditions. 
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Appendix 2 – Supplementary information for Chapter 3 
 
This appendix contains the following supplementary information: 
A2.1 Supplementary methods 
A2.2 Supplementary figures and movie 
A2.3 Supplementary tables  
A2.4 Supplemental references 
 
A2.1 Supplementary methods 
A2.1.1 Microfluidic Flow Cell and Glass Cleaning 
Experiments were performed in microfluidic channels formed using either double-sided 
tape sandwiched between quartz top and cover slips bottom as described previously [1], or 
multi-channel PDMS chips. PDMS (polydimethylsiloxane; Dow Corning, Slygard 184) based 
multichannel microfluidic chips were formed by standard PDMS cast molding techniques [2,3]. 
Each chip housed five microfluidic channels having inner dimensions 0.5(w) x 0.2 (h) x 10(l) 
mm3 and separated by 0.5 mm. PDMS chips were non-permanently adhered to the surface of 
the cleaned glass microscope cover slips (No. 1, VWR, USA) and housed in a home-built 
microscope adapter. Inlet and outlet polyethylene tubing (PE20 and PE60, respectively; 
Intramedic)) was coupled to each microfluidic channel to allow for rapid buffer exchange via 
connection to a syringe pump (New Era Pump Systems Inc., NE-1000). All chips and flow 
channels were used only once. 
 
A2.1.2 Virus and IgG/Fab Labeling 
Influenza A strains PR/8/34 (H1N1) and A/Aichi/2/68 (X-31, H3N2) propagated in SPF 
eggs were purchased from Charles River (North Franklin, Connecticut, USA) and used without 
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further purification. Stock samples were certified by the manufacturer to have 2 mg of total viral 
protein per milliliter. Electron microscopy confirmed that the viruses used were mono-disperse, 
spherical particles of uniform size, the latter being due to the method of virus propagation. 
Labeling was performed by diluting virus stocks 1:3 into HNE buffer (5.0 mM Hepes, 140 mM 
NaCl, 0.2 mM EDTA, pH 7.4), then adding 0.5 % volume equivalent of octadecyl rhodamine B 
lipophilic dye (R18, Invitrogen Inc.) in DMSO to a final dye concentration of 1 M. The virus-dye 
mixture was placed on a rotating micro-tube mixer (Cole-Parmer) for three hours. 
Unincorporated dye was removed using a PD-10 desalting column (GE Healthcare). Fractions 
of 200 l were collected and checked for labeled virus using the microscope setup. The three to 
four fractions with highest particle count were pooled into a single volume, aliquoted, frozen 
using liquid nitrogen and stored at -80ºC until use. Labeled viruses were previously confirmed to 
be infectious [4]. 
 
A2.1.3 IgG and Fab production 
Human IgG1 antibodies CR6261 and CR8020, were constructed by cloning the heavy 
(VH) and light (VL) chain variable regions into a single expression vector containing the IgG1 
constant regions. HEK293-F cells were transfected with the IgG expression constructs and the 
expressed antibodies were purified from serum-free culture supernatants using protein A 
chromatography (HiTrap, GE healthcare) followed by a desalting step (HiPrep 26/10, GE 
healthcare). The Fab fragments were obtained by IdeS digestion of the purified IgG, followed by 
protein G purification (GE Healthcare), cation exchange (MonoS, GE Healthcare), and gel 
filtration (Superdex200, GE Healthcare).  
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A2.1.4 IgG/Fab labeling and degree of labeling determination 
HA-specific antibodies CR6261 and CR8020 were fluorescently labeled with Alexa Fluor 
488 (AF488, Molecular Probes) according to manufacturers’ guidance. In brief, IgG/Fab 
fragments were added to AF488 dye in sodium bicarbonate buffer. The solutions were mixed at 
moderate speed on a Ferris wheel mixer for 2h and protected from light. Free dye was removed 
from the sample using a PD10 desalting column (GE Healthcare). The AF488-labeled IgG/Fab 
were eluted into 20mM sodium acetate, 75mM NaCl, 5% sucrose, pH 5.5. 
The number of Alexa-488 molecules bound to the IgG/Fab molecules was determined 
using photobleaching analysis and MALDI mass spectrometry. The degree of labeling was 
taken as an average of these two results and the percentage of labeled IgG/Fab molecules 
visualized was estimated from a Poisson calculation (Table A2-1).  
Photobleaching measurements were performed by adsorbing labeled IgG/Fab molecules 
to a clean glass surface and illuminating with ~5 W/cm2 488 nm laser power to observe 
individual photobleaching steps. Distributions of the final bleaching height were extracted and 
well-fit by Gaussian distributions. The initial fluorescence intensity of visualized molecules was 
divided by the mean intensity identified by Gaussian fitting to obtain the distributions for the 
number of fluorophores bound to each IgG/Fab (Figure A2-2.i). These distributions for IgG were 
well fit by Poisson distributions to determine the expected number of covalently linked Alexa-
488 molecules. The distributions for Fab were reasonably well fit by Poisson distributions, but 
showed higher than expected population densities at lower number of linked Alexa-488 
molecules, indicating that not all available N-terminal amino groups are equally accessible for 
labeling.  
MALDI mass spectra at mass-to-charge ratios of one (m/z=1) and two (m/z=2) were 
obtained for unlabeled and Alexa-488 labeled IgG/Fab using sinapinic acid as the matrix. The 
peak value in the mass spectra of the unlabeled IgG/Fab was subtracted from the mass spectra 
of the labeled molecules. The shifted mass spectra of the labeled molecules was then divided 
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by the mass of individual Alexa-488 molecules, determined to be 515 Da using molecular 
structures provided by the manufacturer, to scale the mass values in terms of numbers of 
covalently linked Alexa-488 molecules (Figure A2-2). The resulting spectra were well fit by 
Poisson distributions to identify the expected number of Alexa-488 per IgG/Fab (Figure A2-2.ii).  
 
A2.1.5 Proteoliposome Preparation 
Proteoliposomes were composed of a 0.8:0.2:2.5x10-5 ratio of molar fractions of 
DOPC:CH:biotin-DHPE (respectively: 1,2-dioleoyl-sn-glycero-3-phosphocholine and 
Cholesterol, Avanti Polar Lipids, Alabama, USA; N-((6-(biotinoyl)amino)hexanoyl)-1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt, Invitrogen) mixed in 
chloroform solutions, dried under argon, then desiccated for two hours. Dried lipids were 
suspended in HNE buffer at 5 mg/ml, freeze/thawed five times, then extruded using 0.2 m-pore 
size polycarbonate filters (mini-extruder, Avanti). Liposomes were solubilized by Triton X-100 
(molecular biology grade, VWR International) to a final concentration of 0.5% (w/v) and 
incubated at 37°C for 15 minutes then on ice for 15 minutes. The sialoglycoprotein glycophorin 
A (GYPA; Abnova, Taipei City, Taiwan; full-length recombinant protein with a GST tag) was 
added to solubilized lipids at lipid:protein molar ratio of approximately 1:40,000 and mixed at 
4°C for 30 minutes. Bio-Beads (SM-2 absorbent, Bio-Rad Laboratories, Inc.) removed the 
Triton-X detergent by two subsequent two-hour incubations at 4°C with constant rocking, using 
200 mg Bio-Beads per 300 l of solution. Proteoliposome preparations were stored at 4°C 
under an argon atmosphere for up to 48 hours prior to use with no further treatment. 
Glycophorin A membrane protein was used in lieu of membrane-bound gangliosides, 
such as GD1a [1], because we found that the H1N1 virus strain did not become immobilized 
upon planar bilayers when sialic acid was presented in this fashion (including use of ganglioside 
mixtures (Calbiochem, USA, cat# 345717) and S-Sialyl-a(2,6)-lactosylceramide (Wako Pure 
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Chemical Industries, Japan)). Previous bulk fusion studies had shown a difference in fusion 
kinetics for H1N1 in fusing with ganglioside-containing liposomes versus GYPA-containing 
proteoliposomes (Alford et al., 1994). Both the H1N1 and H3N2 virus strains used bound readily 
to planar bilayers comprising the GYPA membrane protein. 
 
A2.1.6 Microscope Specifications 
Measurements were conducted on an inverted fluorescence microscope (Olympus IX-
71) equipped with a custom-ordered microscope filter cube (Chroma Ltd. filters zet488/561m 
and zt488/561rpc) and either a 60x NA 1.49 objective (Olympus APON60OTIRF) or a 60x NA 
1.45 objective (Olympus PLANAPON60TIRF). The NA 1.45 objective was found to exhibit less 
chromatic aberration at the edge of the images, improving the co-localization between virus and 
IgG/Fab signal. Virus particles and labeled IgG/Fab were illuminated, respectively, with ~0.25 
W/cm2 561 nm and ~0.2 W/cm2 488 nm continuous-wave solid state lasers (Sapphire models, 
Coherent Inc.) focused onto the back-focal plane of the microscope objective and aligned in 
objective-based total internal reflection (TIR) mode. The configuration was optimized to 
homogeneously illuminate the entire virus particle and the fluorescence intensity of labeled 
IgG/Fab bound to viruses was found to be independent at TIR incidence angles less than 57° 
(Figure A2-4), while still suppressing background fluorescence. Emitted green and red 
fluorescence was separated by a home-built dual view with Thorlabs DMLP567 long-pass filter 
or by a commercial Dual-View system (Photometrics, Tucson, AZ, USA)) with Chroma 
T560LPXR long-pass filter. Signals were filtered to remove stray laser light and background 
from Raman scattering (Chroma ET525-50m and ET605-70m, green and red respectively), then 
focused onto either half of an electron multiplying CCD camera (Hamamatsu Photonics K.K., 
Image-EM model C9100-13). False-color representative images resulting from this setup are 
depicted in Figure 3-1. 
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A.2.1.7 Fusion Experiment 
Glass-supported planar bilayers were formed by adding the proteoliposome solution to a 
HNE-hydrated microfluidic flow cell mounted upon the microscope and incubated with the glass 
surface for a minimum of 45 minutes at room temperature. R18-labeled viruses were diluted 10-
fold into a solution of 100% Alexa-488 labeled IgG/Fab, bringing the IgG/Fab to the desired final 
concentration. Virus and IgG/Fab were incubated for 45-60 minutes at room temperature, and 
then added to the microfluidic flow cell at 5 l/min wherein the viruses immobilized on the planar 
bilayer through specific HA-GYPA interactions. Fluorescein-labeled streptavidin (Invitrogen) was 
subsequently added at 0.2 g/ml using a flow rate of 10 l/min for 5 minutes; therein the labeled 
IgG/Fab not bound to viruses washed away to leave a low background. A 2-minute wash with 
clean HNE buffer at a high (100 l/min) rate removed unbound viruses, IgG and streptavidin-
fluorescein. Finally, viral fusion was initiated by rapid injection of a citric acid buffer (10.0 mM 
citric acid, 140 mM NaCl, 0.2 mM EDTA, pH 5.0) at 200 l/min and recorded using Metavue 
imaging software (Life Science Imaging Ltd., Marlow, Buckinghamshire, England) at an 
acquisition rate of 5 Hz for 240 seconds and maximal EM gain. Laser illumination during the first 
5-6 seconds and before the pH drop was with 561 nm only, then the 488 nm illumination was 
initiated. This alternation allowed for identification of viruses in the red channel, then co-
localization in the green channel. Total laser illumination was approximately 400 mW/cm2 and 
was set such that at high neutralizing molecule concentration there were very few saturated 
pixels together with a large range of pixel intensity values. Following immobilization of the virus 
on the bilayer surface, the fusion experiments required 10 to 20 minutes total experimental time.  
 
A2.1.8 Data Extraction and Analysis 
The laser illumination profile in each channel was identified after the pH drop by 
smearing out fluorescent peaks with a 40-pixel radius median filter, which allowed for fitting of 
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the underlying beam profile with a two-dimensional Gaussian. The fitted profile was set to have 
a maximal value of one at its peak. Each image extracted from the recording was corrected for 
the illumination profile (flattened) by first removing dark-counts and then dividing by the fitted 
profile.  
Individual viral particles were identified and their fluorescent trajectories extracted using 
custom MATLAB code similar to that described previously [1]. The arrival of the low-pH buffer 
was detected, as previously described [1], as a sudden loss of fluorescein signal in the green 
channel. Red-channel fluorescence peaks were identified by averaging ten frames under 561 
nm illumination only, flattening and removing global fluorescence background (next paragraph), 
and then applying a discoidal averaging filter [5]. Peaks were identified by thresholding using a 
+2* criterion, where  and  are the average intensity and intensity standard deviation, 
respectively, of the filtered red channel. Green-channel peaks were similarly identified by 
averaging ten frames after the pH drop. Co-localization was achieved by translating the 
locations found in the red channel onto the green channel and grouping the nearest neighbor 
pairs of peaks. 
Peaks in the green channel were fit with a two-dimensional Gaussian profile and all 
pixels within 3 of the peak center were identified for signal integration; red channel peaks were 
surrounded with a 4x4 pixel square box for fluorescence signal integration. Fluorescence 
background in the green channel was identified on a per-particle basis as the baseline offset 
resulting from Gaussian fitting, while the red channel background was found globally by taking 
the peak of the distribution of the pixel intensities from the flattened image used for particle co-
localization. 
Red-channel fluorescent trajectories were plotted and manually selected as exhibiting 
hemifusion similar to previous description [1]. Those showing clear dequenching spikes followed 
by dissipative signal loss, as shown in the Figure 3-1B, were directly classified as fusing virions. 
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Trajectories showing characteristics of dequenching and/or dissipative signal loss, but that were 
not as overtly similar to the trajectory of Figure 3-1B, were subjected to further manual 
inspection. In these cases, a virus particle in question is observed in the recorded fusion movie 
and those showing a rapid, outward movement of R18 molecules away from the virus 
identifiable by eye were also classified as fusing virions. Absolute hemifusion efficiency in each 
experiment was calculated as the number of particles in a field of view determined to undergo 
hemifusion divided by the total number of particles initially detected in the same field of view. 
Hemifusion efficiency data was fit using a four-parameter logistic model using the transform 
both sides approach for variance stabilization [6] utilizing a logit transformation (Equation 1, 
Table A2-2). For fitting, conditions with no fusion events were set to 1 event.  
The integrated green-channel fluorescence corresponding to the virus-bound labeled 
IgG/Fab was averaged over 15 frames (three seconds), starting five frames (one second) after 
the pH drop (dark green square, Figure 3-1C). Separately, the average integrated intensity of 
individual labeled IgG or Fab molecules was obtained by non-specifically adsorbing them to a 
clean glass surface within a microfluidic channel and measuring their fluorescence intensity 
under identical illumination conditions as used in the fusion experiments (Figure A2-4). Laser 
power was varied to ensure fluorophore excitation occurred within the linear response regime 
(Figure A2-4) and to obtain photobleaching data (Figure A2-2).  
The number of molecules bound to HA on the surface of each virus was calculated by 
dividing the average integrated fluorescence intensity measured from the fusion experiments by 
the average integrated intensity measured for the individual antibodies. The value for the 
number of IgG/Fab bound to each virus was corrected for the presence of unlabeled IgG/Fab 
using the visualized fraction measured by MALDI and photobleaching (Table A2-1). For each 
experimental run, the distribution for the numbers IgG/Fab bound to all virions (both fusing and 
non-fusing) was determined and its median value calculated (Figure 3-2). The median values for 
the numbers of IgG/Fab bound were fit with a hyperbola using the transform both sides 
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approach for variance stabilization [6] utilizing a square root transformation (Equation 2, Table 
A2-2).  
Numbers of IgG/Fab were related to hemifusion efficiency by combining both models 
into one analysis (proc NLMIXED, SAS v9.2). In this combined method, the number of bound 
IgG/Fab at each point along the fit line was used to back-calculate the corresponding IgG/Fab 
concentration. From this estimated concentration, the hemifusion efficiency and 95% confidence 
interval were calculated using the delta method [7] and the lowest degrees of freedom from the 
two models. 
Hemifusion time-to-event for each particle was determined as the elapsed time between 
the pH-drop frame and the frame when hemifusion occurs, defined as the time-point with the 
maximal rate of fluorescence increase. The time-to-hemifusion distribution for each 
experimental run was determined and its geometric mean time and geometric standard 
deviation (error) determined. The geometric mean was utilized to preserve the semi-log 
distribution, often used to analyze waiting time distributions [8]. The times resulting from each 
experiment were log10 transformed fitted by a hyperbola with a constant offset (Equation 3, 
Table A2-2). The geometric means in the absence of IgG/Fab reported in Chapter 3 (46 
seconds for H1N1, 30 seconds for H3N2) are comparable to estimates obtained from data fitting 
(Table A2-2), indicating our models were properly anchored. 
 
A2.1.9 Monte Carlo Simulation 
To simulate protein packing on the viral surface we used a simple 2D hard sphere 
model. Each protein was approximated with a number of spheres (Figure A2-7) such that their 
final dimensions were in agreement with appropriate crystal structures. Model viral membranes 
were comprised of the envelope embedded proteins hemagglutinin (HA), neuraminidase (NA) 
and M2 proton pump. Binding geometry of IgG/Fab to the HA proteins was constrained to be in 
agreement with the CR8020-HA co-crystal structure (PDB code 3SDY [9]).  
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IgG molecules (14 nm in total length) containing two paratopes were modeled with the 
Fc domain pointing vertically from the in silico viral surface and were allowed to have flexibility 
about their midpoint. They were constructed from five spheres - two for each fab, one 
representing the variable and the other, the constant region, and one sphere corresponding to 
the Fc tail. Fab fragments (7 nm in length), were not flexible, had a single paratope and were 
constructed from two spheres. HA was approximated with four spheres: one larger for the stem, 
and three for the HA1 heads. The diameter of the HA stem was measured around the epitope 
area of the CR8020 antibody in order to assure correct binding geometry. The approximate size 
of the extracellular domain of the M2 ion-channel was estimated from its the molecular mass, 
accounting for the protein’s tetrameric quaternary structure. Neuraminidase was modeled as a 
single sphere.  
The spike protein (HA and NA) density was set at 8000 spikes per m2 and an HA:NA 
ratio of 7:1 in agreement with previous studies of similar influenza virus samples [10,11]. From 
this density, a surface representing our average 125 nm virus particles contained 392 spike 
proteins, 341 of which were HA.  
Simulations were performed by placing viral proteins randomly within a 2D periodic 
simulation surface. The surfaces were minimized with a Monte Carlo-like algorithm in order to 
remove protein overlap from a randomly generated surface. The overlap energy was modeled 
as a square well potential with additional term proportional to the overlap surface. Increasing 
IgG/Fab concentrations were added and their final structure and position determined using the 
Monte Carlo sampling. The paratope-epitope interaction energy was modeled using the patchy 
spheres approach [12] so as to impose appropriate distances and angles between the epitope 
and paratope as dictated by their co-crystal structure [9]. We found that employing a smooth 
potential instead of a square-well interaction energy allowed Monte-Carlo minimization to 
converge faster due to the longer range interactions. For the minimization we use the following 
moves: single protein rotation and perturbation, two proteins swapping, IgG/Fab jumping to 
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another binding site, randomizing Fab-Fab angle of the IgG (only). The concentration at which 
we were not able to get rid of the protein overlap was taken as the steric packing limit.   
Previous studies have argued that groups of HA in close proximity could represent 
fusogenic clusters that cause nucleation of membrane fusion events [13]. Simulation data was 
analyzed to identify HA clusters defined to be groups of HA trimers free from IgG/Fab that were 
in close proximity to each other without any additional surface proteins between them; cluster 
disruption was defined to occur when these conditions were not met. Unfortunately defining 
clusters of fixed sizes from 3–6 neighboring HA trimers did not result in replication of trends 
observed in the experimental data of hemifusion efficiency, namely a need for more Fab than 
IgG to achieve equal cluster disruption, and the results of these analyses are not included. 
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A2.2 Supplemental figures and movie 
 
 
  
Figure A2-1 – Association (A) and dissociation (B) of CR6261 (i) and CR8020 IgG (ii), and of 
crF6261 (iii) and crF8020 Fab (iv). A) For IgG/Fab association plots, H1N1 (i,iii) or H3N2 (ii,iv) 
viruses were incubated with 130 nM IgG or Fab for the time indicated on the horizontal axis, 
then added to flow channels to become immobilized on the supported lipid bilayer (SLB). Flow-
in time of the virus plus IgG/Fab solution was ~20 minutes. Two fields of view were imaged in 
rapid succession and the average IgG/Fab coverage ± SEM is reported. B) For dissociation 
after immobilization, IgG/Fab coverage on the same virus samples as in (A) were quantified at 
~10-20 minute intervals without repeated imaging of the same fields of view. Typical experiment 
run time after flow-in of the virus-IgG/Fab solution was 10 minutes.  For clarity, only dissociation 
measurements corresponding to 60 minute incubation (blue) from (A) are shown. Mean values 
of the number of bound IgG/Fab ± standard deviation over the times after immobilization are 
indicated by the horizontal line and shaded regions. Fluorescence intensity fluctuated between 
fields of view, as indicated in the scatter of the data points, but did not systematically decrease 
as would be expected if non-specific binding occurred or if the IgG/Fab otherwise dissociated 
from the virus. Non-specific binding occurred only for 360 minute incubation of crF6261 with 
H1N1 (A.iii, filled symbol at 360 minutes), which was observed to systematically decrease to 
coverage levels equivalent to 60 minute incubation (open-faced symbol at 360 minutes in A.iii) 
after 70 minutes of immobilization on the SLB surface. 
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Figure A2-2 – Immobilization of the virus to target bilayers through glycophorin A binding was 
largely unaffected by IgG/Fab binding to the viral surface. Each data point corresponds to a 
single fusion experiment and represents the total number of virions imaged in equal sized fields 
of view. While there is some decrease in binding at the highest concentrations, many virions are 
still imaged at the highest IgG/Fab concentrations indicating that binding does not prevent HA-
receptor recognition. 
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Figure A2-3 – Degree of Alexa-488 labeling for 6261 IgG (i) and Fab (ii), and for 8020 IgG (iii) 
and Fab (iv) as measured by photobleaching analysis (A) and MALDI mass spectrometry (B). A) 
Photobleaching measurements resolved the distribution of number of Alexa-488 molecules 
bound to each molecule as described in SI Methods. These distributions were fit with a Poisson 
distribution (red lines) to identify the expected number of fluorophores bound to each IgG/Fab. 
B) Mass spectra at mass:charge ratios of 1 and 2 were determined for the unlabeled IgG/Fab 
mass spectra (black) and the Alexa-488 labeled IgG/Fab mass spectra (blue). The peak value 
from the unlabeled spectra was subtracted from each labeled spectra and divided by the 
molecular mass of Alexa-488. The labeled mass spectra was fit with a Poisson distribution (red) 
to identify the expected number of fluorophores linked to each IgG/Fab. Spectra for Fab 
molecules resolved identifiable peaks corresponding to molecules having one, two, three and 
four dye molecules (B.iii and B.iv). Results of fitting are summarized in Table A2-1. 
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Figure A2-4 and Movie M2-1 – Pore formation is inhibited by CR8020 in a similar fashion as 
hemifusion. IgG inhibits pore formation similarly to hemifusion inhibition. H3N2 viruses were 
content labeled with aqueous sulforhodamine B dye, as described previously [1], and incubated 
with Alexa 488-labeled CR8020 IgG (CR8020af488). Planar bilayers were formed in a 
microfluidic chamber upon dextran-functionalized glass cover slips [1] or upon polyethylene 
glycol (PEG) functionalized glass cover slips where 5% of the PEG used was covalently coupled 
to DSPE (3-(N-succinimidyloxyglutaryl)aminopropyl, polyethyleneglycol-carbamyl 
distearoylphosphatidyl-ethanolamine) [14,15]. Bilayer composition was supplemented with 1% 
molar fraction of the ganglioside Gd1a to allow virus immobilization. Upon pH drop, the viruses 
underwent membrane fusion as measured by the loss of content dye from the viral lumen [1]. A, 
top) the efficiency of full fusion decreased as the concentration of CR8020af488 increased 
(magenta data). The raw hemifusion efficiency data (black) aggregated from the data shown in 
Figures 2-2F,G and 3-2A is shown for comparison; full fusion shows a lower overall efficiency 
compared to hemifusion. A, bottom) Full fusion and hemifusion data were normalized to their 
respective efficiencies in the absence of CR8020. Best fit lines using Equation 1 (Table A2-2) 
show good overlap between the two functional read outs and indicate that hemifusion inhibition 
is an appropriate read out for full fusion inhibition. B) Some viruses fusing to DSPE-PEG 
supported bilayers showed outward diffusion of HA-CR8020af488 complexes concomitant with 
content release. In the image montage of full fusion from Movie M2-1 depicted here, the SRB 
label (magenta) co-localizes with the CR8020af488 signal (green). The SRB content is 
observed to rapidly diffuse outward from the site of fusion in what appears to be 1D diffusion 
along a line (frames 188 and 189 sec). The one-dimensional nature is presumably the result of 
bilayer defects that arose during lipid hydration. Shortly after SRB release, the CR8020af488 
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(Figure A2-4 Continued) signal is seen to diffuse along the same one-dimensional area 
(frames 190-193 sec). This green diffusion signal indicates that the HA trimers diffuse outward 
from the viral envelope into the DSPE-PEG supported bilayer after full fusion has occurred, 
since HA is in a stable complex with CR8020af488 (Figure A2-1). Scale bar (yellow) is 2 m. C) 
Kymograph over the cyan line in (B) shows co-localization of the virus and CR8020af488 
signals (white) until the fusion event. At the point of fusion, the SRB content label rapidly 
diffuses as described in (B), followed by outward diffusion of the HA-CR8020af488 complexes. 
 
 
Movie M2-1) Content labeled H3N2 virus bound by a sub-inactivating number of CR8020af488 
IgG molecules is immobilized upon a DSPE-PEG tethered bilayer. Content labeling is false-
colored magenta, signal from the labeled antibodies bound to HA is false-colored green and the 
co-localization between them is white. As described in the caption to Figure A2-4, the SRB 
content is observed to rapidly diffuse outward from the site of fusion in what appears to be 1D 
diffusion along a line, which is likely a result of bilayer defects that arose during lipid hydration. 
Shortly after SRB release, the CR8020af488 signal is seen to diffuse along the same one-
dimensional area, indicating that the HA trimers diffuse outward from the viral envelope into the 
target bilayer after fusion occurs. Two non-fusogenic viruses can also be seen on the left hand 
part of the movie. Scale bar is 2 m. 
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Figure A2-5 – Imaging of individual, labeled IgG molecules. A) Representative image of 
CR8020af488 labeled IgG molecules adsorbed to a clean glass surface, visualized at ~0.1 
W/cm2 in pH 5.0 citric acid buffer, averaged over 100 frames acquired at 200 ms exposure 
time, and corrected for the Gaussian laser beam illumination profile. Image size is 512 x 256 
pixels (140 x 70 m). B) Distribution of integrated fluorescence intensities acquired from (A). 
The distribution is well fitted by a Gaussian distribution (red curve, R2 = 0.932). The median 
value of this distribution (solid vertical line ± median absolute deviation, dashed lines) is 
taken as the integrated fluorescence intensity per IgG/Fab molecule used in calculating the 
number of bound IgG/Fab. C) Median values of the averaged integrated fluorescence 
intensities, as measured in (B), increases linearly with increasing laser illumination power, 
indicating that fluorescence read out of individual labeled IgG/Fab is linearly dependent on 
illumination input. D) The angle of incidence of the excitation lasers upon the glass-water 
interface (horizontal axis) was varied to measure the fluorescence intensity (vertical axis) of 
CR8020af488 IgG bound to H3N2 virus incubated with 130 nM IgG and immobilized upon a 
glass-supported bilayer. As expected, total internal reflection occurred near 61° relative to 
the axis perpendicular to the glass surface. Data points are median values ± interquartile 
range. For angles smaller than 57°, the fluorescence intensity varied only slightly (blue line), 
indicating a homogenous evanescent field over the length-scale of a virus. The effect of the 
evanescent wave was apparent for larger incidence angles (red line). The TIR angle was set 
to ~56° (orange circle) for all experiments to minimize the effect of the evanescent field, but 
still achieve high signal-to-background recordings ((A) and Figure 3-1A).  
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Figure A2-6 – Electron microscopy of influenza strains H1N1 and H3N2. A) H1N1 and H3N2 
viral strains were negatively stained with uranyl acetate upon a carbon-coated TEM grid and 
imaged at 45,000x magnification. Both virus strains were spherical in appearance and 
surface spike proteins were visible. Diameters of the virus particles were measured at the 
base of the spike proteins and the area of high contrast surrounding the virus, indicated by 
the yellow circle in the image. B) Box plot of the diameters of the H1N1 (n = 19 particles, 
blue) and H3N2 (n = 23 particles, black). The square data point and vertical line inside the 
box represent the mean and median diameters, respectively. Left and right edges of the box 
are the 25th and 75th percentiles, respectively, and similarly the left and right whiskers are the 
1st and 99th percentiles, respectively.  
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Figure A2-7 – Monte Carlo simulations of protein packing on a viral surface. A) Simulations 
represented relevant proteins as spheres of crystallographic dimensions (left) – HA in cyan, NA 
in green, M2 proton pump in violet and IgG (or Fab) in gray. The spike protein (HA or NA) 
density shown corresponds to 8000 spikes/m2 (right) with a 7:1 ratio of HA:NA. Epitopes on the 
HA and paratopes on the antibodies are depicted as dark blue and black circles, respectively. 
Binding of an epitope by an antibody is indicated with a red circle.  B) The number of sterically 
available epitopes (vertical axis) diminished as the number of IgG (left, green points) or Fab 
(right, blue data points) molecules on the viral surface increased. We see that no epitopes are 
sterically available when ~250-300 IgG or ~500 Fab molecules are bound. Lines having slopes 
of -2 (black) and -1 (red) are included for visual comparison of the rate of epitope loss upon 
IgG/Fab binding. For IgG, the data nicely follows the black line until ~175 IgG are bound, 
suggesting that each IgG binds with both paratopes to remove two binding sites up to this point. 
Beyond this region the slope is more similar to the red line, suggesting that steric interactions 
primarily allow single paratope binding by the IgG. A majority of the Fab data is roughly parallel 
to the red line, as would be expected for single paratope binding and low amounts of steric 
interactions until high coverage regimes. 
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A2.3 Supplementary tables 
 
 
 
 
Table A2-1 – Degree of IgG/Fab labeling and Percent Visualized 
Fusion 
Inhibiting 
Molecule 
Photobleaching MALDI Mass Spectroscopy 
Dyes per 
Molecule ± 
SEM 
Percent 
Visualized ** 
 R
2 
  
(m/z = 1) 
R
2 
  
(m/z = 2) 
R
2 < >  
± SEM 
CR6261 4.2 ± 0.1 0.950 6.87 ± 0.03 0.934 6.34 ± 0.03 0.959 6.6 ± 0.2 5.4 ± 0.8 99.5 ± 0.4  
CR8020 4.3 ± 0.1 0.958 5.94 ± 0.02 0.955 5.29 ± 0.02 0.978 5.6 ± 0.2 5.0 ± 0.5 99.3 ± 0.3  
crF6261 1.9 ± 0.2 0.850 2.73 ± 0.01 0.974 2.86 ± 0.02 0.941 2.80 ± 0.05 2.4 ± 0.3 91 ± 3 
crF8020 2.1 ± 0.2 0.881 2.39 ± 0.01 0.964 2.56 ± 0.03 0.853 2.48 ± 0.06 2.3 ± 0.1 90 ± 1 
* Results for Poisson distribution (p(k,) = A*(^k)*exp(-)/ (k+1)) fits from Figure A2-3, where A was unconstrained 
to allow for various amplitudes; parameter errors are those reported by Originlab plotting software during chi-squared 
minimization using mean residual variance and the parameter covariance matrix.  
** Percent visualized corresponds to the percentage of labeled IgG/Fab molecules bound with at least one 
fluorophore. Error is calculated by error propagation for a Poisson distribution.  
  
 224 
 
 
 
 
Table A2-2 – Fit lines and corresponding estimated parameters determined by fitting data 
points from all experimental runs. 
   H1N1 H3N2 
Data & Fit Model Param CR6261 crF6261 CR8020 crF8020 
Hemifusion Efficiency [E(c)] 
Equation 1 * 
 
  
A  0  
(Constrained) 
 0.011  
(-0.001, 0.023) 
 0.031 
(-0.043, 0.104) 
 0.033  
(0.017, 0.049) 
Co 
 1.812  
(1.324, 2.299) 
 2.151  
(1.906, 2.397) 
 2.115 
(1.819, 2.412) 
 1.894 
(1.726, 2.063) 
D  0.469 
(0.309, 0.628) 
 0.454 
(0.326, 0.582) 
0.591 
(0.500, 0.682) 
 0.603 
(0.490, 0.716) 
p  -1.048  
(-1.424,-0.672) 
 -2.232 
(-3.755, -0.708) 
 -1.299 
(-2.077, -0.521) 
 -2.245 
(-3.460, -1.030) 
Number Molecules Bound [N(c)] 
Equation 2 
 
         
 
M  154.7  
(107.1, 202.2) 
 248.1 
(158.1, 338.1) 
 130.2 
(111.5, 148.9) 
 492.5 
(393.5, 591.6) 
 
z  2.411  
(2.086, 2.736) 
 2.525 
(2.162, 2.887) 
 1.871 
(1.691, 2.050) 
 1.843 
(1.576, 2.111) 
Time to Hemifusion [t(c)] 
Equation 3 ** 
 
        
to 
 1.660 
(1.546, 1.773) 
 1.704 
(1.531, 1.877) 
1.421 
(1.318, 1.524)  
1.466 
(1.416, 1.515)  
B  0.339 
(0.207, 0.470) 
 0.433 
(0.212, 0.655) 
 0.326 
(0.184, 0.468) 
 0.414 
(0.353, 0.478) 
C1 
 1.461 
(0.861, 2.060) 
 1.937 
(0.985, 2.889) 
 1.982 
(1.229, 2.736) 
 1.657 
(1.415, 1.898) 
Values in parenthesis represent 95% confidence bounds (lower, upper).  
* Confidence intervals for 50% hemifusion efficiency reduction reported in Chapter 3 was calculated using the delta 
method [7] and the lowest degrees of freedom from the two models.  
** Parameters B, C1, and t0 were modeled on a log10 scale. 
Parameters:  
Equation 1 – E represents the proportion fusion events over total events, D and A represent respectively the upper 
and lower asymptote, p represents a slope factor, C represents the IgG/Fab concentration (in nM) and C0 represents 
the inflection point. Equation 2 – N represents the number of bound IgG/Fab defined as (median intensity)/(labeling 
correction * intensity per molecule), C is the concentration of IgG/Fab (in nM), M is the maximum number of IgG/Fab 
that can bind and Z is the IgG/Fab concentration where the half-maximum number of molecules is binding.   
Equation 3 – t represents the time to hemifusion, t0 the time to hemifusion without IgG/Fab, B the interval between t0 
and the upper asymptote, C represents the IgG/Fab concentration (in nM) and C1 represents the IgG/Fab 
concentration corresponding to the geometric mean of t0 and B being modeled on a log10 scale.   
For stabilization of all models, the hemifusion data without IgG were placed at an infinite low IgG concentration. All 
statistical analysis for fitting was performed using proc NLMIXED (SAS v9.2). Where necessary (Equation 1, Table 
A2-2), fitting involved a restriction that the lower asymptote was ≥ 0. Standard errors and 95% confidence limits were 
estimated using the delta method [7,16]. 
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Appendix 3 – Fusion Tracker User’s Guide 
 
This appendix contains the following information: 
A3.1 Getting started with the Fusion Tracker program 
A3.2 Input data and user-defined parameters 
A3.3 Output data 
A3.4 Rejection reason explanations 
A3.5 Supplementary references 
 
A3.1 Getting started with the Fusion Tracker program 
Information contained in this appendix describes the Fusion_Tracker automated data 
analysis software described in Chapter 4.  Inputs required for running the program are 
described in Section A3.2.  Outputs obtained from successful completion of the program are 
described in Section A3.3.  Reasons for rejection of a particle’s fluorescence trajectory or any 
fits performed upon it are described in Section A3.4.  It is assumed that readers have a basic 
understanding of the various MATLAB variable types, such as structures, structure arrays, cells, 
character strings and arrays.  To use the program, the ‘Fusion_Tracker’ folder should be 
saved into a user’s main MATLAB folder with all subfolders and files.  A recommended directory 
would be the following: D:\MATLAB\Fusion_Tracker.  Saved within this main folder are a 
number of scripts meant to be altered by a user:   
- Files2Analyze.m – script defining files to be analyzed in batch (see Section A3.2.2).  
- SetImageAnalysisParam.m  – script defining parameters for image analysis and   
  particle detection(see Section A3.2.2.1).   
- SetTrajectoryAnalysisParam.m – script defining parameters for trajectory selection (see   
  Section A3.2.2.2).  
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- Detection_Tracking_Analysis.m – main analysis script handling data calling and   
  handling. 
 
A3.1.1 Program initialization  
Program Initialization is performed by navitating first the current MATLAB folder to the 
‘Fusion_Tracker’ folder and running the setup_Fusion_Tracker.m script from the 
command line.  Execution of this script will open the MATLAB pool of workers that enables 
parallel processing using the default ‘local’ cluster profile.  It also establishes working 
directories needed by Fusion_Tracker and adds relevant folders to the MATLAB path.   
Once setup has been completed, users should appropriately define the Files2An, 
imgParam and anParam variables described in Section A3.2.  Analysis of all files included in 
Files2An can be analyzed by initiating the script Detection_Tracking_Analysis.m either 
from the command line or by running the script from the Editor window.  FIRST TIME USE: prior 
to first use of Detection_Tracking_Analysis.m, users should ensure that the path 
specified on approximately line 30 of the code is correct.  This path should describe the location 
of the .tif data files that will be subsequently analyzed.  Files should be named according to 
the format described in Section A.3.2.2.  Processing time on a single CPU running with a 3.4 
GHz clock speed is approximately 400 trajectories analyzed per hour, when extracting only 
fluorescence information at the locations of particles and not surrounding them. 
In sections below describing a number of field names present in structure variables, a 
short hand forward-slash / is utilized to indicate similar field names present in the structure.  
The forward-slash itself does not constitute part of the field name.  For instance, the 
Trajectory structure variable has the fields ch1analysis and the field ch2analysis; the 
short hand notation preceding their description is: Trajectory.ch1/2analysis. 
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A3.2 Input data and user-defined parameters 
A3.2.1 File type and recording orientation 
Input files tested thus far are multi-stack .tif images containing 16-bit greyscale 
information recorded with split-field imaging.  The tested images were recorded at 60x 
magnification using an Andor iXon 887-BI EMCCD camera controlled by the Andor imaging 
software identical to [1].  This camera has 16 m pixel size, such that one pixel in the image 
corresponds to 0.267 m in real space.  Time stamp information is automatically extracted from 
the .tif images via the getandortiffinfo2.m script written by Milos Popovic.  The output 
of this script is an column vector containing the time stamp in milliseconds for each frame of the 
.tif image.  For images recorded using a Hamamatsu C9100-13 EMCCD camera controlled 
by the MetaVue imaging software, a script is included in the Fusion_Tracker package titled 
getmetavuetime.m that can extract time stamp information into a column vector containing 
the time stamp in seconds for each frame of the .tif image.  Automatic detection of which 
script is used to extract time stamp information is not incorporated and instead requires manual 
selection. 
Fluorescence recordings tested thus far having a top-bottom split-field orientation.  
Channel 1 on the top half-image corresponds to red/orange fluorescence emission for recording 
of the virion’s sulforhodamine B content label.  Channel 2 on the bottom half-image corresponds 
to green fluorescence emission for recording of the virions octadecyl rhodamine 110 lipid label 
and the pH-detecting fluorescein dye bound to the surface of the glass-supported bilayer. 
 
A3.2.2 User defined parameters 
This section lists and describes the parameters Fusion_Tracker requires a user to 
define before analyzing a fusion movie.  All user-defined parameters and input data are called 
by the main program script Detection_Tracking_Analysis.m (DTA).  Multi-stack image 
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files in .tif format can be processed in batch once the Files2An variable is defined in 
Files2Analyze.m.  Essential to batch mode operation is the definition of all files to be 
analyzed as well as relevant frame numbers.  The Files2An cell array has one row dedicated 
to each movie to be analyzed and the following format for its columns: 
Column 1 Column 2 Column 3 Column 4 Column 5 
File name 
(include .tif 
extension) 
pH drop frame 
Number of 
frames to be 
analyzed 
Type of principal 
bilayer lipid 
Molar percent of 
cholesterol in 
bilayer 
 
The file name of column 1 must have the format: YYMMDD_pH#, where YYMMDD is a six-digit 
string representing the year (YY), month (MM) and day (DD) the recording was made, pH is a 
two-digit string indicating the pH used to induce fusion and # is the iteration of the given 
experimental conditions.  For instance, the file name 100115_501 indicates the movie was 
recorded on January 15, 2010 using pH 5.0 fusion inducing buffer and is the first iteration of this 
experiment type of the day.  The pH drop frame from column 2 is an integer value used in 
defining parts of the image analysis and must be identified before running the Fusion_Tracker 
analysis algorithm. A script is included in the Fusion_Tracker package titled phFind.m that will 
read in a defined number of frames from a given recording having the above described file 
name format and via user interaction will determine the pH drop frame.  Column 4 and 5 are 
character strings representing meta-data about the experiment that is saved into the 
description variable (see Section A3.3). 
 
A3.2.2.1 Image analysis parameters  
Image analysis parameters are saved in the imgParam variable defined by the user in 
the script named SetImageAnalysisParam.m.  This structure variable has a number of 
parameters, some optional and others required, that determine how images are handled and 
corrected, and how particles detected.  It is relevant to the image analysis portion of the 
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programmatic outline of Figure 4-2.  The list here describes the field names indicating 
parameters to be defined in SetImageAnalysisParam.m. 
AnalyzeAround: REQUIRED. Binary value determining if the integrated fluorescence from the 
pixels surrounding virus particles is extracted.   
- A value of ‘0’ indicates the intensity surrounding a particle will not be extracted. 
- A value of ‘1’ indicates the intensity surrounding a particle will be extracted. 
- If BkCorr is set to ‘local’ then it is obligatory for AnalyzeAround = 1. 
aroundPeak: REQUIRED. Single value multiplication factor used to determine the radius of the 
circle centered at each particle that identify which pixels are used for fluorescence signal 
integration.  The radius of the circle is defined by its 2D Gaussian width as: w. 
BkCorr: REQUIRED. String array having one of the two permitted values below.  It determines 
how fluorescence background will be measured and removed from the integrated 
fluorescence signals extracted from each frame of a movie.  It is used in 
ExtractIntensity.m. 
- ‘global’ indicates that after an image is corrected for electronic offset and the  
  illumination profile, the peak value of the distribution of pixel intensities in the flattened  
  image is set as the global fluorescence background.  This global background is  
  subtracted from the entire flattened image such that the peak of the pixel intensity  
  distribution is located at zero.  Once this operation is carried out, fluorescence signals  
  comprising the fluorescence trajectories are extracted. 
- ‘local’ indicates that for each particle being analyzed, the average value of the pixels  
  identified inside the doughnut ring surrounding a particle is subtracted from the each  
  pixel lying within the doughnut center.  The pixels corrected for average local  
  background lying within the center of the doughnut are then used for extraction of the  
  integrated fluorescence signal comprising the fluorescence trajectories.  This option is  
  particularly useful if the intensity extraction scripts are adapted to obtain photobleaching  
  traces. 
edge: REQUIRED. Two-element array defining the number of pixels away from the edges of the 
half-images for each channel wherein particles are not identified. 
- Format: [x_edge, y_edge] where x = columns, y = rows. 
dxdy:  OPTIONAL. Two-element array that defines the rigid ‘x’ and ‘y’ (‘column’ and ‘row’) 
translations necessary for moving from channel 1 to channel 2.  It is set as channel_2 = 
channel_1 – dxdy.  Design intent: dxdy should be first correctly identified by the 
program automatically before a user attempts to initialize its value.  Its definition serves 
as a programmatic override and is intended to be used only when the automated 
detection of dxdy fails. 
- If defined, it must be a two-element array of values in the order:  
  [column_translation, row_translation]. 
- If undefined, then it should be an empty array and will be determined by the script  
  ChannelRegistration.m.  
frames: REQUIRED. Three-element array containing information about the frames to be used 
for particle tracking.  
- Format is [start_frame end_1 end_2]. 
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  From start_frame to end_1, the particles are tracked in frames separated by step_1  
  defined below.  From end_1 to end_2 particles at tracked in frames separated by  
  step_2 defined  below. 
  - The second element end_1 can be defined as the pH drop frame plus a value. 
frames_id_particles: REQUIRED.  Two-element array that will define the frames to be 
used for localizing the final, fixed positions of the virus particles after pH drop.  The 
values of the array are the number of frames post-pH drop and pre-fusion that 
localization should occur. 
margins: OPTIONAL. Two-element array that defines the number of pixels at the edges of the 
half-images for each channel that lie outside the co-registered image.  Design intent: 
margins should be first correctly identified by the program automatically before a user 
attempts to initialize its value.  Its definition serves as a programmatic override and is 
intended to be used only when the automated detection of margins fails. 
  - If defined, it must be a two-element array of values in the order: 
   [column_margin, row_margin] 
  - If undefined, then it should be an empty array and will be determined by the script  
   ChannelRegistration.m. 
minTrackLength: REQUIRED.  Two-element vector whose values are in units of frames.   
These are the minimum number of frames that a particle tracking trajectory must be 
followed over if it is to be accepted and assigned to one of the particles identified in 
centroid_fix.  
- Format: [length_step_1 length_step_2].  Suggestion: length_step_1 > length_step_2 
  The first value is the tracking trajectory length during high temporal resolution tracking  
  at the beginning of a movie between start_frame and end_1 of frames.  The second  
  value is the track length required when following particles between end_1 and end_2 of  
  frames to correct for microscope drift. 
movethresh: REQUIRED. Single value threshold value in units of pixels that is the minimum 
number of pixels a particle must move while rolling between frames start_frame and 
end_1 if it is to be counted as rolling.  Particles surpassing this minimum displacement 
have their distance trajectories subjected to MLE-based fitting for determination of the 
frame when they stop rolling. 
multfact: REQUIRED. Two-element vector defining the multiplication factor used when 
setting the threshold for particle detection after discoidal image filtering.  The threshold is 
calculated as +m*  where  and  are the average and standard deviation of the pixel 
intensities following discoidal filtering, respectively, and m is the channel-appropriate 
multiplication factor. 
- Format: [multfact_channel_1 multfact_channel_2] 
orientation: REQUIRED. Field defining a character string that sets the recording orientation 
of the movie.   
  - Two values are permitted:  
   ‘TopBottom‘ where channel 1 is on the top half-image channel 2 is on the  
   bottom half-image. 
   ‘LeftRight‘ where channel 1 is on the left half-image and channel 2 is on the  
   right half-image.  
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outsidePeak: REQUIRED. Single value additive factor that is added to the aroundPeak field 
when determining the outer radius of the doughnut used to extract fluorescence intensity 
surrounding a particle.  For example, if the aroundPeak field is set to 2 and 
outsidePeak is set to 1, then the doughnut used for signal integration to set 
TrajectoryAround would have an inner radius 2*w and an outer radius 3*w. 
pixelAccuracy: OPTIONAL.  Single value used by dftregistration.m [2].  Default value 
is 0.1. 
radius_link: REQUIRED. Single value distance in pixels that is the maximum distance 
allowed for assigning a tracking trajectory to the location of a particle’s fixed position, as 
determined in the frames imgParam.frames_id_particles and save in the 
centroid_fix variable.   
radius_track: REQUIRED. Single value distance in pixels that is the maximum distance 
between a particle in frame f and in frame f+step allowed for linking the two localization 
positions together into a trajectory during particle tracking.  The same value is used both 
when linking localizations to follow rolling viruses (step_1) or to correct for drift (step_2). 
sigmult_rej: REQUIRED. Single value multiplication factor, m, used to remove particles 
having a fitted 2D Gaussian width that is too large or too small.  The mean, , and 
standard deviation, w, of the distribution of 2D Gaussian widths are calculated in both 
the ‘x’ columns and ‘y’ rows directions.  Particles having their width in either ‘x’ or ‘y’ 
larger than +m*w are removed. 
step: REQUIRED two-element array defining the inter-frame step size used in particle tracking.  
This variable determines the temporal resolution with which particles are tracked in the 
frames of the movie defined by frames above. 
- Format: [step_1 step_2], where step_1 < step_2 
  > From start_frame to end_1 of frames, images separated by step_1 frames are used,  
   first for particle localization, then for linking of particle locations to create tracking  
   trajectories of high temporal resolution and follow rolling viruses. 
 > From end_1 to end_2 of frames, images separated by step_2 frames are used, first  
   for particle localization, then for linking particle of locations to create tracking  
   trajectories that compensate for microscope drift. 
 
A3.2.2.2 Trajectory analysis parameters  
Trajectory analysis parameters are saved in the anParam variable defined by the user in 
the script named SetTrajectoryAnalysisParam.m.  This structure variable has a number 
of parameters, some optional and others required, that determine how extracted fluorescence 
trajectories are handled and smoothed.  It also serves to define aspects critical to the Boolean 
decision function outlined in Figure 4-2B.  It contains two nested substructures that determine 
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how the trajectories from the two channels are handled and selected for either depicting fusion 
events or not.  The list here describes, first, the field names indicating parameters used on 
trajectories from both channels, then the channel-specific substructures ch1 and ch2 are 
described in detail.  All parameters are defined in the script : 
SetTrajectoryAnalysisParam.m. 
 
A3.2.2.2.a – parameters common to trajectory analysis of both channels: 
alphaval: REQUIRED. Single value between 0 and 1 that sets the confidence/significance 
level, , used during maximum likelihood estimator calculation during trajectory fitting.  
This value also specifies the theoretical false-positive limit when determining the 
statistical significance of a fit over the null, linear fit. 
bleedThruFrac: REQUIRED. Single value between 0 and 1 that represents the fraction of the 
short wavelength fluorescence emission intensity that bleeds through into the long 
wavelength detection channel.   
maxiter: REQUIRED. Single value determining the maximal number of fitting iterations to be 
performed when searching for maximal QS values during the MLE-based trajectory 
selection.  This parameter greatly determines the processing time required to determine 
optimal fitting parameters that are statistically significant.  During testing, a value of 10 
worked well to identify good fitting domains. 
niter: REQUIRED. Single value determining the maximal number of iterations to be performed 
when changing sliding window sizes while searching for intensity up- or down-shots 
using the SGolay and sliding window difference filters (see Chapter 4).    
noiseExlFr: REQUIRED. Single value indicating how many frames to use when defining the 
sampling frequency for Fourier filtering of trajectories to smooth them.  For instance, 
noiseExlFr = 3 will define a cutoff frequency of 1/3 frames.  See fftf.m for more 
information [3].  
numfrq: OPTIONAL. Single value indicating how many frequencies to use when reconstructing 
a trajectory after Fourier filtering.  Define an empty array if no value is desired.  See 
fftf.m for more information [3]. 
numcores: REQUIRED. Character string containing the number of processing cores (CPU’s) 
present on the computer being used for analysis. 
paramconf: REQUIRED. Single value between 0 and 1 that determines the percent confidence 
intervals for the MLE-determined fitting parameters.  For instance, a value of 0.9 
determines the 90% confidence intervals for all fit parameters calculated by the program. 
pthresh: REQUIRED. Single value between 0 and 1 that determines the p-value required for 
passing the t-test testing for the “Normalcy” of the signal noise distribution.  Rejection of 
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the t-test null hypothesis with a p-value less than 1-pthresh results in particle rejection 
for not having a sufficiently Normal noise profile.  
shortWavelength: REQUIRED. Character array of strings having one of two values that 
dictates which of the two emission channels corresponds to the shorter wavelength 
emission that will bleed thru into the long wavelength channel. 
- Permitted values: ‘ch1’ or ‘ch2’. 
SNsite: OPTIONAL.  Single value dictating the signal-to-noise that a particle fluorescence 
trajectory is required to have in the period starting with the pH drop and ending of 
particle identification, i.e. in the frames determined by: [pHdrop 
imgParams.frames_id_particles(2)].  If a value is not set, then the user will be 
prompted during analysis by the script  SignalIntensitySelection.m to determine 
a value by selecting it from the distribution of signal-to-noise values measured from 
trajectories of the two channels.   
stepsz: REQUIRED. Single value determining the step size increases in the smoothing 
windows between iterations when finding potential up- and down-shots using the SGolay 
and sliding window difference filters.  Together with the winfilt_st value set for each 
channel, the maximal smoothing window size that will be tested for intensity up- or 
down-shots is:  winfilt_st +stepsz *niter . 
  
 Channel-specific parameters contained in the ch1 and ch2 substructures are used 
when compiling the results of the MLE-based fitting.  With the exception of winfilt_st, these 
values can be altered to allow for re-analysis of trajectories without having to pass through a 
second round of MLE-based fitting.   
 
A3.2.2.2.b – parameters varying between the channels during trajectory analysis: 
deqlim: OPTIONAL.  Two-valued array placing absolute limits on the permitted values of the 
dequenching time, p4, found for dequenching fits of Equation 4-1. 
- Format: [minimum maximum] 
dissiplim: OPTIONAL.  Two-valued array placing absolute limits on the permitted values of 
the diffusion constant, p4, found for dequenching fits of Equation 4-2. 
- Format: [minimum maximum] 
mtfc: REQUIRED.  Two-element array setting the multiplication factors used when determining 
large intensity up- and down-shots during sliding window filtering by the SGolay and 
sliding window difference filters. 
- Format: [up-shot_multiplication_factor, down-shot_multiplication_factor] 
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ndeqfr: OPTIONAL.  Two-valued array setting the maximum and minimum number of frames a 
dequenching event is allowed to occur over.  It is an alternative method for placing upper 
and lower limits on the dequenching time, p4.  Values set here are converted into limits 
by multiplying their values by the elapsed time between frames: dequench limit = 
ndeqfr*time_between_frames. 
- Format: [minmum maximum]. 
ndissipfr: OPTIONAL.  Two-valued array setting the maximum and minimum number of 
frames a dissipation event is allowed to occur over.  It is an alternative method for 
placing upper and lower limits on the diffusion constant, p4.  Values set here are 
converted into limits by first calculating the average radius used for intensity signal 
integration: avg_r = imgParam.aroundPeak*mean(Sigma(:))*0.267, with units 
resulting in m.  The diffusion constant limits = avg_r^2/(4*time_between_frames).  
- Format: [minmum maximum]. 
readout: REQUIRED.  Character array containing one of two values describing the 
interpretation of the signal in each channel. 
- ‘Hemifusion’ indicates the ascribed channel depicts the lipid signal of the dual  
  labeled virus. 
- ‘Pore Formation’ indicates the ascribed channel depicts the content signal of the  
  dual labeled virus. 
signalType: REQUIRED.  Character array containing one of four values indicating the type of 
events that will be detected in the trajectories of the ascribed channel: 
- ‘dequench_dissipation’ indicates the trajectories will be scanned for both intensity  
  up-shots corresponding to dequenching and intensity down-shots corresponding to  
  dissipation. 
- ‘dissipation’ indicates the trajectories will be scanned for both intensity  
  up-shots corresponding to dissipation only. 
- ‘dequenching’ indicates the trajectories will be scanned for both intensity  
  up-shots corresponding to dequenching only. 
- ‘no_analysis’ indicates the trajectories will not be analyzed to detect membrane  
  fusion signals 
SNthresh: REQUIRED.  Two-element array setting the required signal-to-noise thresholds that 
must be surpassed by fits of dequenching with Equation 4-1 and from fits of dissipation 
from Equation 4-2.  Signal-to-noise calculations are described for the SN field of the 
Trajectory variable in Section 3.3.  
- Format: [up-shot_S/N_threshold, down-shot_S/N_threshold]. 
winfilt_st: REQUIRED.  Single value setting the starting window size for SGolay and sliding 
difference window filtering when identifying intensity up- and down-shots.  Smaller 
values are needed for detecting short-lived events, larger values will smooth over short-
lived events to detect only longer-lived events. 
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A3.3 Output data 
Upon completion of the DTA script running the entire Fusion_Tracker algorithm, a 
MATLAB file is saved titled filename_automated_analysis.mat located in the folder 
containing the .tif file analyzed.  This file contains all of the variables saved during analysis.  
The list below describes the variables saved in the .mat file along with their format.  If a user 
wishes to re-compile the results of an analysis using different trajectory analysis parameters 
(see Section A3.2.2.2), then this .mat file must first be loaded into the MATLAB working 
memory.  Once loaded, the trajectory analysis parameters can be changed and the results 
compiled using the  Compile_fit_parameters script, which can be found on in the ‘goto 
== 4’ section in the DTA script.  Running this command will alter the Trajectory variable in a 
reversible fashion; specifically the reasons some fits are rejected is updated in accord with the 
trajectory analysis parameters, but no fits are removed or overwritten.  The shorthand 
‘nchannel’ is used in the list that follows to indicate the number of channels analyzed. 
 
A3.3.1  List of variables saved by the Fusion_Tracker algorithm: 
anParam: 
- Contains parameters used during trajectory selection  
- 1x1 Structure array; fields described in User Defined Parameters section 
centroid_fix 
- Contains locations of the final (fixed) particle positions determined in the 
frames_id_particles field of imgParam.  It is used to link movement trajectories with 
particles to be used for fusion detection.   
- Double array containing location for each particle each row.  Format: 
  column 1 = channel 1 ‘x’ position; column 2 = channel 1 ‘y’ position; 
  column 3 = channel 2 ‘x’ position; column 4 = channel 2 ‘x’ position. 
Centroid 
- Contains information about particle tracking ONLY during the initial part of the recording  
  when tracking is performed with HIGH temporal resolution  
- Structure array npart x nchannel in dimensions with each row corresponding to a  
  particle and each column corresponding to a channel analyzed.  Fields present in the  
  structure for each particle in each channel are: 
  > xyCoord: contains the (x,y) or (column, row) positions of the virus during tracking.   
    Column 1 = frame; column 2 = x/column position, column 3 = y/row position 
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  > movement: binary information, 1 = particle moved and was tracked, 0 = particle did  
   not move. 
  > RfrmInit: data of distance from a particle’s initial position during tracking; only present 
   for particles having movement = 1 and whose stop frame was recorded.   
   This field is a structure containing the fields: 
   >> fr_data_fit: Array containing data used to determine stop frame.  Column 1 =  
     frames, column 2 = distance of particle from its initial position, column 3 = sigmoidal  
     fit to the data of column 2. 
   >> param: Sigmoidal fit parameters (Equation 4-1).  Array having row 1 = fit  
     parameters p1, p2, p3, p4; row 2 = fit parameter lower bound estimates; row 3 = fit  
     parameter upper bound estimates 
  > R2final: data of distance from a particle’s final position during tracking; only present 
   for particles having movement = 1 and whose stop frame was recorded.   
   This field is a structure containing the fields:  
   >> fr_data_fit: Array containing data used to determine stop frame.  Column 1 =  
     frames, column 2 = distance of particle from its final position, column 3 = sigmoidal  
     fit to the data of column 2. 
   >> param: Sigmoidal fit parameters (Equation 4-1).  Array having row 1 = fit  
     parameters p1, p2, p3, p4; row 2 = fit parameter lower bound estimates; row 3 = fit  
     parameter upper bound estimates 
CentroidDrift 
- Contains information about particle tracking ONLY during the last part of the recording  
  when tracking is performed with LOW temporal resolution 
- Structure array npart x nchannel in dimensions with each row corresponding to a  
  particle and each column corresponding to a channel analyzed.  Fields present in the  
  structure for each particle in each channel are: 
  > xyCoord: contains the (x,y) or (column, row) positions of the virus during tracking.   
    Column 1 = frame; column 2 = x/column position, column 3 = y/row position 
  > movement: binary information, 1 = particle moved and was tracked, 0 = particle did  
   not move. 
CentroidTracked 
- Contains information about particle tracking throughout the recording and is an  
  aggregation of the xyCoord and movement data stored in the Centroid and  
  CentroidDrift variables.  As well, it stores information about the number of pixels  
  used during intensity integration, which allows for calculation of average pixel intensity in  
  the script SignalIntensitySelection.m. 
- Structure array npart x nchannel in dimensions with each row corresponding to a  
  particle and each column corresponding to a channel analyzed.  Fields present in the  
  structure for each particle in each channel are: 
  > xyCoord: contains the (x,y) or (column, row) positions of the virus during tracking.   
    Column 1 = frame; column 2 = x/column position, column 3 = y/row position 
  > numPixIntIn: number of pixels lying within the circle defined for a particle during  
   intensity integration. The circle is centered at the particle and having a radius defined by  
   the particle’s Gaussian width: imgParam.aroundPeak*w.  Data used in  
   SignalIntensitySelection.m 
  > numPixIntOut: if imgParam.AnalyzeAround is set to ‘1’, then this field appears and  
   records the number of pixels used for integration of the TrajectoryAround signal  
   intensity.  The pixels here are those lying within a doughnut centered at the particle and  
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   having an inner radius defined as for numPixIntIn and an outer radius defined by:  
   imgParam.outsidePeak*w.  Pixels used for signal integration within the circle are  
   excluded here. Data used in SignalIntensitySelection.m. 
description 
- Structure array containing meta-data about the fusion recording.   
- Current field names are: 
  > name: includes the file name of the recording 
  > lipid: type of lipid comprising the target bilayer, set in Files2Analyze.m. 
  > pH: acidity of the fusion buffer used to initiate fusion, extracted from the filename. 
  > ch: molar percent of cholesterol in the target bilayer, set in Files2Analyze.m. 
elecoff 
- Pixel value electronic offset specific to the camera and EM gain settings.  Its value is set  
  either by the user or determined as the minimum value present in the initial frames used to  
  determine centroid_fix. 
filename 
- Character string describing the full name of the file to be analyzed including file type  
  extension. 
illumProf 
- Gaussian-approximated illumination profile of the excitation beam.  The maximum value at  
  its peak is one and the profile is used to flatten the images by dividing it into each frame  
  used for trajectory intensity extraction. 
image 
- Image of the fusion movie averaged over the frames dictated by the user-defined, post-pH 
drop frames set by the input variable imgParam.frames_id_particles. 
imgParam 
- Structure containing all the user-defined input parameters relevant for image analysis. 
mergedDiscMask 
- Binary mask resulting from discoidal filtering [4] and thresholding of  
  the image variable.  Pixels in the filtered image lying above the threshold are ones, those  
  below are zeros. 
mergedImage 
- Overlay of channel 1 and channel 2 from image after registration using the offset found by  
  dftregistration.m  
mergedRGB 
- Three color RGB image of the two color mergedImage variable where channel 1 is in blue  
  and red (thus magenta) and channel 2 is in green. 
nframes 
- Number of frames in the file specified by filename to be included for fluorescence  
  trajectory extraction and tracking. 
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npart 
- Number of particles detected and used in the fusion analysis.   
pHdrop 
- Frame of the fusion recording where the fluorescein signal is set to have disappeared.  Set  
  by the user in Files2Analyze.m. 
Results 
- Structure variable produced by Compile_fit_parameters.m that contains the results of  
  compiling all the kinetic information resulting from fitting and trajectory selection.  Structure  
  field names are the following: 
  > rejectPart: npart x nchannels array, column 1 for channel 1, column 2 for channel  
   2.  A zero value indicates the particle was not rejected in the given channel.  Other  
   values indicate the fits for the particle in the given channel were rejected.   
  > rejectPartReason: npart x nchannels cell array containing a brief description  
   why a particle was rejected. See Section A3.4 for explanations. 
  > rejectDeq: npart x nchannels array, 0 indicates the dequenching fit was not  
   rejected, Other values indicate the dequenching fits were rejected 
  > rejectDeqReason: npart x nchannels cell array containing a brief description why a  
   dequenching signal for a particle was rejected. See Section A3.4 for explanations 
  > rejectDissip: npart x nchannels array, 0 indicates the dissipation fit was not  
   rejected, Other values indicate the dissipation fits were rejected 
  > rejectDissipReason: npart x nchannels cell array containing a brief description  
   why a dissipation signal for a particle was rejected. See Section A3.4 for explanations 
  > kinetics: Structure containing kinetic data in the following structure fields 
   >> DeqWidths: nchannels x 3 cell array containing the time, in seconds, for the width  
     of the dequenching events as measured by the p4 parameter of Equation 4-1.   
     Column 1 contains all p4 values, Column 2 contains the p4 values for the selected  
     particles and Column 3 the p4 values for the rejected particles. Each cell contains an  
     array with two columns.  Column 1 is the dequenching width values and column 2 is  
     the particle number corresponding to the dequenching width value in column 1. 
   >> DiffConst: nchannels x 3 cell array containing the two-dimensional diffusion  
     constant, in m2/second, for the signal dissipation events as measured by the p4  
     parameter of Equation 4-1.  Column 1 contains all p4 values, Column 2 contains  
     the p4 values for the selected particles and Column 3 the p4 values for the rejected  
     particles. Each cell contains an array with two columns.  Column 1 is the  
     dequenching width values and column 2 is the particle number corresponding to the  
     dequenching width value in column 1. 
   >> deqtime: npart x nchannels array containing the recorded dequenching times. A  
    NaN value is present for rejected dequenching fits. 
   >> dissiptime: npart x nchannels array containing the recorded dissipation times  
     (p3 of Equation 4-2). A NaN value is present for rejected dissipation fits. 
   >> deq2dissiptime: npart x nchannels array containing the elapsed time between  
    a dequenching and dissipation event within a trajectory in a single channel.  NaN  
    value indicates no time was detected. 
   >> HPdeq2deqtime: npart x 1 array containing the elapsed time between a  
    hemifusion dequenching event and pore formation dequenching event in the two  
    channels corresponding to a particle.  NaN value indicates no time was detected.   
    Field not present if dequenching was not an option for both channels.  Negative  
    values indicate the pore formation event occurred first. 
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   >> HPdissip2dissiptime: npart x 1 array containing the elapsed time between a  
    hemifusion dissipation event and pore formation dissipation event in the two  
    channels corresponding to a particle.  NaN value indicates no time was detected.  
    Field not present if dissipation was not an option for both channels.  
   >> HPdeq2dissiptime: npart x 1 array containing the elapsed time between a  
    hemifusion dequenching event and pore formation dissipation event in the two  
    channels corresponding to a particle.  NaN value indicates no time was detected.   
    Field not present if dequenching was not an option for the hemifusion channel and  
    dissipation was not an option for the pore formation channel. Negative values  
    indicate the pore formation event occurred first. 
   >> HPdissip2deqtime: : npart x 1 array containing the elapsed time between a  
    hemifusion dissipation event and pore formation dequenching event in the two  
    channels corresponding to a particle.  NaN value indicates no time was detected.   
    Field not present if dissipation was not an option for the hemifusion channel and  
    dequenching was not an option for the pore formation channel.  Negative values  
    indicate the pore formation event occurred first. 
   >> stopframes: array containing the frames detected for viruses to stop rolling. 
  > plotdata: cell array containing information for plotting the data contained in the  
  aforementioned kinetics field.  Each row constitutes one of the field names listed, in  
  order, above in kinetics.  Column 1 is the data corresponding to each field in  
  kinetics, separated into channels where appropriate, Column 2, 3 and 4 indicated the  
  title, ‘x’ label and ‘y’ label of a plot showing the data in Column 1, Column 5 indicates any  
  user-defined limits on the p4 fit parameters, absence of limits is indicated as [0, Inf]. 
Sigma 
- Width, w, in pixels for each particle as determined by fitting the intensity peak with a two- 
  dimensional Gaussian function 
-  Format is a double array, each row corresponding to a particle, column 1 being the width  
  along the ‘x’ direction and column 2 being the width along the ‘y’ direction.  
stopframes 
- Cell array containing information about the detected frames where individual virus particles  
  stopped rolling as a result of buffer drag.  The first row indicates the information contained  
  in each column: channel of detection, particle number, stop frame detected for the distance  
  trajectory relative to start (column 3) or end (column 4) position, and the average of the  
  detected stop frames. 
time 
- nframes x 1 array containing the time stamp, in seconds, corresponding to each frame  
  analyzed in the fusion recording.  Currently, this is detected with the script 
  getandortiffinfo2.m but can also be determined with the included script  
  getmetavuetime.m. 
trackmask 
- Image created during particle tracking that is a summation of all binary masks used for  
  particle tracking during the first round of particle tracking at high temporal resolution.   
  Tracking consists of discoidally filtering and thresholding each frame to obtain a binary 0/1  
  mask and identifying particles.  trackmask image is the sum of all masks generated, so  
  each pixel value will range from 0 to imgParam.frames(2).  It can be used as the base  
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  image for plotting the trajectories determined for the particles and was used to create  
  Figure 4-4. 
Trajectory 
- Structure created by the ExtractIntensity.m script and modified by both the  
  Analyze_Trajectories.m and the Compile_fit_parameters.m scripts. It contains  
  the following field names: 
 > ch1 or ch2: nframes x npart array containing the raw, integrated fluorescence  
   trajectories acquired from particle locations in either channel 1 or channel 2.  Pixels  
   used for signal integration are those lying within a circle centered at the particle having a  
   radius defined by the particle’s Gaussian width: imgParam.aroundPeak*w.  These  
   values are corrected for electronic offset, illumination profile and fluorescence  
   background.  The channel designated to contain fluorescence emission of the lower  
   wavelength is also corrected for inter-channel cross-talk/bleed-thru.  
  > readout: Structure containing meta-information about what the signals in channel 1 and  
  channel 2 are interpreted as.  Valid values are ‘Pore Formation’ or ‘Hemifusion’. 
  > signalType: Structure containing the type of signal present in channel 1 and channel  
  2.  Valid values are ‘dissipation’, ‘dequenching’, ‘dequench_dissipation’ or ‘no_analysis’. 
  > ch1analysis or ch2analysis: npart x 1 structure array where information about  
   trajectory selection and fitting results are saved for each particle (rows).  Contents vary  
   depending on input parameters and determined analysis type.  Data stored in the  
   following field names: 
   >> trajectory: nframes x 2 array containing the trajectory for the particle in  
    question. Column 1 is the trajectory after intensity normalization and Column 2 is the  
    result of Fourier filtering the raw trajectory. 
   >> deqch: Structure containing information about each dequenching peak that was fit  
    using the following field names: 
    >>> param: 3 x 4 array containing the fit parameter values (row 1) for each of the  
     four parameters (columns 1-4) in Equation 4-1.  Row 2 is the lower bound for  
     each parameter and Row 3 is the upper bound for each parameter. 
    >>> conf: Residuals from the dequenching model fit to the raw data are fitted with a  
     Normal distribution.  The R2 value calculated for this fit is calculated here.  It is  
     obsolete and not used when compiling kinetic results. 
    >>> R2val: R2 value resulting from the fit of the dequenching model to the raw data.   
     It is obsolete and not used when compiling kinetic results. 
    >>> fit: array containing the fitting domain used during MLE-based fit testing and  
     can be used for plotting the determined fit. Column 1 is the time, column 2 is the  
     fitted intensity values. 
    >>> initGuessFrame: column vector containing the frame number (column 1) used  
     to obtain the initial guesses for MLE-based fitting.  Column 2 and 3 are the lower  
     and upper estimates for the guess frame.  Column 4 is the signal-to-noise  
     measured at the initial guess point. 
    >>> rejectReason: character string explaining why the particular dequenching fit  
     was rejected.  See Section 3.4 for further details. 
    >>> slope: dequenching fit p4 parameter with lower and upper confidence bounds,  
     extracted from the param field. 
    >>> Delta: Test to ensure the fitted parameters correspond to dequenching.  Row 1  
     is p2 – p1, Row 2 is p2_lower_bound – p1_upper_bound,  
     Row 3 is p2_upper_bound – p1_lower_bound.  If Row 2 is negative, then the fit is  
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     determined to be not dequenching.  
    >>> SN: signal-to-noise for the fit, determined as Delta row 1 divided by noise. 
   >> dissip: Structure containing information about each intensity down-shot that was fit  
    as a dissipation signal using Equation 4-2.  Saved data is identical to the deqch field,  
    with the exception that the slope field is absent and these fields are defined: 
    >>> Diffusion: dissipation fit p4 parameter with lower and upper confidence  
     bounds, extracted from the param field. 
    >>> Delta: Test to ensure the fitted parameters correspond to signal dissipation.   
     Row 1 is p1 – p2, Row 2 is p1_lower_bound – p2_upper_bound,  
     Row 3 is p1_upper_bound – p2_lower_bound.  If p1_lower_bound is less than Delta Row 3, then  
     the fit is determined to be not dissipating. 
    >>> SN: signal-to-noise for the fit, determined as p2 divided by noise. 
   >> noise: Signal noise determined for the normalized data contained in column 1 of the  
    trajectory field.  Its value is set by getSignalNoise.m and results from a two- 
    step process.  A domain of the normalized data domain is selected starting with  
    imgParam.frames_id_particles(1) and ending with either: a) the first initial  
    guess point or b) 30 frames after the frames_id_particles(1) field, whichever  
    is larger.  This domain is fit to a straight line, which is subsequently subtracted from  
    the normalized intensity data to obtain the corresponding residuals.  These residuals  
    are binned and fit by a normal distribution.  The width of residuals’ distribution is set  
    as the signal noise for the particle.  A minimum of 30 frames are utilized to ensure a  
    minimum of 5 bins are available in the distribution. 
   >> reject: binary entry with 0 = not rejected, 1 = rejected particle. 
   >> rejectPartReason: Character string describing why the particle in question was  
    rejected.  See Section 3.4 for further details.  
TrajectoryAround 
- Intensity here is optionally recorded if imgParam.AnalyzeAround is set to ‘1’ or if the  
  background fluorescence correct method is set to ‘local.’   Otherwise it is an empty array. 
- Structure containing the integrated fluorescence intensity information from the doughnut  
  region immediately surrounding each virus particle.  The pixels used for integration are 
  those lying with in a doughnut ring circle centered at the particle and whose radii are  
  defined by the particle’s Gaussian width.  The inner radius is: imgParam.aroundPeak*w  
  and the outer radius is imgParam.outsidePeak*w.  
- Fluorescence data is saved in field names: ch1 or ch2, each being arrays of dimension  
  nframes x npart. 
- Data saved in this variable is used only in the scripts ExtractIntensity.m and  
  SignalIntensitySelection.m.  It is also corrected for inter-channel signal bleed-thru  
  from the shorter wavelength channel to the longer wavelength channel.  It is not  
  normalized. 
TrajectoryAroundOrig 
- This variable is the raw data saved in TrajectoryAround prior to correction of inter- 
  channel bleed thru. 
- Intensity here is optionally recorded if imgParam.AnalyzeAround is set to ‘1’ or if the  
  background fluorescence correct method is set to ‘local.’   Otherwise it is an empty array. 
TrajectoryOrig 
- This variable is the raw integrated fluorescence information saved in Trajectory prior to  
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  correction of inter-channel bleed thru and only contains fields ch1 and/or ch2.  No analysis  
  is performed using this variable. 
 
A3.4 Rejection reason explanations 
The Boolean decision function of Figure 4-2B describes the process of separating 
fluorescence trajectories showing behavior consistent with fusion from those trajectories that do 
not meet this criteria.  Selection of trajectories involves the rejection of the entire trajectory for a 
particle, or the rejection of some fits to portions of a trajectory and acceptance of others.  When 
a particle trajectory or a fit within a trajectory is rejected, the program reports a reason justifying 
the rejection.  These reasons are saved in the rejectPartReason field of Trajectory or in 
the rejectReason field of the deqch and dissip substructures of Trajectory, 
respectively, as described in section A3.3.  Included below are lists describing these reasons, 
the script within the program where rejection occurred and what parameter governs that 
rejection step.  When describing the script responsible for rejecting a trajectory or fit, the 
abbreviation AT is used for scripts called by Analyze_Trajectories.m.  Within AT are three 
main analysis scripts that call a number of the of analysis subroutines responsible for trajectory 
fitting and rejection: analyze_deq_dissip.m, analyze_deq.m and analyze_dissip.m.  
These three trajectories look for dequenching and dissipation, or dequenching or dissipation 
only, respectively.  If a script is not overtly included in AT, it will be included in one of these 
three scripts.   
 
A3.4.1 List of reasons why a particle’s entire trajectory can be rejected: 
“Dissip b/4 Deqch” 
- Originating script: Compile_fit_parameters.m 
- Relevant Parameters: 
  Not under direct parameter control.  Given the model of fusion that is presumed to  
  occur, namely that hemifusion precedes full fusion (pore formation), it is not allowed  
  that a dissipation signal precedes a dequenching event within a single trajectory in a  
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  single channel.  It is allowed for a dissipation event in one channel to precede a  
  dequenching/dissipation event in the second channel. 
”Fitted up/down-shots rejected” 
- Originating script (AT): analyze_deq_dissip.m, analyze_deq.m or  
  analyze_dissip.m 
- Relevant Parameters: 
  Not under direct parameter control.  This message indicates that all MLE-based fittings  
  of possible event points were rejected.  See rejectReason under the deqch and  
  dissip fields in Trajectory for the particles in question. 
 “found no up/down-shots” 
- Originating script (AT): getIncDecIdx.m 
- Relevant Parameters:  
  1) anParam.ch1/2.mtfc – larger values raise the threshold that the rate of intensity  
  change must surpass if a point in a trajectory is to be considered a possible intensity  
  up- or down-shot.  See Figure 4-5 for reference of how these events points are  
  detected by the sliding window filters. 
  2) anParam.alphaval – a t-test is performed on the distribution of intensities  
  immediately before and after a possible intensity up- or down-shot to test for statistical  
  significance of the difference between them.  If the null hypothesis is rejected with a p- 
  value less than anParam.alphaval, then the event point is rejected and not used for  
  MLE-based fitting.  During testing, it was found that more spurious event points were  
  rejected at this point of the decision function if the value of alphaval was used  
  instead  
  of the pthresh value, which is typically lower.   
  > Future expansion suggestion: include an additional parameter to define this  
   threshold separately from alphaval. 
  3) anParam.ch1/2.winfilt_st – if too large a value is set as the first sliding  
  window filter size, then short-lived events may be washed out. 
 “Lims Dqchw” or “Lims D2D” or “Lims Dqchw Lims D2D” 
- Originating script: Compile_fit_parameters.m 
- Relevant Parameters:  
  anParam.ch1/2.ndeqfr/ndissipfr/deqlim/dissiplim – These parameters  
  set permitted values for the p4 parameter of Equations 4-1 or 4-2, whichever is relevant  
  for the type of signal being fit.  See description of these parameters in Section A3.2 for  
  more information. 
 “Multiple good fits” 
- Originating script: Compile_fit_parameters.m 
- Relevant Parameters: 
  Not under direct parameter control.  Only a single dequenching event and a single  
  dissipation event is permitted per trajectory.  If more than one type of event is detected,  
  then all fits of that event type are rejected.  If more than one dequenching and more  
  than one dissipation events are detected, then the trajectory itself is rejected.   
 “non-Gaussian signal noise” 
- Originating script (AT): getSignalNoise.m 
- Relevant Parameters: 
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  anParam.pthresh – as described in the definition of this parameter value and the  
  description of the Trajectory.ch1/2analysis.noise output, a portion of the  
  normalized trajectory data up to the first possible event frame is taken, fit with a line  
  and the residuals of the linear fit modeled by a Normal distribution.  If a t-test performed  
  on the residuals from the Normal distribution modeling rejects the null hypothesis with a  
  p-value lower than 1-anParam.pthresh, then the particle trajectory is rejected. 
 “Poor Dqch & Dssp S/N” 
- Originating script: Compile_fit_parameters.m 
- Relevant Parameters: 
  anParam.ch1/2.SNthresh – This parameter describes the signal-to-noise limit that  
  must be surpassed by the fit parameters obtained from MLE-based fits of Equations 4- 
  1 or 4-2.  Larger thresholds will exclude more fits.  See the SN field of the  
  Trajectory.ch1/2analysis.deqch/dissip variable for details on SN  
  calculation. If all fits for a trajectory are rejected due to poor S/N, then the particle’s  
  whole trajectory will be rejected with this output as evidence. 
“weak/noisy signal” 
- Originating script (AT): SignalIntensitySelection.m 
- Relevant Parameters:  
  anParam.SNsite  – larger values reject more particles.  NOTE: this input value plays  
  a role prior to MLE-based dequenching and dissipation fitting.  As such, altering its  
  value will require additional trajectory analysis by the Analyze_Trajectories.m  
  script. 
 
A3.4.2 List of reasons why a particular dequenching or dissipation fit within a trajectory can be 
rejected: 
“All Deq slope outside limits” or “All D_{2D} outside limits” or  
“Deq duration outside limits” or “D_2D const outside limits” 
- Originating script: Compile_fit_parameters.m 
- Relevant Parameters:  
  anParam.ch1/2.ndeqfr/ndissipfr/deqlim/dissiplim – These parameters  
  set permitted values for the p4 parameter of Equations 4-1 or 4-2, whichever is relevant  
  for the type of signal being fit.  See description of these parameters in Section A3.2 for  
  more information. 
 “Bad deqch params: p2<p1” or “Bad dissip params” 
- Originating script (AT): analyze_deq_dissip.m, analyze_deq.m or  
  analyze_dissip.m 
- Relevant Parameters: 
  Not under direct parameter control.  The fit parameters p1 and p2 are tested to ensure  
  that dequenching events correspond to signal increases and dissipation events to  
  signal decreases.  See the description of the Delta field saved under the variable  
  Trajectory.ch1/2analysis.deqch/dissip for more information. 
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“Failed 1st round Likelihood test – no acceptable fitting range” 
- Originating script: findDequench.m or findDissipation.m 
- Relevant Parameters:  
  anParam.alphaval – this parameter value establishes the CS,1-value that a QS  
  value must surpass if a fit is to be accepted.  This first round only looks at the maximal  
  QS value found, the second round looks at the start/end fitting frame corresponding to  
  maximal QS value relative to the fit R
2 value.   
“Failed 2nd round Likelihood test – no useful Jacobian identified” 
- Originating script: findDequench.m or findDissipation.m  
- Relevant Parameters: 
  Not under direct parameter control.  This rejection reason arises because the Jacobian  
  matrix used for parameter determination during least squares fitting was not properly  
  defined and confidence intervals for the resulting parameters cannot be determined. 
“Failed 2nd round Likelihood test – Z-statistic too small” 
- Originating script: findDequench.m or findDissipation.m 
- Relevant Parameters: 
  Not under direct parameter control.  The first round MLE-based fitting resulted in a  
  maximal QS (or Z) test statistic that was not near the maximal R
2 value.  In the second  
  round of testing, the maximal QS obtained near the average frame taken between  
  maximum QS and maximum R
2 failed to be larger than the CS,1-value (Figure 4-6). 
“Failed 2nd round Likelihood test - max(R^2) not near max(LogLikelihood_val)” 
- Originating script: findDequench.m or findDissipation.m 
- Relevant Parameters: 
  Not under direct parameter control.  The first round MLE-based fitting resulted in a  
  maximal QS (or Z) test statistic that was not near the maximal R
2 value.  In the second  
  round of testing, the maximal QS obtained near the average frame taken between  
  maximum QS and maximum R
2 failed to be larger than the CS,1-value (Figure 4-6). 
“Failed to have Normally distributed fit residuals” 
- Originating script: findDequench.m or findDissipation.m 
- Relevant Parameters:  
  anParam.alphaval – a t-test is performed on the residuals resulting from fitting  
  dequenching or dissipation Equations 4-1 or 4-2 to the normalized intensity data.  If t- 
  test rejects the null hypothesis with a p-value less than 1-anParam.alphaval, then  
  the fit is rejected. 
  > Future expansion suggestion: include an additional parameter to define this  
   threshold separately from alphaval. 
  “Multiple good fits” 
- Originating script: Compile_fit_parameters.m 
- Relevant Parameters:  
  Not under direct parameter control.  Only a single dequenching event and a single  
  dissipation event is permitted per trajectory.  If more than one type of event is detected,  
  then all fits of that event type are rejected.  A particle having a single dequenching  
  event and multiple dissipation events will not be rejected, and vice versa.   
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 “No Dequenching Signal” or “No Dissipation Signal” 
- Originating script: Compile_fit_parameters.m 
- Relevant Parameters: 
  1) anParam.ch1/2.SNthresh – This output is saved to the rejectDeqReason or  
  rejectDissipReason fields when the signal-to-noise threshold of a fit is not  
  surpassed.  Larger threshold values will reject more fits. 
  2) imgParam.winfilt_st – Setting this parameter value too high when searching  
  for initial guess points can wash out short-lived signals, such as dequenching. 
  3) imgParam.frames_id_particles – this is a problem for missing rapid fusion  
  events if the first value of this two-element array is set too far from the pH drop.  If  
  fusion events occur between pHdrop and imgParam.frames_id_particles(1)  
  then they will likely be skipped over because there is not enough signal in the data  
  between imgParam.frames_id_particles(1)  and the event point for detection of  
  a statistical difference in intensity before and after the event point. 
 “Poor deqch fit S/N” or “Poor dissip fit S/N”  
- Originating script: Compile_fit_parameters.m 
- Relevant Parameters: 
  anParam.ch1/2.SNthresh – This parameter describes the signal-to-noise limit that  
  must be surpassed by the fit parameters obtained from MLE-based fits of Equations 4- 
  1 or 4-2.  Larger thresholds will exclude more fits.  See the SN field of the  
  Trajectory.ch1/2analysis.deqch/dissip variable for details on SN  
  calculation. 
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Appendix 4 – Supplementary information for Chapter 5 
 
This appendix contains the following supplementary information: 
A4.1 Supplementary figures 
A4.2 Supplementary movie description 
A4.3 Supplementary tables 
 
A4.1 Supplementary figures 
 
 
 
 
 
 
 
 
 
 
 
  
Figure A4-1 – Correlation between lipid 2D diffusion constant and the time to lipid 
dissipation. Values for TLP and Lipid D2D reported in Figure 5-3A and Figure 5-3B, 
respectively, are plotted against each other here to visualize the correlation between these 
values for pH 5.0, 4.5 and 3.5. Correlation r values are indicated in the figure and show a 
weak correlation between TLP and Lipid D2D for fusion induced at pH 5.3, with significant 
correlation at lower pH values. Data points are median values ± interquartile range, as in 
Figure 5-3. 
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Figure A4-2 – Correspondence of kinetics 
for particles showing two fusion events 
with the population of all viruses. A) The 
lipid dequenching kinetics for double event 
particles, which show lipid dequenching 
along with lipid dissipation and/or content 
dissipation, agree well with the lipid 
dequenching kinetics for all particles 
analyzed. B) The lipid dissipation kinetics 
for double event particles, which show 
lipid dissipation along with lipid 
dequenching and/or content dissipation, 
agree well with the lipid dissipation 
kinetics for all particles analyzed. C) The 
content dissipation kinetics for double 
event particles, which show content 
dissipation along with lipid dequenching 
and/or lipid dissipation, agree well with the 
content dissipation kinetics for all particles 
analyzed. 
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A4.2 Supplementary movie description 
 
Movie M4-1 – Dual colored influenza virus fusing to a dextran-supported planar bilayer at pH 
3.5 that shows content release before exit from a restricted hemifusion state. The fluorescence 
trajectory from this particle is shown in Figure 5-1D of Chapter 5. Content SRB label is false-
colored magenta, lipid label Rh110 is false-colored green, co-localization between the channels 
is shown in white. The same field of view is shown in triplicate with the red and green emission 
channels merged (left), the red content channel alone (middle), and the green lipid channel 
alone (right). In this instance, the content release occurs very shortly after the lipid dequenching 
signal. The increase in fluorescence intensity persists for several seconds before giving way to 
a lipid dissipation signal. Scale bar is 1 m. 
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A4.3 Supplementary table 
 
Table A4-1 – Number of events visualized* 
 
Number 
TLQ 
Number 
TLP 
Number 
TCP 
Number  
TLQ & TLP 
(confinement 
lifetime) 
Number 
TLQ & TCP 
(hemifusion 
lifetime) 
Number 
TLP & TCP 
(inter-
dissipation 
time) 
Total 
viruses 
visualized 
pH 3.5        
diC18:1  301  272  253  48  76  24  1403 
diC18:3  201  811  236  100  44  46  1805 
diC22:1  427  238  398  65  169  30  1701 
diC22:6  97  1075  346  56  43  164  1660 
pH 4.5        
diC18:1  356  364  197  85  32  26  1238 
diC18:3  231  1212  163  140  32  61  1818 
diC22:1  571  299  282  93  94  50  1654 
diC22:6  105  1052  234  63  34  154  1333 
pH 5.0        
diC18:1  591  715  132  212  37  31  1562 
diC18:3  300  1182  186  185  29  62  1930 
diC22:1  582  322  180  137  68  37  1330 
diC22:6  128  1219  248  82  30  151  1673 
pH 5.3        
diC18:1  442  297  136  105  41  19  1095 
diC18:3  123  929  120  64  19  44  1717 
diC22:1  207  477  225  81  54  66  1284 
diC22:6  87  504  111  37  21  64  904 
* Values reported in Chapter 5 Figure 5-3C and Figure 5-3F are the mean values across all 
experiments, not the fraction of total numbers reported here. 
